Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADIPOQ,Adiponectin,38013,-0.24798309564903,0.00605319385326478,-0.259847355601429,-0.236118835696631,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRP,Agouti-related protein,40516,0.263207100492701,0.0047108929969864,0.253973750218608,0.272440450766794,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN1,CCN family member 1,40280,0.357586993430729,0.00694830308510211,0.343968319383928,0.371205667477529,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES1,Liver carboxylesterase 1,40352,0.27702417873488,0.00700047388926843,0.263303249911914,0.290745107557846,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,F7,Coagulation factor VII,40376,0.110521716921807,0.00274715192099513,0.105137299156656,0.115906134686957,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,FURIN,Furin,40411,0.128085842890644,0.00308253890594947,0.122044066634983,0.134127619146305,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCG,Pro-glucagon,39980,0.473993382016687,0.0113977457246399,0.451653800396392,0.496332963636981,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHR,Growth hormone receptor,37671,0.105577957025575,0.00263122614341898,0.100420753784474,0.110735160266677,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,0.279365250691973,0.0068757101128541,0.265888858870779,0.292841642513167,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBC,Inhibin beta C chain,40332,0.159569680074562,0.00390451319110255,0.151916834220001,0.167222525929123,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,0.0869915821577334,0.00201035885301873,0.0830512788058167,0.0909318855096501,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLR,Low-density lipoprotein receptor,40356,0.398318531030165,0.00393636419344552,0.390603257211012,0.406033804849318,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPL,Lipoprotein lipase,40359,-0.181732910074688,0.00417647638452943,-0.189918803788365,-0.17354701636101,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFGE8,Lactadherin,40332,0.214899721554264,0.00369123995387885,0.207664891244662,0.222134551863867,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPY,Pro-neuropeptide Y,40489,0.351780380159598,0.00579524683405074,0.340421696364859,0.363139063954338,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAP1,Proline-rich acidic protein 1,37998,0.154477049229405,0.00386912742773866,0.146893559471038,0.162060538987773,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,40424,0.169189163478431,0.00423301654017585,0.160892451059687,0.177485875897176,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40489,0.122172921961664,0.00302980297868286,0.116234508123446,0.128111335799882,0
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF9,Protein turtle homolog A,37990,0.282406498683615,0.00728976223904834,0.26811856469508,0.29669443267215,1.11347413697632e-308
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.110072447744441,0.00289853822456076,0.104391312824302,0.11575358266458,4.01002521075853e-302
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A5,Zinc transporter ZIP5,40341,0.186128451821921,0.00494275074258817,0.176440660366448,0.195816243277394,2.48447917094855e-297
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP1,Neuropilin-1,40424,-0.0970814868476421,0.00260188776527256,-0.102181186867576,-0.0919817868277079,3.13342197751348e-292
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,0.141758753866939,0.00389574992758407,0.134123084008875,0.149394423725004,1.40330321424177e-278
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROC,Vitamin K-dependent protein C,40372,0.0844822540553726,0.00233676512683459,0.0799021944067768,0.0890623137039684,3.83057283004705e-275
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG2,Desmoglein-2,40332,-0.0901413033884522,0.00249648660111387,-0.0950344171266354,-0.085248189650269,1.90852759502459e-274
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPM,Carboxypeptidase M,40415,0.113439630424588,0.00317671854384723,0.107213262078648,0.119665998770529,9.27708018707236e-269
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS15,Enteropeptidase,40305,0.303209618833935,0.00852664183662124,0.286497400834158,0.319921836833713,1.51169174586893e-266
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH,Parathyroid hormone,37572,0.258356114223503,0.00727217853915104,0.244102644286767,0.272609584160239,4.94521179315141e-264
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL27,C-C motif chemokine 27,40359,0.192264583182765,0.00552229853220437,0.181440878059645,0.203088288305886,5.08274730900986e-256
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTR,Transthyretin,37871,0.0820893014331523,0.00236197254776575,0.0774598352395314,0.0867187676267732,1.70813823463529e-253
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.32681496553994,0.00958372618083592,0.308030862225501,0.345599068854378,4.8612781518947e-246
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL23,C-C motif chemokine 23,40422,0.129136067407316,0.00381473212250321,0.12165919244721,0.136612942367423,1.17218086485402e-242
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39980,0.251495462447745,0.00748136839248153,0.236831980398481,0.266158944497009,3.31805534855264e-239
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40500,-0.366392893380077,0.0109275490981745,-0.387810889612499,-0.344974897147655,2.76896442320686e-238
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,40305,0.273048214322231,0.00816678409903265,0.257041317488127,0.289055111156335,6.81941565241542e-237
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,0.245583120128346,0.00735924825186305,0.231158993554694,0.260007246701998,4.92707546340053e-236
NMR metabolomics,X23501.Triglycerides in Large VLDL,APCS,Serum amyloid P-component,37882,0.109963526461898,0.00333272164758679,0.103431392032628,0.116495660891168,1.23096182119692e-229
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR37,Prosaposin receptor GPR37,40042,0.205723885025877,0.00626233952221166,0.193449699562343,0.217998070489412,6.49141795488299e-229
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,0.320233028185864,0.00976365154345556,0.301096271160692,0.339369785211037,2.45502441357792e-228
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LG,CMRF35-like molecule 9,40332,-0.114530549595871,0.00351781348598002,-0.121425464028392,-0.107635635163351,3.87068561153989e-225
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD4,T-cell surface glycoprotein CD4,40309,0.0919057523422298,0.00284910318652187,0.086321510096647,0.0974899945878127,3.59416571008927e-221
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN3,Contactin-3,40332,0.104446202723524,0.00326640410202164,0.0980440506835617,0.110848354763487,1.74283191526173e-217
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,40141,0.434614309334495,0.0138166152363131,0.407533743471322,0.461694875197669,1.14490641231983e-210
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF1,Pigment epithelium-derived factor,37790,0.0758106458349319,0.00241444990426309,0.0710783240225762,0.0805429676472875,7.61069654417676e-209
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL6,C-X-C motif chemokine 6,40516,0.22678219440981,0.00727281259040767,0.212527481732611,0.241036907087009,2.6613490657937e-207
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFI,Complement factor I,38013,0.0583923664036274,0.00187430842198022,0.0547187218965461,0.0620660109107086,7.33428380961543e-206
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPIND1,Heparin cofactor 2,37981,0.0788716952671495,0.00255281530970275,0.0738681772601321,0.0838752132741669,1.35493946379031e-202
NMR metabolomics,X23501.Triglycerides in Large VLDL,F9,Coagulation factor IX,40372,0.0517679216587336,0.00168130270615572,0.0484725683546684,0.0550632749627988,2.86209497672173e-202
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA5,Plasma serine protease inhibitor,37835,0.0940898660364753,0.00307235798735723,0.0880680443812551,0.100111687691695,3.92376240018e-199
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCHE,Cholinesterase,37748,0.0805229987599671,0.00263837096656218,0.0753517916655053,0.085694205854429,8.6365303690887e-198
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,0.23944222440276,0.00788154780488475,0.223994390705186,0.254890058100334,5.28982866847554e-197
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR1,Asialoglycoprotein receptor 1,40228,0.0833226973891578,0.00274678060347953,0.077939007406338,0.0887063873719777,1.67866921734317e-196
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.16998853157742,0.00560763814357756,-0.180979502338832,-0.158997560816008,3.05961557474643e-196
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40497,-0.180049717243923,0.00595522775504423,-0.19172196364381,-0.168377470844037,2.45104073205637e-195
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI,Tissue factor pathway inhibitor,40309,0.0880505834150106,0.00291638981392021,0.0823344593797269,0.0937667074502942,9.47436936743463e-195
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,40443,0.0870614943886738,0.00289145893184297,0.0813942348822616,0.0927287538950861,8.83528901685025e-194
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAMR1,Inactive serine protease PAMR1,40332,0.0788229216009089,0.00261843737110548,0.0736907843535422,0.0839550588482757,1.16761204034364e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFH,Complement factor H,37301,0.0650398970538182,0.0021577317015723,0.0608107429187364,0.0692690511888999,6.36855239933096e-193
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHBG,Sex hormone-binding globulin,37987,-0.151620678780149,0.00504054187544052,-0.161500140856013,-0.141741216704286,1.7642483342195e-192
NMR metabolomics,X23501.Triglycerides in Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,0.189131513331586,0.0063222181998067,0.176739965659965,0.201523061003207,2.47235263804153e-191
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR3,Anterior gradient protein 3,39963,0.165577256691268,0.00558209060533689,0.154636359104808,0.176518154277728,4.04440817201366e-188
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,0.150976003210056,0.00511104387896492,0.140958357207285,0.160993649212828,1.20441850329872e-186
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFM,Afamin,38013,0.0511578575359517,0.00174591241873096,0.047735869195239,0.0545798458766644,4.72134861565859e-183
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUSB,Beta-glucuronidase,40419,0.160358548663334,0.0054882474758631,0.149601583610643,0.171115513716026,7.07472270328028e-183
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFP,Properdin,38013,0.0598929762073816,0.00204770363737487,0.0558794770781268,0.0639064753366363,2.01575695203102e-182
NMR metabolomics,X23501.Triglycerides in Large VLDL,MXRA8,Matrix remodeling-associated protein 8,37671,-0.0835725658329385,0.00285626430248238,-0.0891708438658039,-0.077974287800073,2.08135074349788e-182
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA4,Kallistatin,37781,0.0655073767024315,0.0022442098692853,0.0611087253586324,0.0699060280462307,1.27977957556414e-181
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA1,Glutathione S-transferase A1,40333,0.225502455256038,0.00776160442619823,0.210289710580689,0.240715199931386,7.2176264694158e-181
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40536,-0.0941149957765049,0.00325040957225407,-0.100485798538123,-0.087744193014887,9.65259651622155e-180
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,0.0942369797650647,0.00326206741279719,0.0878433276359822,0.100630631894147,6.13052807637846e-179
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIP2,Cysteine-rich protein 2,40228,0.0978859943872501,0.00339289716887089,0.0912359159362632,0.104536072838237,2.08492983820971e-178
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,0.158797091474928,0.00550375834456199,0.148009725119586,0.169584457830269,2.31184338811902e-178
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTA3,Glutathione S-transferase A3,39980,0.204824853566042,0.00710753872150916,0.190894077671884,0.2187556294602,5.95191938657843e-178
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,0.140716952638822,0.00490395089921443,0.131105208876362,0.150328696401283,1.26792392091007e-176
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,0.0510729719560571,0.00178205542188794,0.0475801433291567,0.0545658005829574,3.64516494475119e-176
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLTP,Phospholipid transfer protein,40461,-0.0920675171048957,0.00321560245156046,-0.0983700979099542,-0.0857649362998372,7.1441607479276e-176
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9,Complement component C9,37987,-0.129444764468006,0.00456716657262683,-0.138396410950355,-0.120493117985658,1.01920401769194e-171
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAT,Tissue-type plasminogen activator,40490,0.130340997256896,0.00461009176588751,0.121305217395757,0.139376777118036,1.17144470243209e-171
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP6,Charged multivesicular body protein 6,37990,0.147733401149267,0.00522962678941109,0.137483332642021,0.157983469656513,1.2282202483365e-170
NMR metabolomics,X23501.Triglycerides in Large VLDL,F10,Coagulation factor X,37987,0.0684576749527526,0.00243441064655462,0.0636862300855055,0.0732291198199996,3.78154672282607e-169
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPB1,Beta-ureidopropionase,37990,0.240420118019079,0.00857246415118033,0.223618088282765,0.257222147755392,2.78351458464302e-168
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY1,Aminoacylase-1,40359,0.156201791572174,0.00559340449379242,0.145238718764341,0.167164864380007,1.38200788529638e-167
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA1,Ephrin type-A receptor 1,40400,0.0897055153137883,0.00321238273009256,0.0834092451628068,0.0960017854647697,1.3925581693459e-167
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,0.0482487479857437,0.00174078163197695,0.0448368159870688,0.0516606799844185,4.69501848707801e-165
NMR metabolomics,X23501.Triglycerides in Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,0.192389456804318,0.0069602133888467,0.178747438562179,0.206031475046458,2.83642285804958e-164
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF21,Fibroblast growth factor 21,40453,0.304538728664528,0.0110313802795193,0.28291722331667,0.326160234012386,6.27767791790514e-164
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON3,Serum paraoxonase/lactonase 3,40422,-0.0706817430215576,0.00258083821526135,-0.0757401859234698,-0.0656233001196453,2.04429974627715e-161
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLA,Alpha-galactosidase A,37642,0.0929224675679619,0.00340237758162887,0.0862538075079693,0.0995911276279545,8.36346629352992e-160
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAPIN,SNARE-associated protein Snapin,37959,0.14713047689249,0.00539473329270773,0.136556799638783,0.157704154146197,1.77917912850533e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBP,Protein AMBP,40470,0.0512680007878598,0.00188722260624816,0.0475690444796135,0.0549669570961062,6.42723402831889e-159
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,39980,0.277701611400434,0.0102379900159208,0.257635150969229,0.297768071831639,2.41280857081477e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,40192,0.187186764449107,0.00690615728179551,0.173650696176788,0.200722832721427,3.65638774351426e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,40280,0.0653161068144949,0.00241105437745016,0.0605904402346926,0.0700417733942972,5.03375844945449e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRP,Gastrin-releasing peptide,37628,0.139029540273727,0.0051224531551486,0.128989532089636,0.149069548457818,6.77155167258189e-158
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP5,Retinol-binding protein 5,40305,0.140869814900001,0.0052070522098184,0.130663992568757,0.151075637231245,1.28333994460839e-157
NMR metabolomics,X23501.Triglycerides in Large VLDL,P4HB,Protein disulfide-isomerase,40266,0.0976363375112712,0.0036448879805236,0.090492357069445,0.104780317953097,1.25824503725883e-154
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,40313,0.138683439184595,0.00519554326637591,0.128500174382498,0.148866703986692,1.38238404661983e-153
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF8,Immunoglobulin superfamily member 8,40359,0.0747763968577273,0.00281654150906389,0.0692559754999621,0.0802968182154925,5.30262897524009e-152
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A1,Collagen alpha-1(IV) chain,40359,-0.0989326746856291,0.00373620273929392,-0.106255632054645,-0.091609717316613,3.10780133445232e-151
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM20A,Pseudokinase FAM20A,37990,0.0704844265103634,0.00266307778822672,0.0652647940454391,0.0757040589752878,1.51043968086991e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO3,Beta-enolase,37628,0.141326927679822,0.0053503433074381,0.130840254797244,0.151813600562401,7.1807474146211e-150
NMR metabolomics,X23501.Triglycerides in Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,37598,0.209607459538877,0.0079393679570027,0.194046298343152,0.225168620734603,1.02866512098301e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37900,0.168546007844973,0.00639496706415696,0.156011872399225,0.18108014329072,2.62166242580095e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR5,Cadherin-related family member 5,40359,0.0965389090647386,0.00367152486055075,0.0893427203380591,0.103735097791418,3.40538498258134e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAB2,Stabilin-2,37998,0.0693859707007419,0.0026342637104541,0.0642228138282519,0.074549127573232,3.70855073824643e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL16,C-C motif chemokine 16,40536,0.13119262896956,0.00499109902762037,0.121410074875424,0.140975183063696,3.91572683544545e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS3,"Nitric oxide synthase, endothelial",39961,0.135711857903363,0.00516260843722871,0.125593145366395,0.145830570440331,4.81447300469175e-149
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP4,Metalloproteinase inhibitor 4,40332,-0.100489139347252,0.00383671875719972,-0.108009108111363,-0.0929691705831403,4.56025971648329e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUMB,Protein numb homolog,37598,0.206094221268684,0.00785681332820281,0.190694867145407,0.221493575391962,7.20985913858495e-148
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKB,Creatine kinase B-type,37998,-0.149197792441134,0.00571089919130682,-0.160391154856095,-0.138004430026172,7.94914052033442e-147
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR2,Fibroblast growth factor receptor 2,40411,0.0523268881998565,0.00201896763966604,0.0483697116261111,0.056284064773602,4.16659551721889e-145
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYNU,Kynureninase,40516,0.108790379973802,0.00421127801478241,0.100536275064829,0.117044484882776,3.26681897573184e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS1,Protein MTSS 1,37901,0.269995349319288,0.010440349690038,0.249532263926814,0.290458434711763,5.90303538528536e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCA,Alpha-synuclein,37671,0.277593044922667,0.0107348630973721,0.256552713251817,0.298633376593516,7.05823116778166e-144
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,0.163482183923523,0.00636077238579283,0.151015070047369,0.175949297799677,1.06133517310218e-142
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT2,Linker for activation of T-cells family member 2,40305,0.295226454903101,0.0115325423520118,0.272622671893157,0.317830237913044,1.15146664409135e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37920,0.201424852586838,0.00785715584185158,0.186024827136809,0.216824878036867,1.46861205978469e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,0.337042154711164,0.0131632676109255,0.31124215019375,0.362842159228578,3.1766732363014e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLKB1,Plasma kallikrein,37721,0.0608039508783198,0.00237459223621619,0.056149750095336,0.0654581516613035,3.40677134477483e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROS1,Vitamin K-dependent protein S,38013,0.060590109912043,0.00236767387029333,0.055949469126268,0.0652307506978179,4.22314949927411e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11R,Junctional adhesion molecule A,40332,0.13623424100983,0.00533824664052712,0.125771277594397,0.146697204425263,7.94766814035332e-141
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,0.109714748450748,0.00434341034469238,0.101201664175151,0.118227832726346,4.92583768497782e-138
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB1,BPI fold-containing family B member 1,40261,-0.146744651385282,0.00582206182640426,-0.158155892565035,-0.13533341020553,1.80678526328287e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,40341,0.0657511739576506,0.00261436940233732,0.0606270099290695,0.0708753379862318,6.65226886451922e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA80,N-alpha-acetyltransferase 80,37572,0.282375801593378,0.0112109171912219,0.260402403898583,0.304349199288173,9.46627619219692e-137
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.0643077172106945,0.00257061966528569,0.0592693026667346,0.0693461317546545,1.63706485020571e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,0.098015589519072,0.00391976954681363,0.0903328412073173,0.105698337830827,2.21147419858186e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCS1,Neuronal calcium sensor 1,40489,0.06750657568954,0.00270286832494687,0.0622089537726442,0.0728041976064359,4.21243081111856e-135
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL17,C-X-C motif chemokine 17,40516,0.0975975294163115,0.00391567637004697,0.0899228037310195,0.105272255101604,1.42571249897495e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP29,Synaptosomal-associated protein 29,40411,0.214551094774415,0.00862052514565333,0.197654865488934,0.231447324059896,3.54973377125715e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS8,Prostasin,40293,0.0950077858173858,0.00381829317114589,0.0875239312019398,0.102491640432832,4.29197646170872e-134
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYAP1,Synapse-associated protein 1,37671,0.132404305720996,0.00533755913745504,0.121942689811584,0.142865921630407,8.18074364469326e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,-0.0878598551779862,0.00354978192067497,-0.0948174277425092,-0.0809022826134633,9.59559544643122e-133
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDR,Vascular endothelial growth factor receptor 2,40411,0.059032019814909,0.00238990071957336,0.0543478144045452,0.0637162252252728,3.16554022192622e-132
NMR metabolomics,X23501.Triglycerides in Large VLDL,EEF1D,Elongation factor 1-delta,37990,0.213269709244042,0.00865299477273875,0.196309839489474,0.23022957899861,3.03544203484607e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINF2,Alpha-2-antiplasmin,37755,0.0315720506754212,0.0012817824924961,0.0290597569901289,0.0340843443607136,4.91100808732661e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRN,"Attractin, Isoform 2",38013,0.0380339051049084,0.00154572416589892,0.0350042857397465,0.0410635244700703,7.91290521799867e-131
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLUL1,Clusterin-like protein 1,40338,-0.105603816547463,0.00430290949536262,-0.114037519158374,-0.0971701139365521,1.39196329370138e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,0.132795693621492,0.00540978485401825,0.122192515307616,0.143398871935368,3.78551343823549e-130
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTYMK,Thymidylate kinase,37990,0.16012028502169,0.00654303229381158,0.14729594172582,0.172944628317561,1.87323479314447e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,0.128761706396567,0.00527657204182104,0.118419625194598,0.139103787598536,4.19209115186205e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL16,Pro-interleukin-16,40516,0.0932007486403582,0.0038204334593594,0.0857126990600137,0.100688798220703,4.23435797116966e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,0.204930690739279,0.00840472595063371,0.188457427876037,0.221403953602521,6.3160899093077e-129
NMR metabolomics,X23501.Triglycerides in Large VLDL,YES1,Tyrosine-protein kinase Yes,40305,0.261007677670797,0.0107256253392667,0.239985452005834,0.282029903335759,1.87950783869662e-128
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABL1,Tyrosine-protein kinase ABL1,40305,0.155771756875242,0.00642230607938868,0.14318403695964,0.168359476790844,1.23265463518593e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH9,Myosin-9,37998,0.257915678799087,0.010620804978136,0.23709890104194,0.278732456556234,1.51227190827871e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,FYB1,FYN-binding protein 1,40311,0.209600607900804,0.00864687146163039,0.192652739836008,0.226548475965599,1.73783777262453e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,0.156249629170231,0.00643632669973156,0.143634428838757,0.168864829501705,2.21918364138599e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLN,Promotilin,40341,0.203243312811118,0.00839847515370078,0.186782301509865,0.219704324112372,4.38994908804948e-127
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL22,C-C motif chemokine 22,40204,0.116840360103019,0.00487066642194959,0.107293853915997,0.12638686629004,6.30309046742618e-125
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37900,0.180749898425765,0.00753935901370436,0.165972754758905,0.195527042092626,2.07126849541415e-124
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18R1,Interleukin-18 receptor 1,40516,0.0735695898561885,0.00308404872829649,0.0675248543487274,0.0796143253636496,1.2611133339123e-123
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR2,Cadherin-related family member 2,40305,0.172635051544278,0.00727016420182762,0.158385529708696,0.18688457337986,1.66036031341349e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,0.0879506083200468,0.00370484895948208,0.0806891043594619,0.0952121122806316,1.79371794835256e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,0.0471145085420649,0.00198663943584275,0.0432206952478131,0.0510083218363167,3.12914064534806e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCLY,Selenocysteine lyase,40434,0.106988257521252,0.00451877133922268,0.0981314656963758,0.115845049346129,7.83061058500932e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN2,Ficolin-2,40291,0.0919299129485081,0.00388344618676039,0.0843183584224578,0.0995414674745585,8.98632250347417e-122
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOMO1,Nodal modulator 1,40332,0.0530461205541064,0.00224251810425342,0.0486507850697697,0.0574414560384431,1.32639134199732e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORT1,Sortilin,40330,0.0812272091132793,0.00343792905677877,0.0744888681619929,0.0879655500645656,2.51425720070666e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOST,Sclerostin,40330,0.0863492889207499,0.00365916429327084,0.0791773269059391,0.0935212509355608,4.84383558876236e-121
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4R,Reticulon-4 receptor,40489,0.0754973572723351,0.00321038890180206,0.0692049950248031,0.0817897195198671,2.96849506556385e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,0.211884033481584,0.00902230277856002,0.194200320035606,0.229567746927561,6.43052514715449e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTBS,Di-N-acetylchitobiase,37819,0.0602763245629998,0.00256330508484679,0.0552522465967,0.0653004025292995,7.62463232694575e-120
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJAP1,Tight junction-associated protein 1,40411,0.183420404536561,0.00781920091473806,0.168094770743674,0.198746038329447,1.15843212011981e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREG1,Protein CREG1,40145,0.0800683344194319,0.00341684259621205,0.0733713229308563,0.0867653459080075,2.17012712231922e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPY30,Protein dpy-30 homolog,40414,0.131863012872866,0.00563561361977099,0.120817210178115,0.142908815567618,4.46784017639568e-119
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,0.187141780378685,0.00799742399176667,0.171466829354822,0.202816731402547,1.0998536909097e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37900,0.112891076675373,0.00484100903560585,0.103402698965586,0.12237945438516,6.02886396704298e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL2,Angiopoietin-related protein 2,40377,0.0879311460720197,0.00377823534872267,0.0805258047885233,0.0953364873555161,7.63328038321938e-118
NMR metabolomics,X23501.Triglycerides in Large VLDL,SARG,Specifically androgen-regulated gene protein,37931,0.239219121587197,0.0102840491716949,0.219062385210675,0.259375857963719,2.21551398006334e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXLNA,Alpha-taxilin,40228,0.195813756429239,0.00844336846309472,0.179264754241574,0.212362758616905,4.99854213764164e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEG1,Protein HEG homolog 1,37671,0.0581071187970902,0.00250269067135818,0.0532018450812281,0.0630123925129522,6.46356307452265e-117
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,0.159414538936022,0.0068766731187703,0.145936259623232,0.172892818248812,1.27570648998007e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,0.0756395576680399,0.00327403433649912,0.0692224503685016,0.0820566649675782,3.46683203035648e-116
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH1,Somatotropin,40330,-0.38228538530843,0.0165912302679182,-0.414804196633549,-0.34976657398331,1.40049520760938e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,0.0990543304066832,0.00430545189382964,0.0906156446947771,0.107493016118589,3.05843393042117e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,0.211443700085644,0.00920419947361465,0.19340346911736,0.229483931053929,6.55436655364178e-115
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTD,Biotinidase,38013,0.0449397097141292,0.00195752123693618,0.0411029680897343,0.0487764513385242,1.86254402160612e-114
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC4,Apical endosomal glycoprotein,37900,0.11812907941531,0.00517696523454255,0.107982227555607,0.128275931275014,4.19462002799837e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORD,Sorbitol dehydrogenase,40417,0.14434947439615,0.00634503076393529,0.131913214098837,0.156785734693463,8.85151594191339e-113
NMR metabolomics,X23501.Triglycerides in Large VLDL,YTHDF3,YTH domain-containing family protein 3,40044,0.182909196845391,0.00804575674492212,0.167139513625344,0.198678880065438,1.39901416948659e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES3,Carboxylesterase 3,40305,0.147322945263198,0.0065025856014443,0.134577877484367,0.160068013042028,7.21551153208892e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,0.116549277827932,0.00514650390954717,0.10646213016522,0.126636425490645,9.11718438439649e-112
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHBP1,EH domain-binding protein 1,37990,0.160194775292403,0.0070735995305978,0.146330520212431,0.174059030372375,1.74371363213236e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYY,Peptide YY,37562,0.204125111596752,0.00901400107061205,0.186457669498352,0.221792553695152,2.09691848539154e-111
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,0.131668475806083,0.00584698809335933,0.120208379143098,0.143128572469067,1.57974453800651e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2AP,CD2-associated protein,40359,0.13639039334458,0.00606260177056384,0.124507693874275,0.148273092814885,2.32469401495921e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,0.0858180465377443,0.00381492516353018,0.0783407932172252,0.0932952998582635,4.81493473251683e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,0.17876636634184,0.00795564793609157,0.163173296387101,0.19435943629658,8.33632882329515e-110
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHK,Ketohexokinase,37628,0.137322664410319,0.00611550514198639,0.125336274332026,0.149309054488612,1.29132597153319e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,0.176471730793115,0.00787868464943948,0.161029508880214,0.191913952706017,4.29492022693468e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,HJV,Hemojuvelin,37959,0.0979037113478134,0.00437432181499582,0.0893300405904216,0.106477382105205,5.65076362380394e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37628,0.153654546175582,0.00686531519444949,0.140198528394461,0.167110563956704,6.3420208583098e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPC,C-type natriuretic peptide,40341,0.0913873075921619,0.00409138810755667,0.0833681869013509,0.099406428282973,7.69024126285434e-109
NMR metabolomics,X23501.Triglycerides in Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,40312,0.0429819008930945,0.00192909223447628,0.039200880113521,0.046762921672668,2.58443021428785e-108
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK1,Dickkopf-related protein 1,40471,0.125771715876959,0.00566173754361823,0.114674710291467,0.136868721462451,1.05035664981572e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,MVK,Mevalonate kinase,40044,0.161551530605682,0.00728238330988189,0.147278059318314,0.175825001893051,2.23894873954047e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,39961,0.165988574431795,0.00748872407002843,0.151310675254539,0.18066647360905,3.42048314146607e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,NHLRC3,NHL repeat-containing protein 3,37370,0.0672657335088135,0.00303112155792339,0.0613247352552837,0.0732067317623434,4.09459207714685e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,BECN1,Beclin-1,37628,0.128443872056884,0.00578925509295591,0.11709693207469,0.139790812039077,4.18353073530638e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40471,0.172385681525754,0.00779366453900089,0.157110099029312,0.187661264022195,8.24956930968897e-107
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1B,C-type lectin domain family 1 member B,40471,0.202121343982394,0.00914198695009602,0.184203049560205,0.220039638404582,1.01339601212665e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXIN1,Axin-1,40341,0.196679308218914,0.00891986918179632,0.179196364622593,0.214162251815235,3.74750749493657e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN1,Dynactin subunit 1,40489,0.137647415504808,0.00624443742998931,0.125408318142029,0.149886512867587,4.15586057214114e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,40341,0.221636236071481,0.0100611095340899,0.201916461384665,0.241356010758298,5.82317587154179e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,CES2,Cocaine esterase,40305,0.11179797652766,0.00507721795645974,0.101846629332999,0.121749323722321,7.19057732127108e-106
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADH1B,All-trans-retinol dehydrogenase,37671,0.154271538696415,0.00701399533561428,0.140524107838611,0.168018969554219,2.47383509481873e-105
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPY,Pancreatic prohormone,40337,0.20976863313151,0.00958059615318577,0.190990664671266,0.228546601591755,1.01661578590187e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,0.063881443691384,0.00291817402674765,0.0581618225989586,0.0696010647838094,1.12099012206442e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3S2,AP-3 complex subunit sigma-2,37942,0.0967651022292777,0.00442880444556488,0.0880846455159706,0.105445558942585,5.00437722164956e-104
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.0501844472359653,0.00230362708804687,0.0456693381433934,0.0546995563285372,1.03995849562051e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,0.0439675834971929,0.00201731424593519,0.0400136475751599,0.0479215194192259,1.69710669356612e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,40303,0.100096301346412,0.00460027073277055,0.0910797707101815,0.109112831982642,1.85355190862192e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSD,Cathepsin D,39243,0.0822348360795428,0.00378692484430422,0.0748124633847066,0.0896572087743791,5.9050499720518e-103
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,0.0616962762068043,0.00284302031942351,0.0561239563807342,0.0672685960328744,1.14855336050168e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,0.229818641199878,0.0106026726714265,0.209037402763882,0.250599879635874,2.07067176097604e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD63,CD63 antigen,40203,0.107054990360416,0.00495019168872945,0.0973526146505066,0.116757366070326,3.09519653328288e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,0.137519733692082,0.00636088001314985,0.125052408866309,0.149987058517856,3.74928915667888e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,40434,0.148544586225373,0.00688169202931333,0.135056469847919,0.162032702602827,6.9799887075684e-102
NMR metabolomics,X23501.Triglycerides in Large VLDL,FN1,Fibronectin,38013,0.0537045617411471,0.00248930508328323,0.048825523777912,0.0585835997043822,1.58707885979136e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3F,Semaphorin-3F,40359,0.0527933253980734,0.00245597596686037,0.0479796125030271,0.0576070382931197,4.64372222354499e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,0.0592942523973927,0.00275696494275746,0.053890601109588,0.0646979036851973,6.47333765102815e-101
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNA4,Plexin-A4,40341,0.168252661558656,0.00784125319859427,0.152883805289411,0.183621517827901,1.04264907225384e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,0.0987447745355227,0.00461350127476597,0.0897023120369814,0.107787237034064,6.11085335024616e-100
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP20,Centrosomal protein 20,39980,0.149281775338882,0.00699524998650548,0.135571085365332,0.162992465312433,1.28362341316765e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,0.141856817024942,0.00664996396258107,0.128822887658283,0.1548907463916,1.53092719355445e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK9,Mitogen-activated protein kinase 9,40341,0.0869748563998344,0.00407953114770788,0.078978975350327,0.0949707374493419,1.83145531836898e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCAM,Cell surface glycoprotein MUC18,40403,-0.0688883034940307,0.00323156011837535,-0.0752221613260464,-0.0625544456620151,1.9042634701582e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,0.209563557633955,0.00984891563436565,0.190259682990598,0.228867432277312,4.37739118512421e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL13,C-X-C motif chemokine 13,40471,0.128065853509346,0.0060260267737086,0.116254841032878,0.139876865985815,7.2716893626066e-99
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZN,Kazrin,37901,0.209706891248443,0.00986469455798251,0.190372089914797,0.229041692582089,1.150607157086e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSO,Cathepsin O,40516,0.0606888195531492,0.00286013379502186,0.0550829573149064,0.0662946817913921,1.43480786590589e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,0.0543923074523341,0.00256245645438499,0.0493698928017395,0.0594147221029287,2.21052241925325e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL17,C-C motif chemokine 17,40333,0.182381014468918,0.00860663332797419,0.165512013146089,0.199250015791747,2.65768025121006e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,THOP1,Thimet oligopeptidase,40288,0.0602641558274342,0.00284505700293962,0.0546878441016725,0.0658404675531958,3.20817638059352e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A4,Protein S100-A4,40411,0.116088134478196,0.00548825455580539,0.105331155548818,0.126845113407575,5.8126091815451e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37990,0.131251316359888,0.006199658478219,0.119099985742579,0.143402646977198,6.81225834631984e-98
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,0.217700195699023,0.0102956198427801,0.197520780807174,0.237879610590872,1.19737626625056e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDUA,Alpha-L-iduronidase,40489,0.0907978716043367,0.00430058849080035,0.082368718162368,0.0992270250463054,1.28483559969992e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,0.150412058434442,0.0071171239515771,0.136462495489351,0.164361621379533,1.60130625683487e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP85,Centrosomal protein of 85 kDa,39980,0.126341971340106,0.0059871410774807,0.114607174828243,0.138076767851968,1.76545724268244e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB2,Carboxypeptidase B2,37981,0.0447661983967842,0.00212355382396817,0.0406040329018065,0.0489283638917618,4.31456386194704e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39980,0.0992702753705321,0.00471498571388102,0.0900289033713253,0.108511647369739,4.73293274346513e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARF6,ADP-ribosylation factor 6,37901,0.210512604340939,0.00998823305031837,0.190935667562315,0.230089541119563,4.85329035124564e-97
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,40357,0.0560375851925346,0.00266782598091252,0.0508086462699461,0.0612665241151232,1.20825115369522e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,0.191391237098702,0.00910768134662426,0.173540181659318,0.209242292538086,1.6886685809237e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKBKG,NF-kappa-B essential modulator,40341,0.183426948541143,0.00873999747164254,0.166296553496723,0.200557343585562,1.74803839436669e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTSS2,Protein MTSS 2,37900,0.196303336023553,0.00934677534097017,0.177983656355252,0.214623015691855,2.19040977905219e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,0.0907914395729897,0.00432385788070227,0.0823166781268132,0.0992662010191661,2.55355304541386e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNIP1,TNFAIP3-interacting protein 1,37942,0.17686200483611,0.00843144838857063,0.160336365994511,0.193387643677708,3.66389819490558e-96
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,0.212900916959175,0.0102099322844537,0.192889449681646,0.232912384236704,4.55539030861387e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUCB2,Nucleobindin-2,40447,0.0735465556833813,0.00353237329022146,0.0666231040345472,0.0804700073322153,5.09843063859832e-95
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP23,Synaptosomal-associated protein 23,40359,0.171489265815265,0.00826164271550351,0.155296446092878,0.187682085537652,1.87562614374579e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELP,P-selectin,40403,0.113709153086972,0.0054785548028236,0.102971185673438,0.124447120500507,1.93662581694769e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG16L1,Autophagy-related protein 16-1,37901,0.167164194366152,0.00804940445500327,0.151387361634346,0.182941027097959,2.56715633414624e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,BACH1,Transcription regulator protein BACH1,40341,0.143141815585501,0.00690384243482191,0.12961028441325,0.156673346757752,3.03658002063449e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCR,Breakpoint cluster region protein,40341,0.179422139902281,0.00865552627713287,0.1624573083991,0.196386971405461,3.32226068419435e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAXX,Protein PAXX,37671,0.0892560642807628,0.00431044797529219,0.0808075862491901,0.0977045423123355,9.16923086420752e-94
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP5,Fatty acid-binding protein 5,40432,0.135518786330497,0.00657746717318485,0.122626950671055,0.148410621989939,4.1298505201798e-93
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN1,Perilipin-1,39961,0.0693153835425014,0.0033737282652781,0.0627028761425563,0.0759278909424464,1.43357970601808e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,0.144998827183566,0.00705768480959692,0.131165764956756,0.158831889410376,2.42149042527789e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,0.134696046623284,0.00657154520896015,0.121815818013722,0.147576275232846,3.75168818224625e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBIN,Erbin,40305,0.199346163793015,0.00973317024496788,0.180269150112878,0.218423177473152,4.91394049084431e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEP,Leptin,40359,0.124374715878172,0.00607343140150662,0.112470790331219,0.136278641425125,5.13134366213868e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFC,Platelet-derived growth factor C,39980,0.0578346190481486,0.00282618398602934,0.0522952984355311,0.0633739396607661,7.3394869350538e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL5,C-X-C motif chemokine 5,40309,0.223274431138617,0.0109123093754364,0.201886304762761,0.244662557514472,7.37252122395942e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD6,T-cell differentiation antigen CD6,40502,0.103403419736461,0.00505638887572339,0.0934928975400433,0.113313941932879,8.8462797055072e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAB2,Disabled homolog 2,40489,0.214488318245948,0.010489590441449,0.193928720980708,0.235047915511188,9.28624394836592e-92
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R9B,Neurabin-2,40516,0.182480504569561,0.00893007514283724,0.1649775572896,0.199983451849522,1.20709192302648e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGF,Hepatocyte growth factor,40516,0.0665432160611574,0.00325933876031514,0.0601549120909398,0.0729315200313751,1.73585072340496e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40536,0.0950939058230789,0.0046688103587051,0.0859430375200169,0.104244774126141,4.52615009114243e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD7B,OTU domain-containing protein 7B,37959,0.122440254808181,0.00601522613844066,0.110650411576837,0.134230098039525,9.5693294350199e-91
NMR metabolomics,X23501.Triglycerides in Large VLDL,YOD1,Ubiquitin thioesterase OTU1,37562,0.123199699658565,0.00605337804335245,0.111335078693594,0.135064320623536,1.11047080662526e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,EZR,Ezrin,40471,0.0457541966194687,0.00225216770504176,0.0413399479175869,0.0501684453213505,1.29314485581622e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,MME,Neprilysin,40305,0.156881025728677,0.00773132939044445,0.141727620123406,0.172034431333949,2.13988949690315e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBR,Delta(14)-sterol reductase LBR,40471,0.126284856411869,0.00624114233628963,0.114052217432741,0.138517495390996,6.4851384845204e-90
NMR metabolomics,X23501.Triglycerides in Large VLDL,AAMDC,Mth938 domain-containing protein,37628,0.103405907175402,0.00511127526479366,0.0933878076564063,0.113424006694397,1.19553899549692e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,40228,0.113744146964207,0.00563487796165833,0.102699786159356,0.124788507769057,1.75810213889473e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGRN,Agrin,40422,0.0637314549234612,0.00315848289167499,0.0575408284557783,0.0699220813911442,1.99040245866848e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,0.199504811727454,0.00990961944884582,0.180081957607716,0.218927665847191,4.98462221504783e-89
NMR metabolomics,X23501.Triglycerides in Large VLDL,FETUB,Fetuin-B,40372,0.0644632970438693,0.00321432652385849,0.0581632170571066,0.0707633770306319,2.24824329678494e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37628,0.196464556843007,0.00979369417366244,0.177268916262629,0.215660197423386,3.3834697817795e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM7,PDZ and LIM domain protein 7,40422,0.238216217604183,0.0118946506793391,0.214902702272679,0.261529732935688,3.84837685720897e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,40341,0.0718711006206324,0.00359281354300384,0.0648291860763449,0.0789130151649199,6.11753218811848e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,0.104386139900928,0.00522274014947424,0.0941495692079589,0.114622710593898,9.21531183284034e-88
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37900,0.217286417656797,0.0108748986228757,0.195971616355961,0.238601218957634,1.50810614459345e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSP1,Lymphocyte-specific protein 1,40341,0.0757623084507514,0.00380394963247945,0.0683065671710917,0.0832180497304111,3.36787435787281e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37990,0.202757303196432,0.0101889894084726,0.182786883955825,0.222727722437038,7.11946614257282e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEXIM1,Protein HEXIM1,40341,0.154524917731142,0.00777625650045994,0.13928345499024,0.169766380472043,8.14334519560983e-87
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFC,Vascular endothelial growth factor C,40411,0.10519963404836,0.00531777172362828,0.0947768014700483,0.115622466626671,4.50556279993012e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,0.188317896879806,0.00952064642199015,0.169657429892705,0.206978363866907,4.67585367970254e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",40305,0.144664747445736,0.00732504941778072,0.130307650586885,0.159021844304586,8.71958069513761e-86
NMR metabolomics,X23501.Triglycerides in Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,40044,0.131031588878196,0.00664350094964301,0.118010327016895,0.144052850739496,1.4990995439053e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,40305,0.159794409450122,0.00811404390167517,0.143890883402838,0.175697935497405,2.55761359864384e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHACTR2,Phosphatase and actin regulator 2,37959,0.214122665620268,0.0108615349710327,0.192834057077044,0.235411274163492,2.58403548655161e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK2,Docking protein 2,40359,0.225704526294487,0.0114834743083544,0.203196916650113,0.248212135938862,5.36047243561922e-85
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.0385598034823473,0.00196592041138974,0.0347065994760234,0.0424130074886712,1.17883948604963e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,MASP1,Mannan-binding lectin serine protease 1,40192,0.0444022028171314,0.00226475361266154,0.0399632857363148,0.048841119897948,1.40697280702843e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPL,N-acetylneuraminate lyase,37990,0.0805037168013427,0.00410685964679956,0.0724542718936156,0.0885531617090698,2.17902694169359e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40502,0.070656660002534,0.00360988026371002,0.0635812946856624,0.0777320253194057,2.51700389196704e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,0.202835458767521,0.0103715974114867,0.182507127841007,0.223163789694034,5.27814693889766e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37901,0.073738215538424,0.0037750237006182,0.0663391690852123,0.0811372619916357,8.28153098014145e-84
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,40391,0.0430549958908937,0.00220790849855581,0.0387274952337243,0.0473824965480631,1.02860112417763e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLA2,Src-like-adapter 2,37959,0.19129388057693,0.00982703450273601,0.172032892951567,0.210554868202292,2.933010036855e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS6,Growth arrest-specific protein 6,40429,-0.0476037160961699,0.00244881256131722,-0.0524033887163516,-0.0428040434759881,3.26461816871202e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,0.0929238526347648,0.00478828159170053,0.0835388207150318,0.102308884554498,6.52821478700361e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLSCR3,Phospholipid scramblase 3,37919,0.110837475616244,0.00570881582869987,0.0996481965919923,0.122026754640496,7.76406072342194e-83
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFX1,Transcriptional repressor NF-X1,37562,0.125561162392183,0.00647330539787384,0.11287348381235,0.138248840972016,1.17838785516191e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,40305,0.253476555097452,0.0131031619822689,0.227794357612205,0.279158752582699,2.01086013733725e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.180803817916039,0.00934669852848364,-0.199123347031867,-0.162484288800211,2.01709586135451e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,0.155158681156756,0.00801476380606546,0.139449744096868,0.170867618216645,2.22350812929575e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,0.191012569466421,0.00988363333225998,0.171640648135191,0.21038449079765,2.81215234852583e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPK2,SRSF protein kinase 2,40341,0.152037329720011,0.0078762587375555,0.136599862594402,0.167474796845619,4.38522802715482e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGFR,Opioid growth factor receptor,40305,0.0606759590102351,0.00314470033212678,0.0545123463592666,0.0668395716612036,5.18164139504711e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMIP,C-Maf-inducing protein,37900,0.151056432926202,0.00782548037133049,0.135718491398395,0.16639437445401,6.45855987003561e-82
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC1,Stanniocalcin-1,40471,0.0759540552448105,0.00394530334924635,0.0682212606802877,0.0836868498093334,1.13975040078192e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO1,Forkhead box protein O1,40341,0.155112194854329,0.00805883986734992,0.139316868714323,0.170907520994335,1.25750443143876e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP2B,DNA topoisomerase 2-beta,37598,0.144985030503738,0.00753338233811688,0.130219601121029,0.159750459886447,2.01482684758679e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPD52L2,Tumor protein D54,37671,0.197939121179768,0.0102871361323927,0.177776334360278,0.218101907999257,2.15204106409634e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,0.126499399793516,0.00657706227906768,0.113608357726543,0.139390441860489,2.37775243077051e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCK2,Cytoplasmic protein NCK2,40422,0.191123563749656,0.00995286799646987,0.171615942476575,0.210631185022737,2.88256796966431e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,37950,0.0363528451779369,0.00189184271435265,0.0326448334578057,0.040060856898068,3.31850634628886e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINH1,Serpin H1,37714,0.235800015063539,0.0122767608460909,0.211737563805201,0.259862466321878,4.06891355667094e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL5,C-C motif chemokine 5,40403,0.182948883901963,0.00953827953115794,0.164253856020894,0.201643911783033,4.40156809194532e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLB1,Beta-galactosidase,40228,0.074549856802742,0.00388726308701753,0.0669308211521877,0.0821688924532964,4.72127907289896e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,THPO,Thrombopoietin,40042,0.0697886890612004,0.00364008435665379,0.062654123722159,0.0769232544002418,5.3883367482914e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,0.0378985924095504,0.00197764163774555,0.0340224147995692,0.0417747700195317,6.29274962677813e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,0.173921806600928,0.00908295740127012,0.156119210094438,0.191724403107417,8.07249985135944e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,0.172600022554571,0.00901650883641341,0.154927665235201,0.190272379873942,9.1624600435998e-81
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN1,Pantetheinase,37987,0.131937028220292,0.00689642186883086,0.118420041357384,0.145454015083201,1.59826832351497e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,0.175553265223336,0.00919766999471589,0.157525832033693,0.193580698412979,2.67838772297122e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD5,Programmed cell death protein 5,40471,0.105982711984758,0.00555889481917234,0.0950872781391804,0.116878145830336,3.77223106784738e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE2,Angiotensin-converting enzyme 2,40042,0.0887477901102066,0.00466182236171349,0.0796106182812482,0.0978849619391651,6.7600529968677e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,0.186334858464371,0.00978314763025478,0.167159889109072,0.205509827819671,7.86977449838822e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,0.0794008776166477,0.00417449149514692,0.0712188742861598,0.0875828809471357,8.91411812166177e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0469643880150151,0.00246999917596767,0.0421231896301185,0.0518055863999118,9.81157576149538e-80
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXT,Oxytocin-neurophysin 1,40471,0.239433116894142,0.0126058673740372,0.214725616841029,0.264140616947254,1.43616841641596e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,BID,BH3-interacting domain death agonist,40341,0.121157157151373,0.00638228512353976,0.108647878309235,0.13366643599351,1.77259003582706e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,37671,0.14277745902998,0.00752690786083252,0.128024719622748,0.157530198437211,3.45899172681256e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNMBP,Dynamin-binding protein,40228,0.111077639961033,0.00587042046705472,0.0995716158456059,0.12258366407646,5.66614475606841e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,40536,0.121736304484427,0.00643457496565935,0.109124537551735,0.13434807141712,5.71317392719988e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNST,Consortin,40359,0.194213766885566,0.0102707605893832,0.174083076130374,0.214344457640757,6.98969145812991e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCXR,L-xylulose reductase,40411,0.0941827712313941,0.00498249083000503,0.0844170892045842,0.103948453258204,7.85466726646438e-79
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINK1,Misshapen-like kinase 1,37942,0.167054595775535,0.00883734409958496,0.149733401340348,0.184375790210721,1.11132903633813e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCTN3,Tectonic-3,37990,0.0524934566565481,0.00278267699455826,0.0470394097472139,0.0579475035658822,2.25885050600601e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL13,C-C motif chemokine 13,40483,0.125222736568945,0.0066461220536954,0.112196337343702,0.138249135794188,2.42093904382538e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELE,E-selectin,40536,0.0897047896625072,0.00476408922606369,0.0803671747794223,0.099042404545592,3.00884407327701e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN2,CCN family member 2,40358,0.103344410270704,0.00548979789845103,0.0925844063897395,0.114104414151668,3.34365581048413e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC27,Cell division cycle protein 27 homolog,39980,0.109170715136798,0.00580377491149224,0.0977953163102727,0.120546113963322,4.58047241875945e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAT,Linker for activation of T-cells family member 1,40516,0.135297310127753,0.00720238307487359,0.121180639301001,0.149413980954505,6.829805472891e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELN,Elastin,37990,0.063017408860704,0.0033513134486727,0.0564488345013055,0.0695859832201025,6.88801915224525e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,USO1,General vesicular transport factor p115,40305,0.162076103492175,0.00862976587398317,0.145161762379168,0.178990444605182,7.54270770480979e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,0.199800237543347,0.0106402878118491,0.178945273432123,0.220655201654571,8.13310919024224e-78
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,0.129515484718547,0.00689599606632787,0.115999332428545,0.14303163700855,1.05764008802297e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2D1A,SH2 domain-containing protein 1A,40341,0.0978679745877165,0.00522582919079578,0.0876253493737568,0.108110599801676,2.00297258672128e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK11,Serine/threonine-protein kinase STK11,40042,0.130245691929325,0.00695636433348167,0.116611217835701,0.143880166022949,2.25580910866554e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP43,Centrosomal protein 43,39934,0.123152423271977,0.00658052618328421,0.11025459195274,0.136050254591214,2.67553031232704e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,0.137549454800012,0.00734619622396996,0.123150910201031,0.151947999398993,2.98148647387487e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGLN1,Egl nine homolog 1,40341,0.0943221353000177,0.0050598170849917,0.084404893813434,0.104239376786601,9.75191492945804e-77
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40516,0.0994147315158474,0.00533394629895637,0.0889601967698929,0.109869266261802,1.01499587798984e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLK1,Protein delta homolog 1,40536,0.0941904779584787,0.005054243582113,0.0842841605375372,0.10409679537942,1.05427839684611e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,40341,0.109987468793645,0.00591219773377114,0.0983995612354533,0.121575376351836,1.95054539607688e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD36,Platelet glycoprotein 4,37598,0.0786745071140763,0.00423343602643236,0.0703769725022689,0.0869720417258837,4.07083419048913e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,0.136306388462198,0.00733900366912735,0.121921941270708,0.150690835653687,4.70431339505517e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,40341,0.197561258289245,0.0106539304997305,0.176679554509773,0.218442962068717,5.82115714889537e-76
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,37959,0.133792306074589,0.00723285441322209,0.119615911424673,0.147968700724504,1.83270326680382e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM1,Isthmin-1,40341,0.0687329305178654,0.00372016295323897,0.061441411129517,0.0760244499062137,1.99285484501308e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,0.160268861673436,0.00867588931388899,0.143264118618214,0.177273604728659,2.90387207518412e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,0.133777004944994,0.00725118176737943,0.11956468868093,0.147989321209058,3.25201170863148e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,40396,0.0910980648223539,0.00493858818608015,0.0814184319776368,0.100777697667071,3.38760300872497e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,0.0403327184668622,0.00218728120612118,0.0360456473028647,0.0446197896308597,3.83931875772359e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON2,Serum paraoxonase/arylesterase 2,40042,0.0604472205048727,0.00328039783935161,0.0540176407397436,0.0668768002700019,5.0084193933999e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39980,0.112744257967699,0.00611951809898521,0.100750002493688,0.12473851344171,5.33368673475741e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39961,0.118711799695924,0.00644578285944329,0.106078065291415,0.131345534100433,6.03863617045771e-75
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSG,Alpha-2-HS-glycoprotein,37987,0.0474722609042098,0.00258067670800501,0.04241413455652,0.0525303872518996,1.16194293521838e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39961,0.107209288158506,0.0058358963773536,0.0957709312588933,0.118647645058119,1.39325210594072e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESM1,Endothelial cell-specific molecule 1,40357,-0.0593344461984733,0.00323198290027371,-0.0656691326830097,-0.0529997597139368,1.65836994235136e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS9,Galectin-9,40350,0.0562717207297532,0.00306829893501314,0.0502578548171275,0.062285586642379,2.32954871556944e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,0.112963965029577,0.0061582120238707,0.10089386946279,0.125034060596364,2.93879280214059e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,EREG,Proepiregulin,40192,0.139831246583833,0.00765358926127525,0.124830211631734,0.154832281535933,8.29728816352237e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL7,Angiopoietin-related protein 7,40489,0.0645366317034905,0.00353307909716509,0.057611796673047,0.0714614667339341,8.57541282598671e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBPL,FK506-binding protein-like,37901,0.102886488602285,0.00562762932817217,0.0918563351190674,0.113916642085502,8.92630183665812e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME1,Proteasome activator complex subunit 1,40216,0.0656401418343779,0.00359469801951829,0.0585945337161221,0.0726857499526337,9.85837447579651e-74
NMR metabolomics,X23501.Triglycerides in Large VLDL,A1BG,Alpha-1B-glycoprotein,38013,0.0305347171971339,0.00167185636930308,0.0272578787132999,0.033811555680968,1.22055023435629e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB3,Plexin-B3,40310,0.081141826192806,0.00444866529804695,0.072422442208634,0.089861210176978,1.41369318284157e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFA,Vascular endothelial growth factor A,40456,0.102177968019499,0.00560476334094887,0.0911926318712393,0.113163304167759,1.63627345220011e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM5,Tripartite motif-containing protein 5,40341,0.147826563303198,0.00812136615244918,0.131908685644398,0.163744440961999,2.75263030478196e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,0.159793126058132,0.00879284081702791,0.142559158056757,0.177027094059507,4.78038973111019e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCBP2,Poly(rC)-binding protein 2,37959,0.12460881912845,0.00685289588540122,0.111177143193064,0.138040495063837,5.17982300449288e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,0.158070112442732,0.00869372466773944,0.141030412093963,0.175109812791502,5.31314753952841e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,40422,0.180880598962895,0.00995948146657656,0.161360015288405,0.200401182637385,5.63017819704357e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RB,Interleukin-17 receptor B,40126,-0.0926468876835048,0.00510227746946326,-0.102647351523653,-0.0826464238433568,6.20673968651751e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP3B1,AP-3 complex subunit beta-1,37901,0.13245396520064,0.00728897107457636,0.118167581894471,0.14674034850681,6.41586578194378e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC13,Mucin-13,39961,0.0869861219741446,0.00479173188286639,0.0775943274837264,0.0963779164645627,6.85626240207051e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,0.108147236831162,0.00595488194237197,0.0964756682241127,0.119818805438211,7.71819300025399e-73
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,0.0912326319943611,0.00503509738840517,0.081363841113087,0.101101422875635,1.67581831308964e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP2,Methionine aminopeptidase 2,40453,0.101591872079253,0.00561858237382095,0.0905794506265641,0.112604293531942,2.34315243423397e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,37671,0.0648807638963902,0.00359285949424724,0.0578387592876657,0.0719227685051148,4.97431662573078e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1S,Complement C1s subcomponent,38013,0.0357129261223791,0.0019805396972734,0.0318310683157232,0.0395947839290349,7.54118095725904e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAMBP,STAM-binding protein,40192,0.111060461805163,0.00616836142181741,0.0989704734184005,0.123150450191925,9.35543441708528e-72
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,0.141183573890429,0.00785850464259439,0.125780904790944,0.156586242989914,1.91092450617518e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIT1,ARF GTPase-activating protein GIT1,37598,0.167689343399683,0.00933298784467975,0.149396687224111,0.185981999575255,2.4965406191564e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASHC3,WASH complex subunit 3,37942,0.128656426043668,0.00716436879065369,0.114614263213987,0.142698588873349,2.81210715307412e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNCG,Gamma-synuclein,40228,0.114457216528372,0.00638587727528436,0.101940897068815,0.126973535987929,3.92124203004608e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37557,0.144766601482565,0.00807053026747146,0.128948362158321,0.160584840806809,4.2330570318337e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAX1BP1,Tax1-binding protein 1,37942,0.109895531533256,0.00612800013247557,0.0978846512736036,0.121906411792908,4.32414272821572e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUOM,Fucose mutarotase,37671,0.106853145313308,0.00595764858697119,0.0951761540828443,0.118530136543771,4.32934130014787e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYTL4,Synaptotagmin-like protein 4,37990,0.125291450688571,0.00698944122490896,0.111592145887749,0.138990755489393,4.90274639080441e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZI2,5-azacytidine-induced protein 2,37959,0.0943211032971058,0.00526181588281066,0.0840079441667969,0.104634262427415,4.94430291370604e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD1,COMM domain-containing protein 1,37628,0.105438586934779,0.00588252287855806,0.0939088420928055,0.116968331776753,5.3229966774876e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,0.119855744067744,0.00669563352892523,0.106732302351051,0.132979185784438,8.03270313044532e-71
NMR metabolomics,X23501.Triglycerides in Large VLDL,QDPR,Dihydropteridine reductase,40290,0.0745694721377276,0.00417864138812438,0.0663793350170038,0.0827596092584513,1.53881116854701e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTDH,Protein LYRIC,37598,0.155918837016729,0.00873699061585214,0.138794335409659,0.173043338623799,2.10362254199745e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,0.121321766715703,0.00680270074806795,0.10798847324949,0.134655060181917,2.54419460835865e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,0.181004057386655,0.0101506180414918,0.161108846025331,0.200899268747979,2.6429838339676e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEC31A,Protein transport protein Sec31A,37628,0.130358292626763,0.00731185034386833,0.116027065952781,0.144689519300744,2.84223587590704e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,GASK1A,Golgi-associated kinase 1A,37562,0.0737791281553305,0.00414435395781414,0.0656561943980148,0.0819020619126462,4.518994881416e-70
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39961,0.0452416104558723,0.00255339503147404,0.0402369561941832,0.0502462647175615,1.46926584957662e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,MITD1,MIT domain-containing protein 1,40228,0.163155375313264,0.00921948872754392,0.145085177407278,0.18122557321925,2.07840323077088e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMN,Protein amnionless,40044,0.0805754415993308,0.00455335066433001,0.071650874297244,0.0895000089014177,2.15083154584146e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,0.127728812543246,0.00722025557564042,0.113577111614991,0.141880513471502,2.31360650916668e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,0.110874467264751,0.00627287160293362,0.0985796389230012,0.123169295606501,3.89953699212686e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH2B3,SH2B adapter protein 3,39980,0.164536922734852,0.00932341737518949,0.146263024679481,0.182810820790224,4.99784088151271e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,0.0858907192361643,0.0048668072419644,0.0763517770419141,0.0954296614304145,6.26761645122706e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,37671,0.138623753748644,0.0078589158881763,0.123220278607818,0.154027228889469,7.58025783342235e-69
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCC,Tubulin-specific chaperone C,40228,0.136435784858818,0.00775333011405508,0.12123925783527,0.151632311882365,1.17408028969355e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL7,C-C motif chemokine 7,40341,0.102186076233433,0.00580725852823861,0.0908038495180855,0.113568302948781,1.17766741955157e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSB,Arylsulfatase B,40305,0.0920775203845655,0.00523804783603215,0.0818109466259425,0.102344094143188,1.60439887202009e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRAP,BRCA1-associated protein,37778,0.183936611770076,0.0104582519622391,0.163438437924088,0.204434785616065,1.81334098078906e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFB,Platelet-derived growth factor subunit B,40422,0.143705802398905,0.00817952325126395,0.127673936826427,0.159737667971382,1.87458580964614e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CMC1,COX assembly mitochondrial protein homolog,37990,0.151114278443598,0.00859568466256436,0.134266736504972,0.167961820382224,2.00621237197947e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGCC,Regulator of cell cycle RGCC,37959,0.125792990482258,0.00715536464634206,0.111768475775428,0.139817505189089,2.01466078612579e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,0.168176536034653,0.00959430598486569,0.149371696304316,0.18698137576499,3.78052731946687e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDHD2,Phospholipase DDHD2,37959,0.11086948864723,0.00632407187374381,0.0984743077746916,0.123264669519767,4.67532633974396e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,0.0586613405296466,0.00334960364202088,0.0520961173912856,0.0652265636680075,6.91442618174198e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,0.149442731893964,0.00854130909317488,0.132701766071341,0.166183697716587,8.57486958354175e-68
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,0.1795789876895,0.010295181706588,0.159400431544588,0.199757543834413,2.12784398983124e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGF,Placenta growth factor,40516,0.0436838148511071,0.00250832101744839,0.0387675056569082,0.0486001240453059,2.6094209084662e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,40283,0.0535534860048443,0.00307660425538563,0.0475233416642884,0.0595836303454001,3.10154414915754e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG4,BAG family molecular chaperone regulator 4,37598,0.0809322819005371,0.00464884217815789,0.0718205512313476,0.0900440125697266,3.97541216678928e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0611845445349978,0.0035194820966675,0.0542863596255295,0.0680827294444661,5.79206652525339e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP8,Vesicle-associated membrane protein 8,37598,0.147098701636539,0.00847471869360593,0.130488252997072,0.163709150276007,9.60952449237069e-67
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL10,C-X-C motif chemokine 10,40422,0.111760221523229,0.00644635642630272,0.0991253629276753,0.124395080118782,1.00970717246049e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAG1,Dystroglycan,40422,0.0782710510708621,0.00451917507500496,0.0694134679238523,0.0871286342178718,1.35402534875234e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX15,Sorting nexin-15,37671,0.0897482958500753,0.00518038102861429,0.0795947490339913,0.0999018426661593,1.66061776065654e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,NSFL1C,NSFL1 cofactor p47,40471,0.110193639987049,0.0063676557846806,0.0977130346490752,0.122674245325023,1.72801997676977e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA5,Integrin alpha-5,40332,0.0411483719886739,0.00237785597925082,0.0364877742693423,0.0458089697080055,1.7606601790443e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIAE,Sialate O-acetylesterase,40374,0.0773368553531605,0.00447327069693032,0.068569244787177,0.0861044659191439,2.31017305678799e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,0.0968481698829427,0.0055990788343919,0.0858739753675345,0.107822364398351,2.64868350443094e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT2,Omega-amidase NIT2,37936,0.124830578371841,0.00721970325469774,0.110679959992633,0.138981196751048,2.88238066900117e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,0.095416982654928,0.0055212811957,0.084595271511356,0.1062386937985,3.34872212380111e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIRBP,Cold-inducible RNA-binding protein,37901,0.15733381949121,0.0091072371549243,0.139483634667558,0.175184004314861,3.70633350914418e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,0.0459084470198351,0.00266066870077722,0.0406935363663118,0.0511233576733585,4.13742382190017e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,0.0723946055656959,0.00419542814985189,0.0641715663919862,0.0806176447394056,4.17339001585929e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,0.130751634347286,0.00757425154640752,0.115906101316328,0.145597167378245,4.59155556385084e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,0.100710981171954,0.0058395691038789,0.0892654257283511,0.112156536615556,4.76443196288282e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,0.131787893576044,0.00765151620548987,0.116790921813284,0.146784865338804,6.98063512952398e-66
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,0.0515099044364217,0.00299268724211462,0.0456442374418771,0.0573755714309664,1.12739811919782e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYDGF,Myeloid-derived growth factor,37990,0.164955949668929,0.00959169066762682,0.14615623596038,0.183755663377477,1.37028719251227e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRP14,Signal recognition particle 14 kDa protein,40305,0.0972046341104868,0.00566150988308906,0.0861080747396323,0.108301193481341,1.75896514578034e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGA,Protein O-GlcNAcase,37901,0.115221849610085,0.00671126177752293,0.10206777652614,0.12837592269403,2.2724536557666e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH2,Neutral ceramidase,40228,0.0859501775683946,0.00501697026729148,0.0761169158445033,0.0957834392922859,3.33579664066035e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,0.0808941248419959,0.00471982174144656,0.0716432742287606,0.0901449754552311,3.86948482628924e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKA,Diacylglycerol kinase alpha,37598,0.0889482631702235,0.00519266759680783,0.0787706346804802,0.0991258916599669,4.53133569827532e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSZ,Cathepsin Z,40345,0.0507426172191578,0.00296661230962419,0.0449280570922944,0.0565571773460212,5.23643619012531e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1A,Meprin A subunit alpha,37901,0.111872865654614,0.0065448023868487,0.0990450529763901,0.124700678332837,8.03018958739729e-65
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL11,Eotaxin,40516,0.0613333836331158,0.00359627403363376,0.0542846865271937,0.068382080739038,1.19516687351959e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0515801061957272,0.00302532876108434,0.0456504618240018,0.0575097505674525,1.31723894220923e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRKL,Crk-like protein,40374,0.173389801831357,0.0101719836856894,0.153452713807406,0.193326889855308,1.40364293059196e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAO1,Hydroxyacid oxidase 1,40489,0.212158460216583,0.0124601016007656,0.187736661079082,0.236580259354084,1.90657867348062e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,40422,-0.0335206754909316,0.00196974696981293,-0.037381379551765,-0.0296599714300983,2.23936937861004e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,0.149136755024985,0.00876976428257392,0.13194801703114,0.16632549301883,2.82421752996005e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,0.138889238766304,0.0081738215668842,0.122868548495211,0.154909929037397,4.51911154993693e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB27B,Ras-related protein Rab-27B,37990,0.133093388317163,0.0078384215379012,0.117730082102876,0.148456694531449,5.33638701969808e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5,T-cell surface glycoprotein CD5,40470,0.0541826818238162,0.00319490407009743,0.0479206698464253,0.0604446938012072,5.95738987415007e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,0.102677686326682,0.00605647200416483,0.0908070011985186,0.114548371454845,6.82171616448085e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDRKH,Tudor and KH domain-containing protein,39961,0.137706685430958,0.00812720556344589,0.121777362526604,0.153636008335312,8.00278025508149e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,0.100611319380633,0.00593369959813144,0.0889812681682954,0.112241370592971,8.31798929438316e-64
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYN,Tyrosine-protein kinase Lyn,40305,0.135471951165901,0.00800791312287306,0.11977644144507,0.151167460886733,1.21370302698335e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,0.187156804860699,0.0110634598836673,0.165472423488711,0.208841186232687,1.22588518689694e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPHN1,Oligophrenin-1,37942,0.173034988148294,0.0102247689122871,0.152994441080212,0.193075535216377,1.37474451751512e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOD,Apolipoprotein D,37345,-0.0720782987994358,0.00426034021073936,-0.080428565612485,-0.0637280319863867,1.59188501643655e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,0.0713083970722871,0.00422055538756815,0.0630361085126536,0.0795806856319207,1.74419109691793e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXN,Paxillin,39961,0.0835450585823491,0.00494508796089183,0.0738526861790011,0.0932374309856971,1.82223494388837e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLGA3,Golgin subfamily A member 3,37959,0.126652488546564,0.00749393795080789,0.11196437016298,0.141340606930147,1.99304797547318e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAT2,Signal transducer and activator of transcription 2,37598,0.124075693644365,0.00734542049686567,0.109678669470508,0.138472717818222,2.41346423931487e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,37901,0.0755388295845466,0.00448089627011893,0.0667562728951135,0.0843213862739798,4.07168568526575e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,-0.0728360973312359,0.00432533689114553,-0.0813137576378811,-0.0643584370245906,4.37597926143579e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA1,GDNF family receptor alpha-1,40453,0.0448023880901582,0.00266197358940972,0.0395849198549152,0.0500198563254013,5.07878973282887e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99L2,CD99 antigen-like protein 2,40332,0.0382329517829292,0.00227215868649949,0.0337795207573902,0.0426863828084682,5.46102905682398e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,NIT1,Deaminated glutathione amidase,37628,0.0799125672685395,0.00474737033611314,0.0706077214097578,0.0892174131273213,6.34384140623366e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37598,0.144569590915929,0.00859109052258072,0.127731053491671,0.161408128340187,6.93308160703833e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,0.0766804991885388,0.00456152439502098,0.0677399113742976,0.0856210870027799,8.96418946117625e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT5,ADP-sugar pyrophosphatase,40332,0.0837312725881612,0.00498576639567986,0.0739591704526286,0.0935033747236937,9.38138415198514e-63
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF2,TNF receptor-associated factor 2,40341,0.114210125110244,0.00680238273728169,0.100877454945172,0.127542795275317,1.00731359149834e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD1,Sushi domain-containing protein 1,40042,0.0790548665689209,0.00470821834655285,0.0698267586096773,0.0882829745281645,1.01273525888238e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM13A,Protein FAM13A,37901,0.108033590031101,0.00644149160264766,0.0954082664899117,0.120658913572291,1.69938978489308e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D23,TBC1 domain family member 23,40305,0.143115214490268,0.00855552990918073,0.126346375868274,0.159884053112262,2.81043519442935e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH2,Cadherin-2,40359,0.0561607767444941,0.00336666312625291,0.0495621170170384,0.0627594364719498,6.00803985654944e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,0.0927350116093554,0.00556954814184623,0.0818186972513368,0.103651325967374,9.97179071807707e-62
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,40350,0.078534219937398,0.00472212237621326,0.06927886008002,0.087789579794776,1.37399583370658e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,TALDO1,Transaldolase,37966,0.0710639081394941,0.00427035153203052,0.0626940191367143,0.0794337971422739,1.43462716048117e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,0.12380924334206,0.00745005375148816,0.109207137989144,0.138411348694977,1.70366797353735e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,40042,0.118610416867742,0.00714548602255564,0.104605264263533,0.132615569471951,2.36741868438412e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,0.0842929929143579,0.00508272132916008,0.0743308591092041,0.0942551267195116,3.66547520262171e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS8,Galectin-8,40471,0.0955531930106839,0.00577385857064491,0.0842364302122199,0.106869955809148,5.19943780624646e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDLIM5,PDZ and LIM domain protein 5,37959,0.187391062851887,0.0113239486260249,0.165196123544878,0.209586002158896,6.5530095389619e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,40044,0.0641202127806094,0.00387742451929012,0.0565204607228008,0.071719964838418,6.57739282591566e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS1BP3,HCLS1-binding protein 3,37628,0.141654085373196,0.00856027892200826,0.12487593868606,0.158432232060333,6.82219564990441e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,0.11483606944191,0.00695530041251259,0.101203680633385,0.128468458250435,9.81609917327419e-61
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBNL,Drebrin-like protein,40422,0.145572211104284,0.00882034736959908,0.12828433025987,0.162860091948699,1.08945920959705e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,F13B,Coagulation factor XIII B chain,37934,0.0407475528810504,0.00246912774898322,0.0359080624930433,0.0455870432690575,1.3741425015121e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTPBP2,GTP-binding protein 2,37572,0.12602041467306,0.00764052388600837,0.111044987856483,0.140995841489636,1.65378002471715e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0955026634660196,0.00581068344649663,0.0841137239108862,0.106891603021153,3.33256820136931e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.0449280214662988,0.00273381503071834,0.0395697440060908,0.0502862989265067,3.36910933800122e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE4,Ribonuclease 4,37575,0.0428925672863892,0.00261487450310404,0.0377674132603053,0.0480177213124731,7.13364890071053e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,0.0696951016109514,0.00425455220644664,0.0613561792863159,0.0780340239355868,8.25393067236933e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYOU1,Hypoxia up-regulated protein 1,40536,0.0338818354915566,0.00206900110016026,0.0298265933352425,0.0379370776478707,8.65310262707478e-60
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,0.134011535560794,0.0081872705304832,0.117964485321047,0.150058585800541,1.018655804683e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOK1,Docking protein 1,37942,0.213734490661241,0.0130504910399761,0.188155528222888,0.239313453099595,1.0423377910908e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,39980,0.145002979244173,0.00886843364578679,0.127620849298431,0.162385109189915,1.35813440038449e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPART,Spartin,37671,0.120802467959971,0.00738447665455527,0.106328893717043,0.1352760422029,1.44292889191865e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINC1,Antithrombin-III,37981,0.0230151278296333,0.00140881413052714,0.0202538521338001,0.0257764035254665,2.00861967869359e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL3,C-X-C motif chemokine 3,40350,0.145208902554935,0.00889948758742167,0.127765906883588,0.162651898226281,2.28544656436384e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,0.229462880642818,0.0141076175521819,0.201811950240541,0.257113811045094,6.35928691205542e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICA1,Islet cell autoantigen 1,40044,0.123351204881088,0.00758889553567069,0.108476969631174,0.138225440131003,6.36407825601332e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,37608,0.0881822098917387,0.00542126053488243,0.0775565392433691,0.0988078805401083,6.45726399908164e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,TWF2,Twinfilin-2,37998,0.128862786493322,0.00793100923187788,0.113318008398842,0.144407564587803,8.29939660031405e-59
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNLR1,Interferon lambda receptor 1,40341,0.0580391782113325,0.00357801156767494,0.0510262755386896,0.0650520808839754,1.05987985644172e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,0.128071458393473,0.00789022691431142,0.112606613641423,0.143536303145523,1.08716493842777e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37959,0.106110067807637,0.00653837696895219,0.0932948489484906,0.118925286666783,1.13151736025552e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMA,Granzyme A,40516,0.0545894371270995,0.00336657833230113,0.0479909435957893,0.0611879306584097,1.15249676716744e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASC3,Protein CASC3,37572,0.0636440607912147,0.00392218192837873,0.0559565842115924,0.071331537370837,1.21462998185805e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTNB,Dystrobrevin beta,37878,0.0647421667022701,0.00399637851526173,0.0569092648123571,0.0725750685921831,1.79985237915885e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.0492780653016511,0.00304567797656886,0.0433085364675762,0.0552475941357261,2.04471712179859e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,0.129753062201788,0.00802136714028309,0.114031182606833,0.145474941796743,2.17935136068173e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,0.111464685792902,0.00689089417762034,0.0979585332047661,0.124970838381038,2.1917383932154e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5E,5'-nucleotidase,40411,0.0894953742478874,0.00553373484864472,0.0786492539445438,0.100341494551231,2.28716877723511e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,RWDD1,RWD domain-containing protein 1,40471,0.0994450711723896,0.00615930883553474,0.0873728258547415,0.111517316490038,3.51639140847536e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR2,GMP reductase 2,37671,0.104882273383213,0.00649077613019314,0.0921603521680342,0.117604194598391,3.55741531699869e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,40359,0.122228013056522,0.00757485500761996,0.107381297241586,0.137074728871457,4.11973994811674e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD69,Early activation antigen CD69,40288,0.135405853157129,0.00840232167221144,0.118937302679595,0.151874403634664,5.75827000159661e-58
NMR metabolomics,X23501.Triglycerides in Large VLDL,COCH,Cochlin,37990,0.0717848608065813,0.00446181079302629,0.0630397116522498,0.0805300099609128,1.04835538315091e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,0.134140236535247,0.00834434058405496,0.117785328990499,0.150495144079994,1.07471154733109e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",39961,0.0751341129102752,0.0046751757357492,0.0659707684682067,0.0842974573523436,1.19254987535838e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,0.0702882755840502,0.00437704356528737,0.061709270196087,0.0788672809720135,1.41800974783095e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOLM2,Protein GOLM2,40471,0.0344379841265239,0.00214602537001019,0.0302317744013039,0.0386441938517438,1.67474397735469e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,C3,Complement C3,37360,0.072230500992785,0.0045018124447558,0.0634069486010637,0.0810540533845064,2.22945804805751e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC4,Syndecan-4,40359,0.069273867981404,0.00432406579759018,0.0607986990181272,0.0777490369446807,2.57861395985887e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHMP1A,Charged multivesicular body protein 1a,40228,0.121491172584433,0.00759492483685641,0.106605119904194,0.136377225264671,3.81162932373614e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,IST1,IST1 homolog,37812,0.153220788808693,0.00958652952929546,0.134431190931274,0.172010386686113,5.66570594453147e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,40341,0.0826821598108027,0.00517710861610526,0.0725350269232364,0.092829292698369,5.67287525609745e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37671,0.102904050211041,0.00643926833474177,0.0902830842749473,0.115525016147135,5.94277459589425e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMPR,GMP reductase 1,40516,0.0778643209196892,0.00488214515529654,0.068295316415308,0.0874333254240704,7.92918090918527e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37572,0.109886202052981,0.00688534631661897,0.0963909232724075,0.123381480833554,8.38050041569938e-57
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST3,Cystatin-C,40372,0.0427320548058312,0.00268294730827146,0.0374734780816191,0.0479906315300432,1.12271026263208e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39836,0.183689193601777,0.011537625986238,0.16107544666875,0.206302940534803,1.28543499018883e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEFTY2,Left-right determination factor 2,40453,0.0790942115319036,0.00496939966003262,0.0693541881982396,0.0888342348655675,1.32876366460117e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,0.0588401172255575,0.00369572689118456,0.0515964925188357,0.0660837419322792,1.4849135714996e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,STIP1,Stress-induced-phosphoprotein 1,40307,0.0995798044279078,0.00626005460157215,0.0873100974088263,0.111849511446989,1.54652339684785e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST13,Hsc70-interacting protein,37671,0.0868142417640545,0.00545593615787788,0.0761206068946138,0.0975078766334952,1.75150030711237e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP10,Stromelysin-2,40341,-0.0911237718540402,0.00573407793250111,-0.102362564601742,-0.079884979106338,1.97066095648145e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,-0.0480245378117773,0.00302255947088924,-0.0539487543747202,-0.0421003212488344,2.03845733259195e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53,Cellular tumor antigen p53,39980,0.0654235834193971,0.00412191743382827,0.0573446252490937,0.0735025415897005,2.73801330920603e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC5,Glypican-5,40228,0.0848963176997328,0.00535591619877399,0.0743987219501358,0.0953939134493298,3.75611712729232e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPB1,Carboxypeptidase B,40536,0.0853000594228863,0.00538773455916803,0.0747400996869169,0.0958600191588556,4.93772228249022e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH1A1,Retinal dehydrogenase 1,40332,0.0798910049914756,0.00505177110051664,0.069989533634463,0.0897924763484882,6.6054000183437e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOA,Elongin-A,40305,0.0770752532785639,0.00487424342268798,0.0675217361700955,0.0866287703870323,6.7936762869396e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF3,Immunoglobulin superfamily member 3,40305,0.0521508472622033,0.0032999765199622,0.0456828932830774,0.0586188012413292,7.86390930794893e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,0.149307966663424,0.00945427245155308,0.13077759265838,0.167838340668468,9.49232636055963e-56
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS1,Galectin-1,40359,0.0507378121585669,0.00321679219493412,0.0444328994564961,0.0570427248606378,1.26362818708217e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP3,Metalloproteinase inhibitor 3,40422,0.198656948269138,0.0126173814639479,0.1739268805998,0.223387015938476,1.95007041285628e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,40044,0.0906966987996259,0.00576281859555868,0.0794015743523309,0.101991823246921,2.20617869045677e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.0405691225473298,0.00258512593729168,0.0355022757102381,0.0456359693844214,4.37462553826657e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFB2,BPI fold-containing family B member 2,37951,0.101992042258436,0.00650335626892591,0.0892454639713416,0.114738620545531,6.03577010653054e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRADD,Death domain-containing protein CRADD,40192,0.114754688097772,0.00732289027006319,0.100401823168448,0.129107553027096,6.24090908078887e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2,Prothrombin,38013,0.0220961166909964,0.00140915409397775,0.0193341746668,0.0248580587151927,6.24924918434518e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,0.133919526142907,0.00855017965999444,0.117161174009318,0.150677878276496,7.00690871060712e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,0.0478361600940794,0.00305219511835543,0.0418538576621028,0.0538184625260561,7.08045238946377e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,0.117400048891991,0.00749614787387239,0.102707599059201,0.132092498724781,7.30109544268889e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLG,Plasminogen,37705,0.0336225112434072,0.00214642391244291,0.0294155203750191,0.0378295021117953,8.20570467960129e-55
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,0.120641733218129,0.0077115501440252,0.105527094935839,0.135756371500418,1.1289241527027e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPP,Lipoma-preferred partner,37562,0.100432115909193,0.00643408288805336,0.087821313448608,0.113042918369777,1.94015655313935e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GLB2,Endophilin-B2,37942,0.100129517938545,0.00641759598680821,0.087551029804401,0.112708006072689,2.09573483216486e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUB1,NEDD8 ultimate buster 1,40341,0.12452766093339,0.00798696668131228,0.108873206238018,0.140182115628762,2.10804978526608e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,0.0844156691563207,0.00541670286610845,0.0737989315387481,0.0950324067738933,2.34953062864433e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,YJU2,Splicing factor YJU2,37900,0.0477489674552631,0.00306637355886032,0.0417388752798969,0.0537590596306294,3.36262092507046e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,RFC4,Replication factor C subunit 4,37900,0.0306090899593813,0.00196755795612101,0.0267526763653841,0.0344655035533785,4.22751247789088e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMNL1,Formin-like protein 1,39961,0.0891731592569484,0.00573600250252425,0.0779305943520008,0.100415724161896,4.31902167155767e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,APPL2,DCC-interacting protein 13-beta,37671,0.166263642938975,0.0106904854650327,0.14531029142751,0.187216994450439,4.60784895815759e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,0.115497182012028,0.00743149192635728,0.100931457836367,0.130062906187688,5.46524901272986e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40453,0.0622611089531878,0.00401750414714301,0.0543868008247875,0.0701354170815881,8.87396032581603e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,0.0440930585154104,0.00284615771726342,0.0385145893895741,0.0496715276412467,9.66859361634966e-54
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK2A1,Casein kinase II subunit alpha,37959,-0.0672001922186578,0.00434066224913525,-0.0757078902269629,-0.0586924942103527,1.33352069004851e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBXN1,UBX domain-containing protein 1,37671,0.102450303636204,0.0066197170666404,0.0894756581855887,0.115424949086819,1.47283834857059e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAX,Protein max,39961,0.154523227681709,0.00999762904926404,0.134927874745152,0.174118580618267,1.72202590881974e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,40357,0.0743825775550374,0.00481457861716348,0.064946003465397,0.0838191516446778,1.86050683216654e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRY2,Protein sprouty homolog 2,40044,0.136036963767257,0.00882184873956061,0.118746140237718,0.153327787296796,2.94802207507103e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUS,RNA-binding protein FUS,39960,0.0581705656764706,0.00377395093430567,0.0507736218452315,0.0655675095077097,3.28374761928341e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESYT2,Extended synaptotagmin-2,37942,0.120470480434017,0.0078183358778709,0.10514654211339,0.135794418754644,4.05210502697764e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,0.154031618851861,0.010004079209528,0.134423623601186,0.173639614102536,4.15305566685484e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37598,0.0848527556652263,0.00551219379691351,0.0740488558232758,0.0956566555071768,5.23328150830134e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,DFFA,DNA fragmentation factor subunit alpha,40516,0.0997436334868951,0.00649817047913805,0.0870072193477845,0.112480047626006,8.45915974981953e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY4,Protein canopy homolog 4,40305,0.109708437714956,0.00714723042632348,0.0956998660793616,0.12371700935055,8.5184939832966e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLG4,Disks large homolog 4,37942,0.103191230383466,0.00671994873271359,0.0900201308673478,0.116362329899585,9.02596027226462e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIP,Gastric inhibitory polypeptide,37628,0.0761268579046134,0.00495706079651361,0.0664110187434467,0.08584269706578,9.06634731003163e-53
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX2,Heme oxygenase 2,39961,0.0669594318258269,0.00436687371015791,0.0584003593539174,0.0755185042977364,1.11188515910349e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILPL2,RILP-like protein 2,37990,0.142803046519805,0.00931565308563173,0.124544366471967,0.161061726567644,1.34527307064166e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40471,0.0981344147891902,0.00641427648603293,0.0855624328765656,0.110706396701815,1.81345878851332e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS2,Trypsin-2,40403,0.0734013805608086,0.00479971961076844,0.0639939301237025,0.0828088309979148,2.00901338196393e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTUD6B,Deubiquitinase OTUD6B,37901,0.0860689131450884,0.00564094832670748,0.0750126544247418,0.0971251718654351,3.98436581090262e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,0.140577277221563,0.0092205568327648,0.122504985829344,0.158649568613782,4.08715221571189e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37562,0.0989515966247254,0.00648686191048701,0.0862373472801709,0.11166584596928,4.32377502104891e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM17,Splicing factor 45,37959,0.111412725815657,0.00731303208554641,0.0970791829279856,0.125746268703328,5.61378301718251e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,0.123176664868862,0.00809535130693812,0.107309776307263,0.139043553430461,6.58443975167003e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA11,Annexin A11,40312,0.097984285261196,0.00644515409132186,0.0853517832422051,0.110616787280187,7.85942780558951e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",40042,0.135405193693505,0.00891050159723481,0.117940610562925,0.152869776824085,8.81220492982987e-52
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,0.151201291163955,0.00995013670358473,0.131699023224929,0.170703559102982,1.0289284570144e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,40305,0.0814704649219142,0.00536700504655481,0.0709511350306668,0.0919897948131617,1.10959662533219e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,40411,0.0483211461908671,0.00318371818788659,0.0420810585426094,0.0545612338391248,1.14217807850568e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDC,Nuclear migration protein nudC,40516,0.0917097621200483,0.00605350499437329,0.0798448923310766,0.10357463190902,1.72249151711778e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,0.0401201272638791,0.00264809197267237,0.0349298669974413,0.045310387530317,1.72255002368785e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADD1,Alpha-adducin,37671,0.101965006425898,0.00672714504865896,0.0887798021305263,0.115150210721269,1.83596534649022e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,0.112153692008318,0.0074121939868995,0.0976257917939954,0.126681592222641,2.30788829259288e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTBDN,Retbindin,40305,0.0423213119255877,0.00279903854001654,0.0368351963871553,0.0478074274640201,2.72595722930171e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIFBP,KIF-binding protein,40305,0.119025684841432,0.00787585028560765,0.103589018281641,0.134462351401223,3.03634434765034e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,BIN2,Bridging integrator 2,40332,0.131098218283592,0.00868371726932796,0.114078132435709,0.148118304131475,3.83606241340033e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPACT,Protein IMPACT,37942,0.0823847290980671,0.00545532698412664,0.0716922882091789,0.0930771699869553,4.12769500854831e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARC,SPARC,40411,0.1022308055868,0.00677668000197415,0.088948512782931,0.11551309839067,4.52621608756677e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX4,Syntaxin-4,40305,0.0860960323451973,0.00571223926463368,0.0749000433865153,0.0972920213038793,5.56459050789763e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATOX1,Copper transport protein ATOX1,40411,0.103391202048113,0.00686625823135105,0.0899333359146651,0.116849068181561,6.85484539494432e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,PF4,Platelet factor 4,37934,0.140361190562097,0.00931840598386207,0.122097114833727,0.158625266290466,7.37401386087441e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL3,C-C motif chemokine 3,40341,0.088620262995361,0.00589092242937401,0.077074055033788,0.100166470956934,8.51780660581872e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,0.0983379189674765,0.00653372212282567,0.0855318236067382,0.111144014328215,9.04110664859964e-51
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD226,CD226 antigen,37598,0.0604100230035742,0.00401652530862741,0.0525376333986645,0.068282412608484,1.05405403312695e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA1,Carboxypeptidase A1,40536,0.0822698254990374,0.00547598433002529,0.0715368962121879,0.093002754785887,1.13247098938307e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,YWHAQ,14-3-3 protein theta,37671,0.106159648229304,0.00707136127915086,0.0922997801221685,0.12001951633644,1.58270585116633e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0417636987915562,0.00278616831722503,0.0363028088897951,0.0472245886933172,1.88176715505873e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPBP,Platelet basic protein,37934,0.120528108305926,0.00803928442169082,0.104771110839412,0.13628510577244,2.09680694593436e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,0.138947965452312,0.009269016931881,0.120780692265826,0.157115238638799,2.15259190699714e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,0.111691649474083,0.00745901357752023,0.0970719828621436,0.126311316086023,2.43687674119659e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,40400,0.10215050046359,0.00682355012576131,0.0887763422170975,0.115524658710082,2.52245295703896e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRAS,Ras-related protein R-Ras,37572,0.18720239356443,0.0124982389726261,0.162705845178083,0.211698941950777,2.64968133150427e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0372811269983609,0.0024895334100749,0.0324016415146141,0.0421606124821077,2.76513639456934e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN3,Ataxin-3,37942,0.0894595917062241,0.00597821673545987,0.0777422869047228,0.101176896507725,3.17776860350084e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,40305,0.0463355201025332,0.00309854686183553,0.0402623682533356,0.0524086719517309,3.22835070292552e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,0.126911196248326,0.00848869437815734,0.110273355267138,0.143549037229514,3.47046658118639e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRAP2,GRB2-related adapter protein 2,40359,0.180960063559481,0.0121340388723727,0.15717734736963,0.204742779749331,5.86402610175982e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACYBP,Calcyclin-binding protein,37642,0.146604441199766,0.00982353620294068,0.127350310242002,0.16585857215753,5.89627882535654e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,0.10925534189563,0.00732924034207623,0.0948900308251605,0.123620652966099,6.59153715200985e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL3,Angiopoietin-related protein 3,40355,0.0517435273205532,0.00347233372934934,0.0449377532110285,0.0585493014300779,6.97821244218069e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,0.120060385984683,0.00805266615314912,0.104277160324511,0.135843611644855,7.27512807275665e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD2,Polycystin-2,37562,0.0852009112409488,0.00571586126313044,0.0739978231652132,0.0964039993166845,7.70137149595494e-50
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED8,Protein TMED8,37901,0.14644024688043,0.0098411850260013,0.127151524229467,0.165728969531392,1.09818658758661e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,0.0948536593047857,0.00637487861419553,0.0823588972209625,0.107348421388609,1.12964402583825e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,0.157301426362022,0.0105795104455898,0.136565585888666,0.178037266835378,1.13427482505616e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,0.0703780801430734,0.00473062914044669,0.0611060470277979,0.079650113258349,1.16644320108625e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN3,Centrin-3,37901,0.109385748495542,0.00735830248620465,0.094963475622581,0.123808021368503,1.36352637974816e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD207,C-type lectin domain family 4 member K,40029,0.0546083100971017,0.00367705303915702,0.0474012861403539,0.0618153340538495,1.49340405848386e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,0.0817729773795457,0.00550767739209487,0.0709779296910398,0.0925680250680517,1.56896344028602e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37628,0.104515749858467,0.00704348559806073,0.0907105180862676,0.118320981630666,2.06381968280126e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCB,Tubulin-folding cofactor B,40228,0.143444138858199,0.00967750140475444,0.124476236104881,0.162412041611518,2.25407899453209e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGF,Pro-epidermal growth factor,40324,0.145705312311995,0.00983684752000507,0.126425091172785,0.164985533451205,2.60774142299169e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R2,Interleukin-1 receptor type 2,40330,0.0276533844154837,0.00186946159411564,0.0239892396910171,0.0313175291399504,3.49728807323098e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,0.0671802618520201,0.004540824328067,0.0582802461690088,0.0760802775350314,3.83979410455289e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4D,Semaphorin-4D,40471,0.0422438744716532,0.00285728184096794,0.036643602063356,0.0478441468799503,3.87963087575787e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKG1,cGMP-dependent protein kinase 1,37671,0.177446614137018,0.0120020509624402,0.153922594250635,0.200970634023401,4.53212616182404e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGBP1,Immunoglobulin-binding protein 1,37959,0.0867150834487637,0.00587169396480409,0.0752065632777477,0.0982236036197798,5.647601983775e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2,Microtubule-associated protein 2,37942,0.0649433934412784,0.00439813551981696,0.0563230478224372,0.0735637390601197,5.83879518826351e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,0.131340761113707,0.00890031897162167,0.113896135929329,0.148785386298086,6.67621031967346e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,MENT,Protein MENT,37671,-0.0306881332920172,0.00207946883945876,-0.0347638922173563,-0.026612374366678,6.7227392756367e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,PENK,Proenkephalin-A,37671,0.0436448398442423,0.00295804573562543,0.0378470702024165,0.0494426094860681,7.02944398708824e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,37901,0.117674109520249,0.00798088961911259,0.102031565866788,0.133316653173709,8.02640969639458e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,AP2B1,AP-2 complex subunit beta,37572,0.0691479642099483,0.0046902632322695,0.0599550482747001,0.0783408801451965,8.39769321231786e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM3,Junctional adhesion molecule C,37671,0.0715768126259763,0.00485520273941316,0.0620606152567265,0.0810930099952261,8.41322694972317e-49
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,40328,0.0512229278943965,0.00348113781693131,0.0443998977732111,0.0580459580155819,1.08993024193513e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,0.0769895185621464,0.00524264147626242,0.066713941268672,0.0872650958556207,1.68923909571068e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,40359,0.0496210339731752,0.00338003987548366,0.0429961558172272,0.0562459121291232,1.78117855556247e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,37572,0.114102847357038,0.00776921592291932,0.0988751841481164,0.12933051056596,1.90540862876792e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINE2,Glia-derived nexin,37990,0.0903393258407124,0.00615384806257341,0.0782777836380685,0.102400868043356,2.03509250128859e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX8,Syntaxin-8,40341,0.0685456629281832,0.00467815762518137,0.0593764739828277,0.0777148518735387,2.69100749884497e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4A,C-type lectin domain family 4 member A,40341,-0.0482246297270799,0.0032958289728666,-0.0546844545138984,-0.0417648049402613,3.61089345029586e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK24,Serine/threonine-protein kinase 24,39961,0.086563550518257,0.0059168593254745,0.074966506240327,0.098160594796187,3.78476075214154e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37863,0.0608158048028018,0.00416062422294644,0.0526609813258268,0.0689706282797769,5.1201944187687e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,40396,-0.118651431827002,0.00812299387830297,-0.134572499828476,-0.102730363825528,5.18676374825357e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,OCLN,Occludin,37959,0.0611121676216316,0.00418238097085282,0.0529147009187601,0.0693096343245031,5.4851908456464e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFA,Platelet-derived growth factor subunit A,40536,0.100391675527865,0.00688085800531045,0.0869051938374563,0.113878157218273,6.58025747788242e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,0.12132598135274,0.00831093339361809,0.105036551901248,0.137615410804231,6.68621613931677e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANG,Angiogenin,40309,0.0481138491915574,0.0032993315232064,0.0416471594060729,0.054580538977042,7.36346871566469e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.0372371042477881,0.00255379363308036,0.0322316687269506,0.0422425397686256,7.53574465372635e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,0.0809105572734231,0.00554878897978513,0.0700349308730442,0.0917861836738019,7.61060529615651e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEXN,Nexilin,37987,0.0953884221745744,0.00654410937442383,0.0825619678007037,0.108214876548445,9.1522687085152e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,0.080717896211916,0.00554188124900709,0.0698558089638621,0.0915799834599699,9.67119937884005e-48
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,0.0736757332502817,0.00506061250200474,0.0637569327463525,0.083594533754211,1.0608942736017e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,0.0759086836782862,0.00521469585036714,0.0656878798115666,0.0861294875450058,1.07563100867928e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,REEP4,Receptor expression-enhancing protein 4,37959,0.0867954776139769,0.0059603725203381,0.0751131474741142,0.0984778077538396,1.12395578796401e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEPR,Leptin receptor,40359,-0.0427316840885333,0.00293627983701268,-0.0484867925690781,-0.0369765756079884,1.13165333231464e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPI,Glucose-6-phosphate isomerase,37987,0.0652993693925963,0.00448624384796345,0.0565063314505879,0.0740924073346046,1.23434344042129e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROD,Uroporphyrinogen decarboxylase,37671,0.0981984780718907,0.00674759592528186,0.0849731900583382,0.111423766085443,1.30225192795816e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,POSTN,Periostin,37998,-0.0528759490998518,0.00363473775178915,-0.0600000350933585,-0.0457518631063451,1.38557656816694e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,0.0803489370066278,0.00552577862278817,0.069518410905963,0.0911794631072926,1.53368643062462e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGL1,Fibrinogen-like protein 1,37987,-0.08744463223138,0.00601869931484959,-0.0992412828884852,-0.0756479815742748,1.8108105325079e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,40359,0.0943508163738472,0.00649973033743914,0.0816113449124665,0.107090287835228,1.92571261245308e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOT,Angiomotin,37671,0.0580058007929271,0.00400272317096193,0.0501604633778417,0.0658511382080125,3.15072093156338e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,37687,0.0893680409343079,0.00616989862190865,0.077275039635367,0.101461042233249,3.48271894315068e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,0.106168815644178,0.00733754426924953,0.0917872288764486,0.120550402411907,3.77001401038074e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,0.0877457133669079,0.00606176694998436,0.0758646501449386,0.0996267765888773,3.98018088973762e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,0.110803165666482,0.00768149428587997,0.0957474368661576,0.125858894466807,8.06072672737658e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2L,Ataxin-2-like protein,37959,0.0667776781674206,0.00462984815977717,0.0577031757742573,0.0758521805605838,8.22239127371966e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP7,Caspase-7,37942,0.115865684852493,0.00803463311846035,0.10011780394031,0.131613565764675,8.53157350980076e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D5,TBC1 domain family member 5,40341,0.108167337199998,0.00750563779314279,0.0934562871254385,0.122878387274558,8.64421445291109e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,0.0797990384303267,0.00553713457083317,0.0689462546714937,0.0906518221891598,8.77977487181555e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37901,0.088839872349129,0.00616425555127673,0.0767579314686266,0.100921813229631,9.67951408645125e-47
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53I3,Quinone oxidoreductase PIG3,37419,0.0741400283503817,0.00514733548123849,0.0640512508071543,0.0842288058936091,1.12568985386212e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,UMOD,Uromodulin,40502,-0.0746240731223196,0.00519293929658674,-0.0848022341436296,-0.0644459121010095,1.54566418385751e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,37541,0.137438981649178,0.00956350205642389,0.118694517618587,0.156183445679769,1.77092165620652e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRL,Appetite-regulating hormone,40359,0.10839565603891,0.00754981303731364,0.0935980224857753,0.123193289592045,1.86857135467074e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,0.0803767577407535,0.00560217990140518,0.0693964851339993,0.0913570303475076,2.156542410114e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,0.117478811217377,0.00819725567921179,0.101412190086122,0.133545432348632,3.03647212313426e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIF,Macrophage migration inhibitory factor,40307,0.0944248430579928,0.00659900973510155,0.0814907839771937,0.107358902138792,3.72951939264476e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF19,Fibroblast growth factor 19,40422,0.104970380575961,0.00733996886517004,0.0905840416002279,0.119356719551694,4.14286638972804e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18,Interleukin-18,40292,0.0648372625492425,0.00453690293680246,0.0559449327931096,0.0737295923053753,4.80771523565306e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXJ3,Forkhead box protein J3,37598,0.0598956982877534,0.00419039889041122,0.0516825164625474,0.0681088801129594,5.30671305759258e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACTB2,Endoribonuclease LACTB2,40359,0.0902651709165863,0.00632008303566589,0.0778778081666811,0.102652533666491,5.43205961092472e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP10,Caspase-10,39961,0.0982038125873102,0.00687711444323971,0.0847246682785604,0.11168295689606,5.72052477994762e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,0.0901176135248241,0.00631812097958848,0.0777340964048307,0.102501130644818,7.06898286201839e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP2,Caspase-2,40341,0.0923452776607597,0.00647443831505792,0.0796553785632462,0.105035176758273,7.13646173033391e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGLL,Monoglyceride lipase,40396,0.117856596148031,0.00826385196528303,0.101659446296077,0.134053745999986,7.25831137613723e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB1,Leukocyte elastase inhibitor,40287,0.121449659187865,0.00851718225880671,0.104755981960604,0.138143336415126,7.53506758412064e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD22,B-cell receptor CD22,40516,0.0559645326664861,0.00392692193593643,0.0482677656720507,0.0636612996609215,8.34489926766547e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG6,Large proline-rich protein BAG6,40042,0.0490506361458062,0.003442298522205,0.0423037310422844,0.055797541249328,8.76658200869113e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK3,NT-3 growth factor receptor,40471,-0.0297985609923611,0.002091733255178,-0.03389835817251,-0.0256987638122123,9.05262079231518e-46
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,0.0642108613856321,0.00452104836185444,0.0553496065963974,0.0730721161748668,1.66624153236747e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,37628,0.0842733262661274,0.00593115561822368,0.072648261254409,0.0958983912778458,1.75585524584616e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CETN2,Centrin-2,39961,0.0912825778335116,0.00643859194416751,0.0786629376229433,0.10390221804408,2.42673498748638e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB33A,Ras-related protein Rab-33A,37562,0.0908007933174119,0.00640328433746984,0.078250356015971,0.103351230618853,2.6208545469955e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,EHD3,EH domain-containing protein 3,37628,0.159268616435788,0.0112438126034908,0.137230743732946,0.181306489138629,3.2380170524659e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK13,Kallikrein-13,40032,0.0588050896236651,0.00415492811590967,0.0506614305164821,0.0669487487308481,3.40545934494003e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37628,0.126714346644555,0.00895244640512951,0.109167551690501,0.144261141598609,3.76945209552351e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37990,0.0637304101800047,0.00450675815338562,0.0548971641993689,0.0725636561606405,4.43735768356244e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",37959,0.0836625625102175,0.00592021221117525,0.072058946576314,0.0952661784441209,5.06946053466577e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,37671,0.160470555463061,0.0113649257614049,0.138195300970708,0.182745809955415,6.08147204078927e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,0.135880873151637,0.00963746811448038,0.116991435647256,0.154770310656019,7.1573655800843e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,0.0607462485232626,0.0043126900549806,0.0522933760155007,0.0691991210310246,8.71520760096412e-45
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASSF2,Ras association domain-containing protein 2,39980,0.0741655198058621,0.00527078792777733,0.0638347754674185,0.0844962641443056,1.07656439639304e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIAPIN1,Anamorsin,40411,0.0858980317490186,0.00611445951739711,0.0739136910949203,0.097882372403117,1.45317467492423e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM3,Dynamin-3,37959,0.0738503775480898,0.00526282037439852,0.0635352496142687,0.0841655054819109,2.02265500723725e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,RILP,Rab-interacting lysosomal protein,40434,0.0809880839974984,0.00577585804585657,0.0696674022276196,0.0923087657673773,2.10089006842653e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.055013379243041,0.00392552341538627,0.0473193533488839,0.0627074051371981,2.35614015322602e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBKS,Ribokinase,39991,0.066657697053172,0.00475798626581799,0.0573320439721688,0.0759833501341753,2.53186473014644e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,FIS1,Mitochondrial fission 1 protein,40354,0.103609470755815,0.00739739846967534,0.0891105697552511,0.118108371756378,2.61889096254515e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,-0.0410509442304676,0.00293113221684682,-0.0467959633754873,-0.0353059250854478,2.65456940111754e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,THTPA,Thiamine-triphosphatase,37884,0.11902015704641,0.0084959447009758,0.102368105432498,0.135672208660323,2.8111488270345e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICALL2,MICAL-like protein 2,37572,0.0919566296764113,0.00656754680608049,0.0790842379364936,0.104829021416329,3.16732673132339e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,0.100902311551453,0.00722319981351587,0.0867448399169623,0.115059783185944,4.44483248234154e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTX3,Pentraxin-related protein PTX3,40341,-0.0657998104340451,0.0047113816699063,-0.0750341185070614,-0.0565655023610287,4.57032982664201e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT1,Angiopoietin-1,40263,0.113236366039175,0.00812839785207232,0.0973047062491135,0.129168025829237,7.46143819200608e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,0.0979664451456605,0.00703226380357692,0.0841832080906497,0.111749682200671,8.35456305042686e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB6,Serpin B6,40433,0.0796914655098254,0.0057254028197336,0.0684696759831475,0.0909132550365032,8.75661153890391e-44
NMR metabolomics,X23501.Triglycerides in Large VLDL,JPT2,Jupiter microtubule associated homolog 2,37901,0.117043667268817,0.00841367629366678,0.100552861733231,0.133534472804404,1.08827911268781e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP170,Centrosomal protein of 170 kDa,37628,0.103206037372977,0.00742283337639366,0.088657283955245,0.117754790790708,1.2200822439309e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO9B,Unconventional myosin-IXb,40044,0.0884319871779254,0.00636398515087755,0.0759585762822054,0.100905398073645,1.22455671029011e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,0.0429779579165081,0.00309412305225034,0.0369134767340974,0.0490424390989188,1.30828775870804e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSNL1,Visinin-like protein 1,37942,0.0499869346778409,0.00359766947493466,0.0429355025069689,0.0570383668487128,1.37006884138931e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37671,0.0726796739495764,0.00523116460045457,0.0624265913326854,0.0829327565664674,1.40213078722904e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,0.143905836927171,0.0103590023088865,0.123602192401753,0.164209481452588,1.41896176042266e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,0.0822852510982707,0.00592652959658303,0.070669253088968,0.0939012491075735,1.56913615218335e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRB1,Chymotrypsinogen B,40332,0.0707793627302192,0.00510227400336459,0.0607789056836246,0.0807798197768138,1.67667755509131e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARK7,Parkinson disease protein 7,40332,0.0710793669233841,0.00512918495706158,0.0610261644075434,0.0811325694392248,2.04135605978133e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB9,Serpin B9,40228,0.0445426876887423,0.00321567899971309,0.0382399568493047,0.05084541852818,2.22878909364221e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TADA3,Transcriptional adapter 3,37900,0.0517642289212644,0.00373508715844477,0.0444434580907127,0.0590849997518162,2.23233572289704e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCT5,T-complex protein 1 subunit epsilon,39980,0.0603382615491279,0.00435822058939133,0.0517961491939209,0.0688803739043349,2.47747707798457e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37598,0.121075557010949,0.00875128334158321,0.103923041661446,0.138228072360452,3.1399653079877e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40471,0.0460196113008972,0.00333234323871848,0.039488218553009,0.0525510040487854,3.91977648670138e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMT,Catechol O-methyltransferase,39877,0.112412727585645,0.00815514414557313,0.0964286450603217,0.128396810110968,5.69753861129756e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,F2R,Proteinase-activated receptor 1,40396,0.0758938153069328,0.00550668165736112,0.065100719258505,0.0866869113553606,5.75686907780546e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,0.135645759579124,0.009837285482839,0.11636468003276,0.154926839125488,5.90261171033351e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH9,Protocadherin-9,37901,0.0447344668045328,0.00324668791133662,0.0383709584983131,0.0510979751107526,6.71502794710133e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,0.0832602929538039,0.00604762802915688,0.0714069420166564,0.0951136438909514,7.01698263764918e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,F12,Coagulation factor XII,38013,0.0551929458577308,0.00400779205100983,0.0473376734377515,0.06304821827771,7.35653628799913e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATG4A,Cysteine protease ATG4A,39980,0.0785194334170309,0.00570764732964583,0.067332444650925,0.0897064221831367,8.2543762276095e-43
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,37987,0.0949960796038272,0.00691803583951926,0.0814367293583695,0.108555429849285,1.26648601684434e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37598,0.12164822830198,0.00886809469843961,0.104266762693039,0.139029693910922,1.56492349058563e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM2,Paralemmin-2,37942,0.0486893373101419,0.00354981341049707,0.0417317030255676,0.0556469715947161,1.56995570847868e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,0.0883126207977816,0.00644360159891597,0.0756831616639063,0.100942079931657,1.84649411263422e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,0.120516174394606,0.00880635904366339,0.103255710669026,0.137776638120186,2.16673203905657e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4G,C-type lectin domain family 4 member G,40341,0.0431447315536377,0.00315643129108269,0.0369581262231156,0.0493313368841597,2.70390667454705e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRGN,Neurogranin,37987,0.118664060275969,0.00868659745709152,0.101638329260069,0.135689791291868,3.32441814157081e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,40422,0.0501236602210808,0.00367219099782871,0.0429261658653365,0.0573211545768251,3.50433475692096e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",40411,0.080304175985888,0.00588480544616921,0.0687699573113964,0.0918383946603797,3.67624283093668e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,39980,0.0775965653322363,0.00569228514009455,0.066439686457651,0.0887534442068216,4.51969584367762e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGH,Gamma-glutamyl hydrolase,40077,0.0446781693581006,0.00328270573908417,0.0382440661094956,0.0511122726067055,6.04305591008352e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,APP,Amyloid-beta precursor protein,40309,0.0873536768694568,0.00642123682238548,0.0747680526975812,0.0999393010413323,6.5275697911017e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMTN,Smoothelin,37905,0.125785229843623,0.0092483128481172,0.107658536661313,0.143911923025932,7.47999762211855e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,0.146353380037714,0.010767900266811,0.125248295514764,0.167458464560664,7.79420025532938e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON2,Spondin-2,40267,-0.0449492372131514,0.00330983597471239,-0.0514365157235877,-0.0384619587027151,8.96293239943627e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,0.06212214394384,0.00457277672794019,0.0531595015570772,0.0710847863306028,9.21636900635404e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,0.143323533184433,0.0105561477982628,0.122633483499838,0.164013582869028,9.32349899999986e-42
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37900,0.0660934940138407,0.00486740146625851,0.056553387139974,0.0756336008877074,1.0074839624241e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,0.0550764227499097,0.0040594657612224,0.0471198698579138,0.0630329756419056,1.18478989252389e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMSB10,Thymosin beta-10,40332,0.0986355000964413,0.0072752678235695,0.084375975162245,0.112895025030637,1.21722328263629e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC22D1,TSC22 domain family protein 1,37959,0.0876089893935529,0.00646155437608109,0.0749443428164339,0.100273635970672,1.32044626147769e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,40042,0.0489945615876137,0.00362806511712708,0.0418835539580446,0.0561055692171828,2.51785366173167e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP3,Caspase-3,40536,0.1138994918627,0.008435989324814,0.0973649527860645,0.130434030939335,2.56876528724983e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD244,Natural killer cell receptor 2B4,40516,0.0344379208247016,0.00255350107508467,0.0294330587175357,0.0394427829318676,3.14615707408298e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,F11,Coagulation factor XI,37810,0.039160292981775,0.00290388006134782,0.0334686880615333,0.0448518979020167,3.53907531729806e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTF1,Cardiotrophin-1,40042,0.109280881790911,0.00810916865944956,0.0933869112183897,0.125174852363432,3.67031646072961e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB1,Heat shock protein beta-1,40116,0.0874911591807659,0.00649379086282436,0.0747633290896302,0.100218989271902,3.81968595230653e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPI,Mannose-6-phosphate isomerase,40305,0.110683006762162,0.0082209874616322,0.0945698713373632,0.126796142186961,4.31538040684631e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA4,Protein disulfide-isomerase A4,37998,0.0781851983770484,0.00580486168677603,0.0668076694709674,0.0895627272831295,4.38048836278781e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MESD,LRP chaperone MESD,40332,0.155942629707445,0.0115976403026089,0.133211254714332,0.178674004700559,5.44169466312521e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG2,Secretogranin-2,40392,0.0415997864266537,0.00309475347147853,0.0355340696225558,0.0476655032307516,5.73176330980992e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37928,0.0525056308253132,0.00390581682320208,0.0448502298518371,0.0601610317987893,6.21638066077481e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,0.0957572370981365,0.00713091478822583,0.0817806441132138,0.109733830083059,7.51805219595257e-41
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF1,Scavenger receptor class F member 1,40536,0.0543616971527647,0.00405883558394433,0.0464063794082338,0.0623170148972956,1.09142234430956e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL32,Interleukin-32,40341,-0.0547973058650717,0.00409591846088964,-0.0628253060484153,-0.046769305681728,1.339110450343e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,0.0514588722422426,0.0038455114708687,0.04392166975934,0.0589960747251453,1.40340404842481e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3BP,Galectin-3-binding protein,38013,0.038035361821015,0.00284321201403192,0.0324626662735124,0.0436080573685175,1.47727779177506e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL4,Angiopoietin-related protein 4,40396,-0.0584764129775464,0.00437660238793698,-0.0670545536579029,-0.0498982722971899,1.68408019365576e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2,Complement C2,40372,0.0306898140224414,0.00229738335156089,0.0261869426533821,0.0351926853915008,1.74338133338987e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6AP2,Renin receptor,39980,0.0534211192623931,0.00399988497164822,0.0455813447179626,0.0612608938068237,1.83551380627059e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,0.132264383672781,0.00990369298716088,0.112853145417946,0.151675621927617,2.00198919749861e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM106A,Transmembrane protein 106A,37900,0.0897402640216299,0.00672738521174356,0.0765545890066125,0.102925939036647,2.45872386305899e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,0.120585406887813,0.00904900169711944,0.102849363561458,0.138321450214167,2.69854786270587e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB2,Calretinin,39961,0.0402613612614072,0.00302221978697356,0.0343378104789391,0.0461849120438754,2.87833675788909e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,0.120128135685851,0.00902002573264142,0.102448885249874,0.137807386121828,2.99269643762204e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBI,Acyl-CoA-binding protein,40270,0.100648994767704,0.00756253194019482,0.0858264321649226,0.115471557370486,3.38014185795507e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37942,0.0679412995544645,0.00510539001540747,0.0579347351242658,0.0779478639846631,3.73656997684584e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,0.120556013495006,0.00906061574958478,0.10279720662582,0.138314820364193,3.85672956348148e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDCP1,CUB domain-containing protein 1,40228,0.0617019202725189,0.00465465369617684,0.0525787990280123,0.0708250415170255,6.81074203642878e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGCT,Gamma-glutamylcyclotransferase,37978,0.0615530836241886,0.00464176544608415,0.0524552233498636,0.0706509438985135,6.93866353377442e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,0.120554139207422,0.00909578061347717,0.102726409205007,0.138381869209837,7.00290657068683e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,GMFG,Glia maturation factor gamma,37990,0.0912301594760688,0.00688358862920873,0.0777383257628197,0.104721993189318,7.64664306897323e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK10,Kallikrein-10,40354,0.0499174211029086,0.00376842886705851,0.0425313005234739,0.0573035416823433,7.71463204445554e-40
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,0.101254453326341,0.00765361008142472,0.0862533775667481,0.116255529085933,1.06116660634847e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,0.0775741613140201,0.00586757154565256,0.0660737210845411,0.0890746015434991,1.18736238566964e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L1,Bcl-2-like protein 1,37942,0.126528195969363,0.00958605022581527,0.107739537526765,0.145316854411961,1.5587200130603e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA2,Apolipoprotein A-II,37987,-0.0602595861637605,0.00456596964889104,-0.0692088866755869,-0.051310285651934,1.58995673232802e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPSE,Heparanase,37848,0.117809553188238,0.00892770322289542,0.100311254871363,0.135307851505113,1.63285983715757e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL2,C-C motif chemokine 2,40203,0.0668828443110587,0.00507192840178906,0.0569418646435522,0.0768238239785653,1.69101891849437e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDT,D-dopachrome decarboxylase,37998,0.0518475248623125,0.00393047579497711,0.0441437923041574,0.0595512574204676,1.72793488565284e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37671,0.110558469636134,0.00838501276376362,0.0941238446191576,0.126993094653111,1.89275756342628e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOF,Apolipoprotein F,37987,-0.0305338844515903,0.00231729903352587,-0.035075790557301,-0.0259919783458796,2.09444739625903e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,0.12369591959119,0.00939896975226282,0.105273938876754,0.142117900305625,2.5786526776956e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,CERT,Ceramide transfer protein,39961,0.0775730710153131,0.00590138086570817,0.0660063645185251,0.0891397775121011,2.95150024499241e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,LARP1,La-related protein 1,37900,0.0801195796154374,0.00609677301728126,0.0681699045015662,0.0920692547293087,3.32886575471113e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAP,Prosaposin,37901,0.035898281382567,0.00273328236589279,0.0305410479454171,0.0412555148197169,3.6731183343008e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUGT1,Protein SGT1 homolog,39980,0.102467856839321,0.00780800435708631,0.0871641682994317,0.11777154537921,3.90454484946011e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTD,Deoxycytidylate deaminase,37671,0.119061037237174,0.00907160954336499,0.101280682532179,0.136841391942169,4.18011983618534e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.0582235926791297,0.0044382451291059,0.0495246322260821,0.0669225531321773,4.52642258159872e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,0.112979281302279,0.00861958553893789,0.0960848936459611,0.129873668958598,5.16836264950044e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7,Interleukin-7,40341,0.0807156548317048,0.00617839741657478,0.0686059958952182,0.0928253137681914,8.36000576899675e-39
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,0.0814632845096634,0.00624312892484134,0.0692267518169744,0.0936998172023525,1.11330312638229e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFB,Complement factor B,37770,0.0411091014247336,0.0031509566069988,0.034933226475016,0.0472849763744513,1.14744633026731e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM2,Neural cell adhesion molecule 2,40332,-0.0337481398240605,0.00259152205975168,-0.0388275230611738,-0.0286687565869472,1.43596411411593e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,0.0439576050076084,0.00337436022373133,0.037343858969095,0.0505713510461218,1.47126850237811e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,APLP1,Amyloid-like protein 1,40359,-0.0649374116806042,0.0049881405167364,-0.0747141670934076,-0.0551606562678009,1.51426318407781e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP5,Platelet glycoprotein V,37671,0.0449231842704566,0.0034489594621061,0.0381632237247286,0.0516831448161846,1.51996059940364e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCN1,Ficolin-1,37967,0.0704269721439664,0.00541551288246521,0.0598125668943346,0.0810413773935982,1.95708935148259e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAP3,Cytosol aminopeptidase,40044,0.061287336162988,0.00471875805260489,0.0520385703798824,0.0705361019460936,2.26271437367964e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,0.0817295163272616,0.00629300517820496,0.0693952261779798,0.0940638064765433,2.28649220051392e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP6,Platelet glycoprotein VI,40311,0.109501472197721,0.0084349546065393,0.0929689611689039,0.126033983226538,2.43132070721696e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP3R1,Calcineurin subunit B type 1,40228,0.0513940000318531,0.00396169549193622,0.0436290768676581,0.0591589231960481,2.74240183875293e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIABLO,"Diablo homolog, mitochondrial",40314,0.136016690415818,0.0104917925802348,0.115452776958558,0.156580603873078,3.05790215414994e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMVK,Phosphomevalonate kinase,39951,0.137718852737425,0.0106259752684266,0.116891941211308,0.158545764263541,3.23337268855225e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39980,0.0446859912947867,0.00345188593696788,0.0379202948583297,0.0514516877312438,3.92987137550114e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,0.0605348388970721,0.00469443011935471,0.0513337558631369,0.0697359219310073,8.13689267896041e-38
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,0.045079039707207,0.00350031025870712,0.0382184316001411,0.051939647814273,1.00154591552514e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,-0.0449394910511687,0.00349485273522091,-0.0517894024122017,-0.0380895796901357,1.29254409474046e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,0.0996936373751476,0.00776812617209582,0.0844681100778398,0.114919164672455,1.63098175511759e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,DXO,Decapping and exoribonuclease protein,37942,0.0565266644986757,0.00440404983957985,0.0478947268130992,0.0651586021842522,1.72639077613318e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA3,Annexin A3,40442,0.086085599877332,0.00671180685253514,0.0729304584463632,0.0992407413083009,1.79437730775829e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSS,Cathepsin S,37057,0.0303102291076816,0.00236532342850003,0.0256741951878216,0.0349462630275417,2.32882059024526e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,0.120159620295693,0.00938201193797026,0.101770876897271,0.138548363694115,2.48670462705497e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL4,C-C motif chemokine 4,40376,0.083066721439604,0.00649008679086841,0.0703461513295019,0.0957872915497061,2.53606495791683e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,40411,0.102729750858114,0.00802774835267974,0.0869953640868618,0.118464137629366,2.60520720473649e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,0.0353854742273045,0.00276436277338683,0.0299673231914664,0.0408036252631427,2.70891953719697e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,37562,0.0835798181608059,0.00653273136004446,0.0707756646951187,0.096383971626493,2.95779722114235e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,0.121648219858437,0.00951394014360478,0.103000897176972,0.140295542539903,3.2133587863533e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,NACC1,Nucleus accumbens-associated protein 1,37900,0.0674869093293658,0.00527981639360948,0.0571384691978912,0.0778353494608404,3.39932128687798e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37671,0.0447202585226017,0.00350879619613448,0.0378430179781782,0.0515974990670253,5.47301339823668e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,BDNF,Brain-derived neurotrophic factor,37998,0.101255450859895,0.00794706072222093,0.0856792118443423,0.116831689875448,5.68451673863747e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12A_IL12B,Interleukin-12,40305,0.0956408086535535,0.0075139724283557,0.0809134226939763,0.110368194613131,6.23463180228149e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZT1,Mitotic-spindle organizing protein 1,39980,0.0644091924805628,0.0050607902801438,0.0544900435314809,0.0743283414296446,6.39272294050618e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOXO3,Forkhead box protein O3,39980,0.118419665017379,0.00930486625426217,0.100182127159025,0.136657202875733,6.43039163820619e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.0363777014078856,0.00286057261104851,0.0307709790902305,0.0419844237255407,7.23270432578029e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCA,Calcitonin,40192,0.0670361831086757,0.00527661548149741,0.0566940167649408,0.0773783494524106,8.47465527886858e-37
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,0.0743629448810277,0.00586788302209832,0.062861894157715,0.0858639956043405,1.25725572150058e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT2A1,Bile salt sulfotransferase,40341,0.064612590246527,0.00510886505198766,0.0545992147446311,0.0746259657484228,1.7390157634472e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSTB,Cystatin-B,40097,0.0507574537242135,0.00401759041113739,0.0428829765183842,0.0586319309300427,2.07015611008091e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,0.074250965982692,0.00587805850392339,0.0627299713150022,0.0857719606503819,2.29305064881489e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,37598,0.10611776976075,0.00841926317029077,0.0896160139469801,0.12261952557452,3.24362108051826e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBN,Nibrin,40044,0.061644248740249,0.00489411900737251,0.0520517754857989,0.0712367219946991,3.35127800385202e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,0.0772827979994904,0.00613909973433345,0.0652501625201969,0.089315433478784,3.62776435511709e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,0.0663061004452246,0.0052696503653107,0.0559775857292156,0.0766346151612336,3.92320900847653e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBCA,Tubulin-specific chaperone A,37671,0.105351742005982,0.00837292487546984,0.0889408092500609,0.121762674761903,4.24687739936534e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.0377918079969988,0.00300389505549541,0.0319041736882278,0.0436794423057698,4.2976104943576e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG3,Proteasome assembly chaperone 3,40341,0.0618238147986758,0.00491767462777918,0.0521851725282286,0.071462457069123,4.48356912605947e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB2,Lysosome membrane protein 2,40011,0.0372334786104894,0.00296160673035817,0.0314287294189873,0.0430382278019914,4.50435901517719e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEMIP2,Cell surface hyaluronidase,37598,0.0408030937890715,0.00324774842482843,0.0344375068764077,0.0471686807017352,5.39477753862438e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,0.0690115210482091,0.00549675388059589,0.0582378834422411,0.079785158654177,5.51530662087384e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP7,Matrilysin,40015,0.0580448192749405,0.00463337768976671,0.0489633990029978,0.0671262395468833,7.8574648826244e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERMAP,Erythroid membrane-associated protein,37598,0.0540869632124449,0.00431594422669544,0.0456277125281218,0.062546213896768,8.00271710913388e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,C19orf12,Protein C19orf12,39961,0.0746931850620596,0.00596450880781502,0.0630027477987422,0.0863836223253771,8.33302818578861e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,0.0448371880323488,0.00358228302686039,0.0378159132997024,0.0518584627649952,8.92163458042382e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL16,C-X-C motif chemokine 16,40517,0.0285262698522912,0.00227912671262975,0.0240591814955368,0.0329933582090455,8.92770345248676e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1,Allograft inflammatory factor 1,39980,0.0633470452269216,0.00506393335650221,0.0534217358481773,0.073272354605666,9.85414181305599e-36
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL18,C-C motif chemokine 18,40172,0.0843271211379528,0.00674313261754179,0.0711105812075709,0.0975436610683347,1.02856126865135e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,0.0917681141577774,0.0073375721189882,0.0773864728045605,0.106149755510994,1.0835376252651e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3B,Protein FAM3B,40305,0.0432539714522688,0.00346188825469251,0.0364686704730715,0.0500392724314661,1.18017616347704e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1RL,Complement C1r subcomponent-like protein,37993,0.0232440663579796,0.00186322990987194,0.0195921357346306,0.0268959969813286,1.59911388688153e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,0.0811979755849389,0.00651420987684232,0.068430124226328,0.0939658269435499,1.71863718925339e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37959,0.15024568568447,0.012069002507951,0.126590440768886,0.173900930600054,2.2169212409958e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,0.12895552128159,0.0103646799113448,0.108640748655354,0.149270293907826,2.48192666906394e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB1,Beta-crystallin B1,37990,0.0774271939466042,0.00622575737824576,0.0652247094852425,0.0896296784079659,2.5789471704098e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,40042,0.131734284192598,0.0106112881567895,0.110936159405291,0.152532408979906,3.19734252002689e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP5,Microfibrillar-associated protein 5,40536,0.0487666697868698,0.00393450633695677,0.0410550373664345,0.0564783022073051,4.0434784489732e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,40422,0.0338517639346915,0.00273271007572433,0.0284956521862718,0.0392078756831112,4.41984670175383e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,0.0425301328599953,0.00343170836108985,0.0358039844722592,0.0492562812477314,4.46440686870775e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,37572,0.0513579632943988,0.00414626435318709,0.0432312851621521,0.0594846414266455,4.85043953189981e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL8,C-C motif chemokine 8,40470,0.0717213778296327,0.00579553967776246,0.0603621200612183,0.0830806355980471,5.14163501519381e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGLAP,Osteocalcin,37998,0.108472838730458,0.00877425906096035,0.0912752909709755,0.12567038648994,6.42272155936933e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,WDR46,WD repeat-containing protein 46,37900,0.0422688283490978,0.00342101978774956,0.0355636295651087,0.048974027133087,7.02205211191505e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,0.105083532558539,0.00850731216312007,0.0884092007188233,0.121757864398254,7.30796623955342e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,RP2,Protein XRP2,40305,0.048903865220463,0.00396080300586572,0.0411406913289662,0.0566670391119598,7.31610731773669e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA2,Carboxypeptidase A2,40398,0.0758631990756623,0.00615121007230175,0.0638068273339508,0.0879195708173737,8.66245851587518e-35
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3C,Protein FAM3C,40330,0.0350504076486593,0.00284649539948816,0.0294712766656625,0.040629538631656,1.1027624386125e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,0.0571350454592126,0.00464121276319828,0.048038268443344,0.0662318224750813,1.14274138960246e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.103868165934028,0.00844032152949282,0.0873251357362217,0.120411196131834,1.2045703418712e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,0.102105781986187,0.00829598716245059,0.0858456471477841,0.11836591682459,1.26040068692904e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,0.0755548650696149,0.00614390493570215,0.0635128113956386,0.0875969187435911,1.35347332163246e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,0.103723896956933,0.00843485028878299,0.0871915903909188,0.120256203522948,1.35864218060719e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,0.139926463309267,0.0113952726631219,0.117591728889549,0.162261197728986,1.67345326867775e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA4,Carbonic anhydrase 4,40536,-0.0274988586496695,0.00224229692366737,-0.0318937606200576,-0.0231039566792815,2.02139111580399e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP1,Syntaxin-binding protein 1,37959,0.0911825990560955,0.00743558422321055,0.0766088539786028,0.105756344133588,2.1800471982555e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40490,0.0376603337456291,0.00307476395222525,0.0316337963992676,0.0436868710919906,2.44539624455816e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD4B,FERM domain-containing protein 4B,37562,0.0830605537321634,0.00677804431878726,0.0697755868673403,0.0963455205969864,2.4535233842666e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB10,Ras-related protein Rab-10,37990,0.0631696638126053,0.00515648651109332,0.0530629502508624,0.0732763773743482,2.5361931513725e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,0.0723902591126978,0.00591409701074341,0.0607986289716408,0.0839818892537549,2.72465044648403e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD72,B-cell differentiation antigen CD72,37671,0.0498496546277163,0.00407315560748828,0.0418662696370392,0.0578330396183933,2.96301897214771e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSNAX,Translin-associated protein X,37562,0.046355076787237,0.003798227595778,0.0389105506995121,0.0537996028749619,4.50669413021601e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA1,Paraneoplastic antigen Ma1,37628,0.0656598247566549,0.00538036828707969,0.0551143029139787,0.0762053465993311,4.54129738748137e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1R,Complement C1r subcomponent,38013,0.0233284905216788,0.00191393062670403,0.0195771864933389,0.0270797945500187,5.37145620747473e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,37901,0.114602244572103,0.0094039426174091,0.0961705170419808,0.133033972102224,5.53341247212429e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBN1,Drebrin,37598,0.0605054753839927,0.00497529368927196,0.0507538997530197,0.0702570510149658,7.60199923638689e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G4A,Cytosolic phospholipase A2,40422,0.101496695587097,0.00835374300103138,0.0851233593050753,0.117870031869118,8.10404418159887e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37879,0.0823367304289137,0.0067741849457653,0.0690593279352137,0.0956141329226136,8.17306913214444e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37562,0.0813514553629234,0.00669289843576697,0.0682333744288202,0.0944695362970267,8.21316937499536e-34
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,0.0863427030254656,0.00711391238986909,0.0723994347413222,0.100285971309609,1.00447647120667e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMMT,MICOS complex subunit MIC60,37900,0.0518088060570698,0.00427325847866411,0.0434332194388881,0.0601843926752514,1.1813290380179e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,40234,0.0343526778242556,0.00283565058498224,0.0287948026776904,0.0399105529708208,1.24702146898251e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF6,SLAM family member 6,39980,0.0442157794498715,0.00365028611770796,0.0370612186591639,0.0513703402405791,1.27854437269075e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,37628,0.065334726876931,0.0053935200916388,0.0547634274973189,0.075906026256543,1.35038001930753e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD274,Programmed cell death 1 ligand 1,40228,0.0403380275800914,0.00333481995601388,0.0338017804663042,0.0468742746938786,1.56034708821501e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,40422,0.0486229892196562,0.00402640840403834,0.040731228747741,0.0565147496915713,1.97753204684146e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37901,0.0893549078421001,0.00739929005423501,0.0748522993357995,0.103857516348401,2.10173286325067e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARSA,Arylsulfatase A,40332,0.0515832433680285,0.00427750613824601,0.0431993313370663,0.0599671553989907,2.4263835380648e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,FADD,FAS-associated death domain protein,40359,0.088188224919847,0.0073229418107758,0.0738352589707264,0.102541190868968,2.95550055933645e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS3,Galectin-3,40374,0.0340978815506229,0.00283859553486239,0.0285342343022926,0.0396615287989531,4.26018486595189e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,0.0654252142799612,0.00544977570673545,0.0547436538947597,0.0761067746651627,4.97032866342545e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,0.0612985032835691,0.00510738576815519,0.0512880271779849,0.0713089793891533,5.16336504235341e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTF2,Transcription termination factor 2,37572,0.0561535313779562,0.00467902606330628,0.0469826402938759,0.0653244224620365,5.21816950081865e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,LONP1,"Lon protease homolog, mitochondrial",37628,0.0999948602697149,0.0083419052732443,0.083644725934156,0.116344994605274,6.16233358278803e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,0.054602279043585,0.00455546253393418,0.045673572477074,0.0635309856100959,6.23203352140523e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,37959,0.0569881324476332,0.00475933541268554,0.0476598350387696,0.0663164298564969,7.1351674219933e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,40063,0.0487755036348882,0.00407553733888124,0.040787450450681,0.0567635568190955,7.29034156922497e-33
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGR,Tyrosine-protein kinase Fgr,39961,0.0632893797079098,0.00530955187516473,0.0528826580325869,0.0736961013832327,1.29391334015796e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37990,0.0811503454128561,0.00680903151580049,0.0678046436418871,0.094496047183825,1.38713477983272e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37942,0.052595018689692,0.0044147100789769,0.0439421869348973,0.0612478504444867,1.46453596659471e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRD1,Natural killer cells antigen CD94,40516,0.0520817430423536,0.00437926038988586,0.0434983926781773,0.0606650934065299,1.76541149107736e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMPER,BMP-binding endothelial regulator protein,37671,0.0257020973630389,0.00216150176395397,0.0214655539056891,0.0299386408203887,1.93236889722549e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,ING1,Inhibitor of growth protein 1,39925,0.050895102111595,0.00428735769833285,0.0424918810228626,0.0592983232003274,2.31478107496063e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL11,C-X-C motif chemokine 11,40471,0.0905134566229681,0.00763081985778964,0.0755570497017004,0.105469863544236,2.5594548277307e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACYP1,Acylphosphatase-1,37622,0.0754172066688014,0.00636083247909161,0.0629499750097818,0.0878844383278209,2.90532685968492e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,0.043404854398766,0.00366298734263289,0.0362253992072056,0.0505843095903265,2.94697880820932e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPP1,Tripeptidyl-peptidase 1,40255,0.0507900665602207,0.00429057564045931,0.0423805383049205,0.059199594815521,3.41304921703736e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRG1,Scrapie-responsive protein 1,37990,0.0312474326696979,0.00263944634257844,0.0260741178382442,0.0364207475011517,3.55138648181643e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PARD3,Partitioning defective 3 homolog,37714,0.0845595289140369,0.00714617367201944,0.0705530285168788,0.098566029311195,3.8312780949327e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,-0.132596280823623,0.0112181104065772,-0.154583777220514,-0.110608784426731,4.21093309701661e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,40044,0.0752276895942852,0.00636716011342052,0.062748055771981,0.0877073234165895,4.47726354866438e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML2,Trem-like transcript 2 protein,40332,0.0379984551970879,0.00321887106709078,0.0316894679055899,0.0443074424885858,5.01195259753073e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,0.0470060314765552,0.00398054001769679,0.0392041730418695,0.054807889911241,5.08207598983341e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39897,0.0649073538668255,0.00550070445531577,0.0541259731344066,0.0756887345992444,5.36687495755752e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN2,Dynactin subunit 2,40305,0.106429296442729,0.00902078511090865,0.0887485576253485,0.12411003526011,5.42461807208375e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39961,0.0752934264859675,0.00638674937832034,0.0627753977044597,0.0878114552674754,6.08801774171862e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRD2,Protein ZNRD2,37901,0.0770471849171989,0.00654439699732885,0.0642201668024343,0.0898742030319634,7.70640941804974e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,37815,0.0350497671366464,0.00298151174532733,0.0292060041158048,0.040893530157488,9.46106418899548e-32
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD84,SLAM family member 5,40341,0.0347134633164177,0.00295739546705234,0.0289169682009951,0.0405099584318403,1.10197132660513e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,40305,0.0605853414787935,0.00516195988020161,0.0504679001135984,0.0707027828439887,1.11522789811536e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFL7,Epidermal growth factor-like protein 7,39980,0.0454292920641863,0.00387707176682018,0.0378302314012188,0.0530283527271539,1.40946748492177e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM1,Probable carboxypeptidase X1,40411,0.0772594832430473,0.00660058009395748,0.0643223462588907,0.090196620227204,1.61741188599322e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF2,Fibroblast growth factor 2,40341,0.0743228283893331,0.00635732062361046,0.0618624799670566,0.0867831768116096,1.90835471800431e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37990,0.0668760142916603,0.00573258856602731,0.0556401407022468,0.0781118878810738,2.6862789386989e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSR1,Macrophage scavenger receptor types I and II,40471,0.0499935598288827,0.00429373089381283,0.0415778472770096,0.0584092723807559,3.31209414444504e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA4,Ephrin-A4,40203,0.0329128443734773,0.00282757024541746,0.0273708066924591,0.0384548820544955,3.4629745487345e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLNK,B-cell linker protein,37598,0.0429348442279472,0.00368859539236013,0.0357051972589214,0.0501644911969731,3.67283229557986e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,FEN1,Flap endonuclease 1,39980,0.0692579974514779,0.00595433167413143,0.0575875073701803,0.0809284875327755,3.83595747708134e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,0.133437786066279,0.011493107910577,0.110911294561548,0.15596427757101,4.87440391100829e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREH,Trehalase,37998,0.0831611786330965,0.00716138127535277,0.069124871333405,0.0971974859327879,4.99691230810986e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12B,Interleukin-12 subunit beta,40516,0.0603993022953778,0.00521200877963923,0.0501837650872849,0.0706148395034707,6.25733226256715e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,0.0858572918181879,0.00740587953852122,0.0713417679226863,0.100372815713689,6.26424719832062e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PQBP1,Polyglutamine-binding protein 1,39980,0.0614197738587221,0.00530063456119663,0.0510305301187767,0.0718090175986675,6.40971068691831e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,0.0440473208328643,0.0038040997558991,0.036591285311302,0.0515033563544265,7.37530413811435e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,0.0753323875613441,0.00650618719197611,0.0625802606650709,0.0880845144576173,7.47549670562638e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,0.0496869931502804,0.00429323201704676,0.0412722583968688,0.0581017279036921,7.92856463850238e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKN3,Serine/threonine-protein kinase N3,37714,0.0859748548272767,0.00743034855662253,0.0714113716562965,0.100538337998257,8.14831172235631e-31
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLO1,Lactoylglutathione lyase,40042,0.0656843956025456,0.00569135116530995,0.0545293473185381,0.0768394438865531,1.09114259131537e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSL,Cathepsin L1,40359,0.026826486039973,0.00232634050523708,0.0222668586497083,0.0313861134302377,1.21000319529376e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37746,0.0617158847887068,0.00535500160588483,0.0512200816411725,0.0722116879362411,1.38080749622088e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO1A,Coronin-1A,39990,0.0995356695349752,0.00864255728815038,0.0825962572502004,0.11647508181975,1.44265141404589e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPLAH,5-oxoprolinase,37628,0.0755019711031295,0.00655500945022389,0.0626541525806907,0.0883497896255684,1.49568802844117e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTC,Probetacellulin,39980,0.083278812307464,0.00723980217587509,0.0690888000427488,0.0974688245721791,1.695117201814e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA6,Integrin alpha-6,40341,0.0586837341267438,0.00510425477310858,0.048679394771451,0.0686880734820366,1.80217947072685e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD83,CD83 antigen,40341,0.0371261848301252,0.00322968339605954,0.0307960053738485,0.0434563642864019,1.83816536872749e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,0.0583633927991313,0.0050805805337712,0.0484054549529397,0.0683213306453228,2.12637492935924e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABHD14B,Protein ABHD14B,40171,0.0644623913079644,0.0056164379526102,0.0534541729208484,0.0754706096950804,2.26279778466685e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38484,-0.0344961586657885,0.00300498329696193,-0.0403859259278339,-0.0286063914037431,2.2811727357513e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,0.0764079425081267,0.00665935333679927,0.0633556099680002,0.0894602750482533,2.34613483416087e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,XCL1,Lymphotactin,40489,0.0621172574108024,0.0054166277706642,0.0515006669803005,0.0727338478413042,2.51127516955435e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37959,0.0432740255473259,0.00378099908568848,0.0358632673393765,0.0506847837552753,3.42657896384845e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,37900,0.0479180043566613,0.00418774938690502,0.0397100155583275,0.0561259931549952,3.53903987098799e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,0.0501219682166448,0.00438157805642558,0.0415340752260507,0.058709861207239,3.66952629476796e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37990,0.0328699946991818,0.00287350666044124,0.027237921644717,0.0385020677536466,3.67301677934469e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,MIA,Melanoma-derived growth regulatory protein,40411,0.0405876692481249,0.00355329572009048,0.0336232096367475,0.0475521288595022,4.22368029660742e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,0.0493242456430706,0.00431770335808245,0.040861547061229,0.0577869442249122,4.41274409293967e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,0.0811539969962919,0.00711608278458062,0.0672064747385139,0.0951015192540699,5.21949969517903e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,0.134159329676581,0.0117665301043078,0.111096930672138,0.157221728681024,5.35875837469084e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164,Sialomucin core protein 24,40332,0.029034987803451,0.00254885925233634,0.0240392236688717,0.0340307519380302,6.03421109164082e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZD2,PDZ domain-containing protein 2,37562,0.0673999047735144,0.00591595626129724,0.0558046305013719,0.078995179045657,6.27258210401868e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.0869639269323181,0.00763695603823031,0.0719954930973866,0.101932360767249,6.6346649924265e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],39978,0.0535577614240376,0.00470585114173002,0.0443342931862468,0.0627812296618285,6.82312746472499e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,37880,0.0956491326583293,0.00841988320424937,0.0791461615780005,0.112152103738658,9.05308588437724e-30
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH7,Protocadherin-7,37901,0.0380943359848707,0.00335666032390922,0.0315152817500086,0.0446733902197328,1.02536982115544e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMD,Dystrophin,37628,0.0566879489763543,0.00500892638365918,0.0468704532643823,0.0665054446883262,1.47353109314982e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,MET,Hepatocyte growth factor receptor,40375,-0.0218283217851271,0.00193030989374273,-0.0256117291768628,-0.0180449143933913,1.54912075905943e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA13,Carbonic anhydrase 13,40173,0.112434810856028,0.00994415392200654,0.0929442691688952,0.131925352543161,1.58211604408746e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD40LG,CD40 ligand,40516,0.0825926565605441,0.0073517415384775,0.0681832431451282,0.09700206997596,3.54905284898985e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPB6,Heat shock protein beta-6,40489,0.0393805418331053,0.00350552384034105,0.0325097151060369,0.0462513685601738,3.57377240037952e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNMT,Histamine N-methyltransferase,40147,0.0500307305739025,0.00445355598580804,0.0413017608417187,0.0587597003060863,3.59204177459839e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,0.0417496233128268,0.00372464567665843,0.0344493177865762,0.0490499288390773,4.94789861748472e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,40332,0.0322125638461932,0.0028753827723683,0.0265768136123514,0.0378483140800351,5.0710338997947e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37942,0.0405839838229704,0.0036224653264533,0.0334839517831219,0.0476840158628189,5.26807059322754e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37714,0.0724826416075285,0.0064714635180781,0.0597985731120955,0.0851667101029616,5.47947494166814e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL2,ADAMTS-like protein 2,37998,0.0332648670343329,0.00297486781561226,0.0274341261157329,0.0390956079529329,6.68731833684171e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPPK1,Epiplakin,37628,0.0791828281004918,0.00708460907390296,0.065296994315642,0.0930686618853416,7.14682505138835e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP1,Metalloproteinase inhibitor 1,40167,0.0301657540215091,0.0027016984923271,0.024870424976548,0.0354610830664702,7.7247023057693e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX9,Sorting nexin-9,40359,0.0734808428543616,0.00659216304304212,0.0605602032899991,0.0864014824187242,9.49685394937057e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,40359,0.0331733881200064,0.00297608398742118,0.0273402635046609,0.039006512735352,9.5010458099775e-29
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAG3,BAG family molecular chaperone regulator 3,40203,0.0424189307831596,0.00380961729785656,0.0349520808793607,0.0498857806869585,1.08816769747941e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",37942,0.113093095222704,0.010157497099008,0.0931844009086481,0.13300178953676,1.14321129047422e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIPF,Gastric triacylglycerol lipase,37628,0.0640753843139391,0.00575630063120323,0.0527930350767807,0.0753577335510974,1.18484701421392e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNAP25,Synaptosomal-associated protein 25,37541,0.0501367494100256,0.0045067301412435,0.0413035583331884,0.0589699404868629,1.27586800503954e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37562,0.0396442583615139,0.00356653841491461,0.0326538430682813,0.0466346736547466,1.41320664141198e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,GET3,ATPase GET3,37990,0.0600285095029703,0.0054037921553006,0.0494370768785811,0.0706199421273594,1.51372162972159e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA2,Integrin alpha-2,37671,0.0361903731586938,0.00325861564476219,0.0298034864949599,0.0425772598224277,1.56747988706316e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAL,Integrin alpha-L,37598,0.0465204549682446,0.00419827915304214,0.038291827828282,0.0547490821082072,2.07603009143693e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNAS,Neuroendocrine secretory protein 55,37959,0.0961753402075752,0.00868782789211488,0.07914719753903,0.11320348287612,2.31938613458667e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL1,Growth-regulated alpha protein,40329,0.103304802579909,0.009339742522127,0.0849989072365404,0.121610697923278,2.46719435011497e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB2B,Ras-related protein Rab-2B,37900,0.0653218085314057,0.00590818354999634,0.0537417687734129,0.0769018482893986,2.70983353793803e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7,Complement component C7,37678,-0.0334757976469962,0.00303025392545408,-0.0394150953408862,-0.0275364999531062,3.00577503559613e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40489,0.0572847934915286,0.00519107715543057,0.0471102822668847,0.0674593047161726,3.26396855638597e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRBP,Acrosin-binding protein,37900,0.0401785012008115,0.003643923293309,0.0330364115459258,0.0473205908556971,3.77239283758261e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37628,0.0605086808556631,0.00548948175133318,0.04974929662305,0.0712680650882761,3.94334128631753e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2,Brorin,40167,0.0411453973864225,0.00373439988426731,0.0338259736132586,0.0484648211595865,3.96914405603215e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN9,Septin-9,40305,0.0297134568158674,0.00270234387914962,0.0244168628127341,0.0350100508190006,5.07481025371823e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK3,Dickkopf-related protein 3,40536,-0.0310701797005328,0.00282955625086593,-0.03661610995223,-0.0255242494488356,5.95534030908734e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39980,0.0809699793893536,0.00737976755420847,0.066505634983105,0.0954343237956022,6.60563079677885e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,POMC,Pro-opiomelanocortin,37628,0.0720311014023884,0.00657088744052647,0.0591521620189565,0.0849100407858203,7.66298722826122e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN4,Cerebellin-4,40489,0.0331758320884594,0.0030280043121911,0.0272409436365649,0.039110720540354,7.77642866115764e-28
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCS,Copper chaperone for superoxide dismutase,40228,0.0507114703522708,0.00463817798105921,0.0416206415093947,0.0598022991951468,1.00246011243923e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.0432722398023439,0.00395691850655031,0.0355166795295053,0.0510278000751825,1.01629325086786e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP1,Interstitial collagenase,39757,0.0976961526707286,0.00893698485341254,0.0801796623580401,0.115212642983417,1.02982719286373e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC79,Protein unc-79 homolog,37482,0.0594817581513821,0.00544627714416975,0.0488070549488094,0.0701564613539548,1.19823697188168e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSB,Cathepsin B,40353,-0.0565713898053407,0.00518984869623929,-0.0667434932499697,-0.0463992863607117,1.43656030165176e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF23,Fibroblast growth factor 23,40469,0.0645189294273791,0.00592689499140114,0.0529022152442328,0.0761356436105253,1.68177827849584e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRN1,Secernin-1,40341,0.0588000084384504,0.0054030912130978,0.0482099496607787,0.0693900672161221,1.74317697253779e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37572,0.0721952238771576,0.00663195672630336,0.059196588693603,0.0851938590607121,1.76236782314569e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,0.0293386998987735,0.00269771478359709,0.0240511789229232,0.0346262208746238,1.97744425159985e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,0.0451757268472847,0.00416318760593193,0.0370158791396581,0.0533355745549113,2.56845894857996e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BP1,SH3 domain-binding protein 1,37901,0.0487866470465006,0.00449917642028804,0.0399682612627361,0.0576050328302652,2.77769767905175e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G15,Phospholipase A2 group XV,40411,0.0267895986660578,0.00247241780349751,0.0219436597712026,0.0316355375609129,2.91126742644779e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFASC,Neurofascin,40516,0.0283401648426549,0.00261659507568234,0.0232116384943175,0.0334686911909923,3.05094639922489e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,0.0910329107064633,0.00840225712896565,0.0745644867336906,0.107501334679236,3.06625009211052e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX,Glutaredoxin-1,40260,0.0588613608980292,0.0054391444735468,0.0482006377298775,0.0695220840661809,3.37994350992564e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSE,Cathepsin E,37671,0.0537094144137974,0.00496376814070305,0.0439804288580194,0.0634383999695753,3.58579008253113e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,TST,Thiosulfate sulfurtransferase,39923,0.078805315357942,0.00728737528475722,0.0645220597998178,0.0930885709160661,3.69750008277622e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.0921688563658777,0.00853335931084233,0.0754434721166267,0.108894240615129,4.2302174636574e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,40536,0.0323709960504422,0.00300684936480291,0.0264775712954285,0.0382644208054559,6.170919612947e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,0.0469197304074449,0.00435907492505953,0.0383759435543282,0.0554635172605616,6.60895756847266e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA14,Carbonic anhydrase 14,40489,-0.0357111033507016,0.00331929656185336,-0.0422169246119342,-0.029205282089469,6.66686877696684e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,0.0511417652787325,0.00475721097812026,0.0418176317616168,0.0604658987958483,7.67102768758908e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS10,Regulator of G-protein signaling 10,37959,0.0619293489626545,0.00576909121321579,0.0506219301847515,0.0732367677405574,8.97072366855615e-27
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,0.122763175571986,0.01146044138329,0.100300710460738,0.145225640683235,1.10386342061107e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTN6,Dynactin subunit 6,39961,0.0728659517451977,0.00680313599984177,0.0595318051855078,0.0862000983048875,1.12467439217406e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL26,C-C motif chemokine 26,40341,0.0913770886399811,0.00853785109830971,0.074642900487294,0.108111276792668,1.21986867019363e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLMH,Bleomycin hydrolase,40536,0.033144666786835,0.00310292396292002,0.0270629358195117,0.0392263977541582,1.52090632847937e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.0510317548293439,0.0047814838604768,0.0416600464628094,0.0604034631958785,1.68618651777301e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37628,-0.0653487284270271,0.00612481288362657,-0.0773533616789352,-0.053344095175119,1.81305657210552e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,38013,-0.0262502779767893,0.0024615983208885,-0.0310750106857307,-0.0214255452678478,1.91101099969316e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1F,Protein phosphatase 1F,37990,0.0536750447294324,0.00503401983951591,0.0438083658439812,0.0635417236148836,1.94167358008325e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPCAL1,Hippocalcin-like protein 1,40516,0.0748688340456811,0.00704688033554023,0.0610569485880223,0.08868071950334,2.80548275505849e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37942,0.0307974845799013,0.00290485958401345,0.0251039597952349,0.0364910093645676,3.69453370332963e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMOX1,Heme oxygenase 1,40184,-0.0477668143778274,0.00450791667027301,-0.0566023310515625,-0.0389312977040923,3.80130567799742e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPPB,Natriuretic peptides B,40042,-0.130619980112673,0.0123525943847491,-0.154831065106781,-0.106408895118565,4.80415600904389e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLF4,Krueppel-like factor 4,37541,0.0398389511175759,0.00376825511195959,0.0324531710981351,0.0472247311370167,5.10211671733138e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,0.0392909139533692,0.00372433611607139,0.0319912151658693,0.0465906127408692,6.4633652837884e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX16,Syntaxin-16,39980,0.0598750345409295,0.00568160095955066,0.0487390966602102,0.0710109724216488,7.02681924108755e-26
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDHB,Succinate dehydrogenase,37901,0.071985588565818,0.00685131878407801,0.0585570037490251,0.0854141733826109,1.01072261934276e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,0.0681586727205524,0.00649051132897662,0.0554372705157582,0.0808800749253466,1.07561143093152e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRL,Prolactin,40471,-0.0774178824718981,0.00737598847988336,-0.0918748198924695,-0.0629609450513268,1.09265802187339e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,0.0289546051219081,0.00276276675443308,0.0235395822832193,0.034369627960597,1.34185933551781e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADM,Pro-adrenomedullin,40489,0.0270257015724916,0.00258950432289147,0.0219502730996244,0.0321011300453589,2.03478117291387e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH5,Cadherin-5,40536,-0.0304646139385138,0.00291948296763153,-0.0361868005550717,-0.024742427321956,2.07007995343018e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN4,CCN family member 4,40489,0.0410000296440071,0.00393528723446321,0.0332868666644592,0.048713192623555,2.45773419999227e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,0.0586635507372971,0.00562908408857221,0.0476305459236956,0.0696965555508986,2.46744457690476e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGXT,Serine--pyruvate aminotransferase,40359,0.0768546106275915,0.00737945746416123,0.0623908739978355,0.0913183472573475,2.56351559812753e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,0.0273288407466252,0.00262778388920138,0.0221783843237905,0.0324792971694599,2.98963477459904e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,0.0408966058663133,0.00393258949715266,0.0331887304518941,0.0486044812807325,3.12707647313777e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39980,0.0475715190274479,0.00458113926279865,0.0385924860723626,0.0565505519825333,3.53723638228786e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.0907352209041458,0.00874596658812412,0.0735931263914226,0.107877315416869,4.02401625749957e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAP18,Chromatin complexes subunit BAP18,37942,0.0647372382209009,0.00624255957813437,0.0525018214477575,0.0769726549940442,4.20534080529371e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,WAS,Wiskott-Aldrich syndrome protein,40044,0.0679803912976122,0.00656856579447145,0.0551060023404481,0.0808547802547762,5.07725153795555e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMOTL2,Angiomotin-like protein 2,37855,0.0479386224522133,0.00463478707731087,0.038854439780684,0.0570228051237426,5.57658556927599e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,37900,0.0489017228936714,0.0047312322298282,0.0396285077232081,0.0581749380641347,6.00890248440101e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPING1,Plasma protease C1 inhibitor,37981,0.0185105431438183,0.00179127800550162,0.0149996382530351,0.0220214480346015,6.14133343616985e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,0.0581781083506816,0.00563237132340718,0.0471386605568036,0.0692175561445597,6.24040822014043e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGES2,Prostaglandin E synthase 2,37484,0.0543325409384797,0.00526566789055163,0.0440118318729985,0.0646532500039609,7.26301251014512e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA1,Apolipoprotein A-I,38013,-0.0273937391639536,0.00265563921806938,-0.0325987920313696,-0.0221886862965376,7.42425019657778e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRP2,Neuropilin-2,40332,-0.0287893658042482,0.00279414504961932,-0.0342658901015021,-0.0233128415069943,8.13721256151579e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARA5,Scavenger receptor class A member 5,40471,0.0289963843742183,0.00281726853258464,0.0234745380503524,0.0345182306980842,9.1098751544938e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,-0.024082043408581,0.00234148607286332,-0.0286713561113931,-0.0194927307057689,9.84263133197403e-25
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPA1,Inositol monophosphatase 1,40228,0.0601803290111276,0.0058546976845833,0.0487051215493443,0.0716555364729109,1.04876416563762e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,0.0940887606497448,0.0091543477959317,0.0761462389697186,0.112031282329771,1.0594119480937e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID2,Nidogen-2,40332,0.0727959646692185,0.00709216601854789,0.0588953192728646,0.0866966100655724,1.21880251228333e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,0.0688826520809684,0.00672068394004117,0.0557101115584877,0.0820551926034491,1.42267237539283e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,0.0589899402590214,0.00575909555685453,0.0477021129675865,0.0702777675504563,1.51858999830133e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKK4,Dickkopf-related protein 4,40203,0.0448222395234059,0.00438184555996303,0.0362338222258784,0.0534106568209335,1.75235673715674e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERI1,3'-5' exoribonuclease 1,37714,0.0331499224443724,0.00324068455083252,0.0267981807247407,0.0395016641640042,1.80694967095004e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37998,-0.0324480468134086,0.00317939135827142,-0.0386796538756206,-0.0262164397511966,2.2895391948103e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NID1,Nidogen-1,40355,0.0386488063747705,0.00379955555006279,0.0312016774966474,0.0460959352528936,3.13902747626591e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,TF,Serotransferrin,38013,0.0213615779806968,0.00210020802615767,0.0172451702494278,0.0254779857119658,3.25751094622998e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFCAB2,Dynein regulatory complex protein 8,37714,0.0340553979925416,0.00335098145267475,0.0274874743452991,0.0406233216397841,3.5629347246458e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOLA1,BolA-like protein 1,37541,0.0536663392329451,0.00528463288584242,0.0433084587766939,0.0640242196891962,3.86147060292588e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL25,C-C motif chemokine 25,40516,0.0476822818887339,0.00469824270411408,0.0384737261886703,0.0568908375887975,3.96014293671013e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100P,Protein S100-P,40042,0.0523406849919231,0.00515766950104264,0.0422316527698796,0.0624497172139667,4.01421500059305e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAM1,Vascular cell adhesion protein 1,40372,-0.0263592753735549,0.00259785758189747,-0.031451076234074,-0.0212674745130359,4.06492192955098e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASAH1,Acid ceramidase,37882,0.0451020751031229,0.00444546025278038,0.0363889730076734,0.0538151771985725,4.23194760786789e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX7,Syntaxin-7,37598,0.0491312658197062,0.00484960414968132,0.0396260416863308,0.0586364899530816,4.93265377783455e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,0.0677048330556278,0.00668600382808041,0.0546002655525902,0.0808094005586654,4.99478316302974e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP4,Secreted frizzled-related protein 4,37671,0.0408180401433153,0.00403004503524411,0.0329191518742369,0.0487169284123938,5.05641806248422e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPQ,Carboxypeptidase Q,37986,0.0356454010346788,0.00352022874404908,0.0287457526963426,0.042545049373015,5.16509717461952e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,37987,0.0587733082707096,0.00580666416218448,0.047392246512828,0.0701543700285912,5.38857892521269e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,0.0506251794117721,0.00501028667980632,0.0408050175193517,0.0604453413041925,6.24446936739936e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,NADK,NAD kinase,40359,0.0518849124521455,0.00514368064318318,0.0418032983915064,0.0619665265127845,7.43067636490943e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOL1,Apolipoprotein L1,37987,0.0631810869588932,0.00626233000704105,0.0509069201450928,0.0754552537726937,7.49837375665634e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDK,Midkine,40352,0.0491492962180701,0.00487308283302464,0.0395980538653418,0.0587005385707983,7.52538375012872e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,BGN,Biglycan,39956,-0.117920824663647,0.0116942212110929,-0.140841498237389,-0.0950001510899053,7.72633921577448e-24
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40470,0.0590793020678426,0.0058800566159643,0.0475543911005525,0.0706042130351326,1.1085321171965e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARFIP1,Arfaptin-1,37959,0.0665090075547186,0.00661764046826255,0.053538432236924,0.0794795828725132,1.10976434134269e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1F,V-type proton ATPase subunit F,39925,0.0638651563513649,0.00635740157683819,0.051404649260762,0.0763256634419677,1.13304453099639e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGRN,Neugrin,37942,0.021322631736408,0.00212328159926624,0.0171609998018462,0.0254842636709698,1.20265300314592e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN2,Nectin-2,40330,0.0278147485110672,0.00277706511936146,0.0223717008771187,0.0332577961450156,1.52465602194707e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGMN,Legumain,40422,0.0341533371659798,0.0034123459943239,0.027465139017105,0.0408415353148547,1.6362659451662e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL24,C-C motif chemokine 24,40396,0.0796811568185767,0.00796897498805,0.0640619658419987,0.0953003477951547,1.8065113422852e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.0370069364656802,0.00370389909565379,0.0297472942381988,0.0442665786931617,1.95090746962795e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37990,0.0311090169063133,0.00311671856560645,0.0250002485177247,0.037217785294902,2.21589706836896e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO2,Gamma-enolase,40471,0.063071188896839,0.00632220450930863,0.050679668058594,0.0754627097350839,2.26826813433984e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF22,Kinesin-like protein KIF22,37562,0.117602616017152,0.0117919684394548,0.0944903578758206,0.140714874158483,2.42043615202011e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SRPX,Sushi repeat-containing protein SRPX,37990,-0.0313983677800275,0.0031494377717951,-0.0375712658127459,-0.0252254697473091,2.49396382175487e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA4,Annexin A4,40279,0.0686910074849257,0.00689294047468857,0.0551808441545361,0.0822011708153153,2.53001393005022e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,0.0788970719807327,0.00791751266043346,0.0633787471662831,0.0944153967951823,2.54197834674798e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENR,Density-regulated protein,37598,0.0551808018292814,0.00554911783761403,0.0443045308675579,0.066057072791005,3.23276283101081e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,0.0357422169422645,0.00359995285473224,0.0286863093469893,0.0427981245375396,3.65429670578364e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPMT,Thiopurine S-methyltransferase,39980,0.0705550008072919,0.00711869447160912,0.056602359642938,0.0845076419716457,4.35660498699881e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37959,0.0496347137215235,0.00501157829721959,0.0398120202589732,0.0594574071840739,4.79184229276355e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,40372,-0.0281828907042245,0.00284942156958065,-0.0337677569806025,-0.0225980244278464,5.3197931343571e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPH,Hephaestin,37990,0.0238655220391055,0.00241409128537032,0.0191339031197797,0.0285971409584313,5.73131872400142e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRK5,G protein-coupled receptor kinase 5,40042,0.0500430516963096,0.00506410526760437,0.0401174053718051,0.0599686980208142,5.825520891405e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.0231157725518151,0.00234273050093518,0.0185240207699821,0.027707524333648,6.7336847777524e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,0.0481992287233093,0.00489235458844089,0.0386102137299652,0.0577882437166534,7.80409214688094e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB8,Serpin B8,40516,0.0516104101022262,0.005244092529,0.0413319887453862,0.0618888314590662,8.64132982829996e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFRP1,Secreted frizzled-related protein 1,40178,0.0412257039732811,0.00418986347912325,0.0330135715541995,0.0494378363923627,8.86259726245092e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX6,Syntaxin-6,39980,0.0651382683598232,0.0066253141378858,0.0521526526495671,0.0781238840700794,9.57781877075052e-23
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPK1,Thiamin pyrophosphokinase 1,37990,0.0255828880488008,0.00260966521975267,0.0204679442180856,0.030697831879516,1.29798595911544e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFA,Protransforming growth factor alpha,40341,0.0450962194621712,0.00460767680834994,0.0360651729178053,0.0541272660065371,1.47999847833088e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,0.0383007297505822,0.00391436602562491,0.0306285723403574,0.0459728871608071,1.56424451507151e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,0.0836322524660856,0.00856782343808462,0.0668393185274397,0.100425186404731,1.9666856596699e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR3,Toll-like receptor 3,40516,0.0570914468470575,0.00585686596647618,0.0456119895527642,0.0685709041413508,2.17506063774716e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP3,Stromelysin-1,40332,-0.0452766715685207,0.00464889899766762,-0.0543885136039492,-0.0361648295330921,2.36892159030182e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,0.0284398391382745,0.00292181395102859,0.0227130837942584,0.0341665944822905,2.49963104291764e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD2,Sushi domain-containing protein 2,40332,-0.0267829549996481,0.00275510115850425,-0.0321829532703165,-0.0213829567289798,2.82455394795076e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,0.108924260329367,0.0112151114837955,0.0869426418211277,0.130905878837606,3.1623303413679e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,SWAP70,Switch-associated protein 70,37901,0.0328950216503945,0.00338901847468787,0.0262525454400062,0.0395374978607827,3.35005940506311e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM,Paralemmin-1,37824,0.0273616784429115,0.00282445019161525,0.0218257560673456,0.0328976008184773,4.03107783560013e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP6,Bone morphogenetic protein 6,40024,0.0392342180238215,0.00407328454569967,0.0312505803142502,0.0472178557333928,6.73662157829053e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,0.0872550353845132,0.00905942600609875,0.0694985604125597,0.105011510356467,6.7692681786913e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNDP1,Beta-Ala-His dipeptidase,40403,0.0422591692890276,0.00439235046652824,0.0336501623746323,0.050868176203423,7.46801891065416e-22
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD46,Membrane cofactor protein,40250,0.0264080295680752,0.0027555473522048,0.0210071567577538,0.0318089023783966,1.07371051381659e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA,Adenosine deaminase,40516,0.0313389585858408,0.00327070496087781,0.0249283768625203,0.0377495403091613,1.09081466170849e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,40291,0.0396557856393343,0.00414670791343269,0.0315282381290062,0.0477833331496624,1.30594385804444e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,STK4,Serine/threonine-protein kinase 4,40359,0.0789300249057176,0.00825993036802918,0.0627405613843804,0.0951194884270548,1.4016780448582e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,0.0629125950317433,0.0065852117889447,0.0500055799254117,0.0758196101380749,1.46513591853972e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDA,Cytidine deaminase,37970,0.0421550858890017,0.00441671717755541,0.0334983202209931,0.0508118515570103,1.59970421829109e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFP,Alpha-fetoprotein,40182,0.0637774193054961,0.0066843336147085,0.0506761254206674,0.0768787131903248,1.61248796203565e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TREML1,Trem-like transcript 1 protein,37987,0.0484062383617898,0.00507791923525431,0.0384535166606913,0.0583589600628882,1.78983209465546e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPAG1,Sperm-associated antigen 1,37959,0.0528921498281125,0.00555030156109139,0.0420135587683734,0.0637707408878516,1.84417957541019e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAA10,N-alpha-acetyltransferase 10,37562,0.0471924101245947,0.00495240443082337,0.0374856974401808,0.0568991228090085,1.86007497881267e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39961,0.0482962819504652,0.0050708308024477,0.0383574535776677,0.0582351103232627,1.90119313034458e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA2,Annexin A2,37441,0.0656787345372672,0.00689666944440381,0.0521612624262357,0.0791962066482987,1.9716597618443e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SF3B4,Splicing factor 3B subunit 4,40305,0.0670691016950377,0.00704840455946446,0.0532542287584873,0.080883974631588,2.06280701719196e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRZB,Secreted frizzled-related protein 3,40176,0.0243784661604539,0.00256225336346553,0.0193564495680615,0.0294004827528463,2.08561988156006e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,FXN,"Frataxin, mitochondrial",40489,0.0676413711807502,0.00711369359680867,0.0536985317310052,0.0815842106304952,2.19988490586398e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,0.0292499234400319,0.00307642267762377,0.0232201349918894,0.0352797118881745,2.2224326511348e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,-0.0353586748955008,0.00372634220260235,-0.0426623056126014,-0.0280550441784002,2.66015233766242e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM1,Intercellular adhesion molecule 1,40291,0.0260066447649326,0.00274172241130423,0.0206328688387763,0.0313804206910888,2.7470840304215e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA9,Serpin A9,40228,0.0655876856013617,0.00692933538357314,0.0520061882495584,0.0791691829531651,3.33455481522632e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNM1,Dynamin-1,37901,0.103288613752115,0.0109325898637427,0.081860737619179,0.124716489885051,4.02432933806056e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGED1,Melanoma-associated antigen D1,39980,0.044176257205944,0.00467773524175179,0.0350078961321105,0.0533446182797775,4.09031426556796e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPR,Nucleoprotein TPR,37562,0.0427693977699677,0.00452996864670942,0.0338906592224173,0.0516481363175182,4.29026582483611e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,0.0314318261097402,0.00334245223449503,0.0248806197301299,0.0379830324893505,5.96962621756225e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSME2,Proteasome activator complex subunit 2,40152,0.0334989942997407,0.00356263037518994,0.0265162387643684,0.040481749835113,6.02656630685481e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPE,Ribulose-phosphate 3-epimerase,37714,0.0633856241904723,0.00674221535148884,0.0501708821015541,0.0766003662793904,6.26061968847402e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,0.0265728928318975,0.00283222513903275,0.0210217315593933,0.0321240541044017,7.31254511345055e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAP,Prolyl endopeptidase FAP,40536,0.0243920507103726,0.00260104205158646,0.0192940082892632,0.0294900931314821,7.61418535599087e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,0.0560831736447357,0.00598305763566237,0.0443563806788374,0.0678099666106339,8.09958863879811e-21
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTGR1,Prostaglandin reductase 1,37990,0.0713513961934378,0.00765263483504059,0.0563522319167582,0.0863505604701173,1.29429940526932e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,0.0583086570191221,0.0062535198560287,0.0460517581013058,0.0705655559369383,1.29490209267359e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP1,Ran-specific GTPase-activating protein,37628,0.0477266353297861,0.0051245205582018,0.0376825750357105,0.0577706956238616,1.43198670622429e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXN,Thioredoxin,37819,0.0399366203470391,0.00429401886210933,0.0315203433773048,0.0483528973167734,1.61168245451256e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,0.0644639113081052,0.00693630987650946,0.0508687439501466,0.0780590786660637,1.68355032816161e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37790,0.0502133940722159,0.00540262273592721,0.0396242535097986,0.0608025346346332,1.70927774405473e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMS,Spermine synthase,37541,0.0571956769235131,0.00616677543419705,0.0451087970724869,0.0692825567745393,2.05488779432777e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDGF,Hepatoma-derived growth factor,40471,0.08517527280951,0.00918751877011117,0.0671677360200921,0.103182809598928,2.07877251267209e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.0213211441861045,0.00230047106452755,0.0168122208996305,0.0258300674725785,2.13229072108679e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,0.0255232097981171,0.00275367058749146,0.0201260154466338,0.0309204041496003,2.17278751075515e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP8,Caspase-8,40434,0.0550556137670332,0.00595520880964932,0.0433834045001205,0.0667278230339458,2.64431625853423e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37990,0.0223997741343033,0.00242262326214527,0.0176514325404986,0.0271481157281081,2.6720515936024e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS27,Serine protease 27,40314,0.0359588545140819,0.00389033762962814,0.0283337927600107,0.043583916268153,2.69211217703463e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,40359,-0.0253078561654589,0.00273839117915288,-0.0306751028765985,-0.0199406094543192,2.7226566396149e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCF2,Neutrophil cytosol factor 2,40324,0.0738773644147296,0.00799647708598133,0.0582042693262062,0.089550459503253,2.80379663488983e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP1,Guanylate-binding protein 1,37931,0.057269069616009,0.00620832790559162,0.0451007469210494,0.0694373923109685,3.26500485070316e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD248,Endosialin,37998,-0.0356284408631897,0.0038633693844811,-0.0432006448567726,-0.0280562368696067,3.33745915775219e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD276,CD276 antigen,40357,-0.0319142293251668,0.00346204122442749,-0.0386998301250447,-0.025128628525289,3.38803234320659e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,0.0332130562090269,0.00360550881964212,0.0261462589225284,0.0402798534955255,3.60436645329373e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39980,0.050655372790074,0.00550600249441053,0.0398636079010294,0.0614471376791187,4.02528349007354e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC5A,C-type lectin domain family 5 member A,40314,-0.0249461295666212,0.00271701927538627,-0.0302714873463783,-0.0196207717868641,4.76876100881581e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CX3CL1,Fractalkine,40228,-0.0301910768713179,0.00328845939766146,-0.0366364572907344,-0.0237456964519014,4.79445297242562e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,0.048410462112971,0.00527640633719445,0.0380687056920699,0.0587522185338722,5.16989389692674e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.0478186032997794,0.00521591171077776,0.037595416346655,0.0580417902529039,5.41992967609015e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX6,Peroxiredoxin-6,40489,-0.0527129660397622,0.00575517972712704,-0.0639931183049312,-0.0414328137745932,5.84636583626861e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD302,CD302 antigen,40305,0.0264787968475023,0.00289174808483845,0.020810970601219,0.0321466230937857,5.99295779100321e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,AK1,Adenylate kinase isoenzyme 1,40359,0.0562088263620052,0.0061458996140736,0.0441628631184209,0.0682547896055894,6.62511186367308e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR2,Interferon gamma receptor 2,40228,0.0452630333348078,0.00496372131247182,0.0355341395623631,0.0549919271072526,8.49694802866201e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,LBP,Lipopolysaccharide-binding protein,40403,-0.0509861703477267,0.00559925338552441,-0.0619607069833545,-0.0400116337120988,9.55097259124817e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,COLEC12,Collectin-12,40357,0.0223782407624812,0.00245806491915428,0.0175604335209388,0.0271960480040236,9.72004290559829e-20
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,0.0588905996939765,0.00647902793908194,0.0461917049333759,0.0715894944545771,1.13703988923699e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.0235674446759172,0.00259981469090382,0.0184718078817458,0.0286630814700887,1.41414467728203e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRSF1,G-rich sequence factor 1,37402,0.0689399231598464,0.00761646400510274,0.054011653709845,0.0838681926098478,1.61041117683037e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLB,Beta-klotho,39961,-0.0640036632565184,0.00708222644688512,-0.0778848270924132,-0.0501224994206235,1.79344098311698e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,0.0498696728977309,0.00552237486035841,0.0390458181714284,0.0606935276240334,1.90585978978084e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,0.0364346587974476,0.00403584104206953,0.0285244103549914,0.0443449072399039,1.95322771441402e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMB1,Laminin subunit beta-1,37628,0.0256965814348607,0.00284739579140901,0.020115685683699,0.0312774771860224,2.05080598312674e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMM2,Phosphomannomutase 2,37562,0.0526271189895229,0.00583550455609712,0.0411895300595726,0.0640647079194733,2.17000371357937e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,0.0482239718978382,0.00535397368454426,0.0377301834761315,0.058717760319545,2.35153058606962e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG2,Bone marrow proteoglycan,37998,-0.0452685643059566,0.00503500370330599,-0.0551371715644363,-0.0353999570474769,2.77654948480658e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNF,Tumor necrosis factor,40014,0.0344344527502751,0.00383133609392532,0.0269250340061815,0.0419438714943687,2.81276659146451e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSCAM,Down syndrome cell adhesion molecule,37959,0.0305198928274567,0.00339652141619073,0.0238627108517228,0.0371770748031905,2.90963732471672e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37572,0.053437596818533,0.00595398808279592,0.041767780176253,0.065107413460813,3.21187329307881e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVR,Poliovirus receptor,40471,0.0317061390223728,0.00353545307282038,0.0247766509996448,0.0386356270451007,3.34571313182456e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPME1,Protein phosphatase methylesterase 1,40305,0.0528040940903988,0.0058918474697491,0.0412560730496906,0.0643521151311071,3.53017071678033e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAST,Gastrin,37942,0.112408315105827,0.0125574376255908,0.0877957373596693,0.137020892851985,3.95858033663305e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC3B,Tetranectin,37681,0.0181590370038099,0.00203149748168335,0.0141773019397106,0.0221407720679093,4.45205168150824e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD93,Complement component C1q receptor,39725,-0.0271350491462199,0.00303711779479852,-0.033087800024025,-0.0211822982684148,4.55111248826708e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA,Lymphotoxin-alpha,40341,0.0345542918533244,0.00387405405117936,0.0269611459130128,0.0421474377936359,5.18962074625615e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,C7orf50,Uncharacterized protein C7orf50,37942,0.0188923816986924,0.00211774343733318,0.0147416045615194,0.0230431588358654,5.20946430563389e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.0293110337581231,0.00328894903593352,-0.0357573738685528,-0.0228646936476934,5.5588811403475e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.0784595060637721,0.00881129271504452,0.0611893723422848,0.0957296397852593,6.06131058509593e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,APRT,Adenine phosphoribosyltransferase,40216,0.0414853055015453,0.00466182106198583,0.0323481362200531,0.0506224747830375,6.24082884312053e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPL14,60S ribosomal protein L14,37628,0.0354953297691278,0.00399017407668178,0.0276745885788315,0.0433160709594241,6.55491979085051e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37901,0.0970821674823524,0.0109218582319355,0.0756753253477589,0.118489009616946,6.95466526560648e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC1,MANSC domain-containing protein 1,40411,-0.0234051795143942,0.00263913681063607,-0.0285778876632409,-0.0182324713655475,8.18568629273979e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,40333,0.082684262572755,0.00932533198431255,0.0644066118835024,0.100961913262008,8.32751332666704e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,0.035236578023033,0.00397599843635879,0.0274436210877697,0.0430295349582962,8.65033665503069e-19
NMR metabolomics,X23501.Triglycerides in Large VLDL,BPIFA2,BPI fold-containing family A member 2,37150,-0.0947124019834769,0.0107146602030536,-0.115713135981462,-0.0737116679854918,1.08691541533185e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL1,Fc receptor-like protein 1,40359,0.0382187518203222,0.00433005730574563,0.0297318395010608,0.0467056641395836,1.19186176869879e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAM,Signal transducing adapter molecule 1,37900,0.0319584601681323,0.00362061189031062,0.0248620608631235,0.0390548594731411,1.20862311272751e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOC1,Apolipoprotein C-I,37981,0.0307558680019498,0.00349012142473374,0.0239152300094716,0.0375965059944279,1.37434238396827e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPT,Dermatopontin,40536,0.0224363356505886,0.00254741912123539,0.0174433941729672,0.02742927712821,1.40837234786472e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.0322490916334593,0.0036679499455248,0.0250599097402307,0.0394382735266879,1.64713664498336e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,0.0456133103638176,0.0051883677800538,0.0354441095149121,0.055782511212723,1.65841658918131e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,0.0405706832846903,0.00461724228717705,0.0315208884018233,0.0496204781675573,1.72303638646244e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELOB,Elongin-B,37562,0.0340332838245174,0.00387533079392445,0.0264376354684255,0.0416289321806093,1.80274044977973e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,STXBP3,Syntaxin-binding protein 3,39980,0.0373347963601657,0.00425396644898481,0.0289970221201555,0.045672570600176,1.85996994061997e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSTN,Growth/differentiation factor 8,40042,0.0430984217898113,0.00492479322267917,0.0334458270733602,0.0527510165062625,2.32169847322244e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,40379,-0.0266608718308981,0.00304694314733551,-0.0326328803996757,-0.0206888632621205,2.34323363300665e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSR,"Glutathione reductase, mitochondrial",37944,0.0186588178295266,0.00213332782456162,0.0144774952933858,0.0228401403656673,2.46208785696985e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL8,Interleukin-8,40209,0.0569600604919901,0.00652824906682227,0.0441646923210184,0.0697554286629617,2.92000554362152e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CIT,Citron Rho-interacting kinase,37572,0.0379329659353876,0.00434711734157372,0.0294126159459031,0.0464533159248721,2.95368510150225e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENAH,Protein enabled homolog,40044,0.0397428933971017,0.00455964251411903,0.0308059940694284,0.048679792724775,3.16175059665838e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,0.0352433629574159,0.00404385294875068,0.0273174111778646,0.0431693147369673,3.18194030368918e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,-0.0351319083169635,0.00403172232281843,-0.0430340840696876,-0.0272297325642394,3.22294841572703e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASET2,Ribonuclease T2,40465,0.022121153802151,0.00254053933022237,0.0171416967149152,0.0271006108893869,3.41221319641812e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR2,Folate receptor beta,40471,-0.0246864842504336,0.00283517999624749,-0.0302434370430786,-0.0191295314577885,3.41404523002194e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,XRCC4,DNA repair protein XRCC4,39961,0.0312080192453745,0.00358669084673136,0.024178105185781,0.0382379333049679,3.61384504841531e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLIF,Cobalamin binding intrinsic factor,40330,0.0610224010635921,0.00702126828445307,0.047260715226064,0.0747840869011201,3.93571676399001e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCRIB,Protein scribble homolog,37628,0.0779176474267934,0.00897912758977353,0.0603185573508373,0.0955167375027495,4.51050303232344e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASS1,Argininosuccinate synthase,37562,0.0672539615757269,0.00775128223401888,0.0520614483970499,0.0824464747544039,4.5584252082049e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL19,C-C motif chemokine 19,40471,0.109323217665449,0.0126055078059975,0.084616422365694,0.134030012965204,4.62075410522288e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMD,Osteomodulin,40422,-0.0369794242635164,0.00426560489160911,-0.0453400098510703,-0.0286188386759626,4.76334419381832e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,40273,0.0279634278838749,0.003238797285468,0.0216153852043576,0.0343114705633922,6.48745915479585e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,37653,0.0452346384681802,0.00526029438417634,0.0349244614751946,0.0555448154611659,8.91987939758918e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL20,C-C motif chemokine 20,40516,0.0733406008460083,0.00853534556796648,0.056611323532794,0.0900698781592226,9.27578609313083e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,0.0723124059337618,0.00841909569495411,0.0558109783716518,0.0888138334958719,9.73594818253158e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,0.0252811377175752,0.00294384731570392,0.0195111969787955,0.0310510784563549,9.82563008550546e-18
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL14,C-C motif chemokine 14,40309,0.0321126283660959,0.00375060283985311,0.0247614467999838,0.039463809932208,1.20989023026042e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN1,Contactin-1,40536,-0.0227479887941768,0.00265707914362167,-0.0279558639156753,-0.0175401136726783,1.21589710083215e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0188088559846152,0.00220230298800779,0.01449234212812,0.0231253698411105,1.45404473637325e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,0.0326638497362897,0.00382912447175133,0.0251587657716571,0.0401689337009223,1.61274751018977e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEP1B,Meprin A subunit beta,40359,0.0969218042952272,0.0113857744584064,0.0746056863567506,0.119237922233704,1.85182058035189e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0308054451183362,0.00361917931794182,0.0237118536551702,0.0378990365815021,1.86864745806491e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,0.0270900161757486,0.00318549970870673,0.0208464367466834,0.0333335956048138,1.98954830259256e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX5,Sorting nexin-5,37628,0.0246148338683554,0.00289389041454721,0.0189428086558429,0.0302868590808679,1.99660320760259e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,0.0574036472276938,0.00676303148557804,0.0441481055159609,0.0706591889394268,2.32865057220027e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRG,Histidine-rich glycoprotein,37934,0.0257699472111203,0.00303784832016946,0.0198157645035882,0.0317241299186524,2.42218588332703e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOBR,Apolipoprotein B receptor,37628,-0.0347267907415521,0.00409370211625635,-0.0427504468894146,-0.0267031345936897,2.4273104030606e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDF1,Endothelial differentiation-related factor 1,37959,0.0568702450737735,0.00671356776810192,0.0437116522482937,0.0700288378992533,2.68371163085377e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,-0.0360765601893194,0.00426204809344742,-0.0444301744524764,-0.0277229459261625,2.79107221758061e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,0.0339200208715606,0.00400691095709713,0.0260664753956502,0.041773566347471,2.82111922150647e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPG,Macrophage-capping protein,40185,0.0472346992648092,0.0055833032065348,0.0362914249800009,0.0581779735496174,2.90655324895656e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL2A1,Collagen alpha-1(II) chain,37628,0.0671447931151316,0.00794192156618801,0.0515786268454031,0.0827109593848601,3.09601491434615e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE6,Ribonuclease K6,37917,0.0238102170872386,0.00284389178850095,0.0182361891817767,0.0293842449927005,6.19861220092629e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCAN,Versican core protein,40471,-0.0242035807692863,0.00289462431080757,-0.0298770444184691,-0.0185301171201034,6.69295632130739e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCOF1,Treacle protein,37990,0.0243732131575676,0.00291458529331551,0.0186606259826692,0.030085800332466,6.73589252904538e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASGR2,Asialoglycoprotein receptor 2,37987,0.0208238317344062,0.0024911213410137,0.0159412339060193,0.025706429562793,6.92483016651868e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL6A3,Collagen alpha-3(VI) chain,40536,0.0275821642435499,0.00330079963763647,0.0211125969537824,0.0340517315333174,7.00015136544356e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIT2,Slit homolog 2 protein,39961,0.0420532741066231,0.00505173357658672,0.0321518762965132,0.0519546719167331,9.16650117499012e-17
NMR metabolomics,X23501.Triglycerides in Large VLDL,MARCO,Macrophage receptor MARCO,40359,0.0212421196335292,0.00255538194787251,0.0162335710156991,0.0262506682513594,1.01036046187598e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QA,Complement C1q subcomponent subunit A,40442,-0.0181810289926102,0.00218869548405712,-0.0224708721413622,-0.0138911858438582,1.06130846955285e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,40305,0.0175371916980305,0.00211247105305489,0.0133967484340429,0.0216776349620181,1.10789457922136e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL5,Insulin-like peptide INSL5,37901,0.075087806912014,0.00906218280011728,0.0573259286237842,0.0928496852002439,1.28302620188507e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,40359,0.0279740966015273,0.00337996669269306,0.0213493618838489,0.0345988313192057,1.36886475569881e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYGD,Gamma-crystallin D,37942,0.0765740534987362,0.0092605099079181,0.0584234540792167,0.0947246529182556,1.47787997134566e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,37714,0.0605355548296075,0.00732211359699645,0.0461842121794945,0.0748868974797206,1.49731527472625e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF2,Growth/differentiation factor 2,40359,0.0283556103489086,0.00343632336095133,0.021620416561444,0.0350908041363732,1.68241073115812e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0178922542949328,0.00217353409408228,0.0136321274705316,0.0221523811193341,1.98464919525456e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRK1,Protein BRICK1,39961,0.0350104778553175,0.00425604803751462,0.0266686237017888,0.0433523320088461,2.08710740297535e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,39980,0.0277523768387652,0.0033777080088879,0.0211320691413449,0.0343726845361854,2.26231712524252e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,0.0661399552492486,0.00806734014779525,0.0503279685595699,0.0819519419389273,2.623367185719e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAM,Basal cell adhesion molecule,40332,-0.0187009895595609,0.00228117618406621,-0.0231720948803307,-0.0142298842387912,2.63019537910935e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBD,Thrombomodulin,40359,0.0218548764128223,0.00266963518538142,0.0166223914494747,0.0270873613761698,2.89231348865806e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,40332,-0.0414894050900501,0.00507465163619139,-0.0514357222969852,-0.031543087883115,3.15888858064407e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK7,Kallikrein-7,37352,0.0305659069895249,0.00374214824132019,0.0232312964365374,0.0379005175425125,3.42536215697458e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,0.0517263959101595,0.00633937702378991,0.0393012169435313,0.0641515748767877,3.65988957960715e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,0.0270819999603479,0.00332363556901242,0.0205676742450835,0.0335963256756122,3.96396475449466e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37628,0.0238287217085245,0.0029255481794615,0.01809464727678,0.029562796140269,4.13075727792669e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37910,0.0322660274514261,0.00396331112614299,0.0244979376441859,0.0400341172586664,4.25652150847167e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,37901,0.0207170913724783,0.00254905537179856,0.0157209428437532,0.0257132399012035,4.76839696619201e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,0.0522790488672912,0.00643935167330168,0.0396579195876199,0.0649001781469625,5.11837721306689e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,39961,0.0570767159571443,0.0070515176850838,0.04325574129438,0.0708976906199085,6.18658028728539e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,0.0422133270327929,0.00521973197873366,0.0319826523544749,0.0524440017111109,6.61794756752472e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,0.0391728508997171,0.00484772114851707,0.0296713174486236,0.0486743843508105,6.9990492731337e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSNK1D,Casein kinase I isoform delta,37598,0.0496434516729151,0.00614881576044615,0.0375917727824407,0.0616951305633896,7.41248250435426e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,PER3,Period circadian protein homolog 3,37598,0.0918742345139581,0.0113922934141078,0.0695453394223069,0.114203129605609,7.98081819071957e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37879,0.0323793550607702,0.00401997814201611,0.0245001979024186,0.0402585122191218,8.64175751734923e-16
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRH,Corticoliberin,39947,0.0672109194453638,0.00837095002869938,0.050803857389113,0.0836179815016146,1.05225250620917e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,40341,0.0409454105869613,0.00510939223022147,0.0309310018157272,0.0509598193581954,1.18935930664947e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SBSN,Suprabasin,37977,-0.0259790260763154,0.00324275758543962,-0.0323348309437771,-0.0196232212088538,1.22641913406463e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG4,Regenerating islet-derived protein 4,40379,0.0374596194771372,0.00468302192443272,0.0282808965052491,0.0466383424490254,1.33972996711444e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYM,Ketimine reductase mu-crystallin,37541,0.0595319886522504,0.00744179405467459,0.0449460723050882,0.0741179049994126,1.35182409895526e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA2,Carbonic anhydrase 2,40291,0.0543539843041268,0.00680261980999208,0.0410208494765423,0.0676871191317112,1.43987193552192e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,0.0367085037072055,0.00459424855978938,0.0277037765300183,0.0457132308843927,1.44276196024232e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR2,TGF-beta receptor type-2,40411,0.0242792296943274,0.00303917250452303,0.0183224515854622,0.0302360078031925,1.45542572264136e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX2,Neuronal pentraxin-2,37998,-0.0251677914354772,0.00315328008165833,-0.0313482203955276,-0.0189873624754269,1.56181156181956e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,C5,Complement C5,38013,0.011767107474518,0.00147492420167345,0.00887625603923802,0.0146579589097979,1.60449156097888e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLTA,Clathrin light chain A,40042,0.0364223190143956,0.0045660465573372,0.0274728677620147,0.0453717702667765,1.60579929853854e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,0.0290919511518278,0.00364723689938235,0.0219433668290384,0.0362405354746172,1.60822118168649e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,40291,0.0222625431347456,0.0027915894893698,0.0167910277355807,0.0277340585339104,1.62902977467407e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",40359,0.0555479394987026,0.00696587980556726,0.0418948150797908,0.0692010639176145,1.63612524525474e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFD,Vascular endothelial growth factor D,40483,-0.0255516364552609,0.00320660096166131,-0.031836574340117,-0.0192666985704047,1.71412744950001e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS7_LGALS7B,Galectin-7,40270,0.0307936740326868,0.00386811581838617,0.0232121670286499,0.0383751810367237,1.82320116355501e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,40359,0.0508155033541308,0.00639102271606446,0.0382890988306445,0.0633419078776172,1.97241533442534e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP6,Gastrotropin,40017,0.0427908634751037,0.00538323930189239,0.0322397144433947,0.0533420125068128,2.00996024808668e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP9,Caspase-9,37598,0.0479047056817214,0.00602749429880886,0.036090816856056,0.0597185945073868,2.05425932227553e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,37562,0.0481603307870165,0.0060616456860538,0.036279505242351,0.0600411563316819,2.09815600506328e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,39980,0.0350037233362349,0.00441742132462884,0.0263455775399624,0.0436618691325074,2.45476877444096e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPCAM,Epithelial cell adhesion molecule,40358,-0.0760602240853775,0.00960863599934074,-0.0948931506440854,-0.0572272975266697,2.6173435587803e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,-0.0261293830597823,0.00330410122455544,-0.032605421459911,-0.0196533446596536,2.78241732626968e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD1C,T-cell surface glycoprotein CD1c,40411,0.0181857854830759,0.00230488575787144,0.0136682093976478,0.0227033615685039,3.21406624379204e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARF2,Scavenger receptor class F member 2,40471,-0.0225519998968851,0.00286252746417198,-0.0281625537266622,-0.016941446067108,3.52904952587698e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI2,Serpin I2,37901,0.0425320210222012,0.00539980501620865,0.0319484031904323,0.0531156388539702,3.6215313404975e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSDE1,Cold shock domain-containing protein E1,37562,0.0888923478215631,0.0113059051691235,0.0667327736900809,0.111051921953045,4.0595559530456e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAPK2,Death-associated protein kinase 2,37598,0.0396262441222034,0.00505423234352011,0.029719948728904,0.0495325395155028,4.84314456559646e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,0.034041103958454,0.00434800439669014,0.0255190153409414,0.0425631925759667,5.2207987481999e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA4,Laminin subunit alpha-4,40422,0.0247163732764977,0.00315721945283195,0.0185282231489471,0.0309045234040483,5.24435966136031e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,0.0412630874904545,0.0052842347394528,0.030905987401127,0.051620187579782,6.1369997052648e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,0.0247539926278907,0.00317195679122592,0.0185369573170879,0.0309710279386935,6.36426290596623e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP12,Macrophage metalloelastase,40346,0.038931819631618,0.00498953033337236,0.0291523401782082,0.0487112990850279,6.434573470881e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37835,0.0441883330108257,0.00566439431512246,0.0330861201531857,0.0552905458684657,6.59164519751392e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L2,Seizure 6-like protein 2,40305,-0.0178156043165783,0.00228542186505842,-0.0222950311720928,-0.0133361774610638,6.82147653279114e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP2,Retinol-binding protein 2,40305,-0.0569844400729853,0.00732319483899824,-0.0713379019574219,-0.0426309781885488,7.61503057556246e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,PZP,Pregnancy zone protein,38013,0.0488621338315747,0.00628786355845575,0.0365379212570014,0.0611863464061479,8.35403203268312e-15
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_E,,40341,0.0214786284661029,0.00277475920418264,0.0160401004259049,0.0269171565063009,1.04782840418655e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40453,0.0493143217712923,0.0063738839713276,0.0368215091874902,0.0618071343550944,1.07891629319853e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,0.0469439097031772,0.00607267929875389,0.0350414582776195,0.0588463611287348,1.13662344645851e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,0.0264465201405667,0.00343221742812677,0.0197193739814383,0.0331736662996952,1.39790110386589e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNC,Tenascin,40403,-0.0349724594152819,0.00454909466002839,-0.0438886849489375,-0.0260562338816262,1.58398132375542e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAX,Apoptosis regulator BAX,39934,0.0660088040405733,0.00860227976583346,0.0491483356995397,0.0828692723816069,1.77438279449443e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRDT,Bromodomain testis-specific protein,37562,0.0275723578819059,0.00359674504633937,0.0205227375910807,0.034621978172731,1.90025297532038e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37628,0.0372424169264547,0.00486359133889453,0.0277097779022214,0.0467750559506879,2.02947941917947e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR3,Small proline-rich protein 3,37942,0.0525102476629559,0.00687481524756591,0.0390356097777267,0.0659848855481851,2.35338293999622e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,0.0288795094805675,0.00378102002695927,0.0214687102277273,0.0362903087334077,2.35808500287317e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTN,Pleiotrophin,40042,0.0368563008930817,0.00483770294259974,0.0273744031255862,0.0463381986605772,2.7123679995197e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,0.0164083647933633,0.00216038081155925,0.0121740184027071,0.0206427111840194,3.27602312718072e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4D,C-type lectin domain family 4 member D,40341,0.0447313086739444,0.0058935710604596,0.0331799093954436,0.0562827079524452,3.3801184193296e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHCY,Adenosylhomocysteinase,40359,0.0494029976308977,0.00652190471842424,0.0366200643827862,0.0621859308790092,3.79021806538071e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,0.0258527462052318,0.00342207429388468,0.0191454805892178,0.0325600118212458,4.42688545340904e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0401451162524193,0.00531919462412304,0.0297194947891382,0.0505707377157005,4.6844316578277e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHCHD6,MICOS complex subunit MIC25,37900,0.0211186445217063,0.00279880896212277,0.0156329789559457,0.0266043100874669,4.79160933049539e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,MPO,Myeloperoxidase,40332,0.0339416297566093,0.00450302383365846,0.0251157030426387,0.0427675564705799,5.04797762258092e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,0.0420862903868951,0.00559193181807392,0.0311261040234702,0.05304647675032,5.50661859554741e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTLC1,Serine palmitoyltransferase 1,37942,0.0260762124635783,0.00346827571428992,0.0192783920635701,0.0328740328635865,5.89032680727038e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39961,0.0466997394896599,0.0062129003998058,0.0345224547060406,0.0588770242732793,5.92978741577112e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,40359,-0.0194364853070437,0.00258639240999198,-0.024505814430628,-0.0143671561834595,5.99793861184673e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,0.0225616369114988,0.00300487693765104,0.0166720781137027,0.0284511957092948,6.30258015535479e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,0.035094244066698,0.00468033068428205,0.0259207959255051,0.0442676922078908,6.80918499405946e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2orf69,UPF0565 protein C2orf69,37572,0.0435281258673293,0.00582165869455367,0.0321176748260041,0.0549385769086545,8.09049905751612e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSF,Cathepsin F,40411,0.0287579408232163,0.00385343290415104,0.0212052123310803,0.0363106693153524,8.89692328550986e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,0.0310173073964848,0.00416135712757211,0.0228610474264435,0.0391735673665261,9.64658707780718e-14
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR1,Complement receptor type 1,37959,0.0259412766883617,0.00349421496807184,0.0190926153509409,0.0327899380257825,1.20373804302629e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS22,Brain-specific serine protease 4,37598,0.0253151642944002,0.00341441737681033,0.0186229062358519,0.0320074223529484,1.29848957042845e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPB2,Coatomer subunit beta',37562,0.0309399025356368,0.00417549178699683,0.022755938633123,0.0391238664381506,1.34148170345465e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIGR,Polymeric immunoglobulin receptor,40154,0.0250869603078603,0.00338658783972926,0.018449248141991,0.0317246724737297,1.34998115903139e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",40359,-0.0550279766570604,0.00743978403996139,-0.0696099533753847,-0.0404459999387361,1.4684609720029e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,0.0338574966351971,0.00458001486954958,0.0248806674908799,0.0428343257795142,1.52631192385833e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLGN,Calmegin,37572,0.0316936855096706,0.00429109732049194,0.0232831347615064,0.0401042362578348,1.60545693822107e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37714,0.0394943590589142,0.00535042349184182,0.0290075290149042,0.0499811891029241,1.65788402284871e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,ULBP2,UL16-binding protein 2,40228,0.0264813562703367,0.00358933898901628,0.0194462518518648,0.0335164606888086,1.68956868966361e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN2,Calsyntenin-2,40516,-0.0277274984695684,0.00376073657310321,-0.0350985421528507,-0.0203564547862861,1.75100521934398e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,-0.0187172589397914,0.00254203602134544,-0.0236996495416285,-0.0137348683379544,1.88515335794035e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL15,C-C motif chemokine 15,40536,0.0313275174640865,0.00428266219081966,0.02293349957008,0.0397215353580931,2.69584878751644e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX2,Sorting nexin-2,37900,0.0550621471401586,0.00752865172219604,0.0403059897646544,0.0698183045156629,2.7462543695754e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM3,Myomesin-3,37671,-0.0636489859649938,0.00870270505915488,-0.0807062878809373,-0.0465916840490502,2.7484239168741e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN3,Calsyntenin-3,37942,0.021551427372511,0.00295259168477907,0.015764347670344,0.027338507074678,3.05774099863018e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A12,Protein S100-A12,40139,0.0534736779091021,0.00736321065937731,0.0390417850167226,0.0679055708014816,3.98502547281778e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGKZ,Diacylglycerol kinase zeta,40044,0.0245515612998182,0.00338167217215346,0.0179234838423974,0.031179638757239,4.04811341530843e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37539,0.0288489822058201,0.00397887862896447,0.0210503800930497,0.0366475843185905,4.38455933625025e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,0.0400995812950579,0.00554201913374402,0.0292372237929196,0.0509619387971962,4.88742983826857e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD209,CD209 antigen,40382,-0.0270205378744382,0.0037434619915608,-0.0343577233778973,-0.019683352370979,5.5113018052068e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,0.0256994973823486,0.0035700372442975,0.0187022243835255,0.0326967703811717,6.40782374130727e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST5,Cystatin-D,40070,0.0382314489255236,0.00531469135638369,0.0278146538670116,0.0486482439840356,6.59991118829629e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCT,Secretin,37572,0.0318714533411402,0.00443850056804037,0.0231719922277811,0.0405709144544994,7.31023935612615e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,C4BPB,C4b-binding protein beta chain,40411,0.0285007691475255,0.00397303042220292,0.0207136295200078,0.0362879087750433,7.6282530468848e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGR2,Anterior gradient protein 2 homolog,39839,0.0699927223976585,0.00976635854907373,0.050850659641474,0.089134785153843,8.03069602277374e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR2,Complement factor H-related protein 2,37911,0.0395207578771299,0.00551576905988805,0.0287098505197494,0.0503316652345105,8.18040726630967e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.0330124422700546,0.00461243340419448,0.0239720727978334,0.0420528117422758,8.59818864413837e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,0.0308882745649244,0.00431791517237666,0.0224251608270661,0.0393513883027826,8.90617768468088e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,LACRT,Extracellular glycoprotein lacritin,37863,0.0367224126443054,0.0051405159786741,0.0266470013261041,0.0467978239625066,9.55244264635683e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,40489,0.0260750191199656,0.00365129573670863,0.0189184794760167,0.0332315587639146,9.64171244461951e-13
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.0500278503516758,0.00700995045293688,0.0362883474639195,0.063767353239432,1.00629224509752e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,EBI3_IL27,Interleukin-27,40453,-0.0214271182300269,0.00300572984720412,-0.027318348730547,-0.0155358877295068,1.0560634460165e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,0.0279449790889769,0.00392781318704846,0.0202464652423619,0.0356434929355918,1.17088678004431e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A14,Protein S100-A14,37959,0.0368480172437389,0.00519554075771029,0.0266647573586267,0.0470312771288511,1.38524741306216e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,-0.0177061724686307,0.00250101249914831,-0.0226081569669614,-0.0128041879703001,1.51689850704463e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,0.0311020081397509,0.00441447825801168,0.0224496307540481,0.0397543855254538,1.94089741898692e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRN,Progranulin,40262,0.016453860764636,0.00233729178749151,0.0118727688611526,0.0210349526681194,2.00560733941323e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37562,0.0378241895243591,0.00537437478608036,0.0272904149436415,0.0483579641050766,2.04898168347844e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN2,Matrilin-2,40379,0.0200865560316364,0.00285782578177697,0.0144852174993535,0.0256878945639192,2.17055814168169e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.0295654761941611,0.00421925601886098,0.0212957343971936,0.0378352179911286,2.53002154970326e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP8,GTPase IMAP family member 8,37482,0.0349989788301884,0.00500041821057963,0.0251981591374523,0.0447997985229244,2.70009643174552e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,0.0317530631429275,0.00453780643666743,0.0228589625270594,0.0406471637587957,2.71365394654237e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD1,Leiomodin-1,37959,-0.0244772445868212,0.00350181885801035,-0.0313408095485215,-0.0176136796251209,2.88062876347054e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,40305,0.0142164328596767,0.00203527300822775,0.0102272977635503,0.0182055679558031,2.96128127781384e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSHB,Follitropin subunit beta,37628,0.0471613240963068,0.00675190400389841,0.033927592248666,0.0603950559439477,2.98757969106127e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,0.0227372554535225,0.00325879932378893,0.0163500087788962,0.0291245021281488,3.13024489388072e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAEP,Glycodelin,40228,-0.0880970938406531,0.0126673506701159,-0.11292510115408,-0.063269086527226,3.6729476144555e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA7,Thyroxine-binding globulin,38013,0.0125393353255311,0.00180482180456319,0.00900188458858723,0.0160767860624749,3.88267438531707e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBS,Cystathionine beta-synthase,37628,0.034079956037005,0.00490550017604588,0.0244651756919551,0.0436947363820549,3.89848054228476e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM4,Intercellular adhesion molecule 4,40341,-0.0352337589803778,0.00508412414936359,-0.0451986423131304,-0.0252688756476251,4.36542844058547e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEPACAM2,HEPACAM family member 2,37942,-0.0272282443534225,0.00393397032720988,-0.0349388261947538,-0.0195176625120911,4.67687860798013e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,0.0324413245864318,0.00469877839258123,0.0232317189369726,0.041650930235891,5.23950985193827e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD101,Immunoglobulin superfamily member 2,37901,0.0283525194258717,0.00410670865980235,0.0203033704526591,0.0364016683990843,5.28443446517808e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHPS,Deoxyhypusine synthase,37900,0.0273734840551882,0.00397608900141129,0.0195803496124221,0.0351666184979544,6.05528726089692e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,-0.016048923034168,0.00233173642607997,-0.0206191264292847,-0.0114787196390513,6.08464503885235e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0677349246779623,0.00984069767219187,0.0484471572404662,0.0870226921154583,6.11414025409244e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPE,Carboxypeptidase E,40360,-0.0253489571133594,0.003686109699516,-0.0325737321244107,-0.018124182102308,6.34521334626638e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.0330257589324968,0.0048088177391519,0.023600476163759,0.0424510417012345,6.80665265746315e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA3,Protein disulfide-isomerase A3,37671,0.0169418356264079,0.00246698184071903,0.0121065512185986,0.0217771200342172,6.82887432004521e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL4,ADAMTS-like protein 4,37628,0.0155507437292797,0.00227066907830893,0.0111002323357942,0.0200012551227652,7.79226354535639e-12
NMR metabolomics,X23501.Triglycerides in Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,40152,0.0761217920983521,0.011176024836621,0.0542167834185749,0.0980268007781293,1.00323966444745e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYZL2,Lysozyme-like protein 2,37482,0.023570282182991,0.00346665875696295,0.0167756310193436,0.0303649333466384,1.09835972342278e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL2,Fc receptor-like protein 2,40442,0.0318457043660299,0.00469137019223599,0.0226506187892474,0.0410407899428125,1.1757784008043e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37900,0.0217080143741923,0.00320890747869602,0.0154185557159481,0.0279974730324365,1.38896233624771e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0156863483348793,0.00232420960884574,0.0111308975015416,0.0202417991682169,1.53901707951598e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOM,Apolipoprotein M,40372,0.0173394516411695,0.00257346633184917,0.0122954576307451,0.0223834456515938,1.66338436841447e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,VGF,Neurosecretory protein VGF,37959,0.0198027665697409,0.002944853772818,0.0140308531750176,0.0255746799644642,1.83238817965997e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,-0.0196072464410451,0.00292478129430179,-0.0253398177778766,-0.0138746751042136,2.09991056779816e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,0.0245176636475661,0.00367144536717923,0.0173216307278948,0.0317136965672374,2.50527619061794e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4M,C-type lectin domain family 4 member M,37969,-0.0310485267959048,0.00468237893091818,-0.0402259895005045,-0.0218710640913052,3.46251592950653e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0351999877566705,0.00531275031147472,-0.0456129783671609,-0.02478699714618,3.57032278341026e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA6,Carbonic anhydrase 6,40295,-0.0406977850591772,0.00614377467800334,-0.0527395834280638,-0.0286559866902907,3.60301199195315e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,FST,Follistatin,40396,0.0331490613296013,0.00500458984421746,0.0233400652349351,0.0429580574242676,3.61445627453943e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN4B,Sodium channel subunit beta-4,37628,0.0268456590338955,0.00405294970673211,0.0189018776087006,0.0347894404590904,3.63835086553711e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXNB2,Plexin-B2,40472,0.0148654550895961,0.00224517931033914,0.0104649036413314,0.0192660065378608,3.67980456166881e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,GC,Vitamin D-binding protein,38013,0.0165554847388538,0.00250856033296434,0.0116387064862437,0.0214722629914639,4.27599436280529e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,40422,0.0163518917972459,0.00248949023520664,0.0114724909362409,0.0212312926582509,5.24404863746051e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PVALB,Parvalbumin alpha,40417,0.0714710400631975,0.0108913580214369,0.0501239783411812,0.0928181017852138,5.4659498922194e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37900,0.0259712552688294,0.00395926066002205,0.0182111043751862,0.0337314061624726,5.59174717735617e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.0208592094887277,0.00318012851867006,-0.027092261385321,-0.0146261575921344,5.6062431157767e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.0244620434697087,0.00373871927632501,0.0171341536881117,0.0317899332513058,6.21886980392874e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.0344561223284163,0.00526836527342415,0.024130126392505,0.0447821182643276,6.37173073090149e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFIC,Nuclear factor 1 C-type,37959,0.0275226862697098,0.00421579580790039,0.0192597264862251,0.0357856460531946,6.88204360731475e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.0346321317656038,0.00531195581105096,0.0242206983759439,0.0450435651552637,7.29838437178109e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE3,Eosinophil cationic protein,40288,0.068103551722626,0.0104596250229209,0.0476026866777011,0.088604416767551,7.68527624255973e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37901,0.0163601664757173,0.00251437979350953,0.0114319820804386,0.021288350870996,7.95715762673947e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.0304355228955398,0.00468112073542323,-0.0396105195369693,-0.0212605262541102,8.17545667909967e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.0174364140060297,0.00269199765270387,0.0121600986067301,0.0227127294053293,9.6214826457129e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.0223280604888369,0.00344770165960136,0.0155705652360183,0.0290855557416556,9.73108450218759e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRK1,NKG2-D type II integral membrane protein,37942,0.0288572816078923,0.00445628838205359,0.0201229563790673,0.0375916068367173,9.76870901315095e-11
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300A,CMRF35-like molecule 8,37671,0.0184840717120308,0.00285720832103546,0.0128839434028013,0.0240842000212603,1.01941909529015e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LGALS4,Galectin-4,40357,0.0328586146761539,0.0050864307807379,0.0228892103459076,0.0428280190064002,1.07705264167525e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGA4,Pepsin A-4,37987,0.0423316298794626,0.00656375193990122,0.0294666760772563,0.055196583681669,1.1618247056595e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFC1,Cryptic protein,39980,0.0286843544733857,0.00445005650085973,0.0199622437317006,0.0374064652150708,1.18352080986531e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS1,Nephrin,37598,0.0215943866951531,0.00335268920013424,0.01502311586289,0.0281656575274162,1.22889389101456e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL15A1,Collagen alpha-1(XV) chain,37998,0.0161096460238639,0.00250362279318584,0.0112025453492196,0.0210167466985081,1.28018689116826e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,-0.0202606429813708,0.00315874304679439,-0.0264517793530878,-0.0140695066096538,1.45624135800679e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,OBP2B,Odorant-binding protein 2b,40184,-0.0408669910005586,0.00638131937916318,-0.0533743769837184,-0.0283596050173987,1.55488517614718e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGA11,Integrin alpha-11,40341,-0.0209886890303931,0.00328198976255729,-0.0274213889650054,-0.0145559890957809,1.64911039924638e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,0.0176320778026936,0.0027619944939869,0.0122185685944793,0.0230455870109079,1.78513855548186e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMB,RGM domain family member B,40471,0.0159555206112651,0.00250115550404491,0.0110532558233371,0.0208577853991931,1.82826503447595e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,0.0314443408653587,0.00493205080469674,0.0217775212881531,0.0411111604425643,1.87504187992931e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPF,Centromere protein F,37714,0.0336519680628224,0.00527897290194259,0.0233051811750149,0.0439987549506299,1.89369175276543e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA12,Carbonic anhydrase 12,40305,-0.0197551774374176,0.00311009331229844,-0.0258509603295225,-0.0136593945453126,2.18386816916659e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZBP1,Z-DNA-binding protein 1,37598,0.0247093728017148,0.00389061571284883,0.0170837660045311,0.0323349795988985,2.20935878427671e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPARCL1,SPARC-like protein 1,40346,-0.0168610770212934,0.00265812826712176,-0.022071008424852,-0.0116511456177347,2.31102963653877e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,AZU1,Azurocidin,39809,0.0474768024050926,0.00749988347583904,0.0327770307924481,0.0621765740177371,2.51415567375881e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH1,Cadherin-1,39806,0.024393943474044,0.00386156499848254,0.0168252760770182,0.0319626108710698,2.73833878238607e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,0.0225381241064,0.00356885659125453,0.0155431651875412,0.0295330830252589,2.78259945099173e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAT,Catalase,37786,0.0331820755822028,0.00525664193363094,0.0228790573922862,0.0434850937721195,2.83426943325106e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A13,Protein S100-A13,37598,0.0212517350282713,0.00336735580816142,0.0146517176442749,0.0278517524122677,2.85946861759745e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP7,Dipeptidyl peptidase 2,40251,0.035219180074022,0.00558313979371888,0.024276226078333,0.0461621340697111,2.89938510507062e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAFA5,Chemokine-like protein TAFA-5,40305,0.0217870428784123,0.00345446062437402,0.0150163000546392,0.0285577857021854,2.92164727560622e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,39980,0.0218671502689891,0.00346901277417598,0.0150678852316042,0.0286664153063741,2.98727928686023e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MBL2,Mannose-binding protein C,37810,-0.0648708762601228,0.0102933852309241,-0.0850459113127341,-0.0446958412075115,3.02687790485258e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,39961,0.0232452029647634,0.00369221505011798,0.0160084614665321,0.0304819444629946,3.1417904799052e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSR,Insulin receptor,37598,0.0102445241685028,0.00163220325685928,0.0070454057850586,0.013443642551947,3.57158245449344e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MST1,Hepatocyte growth factor-like protein,37787,0.0372957092038335,0.00594296232294357,0.0256475030508641,0.0489439153568029,3.59046596176438e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,39535,0.0229960688450266,0.00367010662187126,0.0158026598661589,0.0301894778238943,3.81043886548329e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL21,C-C motif chemokine 21,40422,0.0256399941101449,0.00409530092841015,0.0176132042904611,0.0336667839298288,3.92709730752165e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37562,0.061353683630657,0.00979828545607644,0.0421490441367471,0.0805583231245668,3.92750374228868e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,MATN3,Matrilin-3,40203,-0.0188518533003546,0.00301248805599409,-0.024756329890103,-0.0129473767106062,4.00282018506725e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,0.035097024913787,0.00561709474428146,0.0240875192149953,0.0461065306125787,4.25632956486994e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,39980,0.0362197767047156,0.00579807400194429,0.0248555516609048,0.0475840017485264,4.29686551259058e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGT,Angiotensinogen,37987,0.0145958318067451,0.00233760533879544,0.010014125342706,0.0191775382707841,4.39476491676357e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPA,Apolipoprotein(a),37735,-0.105815604987348,0.0169650246473109,-0.139067053296077,-0.0725641566786182,4.58748481941314e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,-0.0123351425896095,0.00198175922391106,-0.0162193906684752,-0.00845089451074381,4.98253962865322e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0342104121018626,0.00549765960190479,0.0234349992821292,0.044985824921596,5.00875762761339e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAG3,Lymphocyte activation gene 3 protein,40305,-0.0245397569078035,0.003960611391795,-0.0323025552357217,-0.0167769585798853,5.93648736964329e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,0.029105578548867,0.00471023257770848,0.0198735226965584,0.0383376344011757,6.60188488039321e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,0.0172090178977732,0.00278700260651495,0.0117464927890039,0.0226715430065426,6.788438776804e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,0.0442339887154068,0.0071678061039067,0.0301850887517497,0.0582828886790639,6.9745921999908e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39980,0.0306379140000071,0.00497262125573777,0.0208915763387611,0.0403842516612531,7.39205294501223e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,0.0220411178700008,0.00358134802248768,0.0150216757459249,0.0290605599940766,7.71655096933252e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD80,T-lymphocyte activation antigen CD80,37990,0.0201820883203281,0.00328577658460447,0.0137419662145033,0.0266222104261528,8.36341509221264e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSG,Basigin,40502,0.011933855254789,0.00194578355147679,0.0081201194938945,0.0157475910156835,8.81540153319203e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAM1,Neural cell adhesion molecule 1,40403,-0.0162765828614919,0.00266121421318244,-0.0214925627193295,-0.0110606030036543,9.80533765890778e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY75,Lymphocyte antigen 75,40341,0.022922977359311,0.00374971659189197,0.0155735328392027,0.0302724218794192,9.99000896090984e-10
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,0.0357845052534789,0.00586026892768054,0.024298378155225,0.0472706323517327,1.04846864846218e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39925,0.0257787840164541,0.00422295532288406,0.0175017915836013,0.0340557764493068,1.05623179404935e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO2,Roundabout homolog 2,40471,0.0136855414100008,0.00224389641896368,0.00928750442883194,0.0180835783911696,1.09180287043047e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,-0.0153549521918141,0.00252134875943878,-0.0202967957603141,-0.0104131086233141,1.1606957182961e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.0247456289985957,0.00406718670182898,0.0167739430630109,0.0327173149341805,1.2024303139863e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPL,Periplakin,37598,0.0193614760855845,0.00318861247533422,0.0131117956339294,0.0256111565372396,1.29752624559916e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGER,Advanced glycosylation end product-specific receptor,40311,0.0236834956391853,0.00390507828988837,0.016029542191004,0.0313374490873665,1.35121101529071e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC16A1,Monocarboxylate transporter 1,39961,0.0351365997103697,0.0057950456030839,0.0237783103283253,0.0464948890924141,1.36521942147592e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.0155309484613691,0.00256300017456468,0.0105074681192224,0.0205544288035159,1.39472704055461e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37567,0.0347616225915558,0.0057490915683661,0.0234934031175582,0.0460298420655533,1.52090719728802e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENSA,Alpha-endosulfine,37900,0.0307984994488342,0.00509990776548814,0.0208026802284774,0.0407943186691909,1.591299479254e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL1,Follistatin-related protein 1,37628,-0.0131111848442836,0.00217515267814487,-0.0173744840934475,-0.00884788559511962,1.70743816283243e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDM1,Nuclear protein MDM1,37572,0.0181917188610728,0.00302306287217675,0.0122665156316063,0.0241169220905392,1.81689665499255e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,-0.017580443396957,0.00292182258138873,-0.0233072156564789,-0.0118536711374351,1.825084675552e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1,Programmed cell death protein 1,40455,0.0253135967554363,0.00421851007397461,0.0170453170104461,0.0335818765004266,2.0082750721772e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,0.0385911967187964,0.00643906163065694,0.0259706359227088,0.051211757514884,2.11062489176881e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AFAP1,Actin filament-associated protein 1,37671,0.0490288954095715,0.00818345692644295,0.0329893198337433,0.0650684709853997,2.13686091934701e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37900,0.0233299052526443,0.00389971110142986,0.0156864714938418,0.0309733390114468,2.2536146649905e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN4,Contactin-4,40332,-0.0140159033866361,0.00234316873424786,-0.0186085141057619,-0.0094232926675103,2.25695652245948e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAM,Integrin alpha-M,40332,-0.0182579335651131,0.00305345882151592,-0.0242427128552843,-0.0122731542749419,2.2872339553696e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,0.0487281189572433,0.00817827992057444,0.0326986903129174,0.0647575476015692,2.61515735106408e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR15L,Protein GPR15L,37901,0.034674641957667,0.00582515066124113,0.0232573466616344,0.0460919372536997,2.7053057165801e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCOR1,REST corepressor 1,40042,0.0257075461365986,0.004320627783056,0.0172391156818088,0.0341759765913883,2.73957922017245e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,37942,0.136843651751619,0.0230759615136823,0.091614767184802,0.182072536318437,3.10082421878728e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN10,Ataxin-10,39961,0.0413407478187414,0.00698586609881053,0.0276484502650728,0.0550330453724101,3.33213067653718e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.0274268406517886,0.00463643026768855,0.018339437327119,0.0365142439764581,3.38891638095654e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALY,RNA-binding protein Raly,37900,0.0275359670624599,0.00466363830380552,0.018395235987001,0.0366766981379187,3.62478349240552e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALCAM,CD166 antigen,40536,0.0110044965929214,0.00186847476722914,0.00734228604915231,0.0146667071366905,3.94941677865665e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CABP2,Calcium-binding protein 2,37572,0.0372053668361192,0.00632106925728503,0.0248160710918406,0.0495946625803979,4.05492043514438e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,40311,0.049702439592888,0.00844951768112314,0.0331413849378866,0.0662634942478893,4.12792515325662e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300E,CMRF35-like molecule 2,40436,0.02264817437368,0.00385093479521631,0.015100342175056,0.0301960065723039,4.15391268923846e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAS2,Growth arrest-specific protein 2,37714,0.0304323278885421,0.00517418127296304,0.0202909325935346,0.0405737231835497,4.16174793768405e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIMAP7,GTPase IMAP family member 7,37671,-0.0184130642045779,0.00313467857313509,-0.0245570342079227,-0.0122690942012332,4.35665400180426e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0183252546337145,0.00312862034913209,0.0121931587494156,0.0244573505180134,4.79670714561178e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG3,Desmoglein-3,40419,0.0189079375096035,0.00322858861398781,0.0125799038261874,0.0252359711930196,4.82271132579369e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,-0.038989298834232,0.00668085879767026,-0.0520837820776658,-0.0258948155907983,5.47101582677912e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,39980,0.0266408043568997,0.00458333259264168,0.017657472475322,0.0356241362384773,6.27388708068074e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN2,Prefoldin subunit 2,39961,0.0314270591091105,0.00541801305742712,0.0208077535165534,0.0420463647016677,6.74147182739173e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPP,"Alkaline phosphatase, placental type",40305,0.0575507153902611,0.00992274897892866,0.0381021273915609,0.0769993033889613,6.76278370805568e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI3,Elafin,40074,0.0299327193098971,0.00516170599798205,0.0198157755538523,0.040049663065942,6.8001340903614e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNA1,Ephrin-A1,40303,0.0152534319880671,0.00263119579058272,0.0100962882385249,0.0204105757376092,6.87345234045819e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPOCK1,Testican-1,40228,0.0139972601546618,0.00242405823111256,0.00924610602168113,0.0187484142876424,7.87231972442014e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSG4,Desmoglein-4,40250,0.0282927666554955,0.00490053198989892,0.0186877239552936,0.0378978093556973,7.91427212765919e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,DGCR6,Protein DGCR6,37541,0.0253614503402608,0.00439570003974683,0.0167458782623571,0.0339770224181646,8.12564569357804e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,0.019934588069429,0.00345731187881837,0.0131582567869451,0.026710919351913,8.30437512860216e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCP1,Plastin-2,37998,0.0261803755240744,0.00455008642840479,0.017262206124401,0.0350985449237478,8.91367012016556e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL3,Fc receptor-like protein 3,40044,0.0303908523577831,0.00528556770528645,0.0200311396554217,0.0407505650601446,9.10322707179111e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSC,Dipeptidyl peptidase 1,40349,0.0235728227114462,0.0041028231253024,0.0155312893858535,0.0316143560370389,9.33202251480299e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,0.0242036505302053,0.00421640359542606,0.0159394994831702,0.0324678015772403,9.62358654858725e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0380237405610367,0.00663018590349956,0.0250285761901776,0.0510189049318959,9.96869681509397e-09
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEL1L,Protein sel-1 homolog 1,37628,0.0180000728439957,0.00313923084111771,0.0118471803954049,0.0241529652925864,1.00293942780673e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1R1,Interleukin-1 receptor type 1,40303,-0.0123210887501428,0.00215218141604402,-0.0165393643255891,-0.00810281317469652,1.05349158408276e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECE1,Endothelin-converting enzyme 1,39961,0.0194662086897091,0.00340144530063711,0.0127993759004603,0.0261330414789578,1.06641604140467e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCN,Decorin,40042,-0.0125770527128113,0.00219979885273955,-0.0168886584641808,-0.00826544696144182,1.10169666912432e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD59,CD59 glycoprotein,39665,0.0124206018965068,0.00217535765217802,0.00815690089823785,0.0166843028947757,1.15300162914712e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,0.0208805720351641,0.00365785667896633,0.0137111729443901,0.0280499711259381,1.16046938188546e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A11,Protein S100-A11,40207,0.0246989116288819,0.00432965221727818,0.0162127932830166,0.0331850299747471,1.18714606062883e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MILR1,Allergin-1,40044,-0.0274847600987766,0.00482248280937088,-0.0369368264051435,-0.0180326937924096,1.22478140096742e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF7,SLAM family member 7,40341,-0.0316184169714643,0.00556320133277311,-0.0425222915836996,-0.020714542359229,1.34287101035722e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,0.0200892525944778,0.00353529988922735,0.0131600648115922,0.0270184403773634,1.35571481033121e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,40042,0.0320533085372914,0.00566611841899498,0.0209477164360612,0.0431589006385215,1.56735187037304e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37598,0.0209712857216023,0.00372610399378213,0.0136681218937894,0.0282744495494153,1.85815211463228e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP4,Guanylate-binding protein 4,39961,0.0267014229774205,0.00475647398682619,0.0173787339632412,0.0360241119915999,2.01437590788986e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP4,Dipeptidyl peptidase 4,40068,0.0161582569124165,0.00287951228159976,0.010514412840481,0.021802100984352,2.04039719332156e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18BP,Interleukin-18-binding protein,40403,0.0164603021657517,0.00293706229502939,0.0107036600674941,0.0222169442640093,2.12506598253493e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,0.043233062549955,0.00773491368221166,0.0280726317328202,0.0583934933670899,2.31769099360888e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHI3L1,Chitinase-3-like protein 1,40054,0.0400486176700196,0.00716742028599711,0.0260004739094653,0.0540967614305739,2.34090691314258e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,0.0219900009438408,0.00394063246944919,0.0142663613037203,0.0297136405839612,2.44022822043009e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA5,Protein disulfide-isomerase A5,37482,0.0330837278191666,0.00593782419765707,0.0214455923917587,0.0447218632465744,2.57279636614154e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,37671,-0.0134606405972766,0.00241769420536173,-0.0181993212397856,-0.0087219599547676,2.63375836867491e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB2,Lamin-B2,37942,0.0147111224470876,0.0026439148236081,0.0095290493928157,0.0198931955013595,2.68460255285311e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBC1D17,TBC1 domain family member 17,39961,0.0246853483398279,0.00443748613116642,0.0159878755227417,0.0333828211569141,2.69695565862146e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK6,Kallikrein-6,40387,0.0163058320436434,0.00293495407513119,0.0105533220563862,0.0220583420309005,2.80869102077685e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6,Interleukin-6,40305,0.0390050094702732,0.00702735428696168,0.0252313950678283,0.0527786238727181,2.89496380457865e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37562,0.0206188635564549,0.00371915876869294,0.0133293123698167,0.027908414743093,3.01423133762292e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRLB,Fc receptor-like B,39980,0.0326245957495285,0.00588723143579174,0.0210856221353767,0.0441635693636803,3.04621937538785e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,0.0148733794999334,0.00268591091308192,0.00960899411029284,0.020137764889574,3.11554570101723e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37714,0.0230036214410773,0.00416240714552618,0.014845303435846,0.0311619394463086,3.32810714869756e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,BOC,Brother of CDO,40042,-0.0125551070650698,0.00227769705260445,-0.0170193932881746,-0.00809082084196512,3.60013235590981e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPC1,Glypican-1,40489,0.0155863685919297,0.00283100429808511,0.0100376001676829,0.0211351370161765,3.73568301914979e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH6,Cadherin-6,40359,-0.0200876911267925,0.00365309912027718,-0.0272477654025358,-0.0129276168510492,3.8825743113492e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,0.024075023071249,0.00437835515500654,0.0154934469674362,0.0326565991750618,3.89700969647696e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300C,CMRF35-like molecule 6,40471,0.0180675429941199,0.00328654162952183,0.0116259214002571,0.0245091645879827,3.9124834804737e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.0155744790103665,0.00283733416518871,0.0100133040465966,0.0211356539741364,4.1006897172872e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD200,OX-2 membrane glycoprotein,40341,-0.0137216915215998,0.00250730870907497,-0.0186360165913868,-0.00880736645181287,4.49997613268336e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST2,Bone marrow stromal antigen 2,40471,0.028186248502891,0.00515989439279706,0.0180728554930088,0.0382996415127732,4.7630474618494e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLN,Mesothelin,40271,0.028506745286146,0.00521978093500108,0.0182759746535439,0.0387375159187482,4.79812621807387e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,-0.0104488925460124,0.00191561580320991,-0.0142034995203038,-0.00669428557172101,4.98221161523895e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLFM4,Olfactomedin-4,37177,0.0649283304716857,0.0119134288279713,0.0415780099688619,0.0882786509745095,5.13046214524455e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSH,Pro-cathepsin H,40013,0.038003689308703,0.00698329516114503,0.0243164307928587,0.0516909478245472,5.34568884717173e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGA,Glycoprotein hormones alpha chain,40332,0.0468349301471956,0.00863740380323251,0.0299056186928599,0.0637642416015314,5.96837092983152e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO2,Amphoterin-induced protein 2,40305,0.0117744665777393,0.00217147482956527,0.00751837591179141,0.0160305572436873,5.96860628651189e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTB,Lymphotoxin-beta,37900,0.018572544986113,0.00342637352928948,0.0118568528687057,0.0252882371035204,6.04688344068396e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0408319891038749,0.00753340078959875,0.0260665235562613,0.0555974546514884,6.06050862691186e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSBP1,Heat shock factor-binding protein 1,37628,0.0500682520050218,0.00923789993237303,0.0319619681375706,0.0681745358724729,6.06907880735198e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI4,Protein-arginine deiminase type-4,39934,0.0363099337649621,0.00670149401305839,0.0231750054993676,0.0494448620305565,6.11068633301503e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.018873898926555,0.00348992843553399,0.0120336391929083,0.0257141586602016,6.46333926861115e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,0.0125886285574279,0.002332191920974,0.00801753239231884,0.0171597247225369,6.84519583757934e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP3,"Fatty acid-binding protein, heart",37990,0.0247792523872797,0.00459049035979995,0.0157818912820718,0.0337766134924876,6.85416752362053e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO1,Roundabout homolog 1,40379,0.0124787826264797,0.00232056006596758,0.00793048489718323,0.0170270803557762,7.65977207533188e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA1,Annexin A1,37608,0.0215469226358401,0.00401039402363096,0.0136865503495234,0.0294072949221567,7.88573416249107e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCG3,Secretogranin-3,40379,-0.0172585324490315,0.00321624168878512,-0.0235623661590504,-0.0109546987390127,8.1602643755962e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA9,Carbonic anhydrase 9,40489,-0.0231802684707272,0.00434108976195629,-0.0316888044041616,-0.0146717325372929,9.43509882196403e-08
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37714,-0.0149726691129358,0.00281322940431307,-0.0204865987453894,-0.00945873948048218,1.04169258245727e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,0.021602614570007,0.00406039590145875,0.0136442386031479,0.0295609905368662,1.05015165285016e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39980,0.0208404862369442,0.00391872605095652,0.0131597831770694,0.028521189296819,1.06263211840538e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPM3,Tropomyosin alpha-3 chain,37562,-0.0218172860571648,0.00411139203945163,-0.02987561445449,-0.0137589576598396,1.13542536467438e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37572,-0.0193137677499587,0.00364222010364028,-0.0264525191530936,-0.0121750163468237,1.15925165907415e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.0170938213907328,0.00322540845824122,0.01077202081258,0.0234156219688856,1.17788410762359e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2L15,Bcl-2-like protein 15,37598,0.0288668705339412,0.00546128862347858,0.0181627448319232,0.0395709962359592,1.272107086819e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITM2A,Integral membrane protein 2A,40341,-0.0301247548804087,0.00570143737339044,-0.041299572132254,-0.0189499376285634,1.28263092397927e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA7,Carbonic anhydrase 7,37714,-0.0179776058925757,0.00340382758808961,-0.0246491079652313,-0.01130610381992,1.30095302252851e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL2,Apoptosis regulator Bcl-2,37901,0.027554421168919,0.00522528076978155,0.0173128708601472,0.0377959714776909,1.36075347150388e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,0.0182088015568977,0.0034545242154136,0.011437934094687,0.0249796690191083,1.37834468027072e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FSTL3,Follistatin-related protein 3,40293,0.0158467362800451,0.00301083013426268,0.0099455092168903,0.0217479633432,1.43380814184017e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF1C,Kinesin-like protein KIF1C,37562,0.0191476033389924,0.00363855957970244,0.0120160265627757,0.0262791801152092,1.44418646230753e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMMD9,COMM domain-containing protein 9,37900,0.0199738991015703,0.00379631004611966,0.0125331314111758,0.0274146667919649,1.4515945388286e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSM,Oncostatin-M,40268,0.0366962436142123,0.00698887367846094,0.0229980512044288,0.0503944360239957,1.53511366720581e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIT,Vitrin,37990,0.0186830654482914,0.00356102534948439,0.0117034557633019,0.0256626751332808,1.57319588256401e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,HGFAC,Hepatocyte growth factor activator,37849,0.0146666005638233,0.00279682947555721,0.0091848147917312,0.0201483863359155,1.59515173871297e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK4,Kallikrein-4,40489,-0.0307643641959762,0.00586732637380056,-0.0422643238886253,-0.0192644045033271,1.59700661837962e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CILP,Cartilage intermediate layer protein 1,37998,0.0272722332316964,0.00520253921487436,0.0170752563705427,0.0374692100928502,1.61144778964581e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPS10,40S ribosomal protein S10,37562,-0.0214632867914166,0.00409579323742973,-0.0294910415367788,-0.0134355320460543,1.62780536744893e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,VEGFB,Vascular endothelial growth factor B,37598,0.0144546498490696,0.00275850979932166,0.00904797064239916,0.0198613290557401,1.63041122929815e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.0214783579554381,0.0041021951813989,0.0134380553998962,0.0295186605109799,1.66338061432181e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,C8B,Complement component C8 beta chain,38013,0.01542895875274,0.00295032417301088,0.00964632337363869,0.0212115941318413,1.72421578140015e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP3,Cysteine-rich secretory protein 3,37875,-0.0135342222077396,0.00260820415785394,-0.0186463023571333,-0.00842214205834585,2.14397986470465e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,0.0168499710529688,0.0032603130635704,0.0104597574483708,0.0232401846575668,2.39187596649801e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PREB,Prolactin regulatory element-binding protein,40044,0.0147825466096802,0.00286389953914062,0.00916930351296458,0.0203957897063958,2.477437409623e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.0181388770664117,0.00351874248209634,0.0112421418015029,0.0250356123313205,2.56733019756065e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLU,Clusterin,38013,0.0164094252117369,0.00319677049637972,0.0101437550388327,0.0226750953846412,2.88911431013557e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTPN,Myotrophin,40042,0.0164057561799398,0.00319752782685532,0.0101386016393034,0.0226729107205762,2.92034398141289e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA1,Carbonic anhydrase 1,40003,0.0309277558392455,0.00602970639505336,0.0191095313049409,0.04274598037355,2.9442522532553e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR5,Complement factor H-related protein 5,37785,0.0206755507084411,0.00403516099160751,0.0127666351648903,0.0285844662519918,3.03545692214255e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1A,Protein phosphatase 1A,39980,0.0153327154628064,0.00299496582970951,0.00946258243657571,0.021202848489037,3.10013879345583e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBA,Lysosomal acid glucosylceramidase,37572,0.0261226941082585,0.00510918448823613,0.0161086925113157,0.0361366957052014,3.21736694030515e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,XG,Glycoprotein Xg,40458,0.014747778997268,0.00288597503493127,0.00909126792880274,0.0204042900657333,3.25599555479153e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD109,CD109 antigen,40332,-0.0164487805252008,0.00322234515082986,-0.0227645770208274,-0.0101329840295743,3.35325522300267e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17D,Interleukin-17D,40044,0.0168629321774767,0.00330903182583831,0.0103772297988336,0.0233486345561198,3.50900820422474e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKD2,Serine/threonine-protein kinase D2,37562,0.0233701963143438,0.00459261103247792,0.0143686786906871,0.0323717139380006,3.65608630292008e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK8,Kallikrein-8,39801,0.0174379295275027,0.00342720782075876,0.0107206021988155,0.0241552568561899,3.65963817851799e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0176449724652256,0.0034721525969763,0.0108395533751521,0.0244503915552992,3.78012043889246e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PON1,Serum paraoxonase/arylesterase 1,37987,-0.0125803769894185,0.00250025472531963,-0.0174808762510449,-0.00767987772779199,4.92544090057329e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,37541,-0.0162020265639174,0.00322022343591247,-0.0225136644983058,-0.00989038862952891,4.93533165199238e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO3,R-spondin-3,40489,0.0138262021394537,0.00275627767787367,0.00842389789082125,0.0192285063880861,5.32505232506843e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECM1,Extracellular matrix protein 1,37655,0.017920652604612,0.00357690834259802,0.0109099122531199,0.0249313929561041,5.51066365497232e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH15,Cadherin-15,40435,0.0213902039676202,0.0042709960197004,0.0130190517690074,0.029761356166233,5.55134308068833e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,0.035119600099145,0.00702278920695749,0.0213549332535083,0.0488842669447817,5.78079166414191e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,40042,0.0266641014779578,0.00535065257596468,0.016176822429067,0.0371513805268485,6.31671314253697e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,37482,-0.0127313667606973,0.00255600522649846,-0.0177411370046343,-0.0077215965167603,6.40793932983958e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1B,Interleukin-1 beta,39946,0.0271050973832582,0.00544243494278204,0.0164379248954054,0.037772269871111,6.41605253152026e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNXB,Tenascin-X,40332,-0.012212515771156,0.00245674182616932,-0.0170277297504479,-0.00739730179186417,6.72953315530147e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0424857082613149,0.00854828596968707,0.0257310677607283,0.0592403487619016,6.76177588830153e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,JAM2,Junctional adhesion molecule B,40471,0.0125086431928295,0.00251687312879422,0.00757557186039287,0.0174417145252662,6.76740496193799e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTL1,Cytokine-like protein 1,37998,0.0110420181394316,0.00222264714904924,0.00668562972729513,0.0153984065515681,6.84869015517373e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN1,Tetraspanin-1,40042,0.0145996485453129,0.00294569254647656,0.00882609115421886,0.020373205936407,7.26134645499124e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICOSLG,ICOS ligand,40305,0.00910779450387107,0.00184172794177244,0.00549800773799708,0.0127175812697451,7.68266333501635e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN3,CCN family member 3,40522,0.0160835334609428,0.00325389971210658,0.00970589002521386,0.0224611768966717,7.77649631426259e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,0.0191960054841187,0.00388903822256628,0.0115734905678888,0.0268185204003487,8.07202880516099e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,0.0164131800677608,0.00333765338801803,0.00987137942724545,0.0229549807082761,8.84976542079579e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC10A,C-type lectin domain family 10 member A,40228,-0.0170981790909209,0.00347698668174931,-0.0239130729871495,-0.0102832851946922,8.85257986646843e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,LUZP2,Leucine zipper protein 2,37900,0.0212347710521475,0.00431981960101407,0.0127679246341599,0.0297016174701351,8.95267468930023e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB37,Ras-related protein Rab-37,40044,0.0395310897359206,0.00805079006804025,0.0237515412025617,0.0553106382692795,9.18986775639789e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,40228,0.0107154008597922,0.0021842765768534,0.00643421876915953,0.0149965829504248,9.40237618127447e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF16,Fibroblast growth factor 16,37598,0.0233146809841579,0.00475600277225699,0.0139929155505342,0.0326364464177816,9.59208030191783e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB4,Ephrin type-B receptor 4,40536,-0.0116187912394721,0.00237378543887172,-0.0162714106996606,-0.0069661717792835,9.94475593609388e-07
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD300LF,CMRF35-like molecule 1,40489,0.0285538216289365,0.00585672110463838,0.0170746482638452,0.0400329949940277,1.0963120069481e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VAMP5,Vesicle-associated membrane protein 5,40042,0.0262961195692667,0.0054046700503398,0.0157029662706007,0.0368892728679328,1.15316030568057e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,F3,Tissue factor,40393,-0.0131302519166532,0.00270938157515975,-0.0184406398039663,-0.00781986402934008,1.27021851266612e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB6,Integrin beta-6,40044,0.0141129879757215,0.00291440599559507,0.00840075222435513,0.0198252237270878,1.29450798519431e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLYR1,Putative oxidoreductase GLYR1,37900,0.0283369701776015,0.00586073114772082,0.0168499371280687,0.0398240032271343,1.34580010143562e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37598,0.0146513329235779,0.00303544226115848,0.00870186609170723,0.0206007997554485,1.40336785946452e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOA4,Apolipoprotein A-IV,38013,0.0171038662255392,0.00355607358067227,0.0101339620074216,0.0240737704436569,1.5273495573699e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGBL1,Integrin beta-like protein 1,37998,0.0162018439320967,0.00337522261140824,0.00958640761373649,0.0228172802504568,1.60176423231125e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,0.016255702879211,0.00340199315840296,0.00958779628874116,0.0229236094696808,1.78705923772053e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,0.0139394352959637,0.00292420674802104,0.00820799006984242,0.0196708805220849,1.88769216648592e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD1,Bromodomain-containing protein 1,37714,-0.0143131897564777,0.00300242389779966,-0.020197940596165,-0.00842843891679038,1.88777549735186e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST7,Cystatin-F,40376,0.0422323055103617,0.00887279107192324,0.0248416350093921,0.0596229760113312,1.95532139222083e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37998,-0.00974279641808431,0.00204780527514539,-0.0137564947573693,-0.00572909807879933,1.97854278728661e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6,Seizure protein 6 homolog,37572,-0.0143870426541899,0.00302602584715446,-0.0203180533146126,-0.00845603199376712,2.0111734628362e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHISA5,Protein shisa-5,37998,0.0114263528673416,0.00240411469740777,0.00671428806042241,0.0161384176742609,2.02649040771228e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROCR,Endothelial protein C receptor,37562,-0.0169876300812058,0.00357975473114424,-0.0240039493542486,-0.00997131080816313,2.10215965784061e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATXN2,Ataxin-2,37541,0.0527833284671952,0.0111464915665929,0.030936204996673,0.0746304519377173,2.20894118394403e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGA,Fibrinogen alpha chain,37698,0.0140816390443188,0.00297392669680647,0.0082527427185781,0.0199105353700595,2.21289626797118e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37942,-0.0300292400696676,0.00634930350764674,-0.0424738749446552,-0.01758460519468,2.27316144303602e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA12,Serpin A12,39903,0.0520803536749401,0.0110175382923047,0.030485978622023,0.0736747287278573,2.29824836317709e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.0204734143573362,0.0043330710837065,0.0119805950332715,0.028966233681401,2.32181331545445e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCL28,C-C motif chemokine 28,40278,0.0271453080329356,0.00575088266754988,0.0158735780045378,0.0384170380613333,2.37632029468748e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39961,0.0647295485330097,0.0137407752852181,0.0377976289739822,0.0916614680920372,2.48929925097099e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC16,Mucin-16,40305,0.0850189700739268,0.0180537187151568,0.0496336813922195,0.120404258755634,2.50770668496637e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHAD,Chondroadherin,37671,0.0244319943874557,0.00519891448952264,0.0142421219879914,0.0346218667869201,2.6350494180141e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB1A1,Uteroglobin,40384,0.0256861738247245,0.00546923575586049,0.014966471743238,0.0364058759062111,2.66886952382889e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH3,Cadherin-3,40471,0.0160091747442318,0.00341765158541171,0.00931057763682483,0.0227077718516387,2.83278520126057e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF3,Granulocyte colony-stimulating factor,40044,0.0220971941952537,0.00471763104630013,0.0128506373445054,0.031343751046002,2.83759338696283e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMPD3,AMP deaminase 3,37942,0.0328499426093785,0.00701475104714788,0.0191010305569686,0.0465988546617883,2.85489769926632e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0183239891923575,0.00391639928482261,0.0106478465941051,0.0260001317906098,2.91469479268488e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLASP1,CLIP-associating protein 1,37482,0.0322264449665811,0.00691347787412357,0.0186760283332989,0.0457768615998633,3.17189183318016e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSN,Gelsolin,37928,-0.00855135357091481,0.00183643000272733,-0.0121507563762604,-0.00495195076556925,3.24686528179762e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,0.046634494881891,0.01004381213951,0.0269486230884513,0.0663203666753306,3.46537618009828e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,40332,-0.0192792669793686,0.00415449704729342,-0.0274220811920637,-0.0111364527666735,3.50213058363677e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,40009,0.0230099016666193,0.00498463050197619,0.0132400258827459,0.0327797774504926,3.9401192132263e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",40293,-0.0257201639210009,0.00557537364846274,-0.0366478962719879,-0.0147924315700139,3.99673428705413e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,UROS,Uroporphyrinogen-III synthase,37572,0.0313079006119151,0.00678906430170229,0.0180013345805786,0.0446144666432516,4.03513614645216e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPTL1,Angiopoietin-related protein 1,40136,0.0131306148806139,0.00284867217395005,0.00754721741967185,0.018714012341556,4.07054551844486e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD7,T-cell antigen CD7,37567,0.0191141394216277,0.00415078268999665,0.0109786053492343,0.0272496734940212,4.16446819809612e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.017134907281642,0.00372229582556703,0.00983920746353059,0.0244306070997533,4.19096294947859e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5,Eukaryotic translation initiation factor 5,37562,0.0202233583948274,0.00440080222340239,0.0115977860369587,0.0288489307526961,4.35991212059373e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,B2M,Beta-2-microglobulin,38013,0.0140612449509557,0.00306481153245919,0.00805421434733569,0.0200682755545757,4.51601088162005e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL9,C-X-C motif chemokine 9,40422,0.0299407502847396,0.00652858916035837,0.0171447155304372,0.042736785039042,4.55036090936924e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIFR,Leukemia inhibitory factor receptor,40341,-0.0108146508307962,0.00236140311673335,-0.0154430009395936,-0.00618630072199884,4.69052465421537e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSAB1,Tryptase alpha/beta-1,40498,0.0232708660682295,0.00508501316809742,0.0133042402587586,0.0332374918777005,4.7667621808484e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE1,Ribonuclease pancreatic,37987,0.0106758734614205,0.00233291904629382,0.00610335213068458,0.0152483947921563,4.77737730010035e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYAR,Cell growth-regulating nucleolar protein,39980,0.0231846909744181,0.00507272014738966,0.0132421594855344,0.0331272224633018,4.9039432393753e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNPY2,Protein canopy homolog 2,40042,0.0268984837601,0.00589982484290743,0.0153348270680014,0.0384621404521985,5.17393130558353e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP10,Bone morphogenetic protein 10,37671,-0.0126494291821054,0.00277562551334032,-0.0180896551882524,-0.00720920317595836,5.22733270486351e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,-0.0170538142509569,0.0037464648916906,-0.0243968854386705,-0.00971074306324334,5.36072578253402e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUCA1,Tissue alpha-L-fucosidase,40437,0.0356012917177387,0.00782535676380152,0.0202635924606877,0.0509389909747897,5.41746971398271e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,0.0159231282534065,0.00350140223385688,0.009060379875047,0.022785876631766,5.47348406757928e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,LIF,Leukemia inhibitory factor,39961,0.0231060761448918,0.00508144662791168,0.0131464407541849,0.0330657115355987,5.47900188690044e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,YAP1,Transcriptional coactivator YAP1,37942,0.0116984042265962,0.0025759696631026,0.0066495036869151,0.0167473047662773,5.63768057266547e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLIN3,Perilipin-3,40359,0.0185598472121633,0.00408810295230297,0.0105471654256495,0.0265725289986771,5.66760084353827e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWF,von Willebrand factor,40536,-0.0311707405072307,0.00689175135037327,-0.0446785731539623,-0.0176629078604991,6.14325167387012e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GM2A,Ganglioside GM2 activator,37714,0.0167825918987069,0.00371970999991174,0.00949196029887992,0.0240732234985339,6.48318251172951e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB44,Ras-related protein Rab-44,37900,0.0173652584229511,0.00385365298087874,0.00981209858042873,0.0249184182654734,6.65614216618572e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL,Podocalyxin,40305,0.00659319494852507,0.00146449547631194,0.00372278381495367,0.00946360608209647,6.77887479328905e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,37921,0.0168106430917596,0.00373387510752704,0.00949224788100664,0.0241290383025126,6.78188565198096e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP1,Caspase-1,39961,0.0292011256506909,0.00649080527770353,0.016479147306392,0.0419231039949898,6.88200404431745e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.0375456809692782,0.00836076952593296,-0.0539327892401068,-0.0211585726984496,7.15072878191857e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN5,Contactin-5,40367,-0.0160079506703609,0.0035722844081404,-0.0230096281103161,-0.00900627323040569,7.47587279108518e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37959,0.0161696074545576,0.00362364430251186,0.00906726462163434,0.0232719502874808,8.1759344897112e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,40403,-0.0142837510759075,0.00320302599561147,-0.0205616820273059,-0.00800582012450898,8.2729300914299e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.0148889010000506,0.00336403718796859,0.00829538811163217,0.0214824138884691,9.66724363951939e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST6,Cystatin-M,39992,0.0204137067204373,0.00461295187210076,0.0113723210511198,0.0294550923897548,9.69627604071955e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,0.0168604178247468,0.00381052797461873,0.00939178299449404,0.0243290526549995,9.73387742987899e-06
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,0.0209028640119307,0.00473194646872102,0.0116282489332376,0.0301774790906239,1.0069960462809e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,0.0112619937691085,0.00255647341427891,0.00625130587712189,0.0162726816610952,1.06332960844903e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSHB,Thyrotropin subunit beta,40359,0.035565018158347,0.00808039082010574,0.0197274521509398,0.0514025841657543,1.08255893058478e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP6V1D,V-type proton ATPase subunit D,40305,0.0110950796359875,0.00253497743517381,0.00612652386304684,0.0160636354089282,1.21206731822096e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOC,Myocilin,40332,-0.0193179653101596,0.00442185292943083,-0.0279847970518441,-0.0106511335684752,1.25752541178999e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBLN2,Fibulin-2,37998,-0.0130252457707676,0.00298308145215414,-0.0188720854169897,-0.00717840612454551,1.27264097290056e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNX18,Sorting nexin-18,37901,0.0191547783276429,0.00439770155559525,0.0105352832786762,0.0277742733766096,1.33664614908593e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRLF1,Cytokine receptor-like factor 1,40422,0.011025783561734,0.00253433585289138,0.00605848529006689,0.0159930818334011,1.36631928130037e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,0.0113831281649086,0.0026219644300656,0.00624407788198003,0.0165221784478372,1.42411317811916e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,-0.00875431660558194,0.00201705607338782,-0.0127077465094221,-0.00480088670174182,1.43285207177842e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAA4,Serum amyloid A-4 protein,38013,0.013684449190367,0.00315560194221235,0.00749946938363079,0.0198694289971032,1.45776513621783e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM3,Intercellular adhesion molecule 3,40536,-0.0105319444000959,0.00243334498400623,-0.0153013005687481,-0.00576258823144371,1.51257652290586e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.0110192861358083,0.00255953835073522,0.00600259096836725,0.0160359813032493,1.68019830345688e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP3,Dual specificity protein phosphatase 3,39961,0.0352402860915595,0.00818696998243973,0.0191938249259777,0.0512867472571414,1.68438775310593e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL4,Delta-like protein 4,37628,0.0350170212252203,0.00816379474221447,0.0190159835304799,0.0510180589199607,1.80508827781848e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC14A,C-type lectin domain family 14 member A,40332,-0.0129867379139542,0.00303370567691527,-0.0189328010407082,-0.00704067478720032,1.87300935968458e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EP300,Histone acetyltransferase p300,37598,0.012319267142343,0.00288757702680124,0.00665961616981258,0.0179789181148734,2.00133019177863e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK14,Kallikrein-14,40489,-0.0188582272057199,0.00443316006224401,-0.0275472209277181,-0.0101692334837216,2.11268672506719e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC3,Membrane primary amine oxidase,40403,-0.0124577462433397,0.00292992226580719,-0.0182003938843218,-0.00671509860235765,2.13167503059546e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRUNE2,Protein prune homolog 2,37714,0.0121642523540022,0.0028614487955738,0.00655581271467756,0.0177726919933268,2.14196209462737e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,40490,-0.0185659473066518,0.00436912468849033,-0.0271294316960928,-0.0100024629172107,2.15600673697804e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL3,Myosin light chain 3,37628,-0.0280986517342037,0.00661688531067261,-0.0410677469431221,-0.0151295565252854,2.18617910714509e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMBS,Porphobilinogen deaminase,40489,0.0185987613704225,0.00438530502577146,0.0100035635199105,0.0271939592209346,2.23618303908612e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.0239978491197417,0.00566278510181044,0.0128987903201932,0.0350969079192901,2.27006040388135e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOSB,Protein fosB,39961,0.0159878663332606,0.0037750559398332,0.00858875669118758,0.0233869759753337,2.29732736426956e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37572,0.0202543611276144,0.00478680589341821,0.0108722215765147,0.0296365006787141,2.33934134107162e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,40373,0.0109681833423247,0.00259301583646011,0.00588587230286287,0.0160504943817865,2.3510777087463e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39961,0.0167245665227192,0.00395420019345947,0.00897433414353866,0.0244747989018998,2.35481550758595e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGMA,Repulsive guidance molecule A,40471,-0.0126090221011485,0.00298365377323394,-0.0184569834966871,-0.00676106070561002,2.39162808528459e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM2,Myomesin-2,37562,-0.0192097665632432,0.00455180212949769,-0.0281312987370587,-0.0102882343894278,2.45668704013684e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCN5,CCN family member 5,40332,0.0159623272939643,0.00378378621183018,0.00854610631877715,0.0233785482691514,2.47173988685687e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRAL,GDNF family receptor alpha-like,37477,-0.025234593220937,0.00599719372976888,-0.036989092931284,-0.01348009351059,2.5967290386929e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOB,Apolipoprotein B-100,37987,0.00905734125467493,0.00215727894764626,0.00482907451728825,0.0132856079920616,2.7040344509848e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,-0.0201586594557551,0.00480616303490014,-0.0295787390041594,-0.0107385799073508,2.75155762429758e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ELAVL4,ELAV-like protein 4,37541,0.0353362933572623,0.00843999579647542,0.0187939015961704,0.0518786851183541,2.84807229759628e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,40042,0.0252940535059273,0.00604989824684197,0.0134362529421171,0.0371518540697376,2.91935804941903e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD6,Programmed cell death protein 6,40359,-0.0281091334021615,0.00672693021686727,-0.0412939166272214,-0.0149243501771017,2.94878638995672e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN2,Alpha-actinin-2,37562,-0.0221164011339684,0.00529624261722199,-0.0324970366637235,-0.0117357656042133,2.98773574210223e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKAP4,Cytoskeleton-associated protein 4,40457,0.010501298256709,0.00252187936818172,0.0055584146950728,0.0154441818183451,3.14252788863187e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNLY,Granulysin,40332,0.0203727463802321,0.00489619824713674,0.0107761978158441,0.0299692949446201,3.18620204893973e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROBO4,Roundabout homolog 4,37628,-0.0071645984659845,0.00173049245030859,-0.0105563636685893,-0.00377283326337967,3.49151858605927e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLVRB,Flavin reductase,40332,0.0264692839388247,0.00639800135384232,0.0139292012852938,0.0390093665923557,3.53507068362438e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,-0.0112977911216377,0.00273112247965493,-0.0166507911817614,-0.00594479106151407,3.54186414968761e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37714,0.0236893144448456,0.00572916301654946,0.0124601549324087,0.0349184739572826,3.57350033885567e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD58,Lymphocyte function-associated antigen 3,40335,-0.0070502377621515,0.00170533377402623,-0.0103926919592429,-0.00370778356506008,3.57979462644352e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39980,0.0165408521322085,0.00400819999661126,0.00868478013885041,0.0243969241255665,3.69840237043523e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFHR4,Complement factor H-related protein 4,37973,0.0292571196004745,0.00709059080306288,0.0153595616264713,0.0431546775744778,3.71032911618651e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLA2G1B,Phospholipase A2,40514,-0.0166652885911717,0.00404183456365881,-0.024587284335943,-0.00874329284640044,3.75524610827909e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL5,Fc receptor-like protein 5,40332,-0.0222076974647035,0.00539816053226465,-0.0327880921079422,-0.0116273028214648,3.90926773776852e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,37562,-0.0160660554221575,0.00390516724113066,-0.0237201832147736,-0.00841192762954138,3.91151272744976e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALB1,Calbindin,40305,0.0167647108855721,0.00408670844370654,0.00875476233590729,0.0247746594352369,4.11190764946833e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LHB,Lutropin subunit beta,39980,0.0335164890150082,0.00819305692301538,0.0174580974458981,0.0495748805841184,4.31981596271222e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CR2,Complement receptor type 2,40403,0.0183134895530463,0.00448063768515149,0.00953143969014941,0.0270955394159432,4.3865240554926e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNG,Interferon gamma,40044,0.0447449627722922,0.0109800918949442,0.0232239826582016,0.0662659428863829,4.62225346989515e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,0.0150626149237451,0.00370104554658134,0.00780856565244564,0.0223166641950445,4.72753548639969e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP9,Fatty acid-binding protein 9,40341,0.0218826729316753,0.00538970026548252,0.0113188604113296,0.0324464854520211,4.9288681415048e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,0.0223019792197004,0.0054958664069182,0.0115300810621408,0.0330738773772601,4.97465416814592e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0701898025655,0.0173221564135873,0.0362383759948689,0.104141229136131,5.10186700684372e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLIC5,Chloride intracellular channel protein 5,37572,-0.0126489005943684,0.00312428083010835,-0.0187724910213808,-0.00652531016735607,5.18252820696588e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.0122611325448749,0.00303296719569525,-0.0182057482484376,-0.00631651684131216,5.31569507941236e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0100354528050623,0.00248412195745143,0.00516657376845747,0.0149043318416671,5.3739108933187e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,FABP1,"Fatty acid-binding protein, liver",40357,0.0361023622951362,0.00895892623835943,0.0185428668679517,0.0536618577223207,5.60925558822434e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEK,Angiopoietin-1 receptor,40411,0.00835431283043931,0.0020757951637569,0.00428575430947578,0.0124228713514028,5.73276733401736e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,-0.0188995786799661,0.00469850833441768,-0.0281086550154247,-0.00969050234450743,5.7913748877007e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00757874950541114,0.00189153388557358,-0.0112861559211353,-0.00387134308968693,6.19100545128315e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD99,CD99 antigen,40332,-0.00749403931947387,0.00187326551078847,-0.0111656397206193,-0.00382243891832847,6.34895003950596e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0268395961540357,0.00671782308548393,0.0136726629064872,0.0400065294015842,6.49107456680105e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,-0.02016903216913,0.00504811747891084,-0.0300633424277953,-0.0102747219104648,6.49498869733207e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFR,Epidermal growth factor receptor,40536,0.00629631872563724,0.00157773420777147,0.00320395967840516,0.00938867777286933,6.61609917887606e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMH,Granzyme H,40042,0.0287213777560409,0.00720119166846903,0.0146070420858416,0.0428357134262402,6.68184232340694e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAP,Cartilage-associated protein,37572,0.0186463251957546,0.00468759366626195,0.00945864160988122,0.027834008781628,6.99284986200943e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP1,Dipeptidase 1,40192,-0.0194711307299503,0.00489966137644928,-0.0290744670277909,-0.00986779443210973,7.09982660718717e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPA2,Replication protein A 32 kDa subunit,37598,0.0125378937406669,0.00315880603670576,0.00634663390872356,0.0187291535726101,7.25015289530337e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37998,0.0226032006582842,0.00569739213211384,0.0114363120793411,0.0337700892372273,7.30692401473282e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN8,Septin-8,37921,0.0121981182083966,0.00308082167906374,0.00615970771743171,0.0182365286993616,7.5533501580972e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39980,0.0205307259643579,0.005191960156864,0.0103544840569045,0.0307069678718113,7.70897804002335e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL1A1,Collagen alpha-1(I) chain,40536,-0.00988128185231857,0.00250462761029546,-0.0147903519684977,-0.00497221173613946,8.00685789398787e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNU13,NHP2-like protein 1,37562,0.0238238746607802,0.00604224194038563,0.0119810804576243,0.035666668863936,8.09252754683794e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPK13,Mitogen-activated protein kinase 13,37482,0.0157658010387778,0.00399861802840997,0.00792850970309422,0.0236030923744613,8.09528394310305e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,37482,0.0111378466870383,0.0028277394238357,0.0055954774163203,0.0166802159577563,8.23232936977187e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,0.0104929675880135,0.00266477200560979,0.00527001445701831,0.0157159207190087,8.26395595975779e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENO1,Alpha-enolase,40299,0.0300770942490983,0.00764350187732914,0.0150958305695332,0.0450583579286635,8.35555988683188e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAN,Brevican core protein,40228,-0.0126881559370162,0.00323250367838048,-0.0190238631466419,-0.00635244872739043,8.70332058009322e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK11,Kallikrein-11,40260,0.0111808751921099,0.00286738869594016,0.00556079334806719,0.0168009570361526,9.68606069300345e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37900,0.0199406920431443,0.00512261559460354,0.00990036547772136,0.0299810186085672,9.96224503859478e-05
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGB2A2,Mammaglobin-A,37562,-0.0120905045889917,0.00310701642933288,-0.0181802567904842,-0.00600075238749928,0.000100178945080699
NMR metabolomics,X23501.Triglycerides in Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,0.0164198255698341,0.00422839379721659,0.00813217372728958,0.0247074774123786,0.000103568938142214
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD3,Extracellular superoxide dismutase,37987,-0.0221806013674713,0.00571364291705338,-0.0333793414848959,-0.0109818612500467,0.000104074775813477
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,37541,-0.0204148437108014,0.00526039798555628,-0.0307252237624917,-0.0101044636591111,0.000104600181523777
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH1,Protocadherin-1,40475,0.00813213354353023,0.00210096207034979,0.00401424788564464,0.0122500192014158,0.000108966427003006
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXTL1,Exostosin-like 1,37562,0.0178710811579173,0.0046255983874894,0.00880490831843813,0.0269372539973966,0.000112303825988278
NMR metabolomics,X23501.Triglycerides in Large VLDL,EGFLAM,Pikachurin,37901,0.0114673206871264,0.00297611087098096,0.00563414338000375,0.0173004979942491,0.000117162541227339
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00576370776925249,0.00149628186324938,0.00283099531728371,0.00869642022122127,0.000117601792936246
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.0221745789826797,0.00575857958070695,0.0108877630044941,0.0334613949608654,0.000118342662330195
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.0146194849674801,0.0038055434491185,0.00716061980720786,0.0220783501277524,0.000122778370112264
NMR metabolomics,X23501.Triglycerides in Large VLDL,LXN,Latexin,40183,-0.024413377701767,0.00639598558268287,-0.0369495094438254,-0.0118772459597086,0.000135610255218926
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,0.0161325229137925,0.004232829280889,0.00783617752325009,0.024428868304335,0.000138876139729416
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP2,Guanylate-binding protein 2,40044,0.0219106319951248,0.00575038278153902,0.0106398817433083,0.0331813822469413,0.000139336304248173
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40536,-0.0121256397386778,0.00318577042829348,-0.018369749778133,-0.0058815296992226,0.000141648584133564
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX1,Peroxiredoxin-1,39953,-0.0327161641271666,0.0085986510283802,-0.0495695201427918,-0.0158628081115414,0.000142462905651273
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,0.0187628286366604,0.00493340453711331,0.00909335574391835,0.0284323015294025,0.000143458278156252
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.00789081785023103,0.002077333209182,0.0038192447602343,0.0119623909402277,0.000146195934374512
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,40341,0.0238841071551117,0.00630046306721238,0.0115351995433754,0.036233014766848,0.000150687844032762
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37714,0.0251565497223032,0.00664204779771653,0.0121381360387788,0.0381749634058276,0.000152861561217025
NMR metabolomics,X23501.Triglycerides in Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0125261351491175,0.0033073310883311,0.0060437662159885,0.0190085040822464,0.000152917717316612
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL34,Interleukin-34,39934,0.0130909568420625,0.00346486612835891,0.00629981923047901,0.019882094453646,0.000158557807153153
NMR metabolomics,X23501.Triglycerides in Large VLDL,SATB1,DNA-binding protein SATB1,37959,0.0110039198383844,0.00291467729192213,0.005291152346217,0.0167166873305518,0.000160468964039169
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,0.0225629712011713,0.00599489909052032,0.0108129689837515,0.0343129734185911,0.000168152441175922
NMR metabolomics,X23501.Triglycerides in Large VLDL,OPTC,Opticin,40305,-0.0163432232012208,0.00434358545350607,-0.0248566506900927,-0.00782979571234885,0.000168754137086451
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,0.0138517565857182,0.00369509429036731,0.00660937177659822,0.0210941413948381,0.00017850526861721
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.0159312031358721,0.00426141424823319,0.007578831209335,0.0242835750624091,0.000185905150828672
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,0.0159332604760405,0.00426578927094374,0.00757231350499081,0.0242942074470903,0.000188407184826108
NMR metabolomics,X23501.Triglycerides in Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00908945182040254,0.00244209599222767,0.00430294367563631,0.0138759599651688,0.0001983360342149
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,40305,0.0195797003075358,0.00527032259052059,0.0092498680301154,0.0299095325849561,0.000203832260197607
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA1,Alpha-1-antitrypsin,37779,-0.0029153277771405,0.000785197860911614,-0.00445431558452727,-0.00137633996975374,0.000205767563840361
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM3D,Protein FAM3D,37901,0.029460067596366,0.00795791267787942,0.0138625587477224,0.0450575764450097,0.000214774404650845
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHNAK2,Protein AHNAK2,37628,0.0102562172235005,0.00277116017179874,0.00482474328677499,0.0156876911602261,0.000215579247005512
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME1,Nucleoside diphosphate kinase A,37598,-0.00786123326921561,0.00212694070971289,-0.0120300370602529,-0.00369242947817835,0.000219888086908877
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEDD9,Enhancer of filamentation 1,37598,0.0118081568197008,0.00319855979892455,0.00553897961380864,0.0180773340255929,0.000223651799356006
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,-0.0122180446850107,0.00331928360359281,-0.0187238405480526,-0.00571224882196883,0.000233320050398728
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSPN,Persephin,40341,0.035211597938243,0.00958727438640308,0.016420540140893,0.054002655735593,0.000240747855318419
NMR metabolomics,X23501.Triglycerides in Large VLDL,GZMB,Granzyme B,40341,0.0222783230503383,0.00606978659181297,0.0103815413303849,0.0341751047702917,0.000242998606374236
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,0.0221013010958711,0.00602808420372617,0.0102862560565678,0.0339163461351744,0.000246944459550453
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC13A1,Solute carrier family 13 member 1,37900,0.0220337169198469,0.00600973702098156,0.0102546323587231,0.0338128014809708,0.000246998163630671
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.0114799594652384,0.00313221019594087,-0.0176190914492825,-0.00534082748119432,0.000248035989554306
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,0.0218544568336316,0.00599825568977348,0.0100978756816755,0.0336110379855876,0.000270021458304466
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNR,Tenascin-R,40228,-0.0148966651959077,0.00409280739283967,-0.0229185676858734,-0.00687476270594192,0.000273808591290173
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0132797739016684,0.00366033909048652,-0.020454038519022,-0.00610550928431479,0.000286659080995555
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMS1,PMS1 protein homolog 1,37572,0.0181610911714385,0.00503412477960981,0.00829420660340327,0.0280279757394737,0.000310195129236253
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD5,Sushi domain-containing protein 5,37604,-0.0119273400212279,0.00331180990970645,-0.0184184874442526,-0.00543619259820328,0.000317604838833893
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLC,Galectin-10,40333,-0.0227360103185241,0.00634035408162136,-0.035163104318502,-0.0103089163185462,0.000336898417634385
NMR metabolomics,X23501.Triglycerides in Large VLDL,PADI2,Protein-arginine deiminase type-2,40044,0.0194409319410954,0.00542161243079289,0.00881457157674134,0.0300672923054495,0.00033704640437836
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,-0.011054679351046,0.0030841139170424,-0.0170995426284491,-0.00500981607364291,0.000339088381496688
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR1,Folate receptor alpha,40299,0.00980828654309172,0.0027372441236601,0.00444328806071792,0.0151732850254655,0.000340336427905456
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0136993651439267,0.00382541581203018,0.00620155015234752,0.0211971801355058,0.0003431390521299
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,40044,0.0207825410142044,0.00582155218755384,0.00937229872659889,0.0321927833018099,0.000358148373620188
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF1,Macrophage colony-stimulating factor 1,40422,0.00930767747436732,0.00260994189045617,0.00419219136907322,0.0144231635796614,0.000363199401429366
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYOM1,Myomesin-1,37541,0.01616540846636,0.00453722957133384,0.00727243850654567,0.0250583784261743,0.000368173047197148
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,37541,-0.0132450653012531,0.00372229413535062,-0.0205407618065403,-0.0059493687959659,0.000374573558346731
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS4,Thrombospondin-4,40355,0.0154011272313522,0.00434731791991193,0.00688038410832481,0.0239218703543796,0.000397227456107653
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIL1,Nucleotide exchange factor SIL1,37628,0.010975621244809,0.0030984940089844,0.00490257298719958,0.0170486695024184,0.000398109662802923
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,0.00871705333694196,0.0024613205434124,0.00389286507185365,0.0135412416020303,0.000398830142459181
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,37482,0.0264996669854527,0.00749057562665244,0.011818138757214,0.0411811952136915,0.000404979464094461
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKAP12,A-kinase anchor protein 12,37671,-0.00745359300942023,0.00210972403300611,-0.0115886521141122,-0.00331853390472826,0.000412319799674719
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR4,Proline-rich protein 4,37577,-0.023488559947646,0.00667030007829249,-0.0365623481010993,-0.0104147717941927,0.000430788459827046
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,37572,-0.0133638143060849,0.00379828688215245,-0.0208084565951037,-0.00591917201706613,0.000435660447283285
NMR metabolomics,X23501.Triglycerides in Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.024496562373846,0.00696391524034442,0.010847288502771,0.0381458362449211,0.000436604524599925
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCA2A,Guanylin,40276,-0.0113373158763042,0.00322972811001899,-0.0176675829719414,-0.00500704878066695,0.000448845614983559
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,-0.00906058224537507,0.00258271662689706,-0.0141227068340933,-0.00399845765665683,0.000452722202973521
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.0120704896317355,0.00344819729099985,0.00531202294137577,0.0188289563220952,0.000465852485682081
NMR metabolomics,X23501.Triglycerides in Large VLDL,CST1,Cystatin-SN,36179,0.0353308690855708,0.0100946974969646,0.0155452619915203,0.0551164761796214,0.000467084925597807
NMR metabolomics,X23501.Triglycerides in Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,0.00922958173681425,0.0026426631731859,0.0040499619173699,0.0144092015562586,0.000479760776245839
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37572,0.0181978479140489,0.00521239585298382,0.00798155204220061,0.0284141437858972,0.000482322208349412
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENG,Endoglin,40536,-0.0057381736960874,0.00164372265186452,-0.00895987009374186,-0.00251647729843294,0.000482574334749096
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,0.0182942850462928,0.00524623775282716,0.00801165905075157,0.028576911041834,0.000489797935350057
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLPS,Colipase,40311,0.023054410213005,0.00661324658768393,0.0100924469011445,0.0360163735248655,0.000491451194474228
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN1,Nectin-1,37598,0.0107648445559636,0.00309172015815621,0.00470507304597747,0.0168246160659498,0.000499617005260067
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDHB15,Protocadherin beta-15,37900,-0.0135175959401883,0.00389912999042379,-0.0211598907214189,-0.00587530115895763,0.0005282928236226
NMR metabolomics,X23501.Triglycerides in Large VLDL,MERTK,Tyrosine-protein kinase Mer,40516,-0.00874266526333427,0.00252349745318425,-0.0136887202715754,-0.00379661025509314,0.000532597377836052
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINI1,Neuroserpin,37642,0.0106704383496001,0.00308560183402434,0.0046226587549124,0.0167182179442878,0.000545638373763201
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,40305,0.0103211554962457,0.00298529065620248,0.00446998581008881,0.0161723251824025,0.000546973410564505
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAMDC2,MAM domain-containing protein 2,37990,-0.0113458544140988,0.00328422823693486,-0.0177829417584911,-0.00490876706970643,0.000552698369384529
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF8,SLAM family member 8,39980,0.0178445611450186,0.00516597212415087,0.00771925578168287,0.0279698665083543,0.000553297715029488
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,40332,0.01441507858455,0.00418126151568676,0.00621980601380391,0.022610351155296,0.000567176308333345
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH23,Cadherin-23,37942,-0.00875445522719244,0.00255931505375863,-0.0137707127325594,-0.00373819772182553,0.000626626912855796
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX5,Syntaxin-5,37598,0.0138425618372766,0.00405574792201467,0.00589329591012782,0.0217918277644253,0.000644285450915379
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHB6,Ephrin type-B receptor 6,40192,0.0102711635337686,0.00301022259094217,0.0043711272555219,0.0161711998120152,0.000646279559453327
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDI2,Protein DDI1 homolog 2,37671,0.0257356716417504,0.00756427421305722,0.0109096941841582,0.0405616490993425,0.000670276623149585
NMR metabolomics,X23501.Triglycerides in Large VLDL,DSC2,Desmocollin-2,40177,-0.0110432901132506,0.0032513489726003,-0.0174159340995472,-0.00467064612695403,0.000684161065930202
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTG,Protogenin,40489,0.00823977607166506,0.00242910752729362,0.00347872531816956,0.0130008268251606,0.00069526612847287
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA1549,UPF0606 protein KIAA1549,37714,0.0232913568462544,0.00686737983046315,0.00983129237854664,0.0367514213139622,0.000696904816356649
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM5,Intercellular adhesion molecule 5,40359,0.0144184888722787,0.00425283802637889,0.00608292634057609,0.0227540514039813,0.000699803349732057
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIMP2,Metalloproteinase inhibitor 2,37990,-0.00818268442085924,0.00241378851292271,-0.0129137099061878,-0.00345165893553072,0.000700983857841867
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0124768912787098,0.00368529455665968,0.00525371394765678,0.0197000686097627,0.000711975299310155
NMR metabolomics,X23501.Triglycerides in Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,0.048773296111711,0.0145120181901182,0.0203297404590793,0.0772168517643426,0.000778747924157152
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A2,Collagen alpha-2(IX) chain,37714,0.015078343514979,0.00449361846996687,0.00627085131384399,0.0238858357161141,0.000794435185222639
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERC2,ERC protein 2,37572,0.0249566632943196,0.00744854796826449,0.0103575092765212,0.0395558173121179,0.00080881459470141
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,37942,0.00943849925723814,0.00282025864793953,0.00391079230727666,0.0149662062071996,0.000820093878419637
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPB1,Signal-regulatory protein beta-1,40335,0.0144828970304527,0.00433089109795661,0.00599435047845778,0.0229714435824477,0.000827433993313271
NMR metabolomics,X23501.Triglycerides in Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.00869862322419641,0.00260154425446462,0.00359959648544576,0.0137976499629471,0.000829122733022806
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA2,Ephrin type-A receptor 2,39759,0.00992478836239596,0.00297007979105923,0.00410343197191986,0.0157461447528721,0.000834994515462222
NMR metabolomics,X23501.Triglycerides in Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,0.00974445999576913,0.00291618956908019,0.00402872844037195,0.0154601915511663,0.00083522315097299
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPEP2,Dipeptidase 2,40305,-0.00922386405662325,0.00276471666824788,-0.0146427087263891,-0.00380501938685741,0.000851032167840039
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,39961,0.0124146346893016,0.0037245898059244,0.00511443866968976,0.0197148307089134,0.000860680888064139
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QL2,Complement C1q-like protein 2,37598,0.0138515406094297,0.00415867884277522,0.0057005300775903,0.0220025511412692,0.000868493048892747
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,40451,0.0137380949808182,0.00412607986640211,0.00565097844267009,0.0218252115189663,0.000871749764911897
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,-0.0198007357404162,0.00595469555657598,-0.0314719390313051,-0.00812953244952725,0.000885883067827882
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPA4,Carboxypeptidase A4,37410,0.0141383501311967,0.00425247941370118,0.00580349048034242,0.022473209782051,0.00088749509877656
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUP50,Nuclear pore complex protein Nup50,37562,-0.01136742856732,0.00344497332082861,-0.018119576276144,-0.00461528085849588,0.000970413786253303
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD14,Monocyte differentiation antigen CD14,40048,0.013200632761862,0.00400300643606084,0.00535474014718273,0.0210465253765412,0.000977053589119195
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,-0.0130491093358256,0.00395937917869292,-0.0208094925260638,-0.00528872614558752,0.000984212806178999
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRIM26,Tripartite motif-containing protein 26,37482,0.0174377140738672,0.0053302198339592,0.00699048319930721,0.0278849449484273,0.00107263831694892
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,0.0174412096253257,0.00533827665471496,0.00697818738208439,0.027904231868567,0.00108853549381588
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,0.0153148472680964,0.00469825975841072,0.0061062581416114,0.0245234363945814,0.00111811985786281
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,0.0226324523043451,0.00694886208538914,0.00901268261698243,0.0362522219917079,0.00112878865715302
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDHR1,Cadherin-related family member 1,39961,0.0138182258909598,0.00424597047824605,0.00549612375359753,0.022140328028322,0.00113862397729547
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB39B,Ras-related protein Rab-39B,37562,0.0280986571954142,0.0086337889399838,0.0111764308730459,0.0450208835177824,0.00113880486978097
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,0.017598979528104,0.00543738054190513,0.00694171366596993,0.028256245390238,0.00121235634497086
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS5,Transmembrane protease serine 5,40159,-0.011756531354396,0.00364387042284538,-0.0188985173831729,-0.00461454532561902,0.00125621118079251
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,0.0104693434190096,0.00326011071631471,0.00407952641503277,0.0168591604229864,0.00132376211326488
NMR metabolomics,X23501.Triglycerides in Large VLDL,RCC1,Regulator of chromosome condensation,37900,0.0158301738743272,0.0049445920979477,0.00613877336234966,0.0255215743863047,0.00137026020086498
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171B,Protein FAM171B,37900,0.00851832262583029,0.00268027460980516,0.00326498439061218,0.0137716608610484,0.00148552050491427
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG1,Arginase-1,40227,0.0161440717410488,0.00510207841294242,0.00614399805168162,0.0261441454304159,0.00155797238780291
NMR metabolomics,X23501.Triglycerides in Large VLDL,PI16,Peptidase inhibitor 16,37987,-0.00750614431204502,0.00238067351742987,-0.0121722644062076,-0.00284002421788248,0.00161982558529753
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMRK2,Nicotinamide riboside kinase 2,37482,-0.0133234289718073,0.00422701081091516,-0.0216083701612011,-0.00503848778241362,0.00162538117591574
NMR metabolomics,X23501.Triglycerides in Large VLDL,FMR1,Synaptic functional regulator FMR1,39980,0.0106690064045704,0.00339176415342856,0.00402114866385041,0.0173168641452904,0.00166080569686015
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALCB,Calcitonin gene-related peptide 2,37942,0.0121316021190958,0.00386282847955179,0.00456045829917427,0.0197027459390173,0.00168965861488997
NMR metabolomics,X23501.Triglycerides in Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0209443865643518,0.00668456127174679,-0.0340461266569755,-0.00784264647172811,0.00173198431944915
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRXN3,Neurexin-3,37572,0.0105651359368358,0.00337561348491214,0.00394893350640803,0.0171813383672636,0.00175284077603524
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDK1,Cyclin-dependent kinase 1,37482,0.0110989306864,0.00354658419398595,0.00414762566618749,0.0180502357066124,0.00175508180274471
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,0.00795777522743698,0.00254706630789743,0.00296552526395802,0.012950025190916,0.00178553355109515
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDN1,Endothelin-1,37628,0.00876792183740572,0.0028167360502567,0.00324711917890259,0.0142887244959089,0.00185721368321626
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6A,Ras-related protein Rab-6A,40341,0.0142698574249563,0.00460613285933065,0.00524183702066821,0.0232978778292444,0.00195162939489655
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH1,Neurexophilin-1,39961,0.0112101173790137,0.00364076211796266,0.00407422362780685,0.0183460111302205,0.00208019079844221
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,0.00845866880637309,0.00275135018712238,0.00306602243961322,0.0138513151731329,0.00211370202726028
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKD1,Polycystin-1,37990,0.00768695150615975,0.00250094275101542,0.00278510371416952,0.01258879929815,0.00211898048155371
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBPMS,RNA-binding protein with multiple splicing,37598,0.0192225846687066,0.00625989265293764,0.00695319506894884,0.0314919742684644,0.00213955401174367
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYB5A,Cytochrome b5,37482,0.0215872388058886,0.00711354909772338,0.00764468257435078,0.0355297950374264,0.00241277766914681
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,0.0257921868747803,0.00850106942638256,0.00913009079907052,0.0424542829504902,0.00241811149654561
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL1,Protein kinase C-binding protein NELL1,40411,-0.0124193069221152,0.0040983259001299,-0.0204520256863698,-0.00438658815786064,0.00244672516618524
NMR metabolomics,X23501.Triglycerides in Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37598,-0.0183398745592722,0.00605660237054131,-0.0302108152055332,-0.00646893391301121,0.00246590373696478
NMR metabolomics,X23501.Triglycerides in Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,0.0144157029005365,0.00478144369695517,0.00504407325450433,0.0237873325465686,0.00257456994854817
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTA2,"Actin, aortic smooth muscle",40042,-0.0126875207228044,0.00421711222368657,-0.0209530606812301,-0.00442198076437876,0.00262890513675531
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKCQ,Protein kinase C theta type,40044,0.0128742097256927,0.00429055116082721,0.00446472945047141,0.0212836900009141,0.00269878005068436
NMR metabolomics,X23501.Triglycerides in Large VLDL,TERF1,Telomeric repeat-binding factor 1,37598,-0.0085256271766288,0.00287886443409826,-0.0141682014674614,-0.00288305288579622,0.00306736692202012
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSC1,Hamartin,37598,0.0218766693830944,0.00738791175208421,0.00739636234900936,0.0363569764171794,0.0030704645736458
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACRV1,Acrosomal protein SP-10,37598,0.0101089328201236,0.00341410853512961,0.00341728009126957,0.0168005855489776,0.00307260617374326
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDS,Iduronate 2-sulfatase,40516,0.00246329338499513,0.000834215554795013,0.00082823089759691,0.00409835587239336,0.00315335122183825
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALPI,Intestinal-type alkaline phosphatase,37598,0.0346981071021856,0.0117531402392478,0.0116619522332599,0.0577342619711112,0.00316033793219184
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX3,Syntaxin-3,37942,0.0110544042505882,0.00374664065555066,0.00371098856570888,0.0183978199354675,0.00317821502181844
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2B,Sodium channel subunit beta-2,37572,-0.00845039716687941,0.00287327047503079,-0.0140820072979398,-0.00281878703581906,0.00327685923929018
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNPEP,Aspartyl aminopeptidase,37942,0.016870547555932,0.00575229585162537,0.00559604768674626,0.0281450474251177,0.00336444696226549
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM19,Probable RNA-binding protein 19,37562,-0.0136088818471994,0.00464152441125837,-0.0227062696932658,-0.004511494001133,0.00337384717321468
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.00740185187577342,0.00252482044647764,-0.0123504999508696,-0.00245320380067725,0.00337748962926062
NMR metabolomics,X23501.Triglycerides in Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,0.00863423266684202,0.00294812406935012,0.00285590949091578,0.0144125558427683,0.00340944165306303
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD160,CD160 antigen,40516,0.0128777274266754,0.0044075255678172,0.00423897731375374,0.0215164775395972,0.00348545504289608
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL11,Interleukin-11,40044,0.0179899557374273,0.00617563425227294,0.00588571260297231,0.0300941988718822,0.00358420776388793
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,0.0118112406683634,0.0040607070274771,0.00385225489450825,0.0197702264422185,0.00363477448228072
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,0.0293104378798752,0.0100781822164123,0.00955720073570723,0.0490636750240433,0.00363899319733549
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMOD4,Tropomodulin-4,37482,-0.0117957530663481,0.00405930478559396,-0.0197519904461123,-0.00383951568658396,0.00366867101723104
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,40357,0.0819743629997378,0.0282255928068423,0.026652201098327,0.137296524901149,0.00368632990768425
NMR metabolomics,X23501.Triglycerides in Large VLDL,ODAM,Odontogenic ameloblast-associated protein,39934,0.0149750646460418,0.0051744996329595,0.00483304536544119,0.0251170839266424,0.00380884387207452
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMG4,Proteasome assembly chaperone 4,37598,0.015790554950523,0.00546220185098676,0.00508463932258891,0.026496470578457,0.00384797241623491
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,-0.0182754131978554,0.00632326482332123,-0.030669012251565,-0.00588181414414578,0.0038564627177845
NMR metabolomics,X23501.Triglycerides in Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,0.00734107408406236,0.0025530554174986,0.00233708546576511,0.0123450627023596,0.00404043065785882
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,0.00969926226804334,0.00337989231449906,0.00307467333162519,0.0163238512044615,0.00411419415923965
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,0.014319938838878,0.00500554801294064,0.0045090647335143,0.0241308129442416,0.00423206904950712
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,40305,-0.0173516753591515,0.00606612802533994,-0.0292412862888177,-0.00546206442948517,0.00423632777831735
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,-0.0105693410961642,0.00370388356227624,-0.0178289528782256,-0.00330972931410277,0.00432968810167571
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGF,Beta-nerve growth factor,40228,0.00335520479141288,0.00117650722174036,0.00104925063680178,0.00566115894602398,0.00435240757404358
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAG,S-arrestin,37541,-0.0146427520220822,0.00517750758444925,-0.0247906668876027,-0.00449483715656163,0.00468894336564105
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDA1,DET1- and DDB1-associated protein 1,37562,0.0111618178568306,0.00395180779164991,0.00341627458519674,0.0189073611284644,0.0047428296561509
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEG1,Protein LEG1 homolog,37231,-0.0190285226890697,0.0067426398430439,-0.0322440967814357,-0.00581294859670364,0.00477813320582472
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,37598,-0.00880696197167019,0.00312100065977766,-0.0149241232648344,-0.00268980067850598,0.00478207486307094
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL14,C-X-C motif chemokine 14,40044,0.0167554677180251,0.0059416410263772,0.00510985130632582,0.0284010841297244,0.0048083238556124
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00400463810984419,0.00142484432168651,0.00121194323933863,0.00679733298034975,0.00495235603993663
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,0.0164446369050237,0.00585124932484994,0.00497618822831781,0.0279130855817296,0.004953339894405
NMR metabolomics,X23501.Triglycerides in Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.0105440522621308,0.00375797187372158,0.00317842738963648,0.0179096771346251,0.00502684513430252
NMR metabolomics,X23501.Triglycerides in Large VLDL,RETN,Resistin,40283,0.01119796553589,0.00399715337552009,0.00336354491987065,0.0190323861519094,0.00509297249757686
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,-0.016264564856323,0.0058106297435415,-0.0276533991536643,-0.00487573055898164,0.00513192838097977
NMR metabolomics,X23501.Triglycerides in Large VLDL,TUBB3,Tubulin beta-3 chain,37541,-0.00752217091620088,0.00269645633747131,-0.0128072253376446,-0.00223711649475712,0.00528412360445946
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH4,Myosin-4,37562,-0.0128668541869122,0.0046147016987673,-0.0219116695164961,-0.00382203885732826,0.00530730951684214
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGSF21,Immunoglobulin superfamily member 21,37628,0.0105536828783496,0.00378634069703087,0.00313245511216907,0.0179749106445301,0.00532246750677615
NMR metabolomics,X23501.Triglycerides in Large VLDL,TK1,"Thymidine kinase, cytosolic",37714,0.0120513917379988,0.00433213911936944,0.00356039906403467,0.0205423844119629,0.00541251821492907
NMR metabolomics,X23501.Triglycerides in Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,0.0113621371454823,0.00409584852353349,0.00333427403935666,0.019390000251608,0.0055439063959838
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,0.0174414876617191,0.00629312193913035,0.00510696866102361,0.0297760066624146,0.00558633182944227
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAT1,Diamine acetyltransferase 1,37562,-0.0140181915310538,0.00506612662756964,-0.0239477997210903,-0.00408858334101732,0.005664653258876
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF4,Neurotrophin-4,39980,0.0109068580607358,0.0039424077065266,0.00317973895594369,0.018633977165528,0.00567203295603372
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,40306,0.00959563634012592,0.00347544226844005,0.00278376949398343,0.0164075031862684,0.00576939721604753
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL2,Kin of IRRE-like protein 2,39961,0.0106767430978885,0.00387705986489548,0.00307770576269337,0.0182757804330837,0.00589719058667453
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACE,Angiotensin-converting enzyme,37987,-0.00679848567522112,0.00246912923290166,-0.0116379789717084,-0.00195899237873387,0.00590595195890829
NMR metabolomics,X23501.Triglycerides in Large VLDL,DRAXIN,Draxin,40228,0.0114339959195253,0.00417830518146528,0.00324451776385333,0.0196234740751972,0.006216320229283
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.00934710962606836,0.00342317545544163,-0.016056533518734,-0.00263768573340277,0.00633001657687482
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,-0.0108867884342596,0.00399197487396188,-0.0187110591872249,-0.00306251768129431,0.00639653730668855
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",40310,0.0178536271943047,0.00655966397727472,0.00499668579884627,0.0307105685897632,0.00650122937050994
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,-0.0127590677731925,0.00470183587778788,-0.0219746660936567,-0.00354346945272822,0.00666363496606707
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,0.00843824431397003,0.00311064513927685,0.00234137984098741,0.0145351087869526,0.00668103318050816
NMR metabolomics,X23501.Triglycerides in Large VLDL,BMP4,Bone morphogenetic protein 4,40203,-0.0118759501177451,0.0043806723806788,-0.0204620679838756,-0.00328983225161465,0.00671557629737725
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,-0.00843578890192646,0.00311167747392781,-0.014534676750825,-0.00233690105302796,0.00671658761817479
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,0.0138534800679899,0.00514181441586575,0.00377552381289301,0.0239314363230868,0.0070630005234936
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,0.0160938513443251,0.00598924975957955,0.0043549218155492,0.027832780873101,0.00721610571856274
NMR metabolomics,X23501.Triglycerides in Large VLDL,HYAL1,Hyaluronidase-1,40214,0.00594635482186907,0.00221600671382739,0.00160298166276739,0.0102897279809708,0.00729614884922864
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC6A,C-type lectin domain family 6 member A,39980,0.0121206399642928,0.00451995011400091,0.00326153774085102,0.0209797421877346,0.00733512993932357
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSB,Lupus La protein,39961,0.0156444082561859,0.00583648907268108,0.00420488967373096,0.0270839268386408,0.00736012873443105
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPP1,Osteopontin,40497,-0.0122705739633663,0.00459324090452412,-0.0212733261362335,-0.00326782179049901,0.00756024870787137
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN2,Prorelaxin H2,37643,0.0364518729207726,0.0136452183733435,0.00970724490901929,0.0631965009325259,0.00756277071821523
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,37541,-0.0129839670244011,0.00486383032312576,-0.0225170744577276,-0.00345085959107464,0.00760593268137982
NMR metabolomics,X23501.Triglycerides in Large VLDL,L1CAM,Neural cell adhesion molecule L1,40411,-0.0072847499619292,0.00273084812445936,-0.0126372122858695,-0.00193228763798886,0.00764773158173394
NMR metabolomics,X23501.Triglycerides in Large VLDL,JUN,Transcription factor AP-1,40044,0.0133195902210549,0.00501245503963,0.00349517834338015,0.0231440020987297,0.00788498949975074
NMR metabolomics,X23501.Triglycerides in Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,0.0228929181794132,0.00862300564040321,0.00599182712422293,0.0397940092346035,0.00794365348037131
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.00946447172671837,0.00357111464247724,0.00246508702746298,0.0164638564259738,0.00805199696523345
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK1,Kallikrein-1,40209,-0.0325971532408135,0.0123138520836495,-0.0567323033247665,-0.00846200315686056,0.00812435602424537
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRC1,Macrophage mannose receptor 1,37987,0.00722877707788337,0.00273070287383839,0.00187659944516013,0.0125809547106066,0.00812500217822463
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGFR4,Fibroblast growth factor receptor 4,37671,0.013684356146811,0.00517704043858481,0.00353735688718478,0.0238313554064373,0.00822044894707295
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD3,Bromodomain-containing protein 3,37562,0.0124036968854399,0.00469347613964124,0.00320448365174305,0.0216029101191367,0.00823328101073316
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSAP,Gamma-secretase-activating protein,39980,0.0227690837676562,0.00863190278799006,0.00585055430319567,0.0396876132321167,0.00835332164562607
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP290,Centrosomal protein of 290 kDa,37714,0.0136125871590012,0.00516610587730593,0.0034870196394816,0.0237381546785208,0.00842399982270488
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBQ1,Hemoglobin subunit theta-1,40489,-0.015016352143313,0.00570291357398065,-0.0261940627483151,-0.00383864153831094,0.00846901166517164
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,0.00739500031383016,0.00281238146113783,0.00188273265000002,0.0129072679776603,0.00856241128679733
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOE,Apolipoprotein E,38013,0.0189766617519815,0.00724628989837968,0.00477393355115736,0.0331793899528057,0.00883350374379321
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTP1,Glutathione S-transferase P,39871,-0.0176331654613382,0.00674544231318491,-0.0308542323951806,-0.00441209852749576,0.0089553507221203
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUK1,Guanylate kinase,37562,-0.010120203969041,0.00389479204555975,-0.0177539963783381,-0.0024864115597439,0.00937657827163331
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNL1,Thioredoxin-like protein 1,37525,0.024029189888914,0.00924932982778771,0.00590050342645004,0.0421578763513779,0.00938904683452474
NMR metabolomics,X23501.Triglycerides in Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,0.00918538707884036,0.00353848554122875,0.00224995541803201,0.0161208187396487,0.00944616537500282
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39961,0.0121765953950987,0.00469633544305796,0.00297177792670505,0.0213814128634923,0.00952911912775377
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,0.0126192653119348,0.00487359902586252,0.00306701122124426,0.0221715194026254,0.00962717019751879
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCAN,Neurocan core protein,40471,-0.00929289143417061,0.00359599960236303,-0.0163410506548021,-0.00224473221353907,0.00976842282580449
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMBN,Ameloblastin,40044,-0.00740225236068868,0.00287073940958706,-0.0130289016034793,-0.00177560311789804,0.00993160549364095
NMR metabolomics,X23501.Triglycerides in Large VLDL,CENPJ,Centromere protein J,37714,0.0183016550345356,0.00710482431991872,0.00437619936749487,0.0322271107015763,0.0100073015287142
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,0.00783030138187087,0.00304114022088964,0.00186966654892717,0.0137909362148146,0.010040893839156
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARTN,Artemin,40044,0.0110716823417499,0.00430613436540041,0.00263165898556507,0.0195117056979347,0.0101455649848518
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,40424,-0.00519033927088304,0.0020247905747681,-0.00915892879742852,-0.00122174974433757,0.0103744583593988
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTTG1,Securin,37714,0.010257939197027,0.00400695247356088,0.00240431234884769,0.0181115660452063,0.0104771384277909
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",37541,0.0152440395840218,0.00596564611013605,0.00355137320815517,0.0269367059598885,0.0106207128738317
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC7A,C-type lectin domain family 7 member A,40516,0.0144259861797561,0.00565227294973977,0.00334753119826611,0.025504441161246,0.0107122889389733
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL2,Chordin-like protein 2,40359,0.0140043765479672,0.00548905538269716,0.00324582799788075,0.0247629250980536,0.0107406249593509
NMR metabolomics,X23501.Triglycerides in Large VLDL,LEO1,RNA polymerase-associated protein LEO1,37959,0.00764682125923023,0.00299828954188035,0.00177017375714475,0.0135234687613157,0.0107710445525604
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGA,Chromogranin-A,37998,-0.0222662960266511,0.00873512670848628,-0.0393871443752842,-0.00514544767801805,0.0108125330039155
NMR metabolomics,X23501.Triglycerides in Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0124870428508628,0.00492031210814117,-0.0221308545828195,-0.00284323111890611,0.0111628236174634
NMR metabolomics,X23501.Triglycerides in Large VLDL,CADPS,Calcium-dependent secretion activator 1,37572,-0.0110560804519637,0.00436428060242156,-0.01961007043271,-0.00250209047121749,0.0113106080001781
NMR metabolomics,X23501.Triglycerides in Large VLDL,SH3GL3,Endophilin-A3,37643,0.0202961376696244,0.00803696584459911,0.00454368461421014,0.0360485907250387,0.0115699852309375
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,0.00616076462397643,0.0024500967624651,0.00135857496954483,0.010962954278408,0.0119321462840127
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD2,T-cell surface antigen CD2,37562,0.00928865606276503,0.00370350464070448,0.00202978696698426,0.0165475251585458,0.0121511763484925
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,0.0161564604447833,0.00644689020021238,0.00352055565236703,0.0287923652371995,0.012219474214296
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANGPT2,Angiopoietin-2,40489,-0.00934814463168294,0.0037375266560987,-0.0166736968776364,-0.0020225923857295,0.0123886849942873
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYMP,Thymidine phosphorylase,40257,0.0159499705870071,0.00642389541819617,0.00335913556734259,0.0285408056066716,0.0130416025244441
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,0.00802500848738224,0.00324035362052664,0.00167391539115002,0.0143761015836145,0.0132749651820968
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEFL,Neurofilament light polypeptide,39903,0.0101822617958171,0.00412336094197034,0.00210047434955522,0.0182640492420789,0.0135443983812985
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH12,Protocadherin-12,37959,0.00611758002597224,0.00247887396736909,0.00125898704992883,0.0109761730020157,0.0136036330387396
NMR metabolomics,X23501.Triglycerides in Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,0.0113960773219661,0.00463212652492646,0.00231710933311027,0.020475045310822,0.0138974438967855
NMR metabolomics,X23501.Triglycerides in Large VLDL,KITLG,Kit ligand,40359,-0.00861274941102225,0.00350779051316957,-0.0154880188168346,-0.0017374800052099,0.0140865318037933
NMR metabolomics,X23501.Triglycerides in Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,-0.0156694063899943,0.00638482407360897,-0.0281836615742679,-0.00315515120572072,0.0141341498178876
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,40182,0.00678355412561919,0.0027736711007937,0.00134715876806354,0.0122199494831748,0.014468197998487
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,40203,-0.00792134836307526,0.00323977999498487,-0.0142713171532456,-0.00157137957290491,0.0144950218343509
NMR metabolomics,X23501.Triglycerides in Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37572,0.014312582242552,0.00585536321775851,0.00283607033574533,0.0257890941493587,0.0145242386364707
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX1,"Adrenodoxin, mitochondrial",37562,0.0148751292691283,0.00609522305264651,0.00292849208594116,0.0268217664523155,0.0146818439317453
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAFB2,Scaffold attachment factor B2,37959,0.00653048871745153,0.00268011702847139,0.00127745934164761,0.0117835180932555,0.0148371284879247
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,-0.0115694726584755,0.00474929786217357,-0.0208780964683357,-0.00226084884861528,0.0148623177197602
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDRG1,Protein NDRG1,39961,0.016159728440976,0.00664384733739052,0.00313778765969056,0.0291816692222614,0.0150151424771778
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37598,0.00866259503812274,0.00357781723860252,0.00165007325046181,0.0156751168257837,0.0154830036485131
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC12A,C-type lectin domain family 12 member A,37598,0.00479573801353711,0.00198213991024197,0.000910743789462843,0.00868073223761138,0.0155564069807878
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPO,Erythropoietin,40341,0.0182262202233455,0.00755260174869924,0.00342312079589497,0.033029319650796,0.0158227638881882
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH22,Cadherin-22,37714,-0.00687457692211489,0.00285825624082428,-0.0124767591541305,-0.00127239469009929,0.0161787900389169
NMR metabolomics,X23501.Triglycerides in Large VLDL,CFD,Complement factor D,38013,0.00442303092728263,0.0018409168822242,0.000814833838123194,0.00803122801644207,0.0162912717892134
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,40341,0.0108975492340308,0.00453878212121715,0.0020015362764452,0.0197935621916164,0.0163624129101154
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.0115384807107608,0.00480627884624314,0.00211817417212421,0.0209587872493973,0.0163750121372063
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,-0.00716742095389669,0.00298872194178848,-0.0130253159598021,-0.00130952594799127,0.0164895814908876
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEPD,Xaa-Pro dipeptidase,37987,0.00597215011034661,0.00249471527145384,0.00108250817829709,0.0108617920423961,0.0166828876374835
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSAPL1,Proactivator polypeptide-like 1,37901,-0.0116842825172874,0.00489618064833167,-0.0212807965880175,-0.00208776844655733,0.0170276276537398
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,0.0075940629346081,0.00322223814804657,0.00127847616443683,0.0139096497047794,0.0184468715822938
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP164,Centrosomal protein of 164 kDa,40044,0.0145718530011141,0.00618643255389136,0.00244644519548705,0.0266972608067412,0.0185124375330374
NMR metabolomics,X23501.Triglycerides in Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,0.0130491173764251,0.00553999774447285,0.00219072179725829,0.0239075129555919,0.0185129903646506
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1B,Lithostathine-1-beta,40536,0.012681959646903,0.00538980669217844,0.00211793853023325,0.0232459807635727,0.0186369832022243
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTRC,Chymotrypsin-C,40360,0.0141701083228873,0.00605119274344899,0.00230977054572724,0.0260304461000473,0.0192081525164088
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,0.0214864708570653,0.00918576383814194,0.0034823737343071,0.0394905679798235,0.0193445353132253
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC12A2,Solute carrier family 12 member 2,37562,-0.00647572216620532,0.00277316109773488,-0.0119111179177657,-0.00104032641464497,0.0195510641866892
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEF,Thyrotroph embryonic factor,37562,0.00975231658767979,0.00417637139606357,0.0015666286513952,0.0179380045239644,0.0195523084720248
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15,Interleukin-15,40341,0.00736032303454525,0.00316306002815394,0.00116072537936354,0.013559920689727,0.0199797474886393
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERVV_1,,37562,-0.0108707571875389,0.00468891614509588,-0.0200610328319269,-0.00168048154315099,0.0204431982771799
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNW1,Interferon omega-1,37562,-0.0082753872284475,0.0035697800560116,-0.0152721561382302,-0.00127861831866478,0.0204549331733623
NMR metabolomics,X23501.Triglycerides in Large VLDL,VIM,Vimentin,40042,0.0264857470052132,0.0114372151025451,0.00406880540422479,0.0489026886062015,0.0205847552343859
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR101,Probable G-protein coupled receptor 101,37541,-0.0144626792895978,0.00626277115426494,-0.0267377107519571,-0.00218764782723856,0.020941882987239
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYH7B,Myosin-7B,37482,-0.0102017418488158,0.00443062515125957,-0.0188857671452846,-0.00151771655234708,0.0213197818294154
NMR metabolomics,X23501.Triglycerides in Large VLDL,GLI2,Zinc finger protein GLI2,37598,-0.00751175040642921,0.00326262425804129,-0.0139064939521901,-0.00111700686066829,0.0213301695180199
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRSS53,Serine protease 53,37942,0.0081814114870361,0.00355533222287884,0.00121296033019357,0.0151498626438786,0.0213973912328074
NMR metabolomics,X23501.Triglycerides in Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,0.0198457186648143,0.00864157550007917,0.00290823068465917,0.0367832066449695,0.0216608780436542
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSPN,Claspin,39925,0.00756331140382445,0.00329746618517417,0.00110027768088307,0.0140263451267658,0.0218225884430346
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPN1,Epsin-1,37714,0.00982495032600486,0.00428767036636057,0.00142111640793814,0.0182287842440716,0.0219534328345996
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN1,Transcobalamin-1,37766,0.00731137357941269,0.00319617242081286,0.00104687563461949,0.0135758715242059,0.022179908383315
NMR metabolomics,X23501.Triglycerides in Large VLDL,QSOX1,Sulfhydryl oxidase 1,37761,0.00989795118449581,0.00433811088031894,0.0013952538590707,0.0184006485099209,0.0225270854312642
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLH1,Glutamate carboxypeptidase 2,37598,0.0237808895820357,0.0104312937160387,0.00333555389859975,0.0442262252654716,0.0226376251713932
NMR metabolomics,X23501.Triglycerides in Large VLDL,MKI67,Proliferation marker protein Ki-67,37598,0.00831752144128999,0.00365711096785508,0.00114958394429403,0.0154854589382859,0.0229614668143926
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,0.00945400312448544,0.00416451469394444,0.00129155432435434,0.0176164519246165,0.0232131612849156
NMR metabolomics,X23501.Triglycerides in Large VLDL,MELTF,Melanotransferrin,37990,0.00641071695295752,0.00282394892038043,0.000875777069011874,0.0119456568369032,0.0232156504497865
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,-0.00585373855031792,0.00258038075328335,-0.0109112848267533,-0.000796192273882551,0.0233110439948706
NMR metabolomics,X23501.Triglycerides in Large VLDL,PODXL2,Podocalyxin-like protein 2,40411,-0.00595858004264908,0.0026335648379522,-0.0111203671250354,-0.000796792960262766,0.0236766419249258
NMR metabolomics,X23501.Triglycerides in Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,-0.00687357315983145,0.00303911385378057,-0.0128302363132414,-0.000916910006421526,0.0237291946347693
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,0.00787545319799769,0.0034865691525159,0.00104177765906653,0.0147091287369288,0.0239121644213295
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100G,Protein S100-G,37959,-0.00970963656877272,0.00430590336512073,-0.0181492071644094,-0.00127006597313609,0.0241518312533598
NMR metabolomics,X23501.Triglycerides in Large VLDL,NMI,N-myc-interactor,37857,0.0155473258907658,0.00692599879182127,0.00197236825879612,0.0291222835227355,0.0247986631240826
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPS,Calcyphosin,37942,0.0206110394365932,0.00918982656585898,0.0025989793675096,0.0386230995056768,0.0249252086771031
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYO6,Unconventional myosin-VI,37959,0.00812518876480021,0.00362628102071216,0.00101767796420437,0.015232699565396,0.0250656186398701
NMR metabolomics,X23501.Triglycerides in Large VLDL,CORO6,Coronin-6,37541,-0.00789212127079622,0.00353386287464981,-0.0148184925051099,-0.00096575003648259,0.025547020774491
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00837220113624172,0.00374981569948364,-0.0157218399072296,-0.00102256236525379,0.0255852372596822
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCP2,Non-specific lipid-transfer protein,39980,0.0167720302183819,0.00753584960277401,0.00200176499694484,0.031542295439819,0.0260531232739076
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTNNA1,Catenin alpha-1,37541,-0.00782351861993045,0.00351865651391486,-0.0147200853872036,-0.000926951852657329,0.0262032081580481
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39865,0.00810416988205699,0.00364594203402322,0.000958123495371489,0.0152502162687425,0.0262442961555322
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNN,Tenascin-N,37998,0.00938889573947168,0.00423556447487607,0.00108718936871458,0.0176906021102288,0.0266614361846126
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,40044,0.00756024197212029,0.00344401802864677,0.000809966635972626,0.014310517308268,0.0281653233293008
NMR metabolomics,X23501.Triglycerides in Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.0119544217482185,0.00544652399749638,0.00127923471312559,0.0226296087833114,0.0281900698753958
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,-0.00605357153061217,0.00276686673958164,-0.0114766303401922,-0.000630512721032154,0.028695988284653
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_DRA,,40288,-0.00760561704593786,0.00347974225322902,-0.0144259118622667,-0.000785322229608977,0.0288533257823812
NMR metabolomics,X23501.Triglycerides in Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.0144569316847997,0.00662102160160599,0.00147972934565193,0.0274341340239474,0.0290169990726754
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC1A,C-type lectin domain family 1 member A,40042,-0.00696060298586084,0.00319199903973351,-0.0132169211037385,-0.000704284867983174,0.0292249011138293
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH17,Cadherin-17,40359,-0.0142379625815434,0.00652935668615711,-0.0270355016864114,-0.00144042347667552,0.029227079399004
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA2,GDNF family receptor alpha-2,40305,0.00445915022017562,0.0020470557505346,0.000446920949127802,0.00847137949122344,0.0293966235282609
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDK2,Protein sidekick-2,37671,0.00803111333939033,0.00369263402156589,0.000793550657121192,0.0152686760216595,0.0296552051792108
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,-0.00866943038278403,0.00400328609918093,-0.0165158711371787,-0.000822989628389406,0.0303614108128012
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANSC4,MANSC domain-containing protein 4,37562,0.0137555131703234,0.0063723692662297,0.00126566940851323,0.0262453569321337,0.0308978789819807
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,37562,-0.0150350062506989,0.00697892493945446,-0.0287136991320297,-0.00135631336936821,0.0312313537259136
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0122954745126225,0.00571020383390457,0.00110347499816957,0.0234874740270755,0.0313145117479113
NMR metabolomics,X23501.Triglycerides in Large VLDL,COMP,Cartilage oligomeric matrix protein,40198,0.00702045258224402,0.00326351178665008,0.000623969480409856,0.0134169356840782,0.0314759205074956
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB116,Beta-defensin 116,37541,-0.016436505393907,0.00767271665557038,-0.0314750300388249,-0.00139798074898903,0.0321956632787041
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD48,CD48 antigen,40396,0.00601262849282111,0.00283009000705794,0.000465652078987538,0.0115596049066547,0.033640679534541
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC1,Sialoadhesin,40422,0.00885584985995621,0.00417775748109365,0.000667445197012666,0.0170442545228998,0.034041537079635
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA4C,Semaphorin-4C,40305,-0.00578777438478365,0.00273080957054978,-0.0111401611430612,-0.000435387626506079,0.0340691899419771
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN7,Septin-7,37714,0.0107537035823182,0.00508856903388702,0.000780108275899694,0.0207272988887368,0.0345932105371121
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYT1,Synaptotagmin-1,37942,0.00798969111230246,0.00378889451349642,0.00056345786584948,0.0154159243587554,0.0349877469312267
NMR metabolomics,X23501.Triglycerides in Large VLDL,CALY,Neuron-specific vesicular protein calcyon,37562,-0.00781837075659656,0.0037112652924369,-0.0150924507297729,-0.000544290783420244,0.0351660920301667
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL19,Interleukin-19,39924,0.0137765004206008,0.00655047891652171,0.00093756174421823,0.0266154390969833,0.0354706243051906
NMR metabolomics,X23501.Triglycerides in Large VLDL,MN1,Transcriptional activator MN1,37572,-0.0121392535954015,0.00578195523065722,-0.0234718858474897,-0.000806621343313378,0.0357913125030275
NMR metabolomics,X23501.Triglycerides in Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0056966096463703,0.00272266431740471,0.000360187584257058,0.0110330317084835,0.0364281839452953
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA4,Ephrin type-A receptor 4,37671,0.00569876580688686,0.00272762635817964,0.000352618144854767,0.0110449134689189,0.0367019080961425
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,-0.00643804920360337,0.00309796285651701,-0.0125100564023767,-0.00036604200483004,0.0377113404689712
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,0.00883184044920537,0.00425959691064259,0.000483030504345901,0.0171806503940648,0.0381511392917561
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,37541,-0.00855148309963828,0.00412651352496403,-0.0166394496085678,-0.000463516590708776,0.0382545393705052
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP9,Matrix metalloproteinase-9,40312,0.0121924340308634,0.00589869046765721,0.000631000714255295,0.0237538673474716,0.0387528848981242
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,0.00802874321163962,0.00388461658266539,0.000414894709615447,0.0156425917136638,0.038772161780044
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,0.0102330343793996,0.00496779888732262,0.000496148560247302,0.019969920198552,0.039427319405727
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B4,Protein ATP1B4,37482,-0.00844537520760899,0.00410014108300324,-0.0164816517302954,-0.000409098684922634,0.0394397070644176
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37572,0.00587151459614245,0.0028573783630949,0.000271053004476444,0.0114719761878085,0.0399122155547588
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1,DNA topoisomerase 1,37901,0.0212216634322415,0.0103353999747873,0.000964279481658309,0.0414790473828246,0.0400629134805361
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,37482,-0.00600350098275573,0.0029274058787649,-0.0117412165051349,-0.00026578546037653,0.0403071497350752
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,-0.00876019866003766,0.00428097059535247,-0.0171509010269285,-0.000369496293146828,0.04074565292211
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.00685064832738889,0.0033584967953776,0.000267994608448791,0.013433302046329,0.0413869527943612
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCC,Netrin receptor DCC,37572,0.0046154948164667,0.00226274194671221,0.000180520600910773,0.00905046903202263,0.0413922727377716
NMR metabolomics,X23501.Triglycerides in Large VLDL,RYR1,Ryanodine receptor 1,37562,-0.00682655751994551,0.00335198006589638,-0.0133964384491024,-0.000256676590788601,0.0417127405118957
NMR metabolomics,X23501.Triglycerides in Large VLDL,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00897951172213843,0.00441521250500032,-0.0176333282319391,-0.000325695212337806,0.0419949976567788
NMR metabolomics,X23501.Triglycerides in Large VLDL,TJP3,Tight junction protein ZO-3,37541,-0.00864111244942951,0.00426257919970062,-0.0169957676808427,-0.000286457218016291,0.042661903125443
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD70,CD70 antigen,40341,-0.00810288625655098,0.00401181472914526,-0.0159660431256757,-0.000239729387426273,0.0434254714618794
NMR metabolomics,X23501.Triglycerides in Large VLDL,JCHAIN,Immunoglobulin J chain,40044,-0.0120459698324068,0.00597275135111879,-0.0237525624805997,-0.000339377184213998,0.0437313136881014
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN4,Prefoldin subunit 4,37482,0.0106288640392822,0.00527059115565803,0.00029850537419243,0.0209592227043719,0.0437539845087959
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.0268747180566509,0.0133323167205482,-0.0530060588289253,-0.000743377284376415,0.0438450419478069
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLNS1A,Methylosome subunit pICln,37572,0.00656119471575227,0.00325594329805081,0.000179545851572678,0.0129428435799319,0.0439099156150285
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSLNL,Mesothelin-like protein,37572,-0.00732058944423925,0.00364361938486727,-0.0144620834385791,-0.000179095449899402,0.0445413360618642
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,40044,0.00897979567911469,0.00447355680519439,0.00021162434093369,0.0177479670172957,0.0447343572299302
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA11,Carbonic anhydrase-related protein 11,39980,0.0064108436119683,0.00319688369508654,0.000144951569598675,0.0126767356543379,0.0449438691520337
NMR metabolomics,X23501.Triglycerides in Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,-0.0111868959616131,0.00558129073055515,-0.0221262257935012,-0.000247566129725037,0.0450525484122829
NMR metabolomics,X23501.Triglycerides in Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,0.00514610566312989,0.00256869266492903,0.000111468039868993,0.0101807432863908,0.0451555928797297
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL5A1,Collagen alpha-1(V) chain,37671,0.00770342758248893,0.00384678101892515,0.00016373678539564,0.0152431183795822,0.0452444259637049
NMR metabolomics,X23501.Triglycerides in Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.0177893523328733,0.00888393920966787,0.000376831481924252,0.0352018731838223,0.0452602060432405
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEZ6L,Seizure 6-like protein,40411,-0.00530182212642989,0.00264917034494454,-0.0104941960025212,-0.000109448250338583,0.0453754450617436
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRELP,Prolargin,40357,0.00447049127693011,0.00223835718402676,8.33111962376711e-05,0.00885767135762256,0.0458183180040523
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD33,Myeloid cell surface antigen CD33,40411,0.0152947425403088,0.0076599957121579,0.000281150944479299,0.0303083341361383,0.0458743241393138
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLMP,CXADR-like membrane protein,40489,0.00392857699142702,0.00196821282865806,7.08798472572238e-05,0.00778627413559682,0.0459494658770851
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCRL6,Fc receptor-like protein 6,40341,0.0129817971001451,0.00651577765003562,0.000210872906075259,0.0257527212942149,0.0463482777562083
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN2,Neuroligin-2,37541,-0.00931940119016774,0.00468491131061837,-0.0185018273589797,-0.000136975021355731,0.0466957757417376
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.0110293465700042,0.00554944641163411,0.000152431603201312,0.021906261536807,0.0468913749783868
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEO1,Neogenin,37959,0.00410034036829562,0.00206484118740397,5.32516409838387e-05,0.00814742909560741,0.0470768633038859
NMR metabolomics,X23501.Triglycerides in Large VLDL,RRP15,RRP15-like protein,37541,-0.0175287010620377,0.0088422329108714,-0.0348594775673456,-0.000197924556729723,0.0474571550875542
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFRA3,GDNF family receptor alpha-3,40194,-0.00545565184423464,0.00275373768549769,-0.0108529777078101,-5.83259806591664e-05,0.0475883893127636
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0133580518639153,0.00676732109185229,9.41025238847884e-05,0.0266220012039458,0.0484095822058835
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.0228822617749432,0.0116173750702915,0.000112206637171753,0.0456523169127146,0.0488951936853634
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,0.0107317137325576,0.00546821188939104,1.40184293512015e-05,0.0214494090357641,0.0497174230801986
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,-0.00991348231175743,0.005058059538291,-0.0198272790068078,3.14383292928169e-07,0.0500241917930925
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOP56,Nucleolar protein 56,37562,0.021013333453447,0.0107319402377259,-2.1269412495712e-05,0.0420479363193897,0.050249064793612
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC4A1,Band 3 anion transport protein,37998,-0.00868837784890684,0.00447085536125478,-0.0174512543569662,7.44986591525287e-05,0.0519961611655073
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTO1,Protein LTO1 homolog,40044,0.00772212543750326,0.00398127644767188,-8.11763999336223e-05,0.0155254272749401,0.0524450612780655
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL4,Early placenta insulin-like peptide,37900,-0.0101398132071655,0.00524168028614066,-0.0204135065680012,0.000133880153670218,0.0530777240210785
NMR metabolomics,X23501.Triglycerides in Large VLDL,GSTM4,Glutathione S-transferase Mu 4,37562,-0.0134372888960769,0.0069489457867878,-0.027057222638181,0.000182644846027164,0.0531695326544841
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,0.00586988053852359,0.00303852814568839,-8.56346270256565e-05,0.0118253957040728,0.0533998598190577
NMR metabolomics,X23501.Triglycerides in Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,-0.00378112664851253,0.0019588185184965,-0.00762041094476567,5.81576477406208e-05,0.0535900023392179
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,40332,-0.00604618134450831,0.0031355283180185,-0.0121918168478246,9.94541588079474e-05,0.0538379243604989
NMR metabolomics,X23501.Triglycerides in Large VLDL,TTN,Titin,37562,-0.0122393894328375,0.00636688629751692,-0.0247184865759707,0.000239707710295644,0.0545832669704283
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN8,Tetraspanin-8,37901,0.0192704383438162,0.0100538355031217,-0.00043507924230236,0.0389759559299347,0.0552940387870401
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD1,Glutamate decarboxylase 1,37482,-0.00478966847235246,0.00250711662072984,-0.00970361704898294,0.000124280104278029,0.0560999177172066
NMR metabolomics,X23501.Triglycerides in Large VLDL,BEX3,Protein BEX3,37482,-0.00884101863961503,0.00463229858167445,-0.017920323859697,0.000238286580466892,0.0563408577877697
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,37900,0.0106183574620088,0.00556960578755539,-0.000298069881599798,0.0215347848056173,0.0566088915657074
NMR metabolomics,X23501.Triglycerides in Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,-0.0106434187999246,0.00558804606066349,-0.021595989078825,0.000309151478975884,0.0568440622089721
NMR metabolomics,X23501.Triglycerides in Large VLDL,INHBB,Inhibin beta B chain,37671,0.00946338300396624,0.00498594461762945,-0.000309068446587485,0.01923583445452,0.0577162565123764
NMR metabolomics,X23501.Triglycerides in Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37598,0.00536440363668007,0.00285194556386803,-0.000225409668501258,0.0109542169418614,0.059999057048376
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36A,Interleukin-36 alpha,37598,-0.0107664545480807,0.00573108245077348,-0.0219993761515967,0.000466467055435325,0.0603202151230006
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37598,0.0124164271008958,0.00661727445979271,-0.000553430840297861,0.0253862850420895,0.0606272114354931
NMR metabolomics,X23501.Triglycerides in Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.00890111308596749,0.00475392064924016,-0.0182187975584782,0.000416571386543227,0.0611772476936637
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",37562,0.00696053908822854,0.00371789563148035,-0.00032653634947294,0.01424761452593,0.0612050935258669
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLK,STE20-like serine/threonine-protein kinase,37714,0.0140329449215063,0.00753421517666443,-0.000734116824756,0.0288000066677686,0.0625459720661745
NMR metabolomics,X23501.Triglycerides in Large VLDL,GBP6,Guanylate-binding protein 6,37562,-0.00857462457390135,0.00460488432236317,-0.0176001978457332,0.000450948697930461,0.0626153474639522
NMR metabolomics,X23501.Triglycerides in Large VLDL,COPE,Coatomer subunit epsilon,39961,0.00869239135481074,0.00467046840863862,-0.000461726726120952,0.0178465094357424,0.0627434434601051
NMR metabolomics,X23501.Triglycerides in Large VLDL,OTOA,Otoancorin,37541,-0.00986496848234742,0.00531600741116949,-0.0202843430082396,0.000554406043544793,0.0635173568129385
NMR metabolomics,X23501.Triglycerides in Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,40403,-0.00490193849452998,0.00265316442971587,-0.0101021407767731,0.00029826378771312,0.0646813577652117
NMR metabolomics,X23501.Triglycerides in Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,0.0102113516026579,0.0055468020137119,-0.000660380344217417,0.0210830835495332,0.0656487605723418
NMR metabolomics,X23501.Triglycerides in Large VLDL,RELB,Transcription factor RelB,37598,0.00914046400424477,0.00499760038599421,-0.000654832752303878,0.0189357607607934,0.0674266598092481
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A16,Protein S100-A16,39934,0.0109690806244391,0.00600640881386252,-0.000803480650731391,0.0227416418996097,0.0678349567716308
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP152,Centrosomal protein of 152 kDa,37482,0.00734977158184761,0.0040272570130276,-0.000543652163686478,0.0152431953273817,0.0680228808223251
NMR metabolomics,X23501.Triglycerides in Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,-0.0130509064422901,0.00715160881547661,-0.0270680597206242,0.000966246836044063,0.0680399661655574
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,-0.00967688426806081,0.00534092476774455,-0.0201450968128401,0.000791328276718503,0.0700343180556268
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL25,Interleukin-25,37429,0.00609476211570728,0.00338607330992515,-0.000541941571746018,0.0127314658031606,0.0718917753173774
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,37541,-0.012352798118733,0.00688323124846343,-0.0258439313657213,0.00113833512825531,0.0727370140591577
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF5,Fibroblast growth factor 5,40044,-0.00556733832339927,0.00311895614980329,-0.0116804923770137,0.000545815730215187,0.0742806678236096
NMR metabolomics,X23501.Triglycerides in Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",37562,0.00995434058926561,0.00558111403025042,-0.000984642910025214,0.0208933240885564,0.0745157268162112
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,-0.00579155410261556,0.00325160238784717,-0.012164694782796,0.000581586577564886,0.074912978600826
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF75D,Zinc finger protein 75D,37714,0.0102719103326522,0.00576852543266092,-0.00103439951536322,0.0215782201806676,0.0749872737352076
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAU,Urokinase-type plasminogen activator,40332,-0.00502384995017547,0.00283383975395801,-0.0105781758679332,0.00053047596758223,0.0762799177240716
NMR metabolomics,X23501.Triglycerides in Large VLDL,RALB,Ras-related protein Ral-B,37598,0.00507787887181671,0.00286939384749962,-0.000546133069282547,0.010701890812916,0.0768053854743361
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,37482,-0.00437596766079376,0.00247687278142546,-0.00923063831238766,0.000478702990800132,0.0772967146078684
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTX1,Neuronal pentraxin-1,40332,0.00672532069942683,0.00380671184508124,-0.000735834516932397,0.014186475915786,0.0772975632479307
NMR metabolomics,X23501.Triglycerides in Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00564584315514874,0.00320503165211396,-0.000636018882994626,0.0119277051932921,0.0781669705812781
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN15,Tetraspanin-15,37562,-0.00871007573241992,0.0049523365815145,-0.0184166554321883,0.000996503967348492,0.0786380318017521
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHGB,Secretogranin-1,40406,-0.00682738729178065,0.00388986306557091,-0.0144515189002996,0.000796744316738324,0.079248707089775
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.00590609952867984,0.00336526452988803,-0.000689818949900702,0.0125020180072604,0.0792755842832803
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,36973,0.00853464803032638,0.00486983951907819,-0.00101023742706688,0.0180795334877196,0.0797033739670309
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM25,Transmembrane protein 25,37959,-0.00743179946315548,0.00424197896669772,-0.015746078237883,0.000882479311572056,0.0798024864254569
NMR metabolomics,X23501.Triglycerides in Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00882513772044454,0.00504855385951694,-0.00107002784420866,0.0187203032850977,0.0804783268926591
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.0116481333826603,0.00668817298252513,-0.00146068566308897,0.0247569524284095,0.0816009303075513
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNG,Uracil-DNA glycosylase,37900,0.00571321373617616,0.00328140118470246,-0.000718332585840658,0.012144760058193,0.0816907288017666
NMR metabolomics,X23501.Triglycerides in Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,-0.00495766881575863,0.0028498925348809,-0.0105434581841252,0.000628120552607928,0.0819529450800913
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,37714,0.00915797441110473,0.00526656793282061,-0.00116449873722367,0.0194804475594331,0.0820775822443001
NMR metabolomics,X23501.Triglycerides in Large VLDL,APOH,Beta-2-glycoprotein 1,40332,0.00594321564875522,0.00342348944728748,-0.000766823667928249,0.0126532549654387,0.0825812693446156
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSLP,Thymic stromal lymphopoietin,40042,0.0101968271691494,0.00588639490048961,-0.00134050683581023,0.0217341611741091,0.083245222230304
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIF1L,Allograft inflammatory factor 1-like,37628,0.00971137276773763,0.00561662201140677,-0.00129720637461965,0.0207199519100949,0.0838250842586996
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUSP29,Dual specificity phosphatase 29,37572,-0.0111641584391127,0.00645953259641062,-0.0238248423280775,0.00149652544985215,0.0839538686769003
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUSD4,Sushi domain-containing protein 4,37900,-0.00746036293279789,0.00431906316189864,-0.0159257267301192,0.00100500086452345,0.0841348843021477
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX2,Transcription factor SOX-2,37937,0.00389964406661746,0.00225889801241332,-0.000527796037712652,0.00832708417094756,0.0843077287458508
NMR metabolomics,X23501.Triglycerides in Large VLDL,NINJ1,Ninjurin-1,39980,0.00938567934715115,0.00544093905614312,-0.00127856120288936,0.0200499198971917,0.0845454005581321
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLSTN1,Calsyntenin-1,39961,0.0087490927765069,0.00507899482543698,-0.00120573708134958,0.0187039226343634,0.0849802401654913
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP8,Neutrophil collagenase,40442,0.0121062616763145,0.00706354375623982,-0.00173828408591552,0.0259508074385446,0.0865650687371821
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRDX2,Peroxiredoxin-2,37763,0.0103823756329799,0.00606551181923663,-0.0015060275327239,0.0222707787986837,0.0869740761338667
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.00695479790222725,0.00409574644772568,-0.0149824609397696,0.00107286513531508,0.0895213174121096
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTN2,Contactin-2,40489,0.007331227897758,0.00432820669357632,-0.00115205722165158,0.0158145130171676,0.090317820539461
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCLRE1C,Protein artemis,37482,-0.00520974787448235,0.00307969237156974,-0.0112459449227591,0.000826449173794349,0.0907374893371394
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,37482,-0.00533216004543087,0.00315594706198492,-0.0115178162869213,0.000853496196059575,0.0911362006114436
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0157896586999973,0.00937463828825072,-0.0341639497449687,0.00258463234497414,0.0921484279912522
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAMA1,Laminin subunit alpha-1,37562,-0.00915780749799178,0.0054453729652164,-0.0198307385098159,0.00151512351383236,0.0926393097624273
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.00827574538550202,0.00492960945081314,-0.0179377799090958,0.00138628913809174,0.0932181230086129
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RG,Cytokine receptor common subunit gamma,37900,0.00627080216778244,0.00373993695931295,-0.00105947427247094,0.0136010786080358,0.0936217942451471
NMR metabolomics,X23501.Triglycerides in Large VLDL,BSND,Barttin,37482,-0.00556908538812612,0.00332585861528921,-0.012087768274093,0.000949597497840723,0.094060202718659
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.00396319135539908,0.00236833612193433,-0.000678747443592215,0.00860513015439038,0.0942668203142491
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.00480831751223187,0.00287935615538671,-0.00083522055232609,0.0104518555767898,0.0949531687992172
NMR metabolomics,X23501.Triglycerides in Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0134819838761262,0.00810314948556256,-0.0024001891155764,0.0293641568678288,0.0961771799085344
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00606931146266917,0.00365386672821463,-0.0010922673246315,0.0132308902499698,0.0967239576660386
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPM1B,Protein phosphatase 1B,37598,0.0101695146091823,0.00614762222748357,-0.00187982495668551,0.0222188541750501,0.0981068608225498
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIF20B,Kinesin-like protein KIF20B,37541,0.0125244491552183,0.00757814800719709,-0.00232872093888803,0.0273776192493245,0.0984147375032246
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D1,DCN1-like protein 1,37541,-0.0119740415896108,0.00725336532974725,-0.0261906376359154,0.00224255445669382,0.0987981705094948
NMR metabolomics,X23501.Triglycerides in Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,0.0110547951753091,0.00669667109570296,-0.0020706801722687,0.0241802705228869,0.0988017867681189
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA11,Serpin A11,40536,-0.00638694103306034,0.00387434309780264,-0.0139806535047535,0.00120677143863284,0.0992650671912028
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,40042,0.0101102846248454,0.00613674875525593,-0.00191774293545622,0.022138312185147,0.0994757685263882
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNLZ,DNL-type zinc finger protein,37541,-0.0151947272241718,0.00922809330934305,-0.0332817901104842,0.00289233566214055,0.099669896751398
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00622651206987504,0.00378793824654221,-0.0011978468933477,0.0136508710330978,0.100246999613191
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA3,Carbonic anhydrase 3,40500,0.00963699293551092,0.00588815733207652,-0.00190379543535905,0.0211777813063809,0.101718250975883
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHPK,Sedoheptulokinase,37714,-0.00678883731748365,0.00415593816673948,-0.014934476124293,0.00135680148932573,0.102381938693789
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRING1,SREBP regulating gene protein,37482,0.00910002851969125,0.00558578712818334,-0.0018481142515481,0.0200481712909306,0.103307586054699
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHRDL1,Chordin-like protein 1,40396,0.00479138506832496,0.00294366310268348,-0.000978194612934654,0.0105609647495846,0.10360937937554
NMR metabolomics,X23501.Triglycerides in Large VLDL,GKN1,Gastrokine-1,39602,0.00437734604539929,0.00269975894072637,-0.000914181478424401,0.00966887356922298,0.104956112282161
NMR metabolomics,X23501.Triglycerides in Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.0141731448869344,0.00878643931613394,-0.0030482761726881,0.0313945659465569,0.106753437617231
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00433085048376464,0.00268744488790296,-0.00959824246405444,0.000936541496525159,0.107091406776972
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,37901,0.00807276757237906,0.00501035415704415,-0.00174752657542747,0.0178930617201856,0.107155909653874
NMR metabolomics,X23501.Triglycerides in Large VLDL,REST,RE1-silencing transcription factor,37482,-0.00559392970103282,0.0034770203489269,-0.0124088895849295,0.0012210301828639,0.107678056477137
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAP1,Antigen peptide transporter 1,37714,-0.00960549467328476,0.0059789705257771,-0.0213242769038079,0.00211328755723836,0.108177675414909
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADA2,Adenosine deaminase 2,40258,-0.00649092120286937,0.00404144949949351,-0.0144121622218766,0.00143031981613791,0.108274679580252
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZPR1,Zinc finger protein ZPR1,37541,0.0151018988461364,0.00942896975127936,-0.00337888186637115,0.033582679558644,0.109257406898051
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,40357,0.00614670319591843,0.00384224540405108,-0.00138409779602169,0.0136775041878586,0.109669809589487
NMR metabolomics,X23501.Triglycerides in Large VLDL,STX1B,Syntaxin-1B,37572,0.00665264920035414,0.00416288425170794,-0.00150660393299343,0.0148119023337017,0.110047804682449
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,37562,-0.00603087836397729,0.00377726331348715,-0.0134343144584121,0.00137255773045752,0.110373110304122
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,0.0070700318202594,0.00443087710182004,-0.00161448729930789,0.0157545509398267,0.110595963277958
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC1,Plexin domain-containing protein 1,39980,0.00523035695590076,0.00327908768470341,-0.00119665490611792,0.0116573688179194,0.11071812335535
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.0070867570042782,0.00445137985464919,-0.0158114615193906,0.00163794751083421,0.111396345801855
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00292294741373541,0.00183772763689305,-0.000678998754574963,0.00652489358204579,0.111740356176889
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.00543362335277926,0.00342662892643495,-0.00128256934303325,0.0121498160485918,0.112830295858595
NMR metabolomics,X23501.Triglycerides in Large VLDL,THBS2,Thrombospondin-2,40332,-0.00543382343853317,0.00345449206906036,-0.0122046278938915,0.00133698101682514,0.115744946231911
NMR metabolomics,X23501.Triglycerides in Large VLDL,SULT1A1,Sulfotransferase 1A1,40471,-0.0194597929364974,0.0124067729034154,-0.0437770678271916,0.00485748195419685,0.116788571397649
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA3G,Semaphorin-3G,37671,0.00656251598694142,0.00418402849194628,-0.00163817985727329,0.0147632118311561,0.11679582143965
NMR metabolomics,X23501.Triglycerides in Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,0.00496589904494964,0.00317290270673487,-0.0012529902602507,0.01118478835015,0.117584290049671
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.0035811219468772,0.00228832046228821,-0.00806623005296209,0.000903986159207685,0.117616539527245
NMR metabolomics,X23501.Triglycerides in Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00844978469446915,0.00540582996045121,-0.00214564202801521,0.0190452114169535,0.118052442248139
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.00918630708107191,0.00587870050622351,-0.02070856007327,0.00233594591112616,0.118156386920607
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.006089986090578,0.00391010206086926,-0.0137537861298818,0.00157381394872575,0.119375829543299
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00442976442877784,0.00285146209859842,-0.0100186301420308,0.00115910128447507,0.120325646484927
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL33,Interleukin-33,40044,0.00578633730452012,0.00374132222403594,-0.00154665425459032,0.0131193288636306,0.121979486260993
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF1,Trefoil factor 1,40261,0.0115905585203229,0.00750185750440163,-0.00311308218830426,0.0262941992289501,0.122360196226373
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.0070665125388912,0.00457840279018666,-0.00190715692987465,0.016040182007657,0.122746239766797
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00403681209422738,0.00262270984427489,-0.00917732338900616,0.0011036992005514,0.123781156541736
NMR metabolomics,X23501.Triglycerides in Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,-0.0141809668038609,0.00925361101590874,-0.032318044395042,0.0039561107873202,0.125428493510184
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD86,T-lymphocyte activation antigen CD86,37901,0.00433282782202264,0.00282875580727306,-0.00121153356023257,0.00987718920427784,0.125618034724656
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00813515178988667,0.00532048589768074,-0.00229300056956757,0.0185633041493409,0.126282605164348
NMR metabolomics,X23501.Triglycerides in Large VLDL,CXCL12,Stromal cell-derived factor 1,40044,-0.00599004115836196,0.00392717446291201,-0.0136873031056695,0.00170722078894559,0.127209525093003
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAPPA,Pappalysin-1,40044,0.00693576056529989,0.00454804091077839,-0.00197839961982576,0.0158499207504255,0.127279479780824
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,-0.00778342477880169,0.00512047397837564,-0.017819553776418,0.00225270421881458,0.128520154428352
NMR metabolomics,X23501.Triglycerides in Large VLDL,WIF1,Wnt inhibitory factor 1,40489,-0.00501215335192193,0.00330410434603353,-0.0114881978701476,0.00146389116630379,0.12929961016499
NMR metabolomics,X23501.Triglycerides in Large VLDL,NTF3,Neurotrophin-3,40341,0.00511474853950114,0.00337216045371441,-0.00149468594977911,0.0117241830287814,0.129347898812698
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00336645098389246,0.00222244664650637,-0.000989544443260019,0.00772244641104495,0.129855465462148
NMR metabolomics,X23501.Triglycerides in Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,-0.0103475341445184,0.00684621670357129,-0.0237661188835182,0.00307105059448131,0.130704638668645
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLL1,Delta-like protein 1,40411,-0.00424739931186984,0.00282551896532487,-0.00978541648390658,0.00129061786016689,0.13280003859259
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.00478457411073633,0.00319128088283376,-0.00147033641961785,0.0110394846410905,0.133828347773789
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSF2RB,Cytokine receptor common subunit beta,37598,-0.00642250800578661,0.00429214692926714,-0.0148351159871502,0.00199009997557699,0.134589272707614
NMR metabolomics,X23501.Triglycerides in Large VLDL,REN,Renin,40359,-0.0102428948363838,0.00687632826811906,-0.0237204982418972,0.00323470856912953,0.136352472414888
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMEM132A,Transmembrane protein 132A,37628,0.00906102722027147,0.00608992753964484,-0.00287523075743241,0.0209972851979753,0.136808819873249
NMR metabolomics,X23501.Triglycerides in Large VLDL,FAM171A2,Protein FAM171A2,37959,0.0231234623241789,0.0155767054898606,-0.00740688043594783,0.0536538050843057,0.137702330116008
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSTN,Osteocrin,37572,-0.00617722354709924,0.00417082347188732,-0.0143520375519984,0.00199759045779989,0.138615638609885
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACAN,Aggrecan core protein,40224,0.00405006345314819,0.00273560972465199,-0.0013117316071697,0.00941185851346608,0.138760492932192
NMR metabolomics,X23501.Triglycerides in Large VLDL,RGS8,Regulator of G-protein signaling 8,40044,0.00951884357775036,0.00643070296621713,-0.00308533423603521,0.0221230213915359,0.138835229219403
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDSN,Corneodesmosin,40456,-0.00615378016918103,0.00416620523061307,-0.0143195424211826,0.00201198208282059,0.139676331673298
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,0.0126981069521381,0.00860289007549092,-0.00416355759582414,0.0295597715001003,0.139960382745994
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF2,Trefoil factor 2,40396,0.00811539282567893,0.00549942099546575,-0.00266347232543394,0.0188942579767918,0.140049210588638
NMR metabolomics,X23501.Triglycerides in Large VLDL,METAP1,Methionine aminopeptidase 1,39961,0.00435821935256999,0.00296847126883912,-0.00145998433435469,0.0101764230394947,0.142078432813289
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.0089551624302731,0.00610538708828971,-0.00301139626277473,0.0209217211233209,0.142464232570843
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.00316993132096389,0.00216849444134939,-0.00108031778408092,0.0074201804260087,0.143816621923134
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFRC,Transferrin receptor protein 1,40391,-0.00553388637507842,0.00381291633524962,-0.0130072023921677,0.00193942964201084,0.146701357497625
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFAP,Glial fibrillary acidic protein,39959,0.00655648036388606,0.00452425916758887,-0.00231106760458812,0.0154240283323602,0.147306650201801
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACTN4,Alpha-actinin-4,40044,0.004547521587764,0.00314256901554764,-0.00161191368270938,0.0107069568582374,0.147897044854855
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,0.00377210922385712,0.00261731244885009,-0.00135782317588906,0.0089020416236033,0.149544116030827
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,0.00380521063205231,0.00264159338024312,-0.0013723123932242,0.00898273365732882,0.149749764412943
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0118189061662582,0.00825572665666011,-0.028000130413312,0.00436231808079564,0.152281295503653
NMR metabolomics,X23501.Triglycerides in Large VLDL,HIP1,Huntingtin-interacting protein 1,37562,0.00469881419354172,0.00330192590052468,-0.00177296057148666,0.0111705889585701,0.154744706591943
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17RA,Interleukin-17 receptor A,40332,0.00596287170831505,0.00423380913557046,-0.00233539419740304,0.0142611376140331,0.159033989676273
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00616672506803719,0.00438092251985151,-0.00241988307087177,0.0147533332069462,0.15926329263468
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37562,-0.0071243100479128,0.00506390676955294,-0.0170495673162366,0.00280094722041095,0.15948662784707
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.0155023211939448,0.0110281214350037,-0.00611279681866239,0.037117439206552,0.159833780134778
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCUN1D2,DCN1-like protein 2,37482,0.0110119551169422,0.00784496217164578,-0.00436417073948356,0.0263880809733679,0.160432728277269
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,-0.00852104520660129,0.00607425437379145,-0.0204265837792325,0.00338449336602996,0.160696181826132
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP13,Collagenase 3,39961,-0.0044611360044364,0.00318525211602423,-0.0107042301518439,0.0017819581429711,0.161365761279312
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISM2,Isthmin-2,37998,-0.00603778736582083,0.00431631746092438,-0.0144977695892326,0.00242219485759095,0.161887348307114
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L2,Mortality factor 4-like protein 2,37482,-0.00493679927710635,0.00353106558976511,-0.011857687833046,0.00198408927883326,0.162105435962667
NMR metabolomics,X23501.Triglycerides in Large VLDL,THY1,Thy-1 membrane glycoprotein,40471,-0.00376605776633262,0.00270269155078212,-0.00906333320586558,0.00153121767320034,0.163503956945034
NMR metabolomics,X23501.Triglycerides in Large VLDL,LPO,Lactoperoxidase,39831,-0.00794183374692494,0.00571749548149775,-0.0191481248906605,0.00326445739681065,0.16484049650048
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF12,Fibroblast growth factor 12,37598,0.00648473220729168,0.00467328238195155,-0.00267490126133335,0.0156443656759167,0.165276822261516
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,0.0109702645866873,0.00796255201400642,-0.00463633736076529,0.0265768665341399,0.168309635976928
NMR metabolomics,X23501.Triglycerides in Large VLDL,SUMF1,Formylglycine-generating enzyme,37598,0.00892417303756021,0.00650389366971962,-0.00382345855509026,0.0216718046302107,0.170047082173519
NMR metabolomics,X23501.Triglycerides in Large VLDL,UBQLN3,Ubiquilin-3,37562,-0.00599696454363758,0.00437773759198554,-0.0145773302239292,0.00258340113665407,0.170748582213011
NMR metabolomics,X23501.Triglycerides in Large VLDL,KEL,Kell blood group glycoprotein,39961,0.00471012489826658,0.00344081830297442,-0.00203387897556328,0.0114541287720964,0.171051385709277
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAL,Galanin peptides,40422,0.00821989547301662,0.0060233627512867,-0.00358589551950531,0.0200256864655385,0.172376383950371
NMR metabolomics,X23501.Triglycerides in Large VLDL,TG,Thyroglobulin,37900,-0.0154786172418627,0.0113708116892195,-0.037765408152733,0.00680817366900752,0.173454732216651
NMR metabolomics,X23501.Triglycerides in Large VLDL,RTKN2,Rhotekin-2,37562,-0.00690538770747932,0.00511076726215848,-0.0169224915413099,0.0031117161263513,0.176672300361876
NMR metabolomics,X23501.Triglycerides in Large VLDL,NECTIN4,Nectin-4,40411,-0.00395961772819546,0.0029497912507132,-0.00974120857959333,0.00182197312320242,0.179505429700873
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPR158,Probable G-protein coupled receptor 158,37959,0.004793311322134,0.00357204697477901,-0.00220790074843285,0.0117945233927009,0.179652659516818
NMR metabolomics,X23501.Triglycerides in Large VLDL,DENND2B,DENN domain-containing protein 2B,37562,-0.00682199477265909,0.00509136408379879,-0.0168010683769047,0.00315707883158653,0.180296225564152
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASA1,Ras GTPase-activating protein 1,39961,0.00421679276642547,0.00314806571437496,-0.00195341603374944,0.0103870015666004,0.180431846257222
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRTN,Neurturin,40044,0.00640274315864099,0.00478839042436217,-0.00298250207310887,0.0157879883903909,0.181196804630601
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17C,Interleukin-17C,40044,-0.00906133962503164,0.00678653057317833,-0.0223629395484612,0.00424026029839788,0.181832125049584
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,-0.00409397506896018,0.00306948647580317,-0.0101101685615344,0.00192221842361403,0.182303938796981
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANPEP,Aminopeptidase N,40370,-0.00361189197630997,0.00272733895875153,-0.00895747633546298,0.00173369238284303,0.185413072976018
NMR metabolomics,X23501.Triglycerides in Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,-0.00633873993380757,0.004802697624885,-0.0157520272785822,0.00307454741096704,0.186915280940002
NMR metabolomics,X23501.Triglycerides in Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,0.00826017662730182,0.00629228502517876,-0.00407270202204854,0.0205930552766522,0.18929070524276
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAGE2A,G antigen 2A,37482,0.0079218369590862,0.00604039302864484,-0.00391733337705769,0.0197610072952301,0.189719743357466
NMR metabolomics,X23501.Triglycerides in Large VLDL,RLN1,Prorelaxin H1,37959,-0.0103864626374906,0.00799207332238182,-0.026050926349359,0.00527800107437775,0.193761817566834
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDCL2,Phosducin-like protein 2,37482,0.00678250347820727,0.00523053095477683,-0.00346933719315532,0.0170343441495699,0.194752522771058
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHH,Sonic hedgehog protein,37598,-0.00545100341644806,0.0042124064610084,-0.0137073200800245,0.0028053132471284,0.195675898544305
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,37541,0.0149019988355465,0.0115896519011197,-0.00781371889064807,0.0376177165617411,0.198534881258654
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,40044,0.00395601751286185,0.00308109367181697,-0.00208292608389941,0.0099949611096231,0.199173158698077
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTF,Ciliary neurotrophic factor,37541,-0.00421220929776275,0.0032854623559241,-0.010651715515374,0.00222729691984849,0.199839029345549
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFHD1,EF-hand domain-containing protein D1,37959,0.00430625827847417,0.00335958018860139,-0.00227851889118456,0.0108910354481329,0.199940205850434
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOX9,Transcription factor SOX-9,37572,0.00336725835208284,0.00262997036247721,-0.00178748355837249,0.00852200026253816,0.200447940385563
NMR metabolomics,X23501.Triglycerides in Large VLDL,STEAP4,Metalloreductase STEAP4,37541,-0.00929012138881176,0.00730751453404547,-0.0236128498755409,0.00503260709791736,0.203640729489258
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPLA2,Acyl-protein thioesterase 2,37541,0.0132262354175456,0.0104930404534861,-0.00734012387128718,0.0337925947063784,0.207519834640031
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.00473877096927411,0.00376363392971762,-0.0121154934715206,0.00263795153297243,0.208014717030846
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,0.00976633436769218,0.00783147868511297,-0.00558336385512924,0.0251160325905136,0.21239383591554
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP2,Contactin-associated protein-like 2,40341,-0.00480587351021176,0.00387372245579864,-0.0123983695235771,0.00278662250315357,0.214759139565675
NMR metabolomics,X23501.Triglycerides in Large VLDL,LAYN,Layilin,40192,-0.00409091826195932,0.00331475609309264,-0.0105878402044209,0.00240600368050225,0.217164088935732
NMR metabolomics,X23501.Triglycerides in Large VLDL,GJA8,Gap junction alpha-8 protein,37482,0.0074478984795403,0.00604077779629641,-0.00439202600120067,0.0192878229602813,0.217621511415829
NMR metabolomics,X23501.Triglycerides in Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00272519052444323,0.00223254140687654,-0.00165059063303478,0.00710097168192125,0.222230167330443
NMR metabolomics,X23501.Triglycerides in Large VLDL,DKKL1,Dickkopf-like protein 1,40305,-0.0103393357762993,0.00847995830475485,-0.0269600540536188,0.00628138250102024,0.222760900341163
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,-0.00576797222026008,0.00477300461480346,-0.0151230612652749,0.00358711682475471,0.226893211208144
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,-0.00441912681956349,0.00367057161088061,-0.0116134471768895,0.00277519353776251,0.228636735631843
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD5L,CD5 antigen-like,37934,0.00542565132116809,0.00450737417071323,-0.00340880205342984,0.014260104695766,0.228715961417114
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBX2,Chromobox protein homolog 2,37562,-0.00479404805317904,0.00398956395635495,-0.0126135934076347,0.00302549730127666,0.229521981982079
NMR metabolomics,X23501.Triglycerides in Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,-0.00696707581434915,0.00580364239696702,-0.0183422149124045,0.00440806328370622,0.229976350673238
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA6C,Semaphorin-6C,37598,0.00309325476977055,0.00257974494310554,-0.00196304531871631,0.00814955485825742,0.230528368985151
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,-0.00919349718876831,0.00768993462896512,-0.0242657690615399,0.00587877468400332,0.23190418699225
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLXDC2,Plexin domain-containing protein 2,37942,-0.00307690222572092,0.00258750889306179,-0.00814841965612203,0.00199461520468019,0.234406742385536
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.00416347003453418,0.00350210262085307,-0.0110275911714062,0.00270065110233784,0.234516990068361
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40536,-0.00336311198066076,0.00284529491137419,-0.00893989000695417,0.00221366604563265,0.23722688540333
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRCAM,Neuronal cell adhesion molecule,40359,0.00317085554495191,0.00269775885497399,-0.00211675181079711,0.00845846290070092,0.239865688184929
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPNMB,Transmembrane glycoprotein NMB,39957,0.0031942107489086,0.0027246209095632,-0.00214604623383528,0.00853446773165247,0.241074367112895
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP112,Centrosomal protein of 112 kDa,37562,0.00535582383698721,0.00457854422041996,-0.00361812283503591,0.0143297705090103,0.242116549146934
NMR metabolomics,X23501.Triglycerides in Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00411172845561244,0.00351777364078416,-0.00278310788032451,0.0110065647915494,0.242487701567097
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVPL,Envoplakin,37714,-0.00390593848981758,0.00334622399923347,-0.0104645375283152,0.00265266054868002,0.243123349560219
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.0136554617800955,0.0117045285751082,-0.00928541422711665,0.0365963377873076,0.243356766939115
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.00339611336506517,0.00291633390124637,-0.00911212781150806,0.00231990108137773,0.244236191905797
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00196138396568432,0.00168502636626145,-0.00134126771218813,0.00526403564355677,0.244438277221891
NMR metabolomics,X23501.Triglycerides in Large VLDL,CNTNAP4,Contactin-associated protein-like 4,37572,0.0114329238720809,0.00984012258981243,-0.00785371640395142,0.0307195641481133,0.245310209712685
NMR metabolomics,X23501.Triglycerides in Large VLDL,C9orf40,Uncharacterized protein C9orf40,37901,0.00925106094715076,0.00797488365138682,-0.0063797110095674,0.0248818329038689,0.246059396768574
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00715231597502144,0.00617275808178777,-0.00494628986528259,0.0192509218153255,0.246599725670941
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17A,Interleukin-17A,40028,0.00477833463569119,0.00412694947800425,-0.00331048634119713,0.0128671556125795,0.246948331004315
NMR metabolomics,X23501.Triglycerides in Large VLDL,POF1B,Protein POF1B,37598,0.00520218553017463,0.00449538236238015,-0.00360876390009045,0.0140131349604397,0.247199957296892
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00925707839886198,0.00800308129878764,-0.0249431177444858,0.0064289609467618,0.247420298741264
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCARB1,Scavenger receptor class B member 1,39961,0.00662658224602666,0.00572923971721092,-0.00460272759970674,0.0178558920917601,0.2474433932968
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUCL3,Mucin-like protein 3,37482,-0.00503765493706979,0.0043715456709224,-0.0136058844520777,0.00353057457793812,0.249188621206828
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRG3,Proteoglycan 3,37998,-0.0055812560323134,0.0048482804450516,-0.0150838857046145,0.00392137363998775,0.249677445660829
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD10,Frizzled-10,37572,0.00677968135221123,0.00590382010538085,-0.00479180605433524,0.0183511687587577,0.250842978067363
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOLR3,Folate receptor gamma,40355,-0.0204177482048053,0.0177902924717099,-0.0552867214493566,0.014451225039746,0.251113652754034
NMR metabolomics,X23501.Triglycerides in Large VLDL,KDM3A,Lysine-specific demethylase 3A,37598,-0.0102649491920704,0.00897916671308394,-0.027864115949715,0.00733421756557409,0.252977960980886
NMR metabolomics,X23501.Triglycerides in Large VLDL,PYDC1,Pyrin domain-containing protein 1,37628,-0.00470156327107147,0.00413708909552212,-0.0128102578982948,0.00340713135615189,0.255792146890266
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF9,Fibroblast growth factor 9,37457,0.00445859577248883,0.00393758320890153,-0.00325906731695818,0.0121762588619358,0.257521702739823
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.003902883895864,0.00345800658519823,-0.00287480901112454,0.0106805768028525,0.25906491605867
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC44A4,Choline transporter-like protein 4,37572,-0.00763149450906759,0.00679086344940721,-0.0209415868699057,0.00567859785177053,0.261123306425561
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPE4,NXPE family member 4,37562,-0.00395732067612498,0.00352828614208734,-0.0108727615146162,0.00295812016236621,0.262053704572115
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX33,Testis-expressed protein 33,37714,-0.00429263722435245,0.0038290053733056,-0.0117974877560314,0.00321221330732653,0.262272345180116
NMR metabolomics,X23501.Triglycerides in Large VLDL,VASN,Vasorin,40116,-0.00295089281578087,0.00264778676991089,-0.00814055488480622,0.00223876925324447,0.265092456881567
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00535141968658533,0.00480567310266773,-0.00406769959464342,0.0147705389678141,0.265487129174112
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.00680753647034593,0.00612430209134174,-0.0188111685693757,0.00519609562868387,0.266346610189402
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALM3,Paralemmin-3,37562,0.00780700391395441,0.00703278634115166,-0.00597725731470285,0.0215912651426117,0.266981946656143
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB118,Beta-defensin 118,37541,0.00625855324467015,0.00565258680560334,-0.0048205168943124,0.0173376233836527,0.268227115932834
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0052705896659319,0.00477341086369784,-0.0146264749587797,0.00408529562691585,0.269542220880624
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.00783021613886971,0.00709359441830517,-0.00607322892100843,0.0217336611987478,0.269680770352088
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL36G,Interleukin-36 gamma,37551,0.00737390858833868,0.00668493794871424,-0.00572856979114123,0.0204763869678186,0.270020014658258
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR4,Toll-like receptor 4,37598,0.00303828932691569,0.00275483955403258,-0.00236119619898817,0.00843777485281955,0.27009444388339
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,40264,0.00283095516982375,0.00257623759380506,-0.00221847051403416,0.00788038085368166,0.271840664302396
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL24,Interleukin-24,40044,0.00520586997250455,0.00477195355915586,-0.00414715900344094,0.01455889894845,0.275320296413609
NMR metabolomics,X23501.Triglycerides in Large VLDL,CA8,Carbonic anhydrase-related protein,37598,-0.00292597204626453,0.00269659460857644,-0.00821129747907435,0.00235935338654528,0.277914141956215
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37901,0.00455569261954199,0.00420910342646581,-0.003694150096331,0.012805535335415,0.279119657651172
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.00496347837244933,0.00458616811721403,-0.0139523678821888,0.00402541113729017,0.279148355416094
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLHL41,Kelch-like protein 41,37959,0.00494021487042737,0.00459896450289508,-0.00407375555524699,0.0139541852961017,0.282751539973607
NMR metabolomics,X23501.Triglycerides in Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,37959,0.00351615644775418,0.00327624039544076,-0.00290527472730972,0.00993758762281808,0.283187521941557
NMR metabolomics,X23501.Triglycerides in Large VLDL,GH2,Growth hormone variant,39980,0.017478792025265,0.0163085148920257,-0.0144858971631054,0.0494434812136354,0.283845103682785
NMR metabolomics,X23501.Triglycerides in Large VLDL,MSMB,Beta-microseminoprotein,40236,0.00715683438492065,0.00668316614039025,-0.00594217125024424,0.0202558400200855,0.284242090229005
NMR metabolomics,X23501.Triglycerides in Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,40225,0.00598497909000168,0.00562617945496705,-0.00504233264173373,0.0170122908217371,0.287447726363535
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,37482,-0.00484278118238208,0.00455661834473699,-0.0137737531380666,0.00408819077330241,0.287891638730889
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEMA7A,Semaphorin-7A,40490,0.00275283497386473,0.00259494479404617,-0.00233325682246577,0.00783892677019523,0.288776188916085
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL2,Interferon lambda-2,37541,0.00666189513724943,0.00628175527095703,-0.00565034519382636,0.0189741354683252,0.288929977991447
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,-0.00657615373221115,0.00622359302249923,-0.0187743960563096,0.00562208859188734,0.290691370056543
NMR metabolomics,X23501.Triglycerides in Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.00521414019563624,0.00494975436220474,-0.0149156587455575,0.00448737835428504,0.292170736788486
NMR metabolomics,X23501.Triglycerides in Large VLDL,NXPH3,Neurexophilin-3,37598,0.00308338555580987,0.00293570521423732,-0.00267059666409527,0.00883736777571501,0.293597262641746
NMR metabolomics,X23501.Triglycerides in Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00373785338329777,0.00357726787713775,-0.00327359165589222,0.0107492984224878,0.296089464921856
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37562,-0.00331198563305381,0.00318207364056384,-0.00954884996855894,0.00292487870245132,0.297975409323044
NMR metabolomics,X23501.Triglycerides in Large VLDL,PROK1,Prokineticin-1,40341,-0.00690182495292225,0.00664629773843933,-0.0199285685202633,0.00612491861441884,0.299078009754011
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCIN,Adseverin,37541,0.0073887147570819,0.00712284539933125,-0.00657206222560734,0.0213494917397711,0.299602982503403
NMR metabolomics,X23501.Triglycerides in Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00508315880784679,0.00490611018000615,-0.00453281714496527,0.0146991347606589,0.300180609898581
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK12,Kallikrein-12,39980,-0.0142862073785657,0.0138345342380579,-0.0414018944851592,0.0128294797280277,0.301784628703438
NMR metabolomics,X23501.Triglycerides in Large VLDL,TBR1,T-box brain protein 1,37572,0.0048822900224312,0.0047282844949724,-0.00438514758771471,0.0141497276325771,0.301823681597635
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFF3,Trefoil factor 3,40309,0.0052009599722661,0.00515225170068953,-0.00489745336108538,0.0152993733056176,0.312772458680845
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMNB1,Lamin-B1,37874,0.00556324965918621,0.00551240086644629,-0.00524105603904851,0.0163675553574209,0.312885202762446
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,-0.0043449262941293,0.00432704393838626,-0.0128259324133664,0.00413607982510777,0.315329882094385
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,-0.00242642807222148,0.00241806224965521,-0.00716583008154568,0.00231297393710273,0.315657025662241
NMR metabolomics,X23501.Triglycerides in Large VLDL,PNMA2,Paraneoplastic antigen Ma2,37541,0.00421921752491983,0.00421416666680504,-0.00404054914201804,0.0124789841918577,0.316749339391065
NMR metabolomics,X23501.Triglycerides in Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,-0.00351402194048833,0.00351062175092661,-0.0103948405723045,0.00336679669132782,0.31686049102217
NMR metabolomics,X23501.Triglycerides in Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,-0.00498697624774515,0.00498384532939744,-0.0147553130933641,0.00478136059787384,0.317025202164329
NMR metabolomics,X23501.Triglycerides in Large VLDL,DLGAP5,Disks large-associated protein 5,37959,-0.00520422940822209,0.00520558049448717,-0.0154071671774169,0.00499870836097275,0.317454038593443
NMR metabolomics,X23501.Triglycerides in Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,0.00363059368497752,0.00363446009865021,-0.00349294810837689,0.0107541354783319,0.317843526227552
NMR metabolomics,X23501.Triglycerides in Large VLDL,TAGLN3,Transgelin-3,37482,-0.00585071221785279,0.00591673880381675,-0.0174475202733336,0.00574609583762804,0.322759442816616
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAC1,Cartilage acidic protein 1,40536,0.0027878683304469,0.00282452573833204,-0.00274820211668389,0.00832393877757769,0.323646824793123
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00466428471352723,0.00472607343723117,-0.00459881922344586,0.0139273886505003,0.323697675717008
NMR metabolomics,X23501.Triglycerides in Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00541567951343175,0.00550023779068227,-0.0053647865563055,0.016196145583169,0.324825800998885
NMR metabolomics,X23501.Triglycerides in Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,0.0045228546304228,0.00460373146669469,-0.00450045904429878,0.0135461683051444,0.325905035129396
NMR metabolomics,X23501.Triglycerides in Large VLDL,LCN15,Lipocalin-15,37959,-0.00605170432741662,0.00617845232960957,-0.0181614708934514,0.00605806223861815,0.327357703963089
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESPL1,Separin,37482,-0.00544145080053997,0.00555972407067981,-0.0163385099790724,0.00545560837799246,0.327733170383626
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINA6,Corticosteroid-binding globulin,38013,-0.0016879437382941,0.00172784005692364,-0.00507451024986444,0.00169862277327624,0.328631277742867
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPT,Microtubule-associated protein tau,39961,0.00500126596251869,0.00513461690508102,-0.00506258317144011,0.0150651150964775,0.330057313083861
NMR metabolomics,X23501.Triglycerides in Large VLDL,YY1,Transcriptional repressor protein YY1,37598,0.00264297209975513,0.00272219182436905,-0.00269252387600821,0.00797846807551846,0.331616662390263
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,40332,0.00321678638458929,0.00332088354082213,-0.0032921453554221,0.00972571812460067,0.332732714686135
NMR metabolomics,X23501.Triglycerides in Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00618364969826765,0.00638456827986073,-0.0186974035267947,0.00633010413025939,0.332797159785027
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,-0.00541965167329292,0.0056004469849922,-0.0163965277638776,0.00555722441729179,0.333203256273474
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDAN1,Codanin-1,37942,0.00217495522681714,0.00224935878737029,-0.00223378799642862,0.00658369845006291,0.333600199692417
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAX,Integrin alpha-X,37714,0.00517946476548113,0.00535668817964123,-0.00531964406661569,0.0156785735975779,0.333603915307765
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCDH17,Protocadherin-17,40359,-0.00323808052798481,0.00336060439898275,-0.009824865149991,0.00334870409402139,0.335290685806335
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCARE,Photoreceptor cilium actin regulator,37541,0.00803434895957119,0.0083566881261715,-0.00834475976772496,0.0244134576868673,0.336355071708224
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,0.0074318118164455,0.00774166575421818,-0.00774185306182212,0.0226054766947131,0.337082279699254
NMR metabolomics,X23501.Triglycerides in Large VLDL,ABO,Histo-blood group ABO system transferase,37987,-0.0133314604952307,0.0139476055603746,-0.0406687673935648,0.0140058464031034,0.339178073917731
NMR metabolomics,X23501.Triglycerides in Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37562,0.0110766883995573,0.0115919195879558,-0.011643473992836,0.0337968507919505,0.339315959693028
NMR metabolomics,X23501.Triglycerides in Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37714,0.00415904811380076,0.00436005726037861,-0.00438666411654132,0.0127047603441428,0.340152869161312
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,-0.00313446127353235,0.00328653451053435,-0.00957606891417968,0.00330714636711497,0.340238756946294
NMR metabolomics,X23501.Triglycerides in Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,0.00426368202557433,0.00448375570191768,-0.00452447915018432,0.013051843201333,0.341661046048884
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRISP2,Cysteine-rich secretory protein 2,40489,-0.00559484389941131,0.00591515024304093,-0.0171885383757715,0.00599885057694891,0.344239432070557
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRR5,Proline-rich protein 5,37598,0.00441182602961673,0.00467673483019021,-0.00475457423755609,0.0135782262967895,0.345516158899238
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC8,Histone deacetylase 8,37598,0.00571094397572026,0.00606408678228667,-0.00617466611756162,0.0175965540690021,0.346330333709473
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD27,CD27 antigen,40411,0.00365600009611779,0.0039261598649717,-0.00403927323922673,0.0113512734314623,0.351769469015113
NMR metabolomics,X23501.Triglycerides in Large VLDL,SEPTIN3,Neuronal-specific septin-3,37959,-0.00657895430457779,0.00713905599990313,-0.0205715040643879,0.00741359545523234,0.356782933587452
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGFBR1,TGF-beta receptor type-1,37598,0.00192083444382045,0.00208756701766471,-0.00217079691080238,0.00601246579844328,0.357521361066347
NMR metabolomics,X23501.Triglycerides in Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00811565072089973,0.00883302787149185,-0.00919708390722429,0.0254283853490238,0.35822513569628
NMR metabolomics,X23501.Triglycerides in Large VLDL,MUC2,Mucin-2,37998,0.00806085802959208,0.00877675800807737,-0.00914158766623956,0.0252633037254237,0.358408940544593
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00599536649676632,0.00654196579194664,-0.00682688645544909,0.0188176194489817,0.359446617406329
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00406781151791138,0.00445307599976474,-0.0127958404774503,0.00466021744162752,0.361005125357412
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHIT1,Chitotriosidase-1,40398,0.0131302768260652,0.0144042443746255,-0.0151020421482008,0.0413625958003312,0.362016220742415
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00287565741391371,0.00315614076935541,-0.0033103784940229,0.00906169332185033,0.362243180473083
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPHS2,Podocin,37598,-0.00923561773733845,0.0101700832592668,-0.0291689809255014,0.0106977454508245,0.363833459605681
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTA4H,Leukotriene A-4 hydrolase,40489,-0.00507477627836177,0.00559257399461663,-0.0160362213078104,0.00588666875108682,0.364201889223715
NMR metabolomics,X23501.Triglycerides in Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37942,0.00625435738428657,0.0069003136097343,-0.00727025729079267,0.0197789720593658,0.364747022919804
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.00520505450144682,0.00575464355064155,-0.0164841558607043,0.00607404685781061,0.365746205653629
NMR metabolomics,X23501.Triglycerides in Large VLDL,ALMS1,Alstrom syndrome protein 1,37714,0.00395122891188563,0.00437029201579987,-0.00461454343908212,0.0125170012628534,0.365952989650251
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00553110945744036,0.0061186502113701,-0.00646144495684504,0.0175236638717258,0.366024849593701
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00612924880486742,0.00679405042846421,-0.0194455876446573,0.00718709003492243,0.366994048764874
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRND,Prion-like protein doppel,37942,-0.00464223485867821,0.00520046713958576,-0.0148351504522663,0.00555068073490987,0.372056656587135
NMR metabolomics,X23501.Triglycerides in Large VLDL,GDF15,Growth/differentiation factor 15,40536,0.00368511732600569,0.00414845823789183,-0.0044458608202623,0.0118160954722737,0.374387255639253
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37942,-0.00265484381242024,0.00300425658847956,-0.00854318672584017,0.0032334991009997,0.376877116127307
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCNE1,G1/S-specific cyclin-E1,37598,0.00801279402731631,0.00908025938221805,-0.00978451436183106,0.0258101024164637,0.37755445635459
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMIGO1,Amphoterin-induced protein 1,37572,0.00423471198958331,0.00484115768839949,-0.00525395707967969,0.0137233810588463,0.381736156188751
NMR metabolomics,X23501.Triglycerides in Large VLDL,NME3,Nucleoside diphosphate kinase 3,40379,-0.00201508343516228,0.00231170512060632,-0.00654602547155067,0.00251585860122611,0.383392262025031
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPEP,Glutamyl aminopeptidase,37562,-0.00388738721031914,0.00449940304555893,-0.0127062171796146,0.00493144275897635,0.387615542759792
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,-0.00379573694111026,0.00444854690111518,-0.012514888867296,0.0049234149850755,0.393534445199907
NMR metabolomics,X23501.Triglycerides in Large VLDL,NLGN1,Neuroligin-1,37572,-0.00576274179826238,0.00675570499643004,-0.0190039235912653,0.0074784399947405,0.393664579717494
NMR metabolomics,X23501.Triglycerides in Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.002257504642869,0.00264957836594834,-0.00745067824012776,0.00293566895438975,0.394213595635629
NMR metabolomics,X23501.Triglycerides in Large VLDL,CBLN1,Cerebellin-1,37541,-0.00808954311177567,0.00952124172030702,-0.0267511768835774,0.0105720906600261,0.395545753357179
NMR metabolomics,X23501.Triglycerides in Large VLDL,PITHD1,PITH domain-containing protein 1,37457,-0.00676052716380643,0.00796254675912191,-0.0223671188116854,0.00884606448407252,0.395874211323868
NMR metabolomics,X23501.Triglycerides in Large VLDL,H2AP,Huntingtin-interacting protein M,37482,-0.0042875235181974,0.00505423615441066,-0.0141938263808423,0.0056187793444475,0.396284849382356
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSG1,Tryptase gamma,37598,-0.00224027208429595,0.00264609396534654,-0.00742661625637516,0.00294607208778326,0.397214785927715
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,0.00769316426785792,0.00909251440220324,-0.0101281639604604,0.0255144924961763,0.397513107763722
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,-0.00496210754346379,0.00589845597005823,-0.0165230812447779,0.00659886615785034,0.400220251657706
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPON1,Spondin-1,40379,0.00266632254390353,0.00317429206295109,-0.0035552898994806,0.00888793498728766,0.40093561849118
NMR metabolomics,X23501.Triglycerides in Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,37541,-0.00659247739145745,0.00784876908655529,-0.0219760648011058,0.00879111001819092,0.400958635686206
NMR metabolomics,X23501.Triglycerides in Large VLDL,FRMD7,FERM domain-containing protein 7,37572,0.00270546320872738,0.00322554538593672,-0.0036166057477086,0.00902753216516336,0.401618453980403
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,-0.0023961604549077,0.00285927912627758,-0.00800034754241175,0.00320802663259635,0.40202888281614
NMR metabolomics,X23501.Triglycerides in Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,0.00458674699646037,0.00547547703164099,-0.00614518798555597,0.0153186819784767,0.402220745575068
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARG2,"Arginase-2, mitochondrial",37900,0.00359772446828471,0.00430546846177632,-0.00484099371679687,0.0120364426533663,0.403385008651518
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,37541,-0.00572838279468267,0.00688880849990726,-0.0192304474545009,0.00777368186513556,0.405678648680235
NMR metabolomics,X23501.Triglycerides in Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37942,0.00320110592727523,0.00386351002395894,-0.00437137371968428,0.0107735855742347,0.40737452651621
NMR metabolomics,X23501.Triglycerides in Large VLDL,DUOX2,Dual oxidase 2,40042,0.00579894189915198,0.0070065840640431,-0.00793396286637249,0.0195318466646764,0.407886052582088
NMR metabolomics,X23501.Triglycerides in Large VLDL,NENF,Neudesin,37900,0.00865723720891739,0.0104837036488946,-0.0118908219429161,0.0292052963607509,0.408943311716575
NMR metabolomics,X23501.Triglycerides in Large VLDL,BRD2,Bromodomain-containing protein 2,37541,-0.00276600766569138,0.00335088326516864,-0.0093337388654219,0.00380172353403915,0.40912763306759
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR2,Toll-like receptor 2,37714,0.00181638850356599,0.00222877667804487,-0.00255201378540194,0.00618479079253393,0.415103507361081
NMR metabolomics,X23501.Triglycerides in Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,-0.00272103835398117,0.00334845408926108,-0.00928400836893289,0.00384193166097054,0.416447794574128
NMR metabolomics,X23501.Triglycerides in Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00534639498018831,0.00659119732964692,-0.00757235178591964,0.0182651417462963,0.417298860008168
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORF4L1,Mortality factor 4-like protein 1,37714,-0.00319188522553267,0.0039635422846966,-0.010960428103538,0.00457665765247267,0.420654524214034
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,-0.00212449922462658,0.00264734205949704,-0.00731328966124079,0.00306429121198762,0.422274068338611
NMR metabolomics,X23501.Triglycerides in Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00466070863330326,0.00585294886570052,-0.00681107114346976,0.0161324884100763,0.425871586407521
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00276353670927943,0.00349433006105252,-0.00408535021038351,0.00961242362894237,0.429038178004302
NMR metabolomics,X23501.Triglycerides in Large VLDL,OMP,Olfactory marker protein,37541,0.00385584676088636,0.00491356435169132,-0.00577473936842863,0.0134864328902013,0.432623059456431
NMR metabolomics,X23501.Triglycerides in Large VLDL,ASPN,Asporin,37990,0.00206006149766211,0.00263790868192426,-0.00311023951890943,0.00723036251423365,0.434848520761747
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.00303464705559234,0.00389140265587508,-0.0106617962611075,0.00459250214992283,0.435500462389193
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPLX2,Complexin-2,37482,-0.00233566103133684,0.00300568863460506,-0.00822681075516276,0.00355548869248908,0.437125580329679
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0130163637685041,0.0167913909745748,-0.0459274900786707,0.0198947625416625,0.438246465189267
NMR metabolomics,X23501.Triglycerides in Large VLDL,HSP90B1,Endoplasmin,39878,-0.00524847843506037,0.0067819518295152,-0.0185411040209102,0.00804414715078942,0.439008249777732
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDIA2,Protein disulfide-isomerase A2,37482,-0.00311566036913803,0.00403352764064808,-0.0110213745448083,0.0047900538065322,0.439867546267294
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00564430999721365,0.00741576917757757,-0.0201792175852657,0.00889059759083839,0.446595362290387
NMR metabolomics,X23501.Triglycerides in Large VLDL,MMP15,Matrix metalloproteinase-15,37990,0.00363461756613134,0.00482674813509258,-0.00582580877865011,0.0130950439109128,0.451453518799645
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00212915863024759,0.00283171834086127,-0.0034210093178405,0.00767932657833568,0.452124407239799
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.00307689951418249,0.00409528333935957,-0.00494985583096227,0.0111036548593272,0.452468596435387
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK15,Kallikrein-15,37880,0.00372021678070016,0.00496079408851059,-0.00600293963278059,0.0134433731941809,0.453313831822311
NMR metabolomics,X23501.Triglycerides in Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,-0.00321156113184552,0.00432961395706623,-0.0116976044876953,0.00527448222400429,0.458242394446673
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,0.00183451068029362,0.00247797249948751,-0.0030223154187019,0.00669133677928913,0.459114263729108
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPBGL,Trophoblast glycoprotein-like,37572,0.00298629585108242,0.00404758543639146,-0.00494697160424484,0.0109195633064097,0.460651093116462
NMR metabolomics,X23501.Triglycerides in Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00522122618568901,0.00708434575726887,-0.00866409149855798,0.019106543869936,0.461130120414922
NMR metabolomics,X23501.Triglycerides in Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,-0.00261606190943642,0.0036074782361991,-0.00968671925238666,0.00445459543351382,0.46835429056451
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.00342842849419107,0.00473365638664901,-0.0127063950120231,0.00584953802364098,0.468915031204877
NMR metabolomics,X23501.Triglycerides in Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,0.00299506317547708,0.00415700689050305,-0.0051526703299089,0.0111427966808631,0.471238962107441
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELL,L-selectin,38013,-0.00159224259788713,0.00224043994055502,-0.00598350488137496,0.0027990196856007,0.477292913059941
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2B,Alpha-amylase 2B,39311,-0.00330521679903695,0.00466658834808326,-0.0124517299612801,0.00584129636320625,0.478787081105745
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTLA,B- and T-lymphocyte attenuator,37482,0.00607649075939747,0.00861717229137778,-0.010813166931703,0.0229661484504979,0.480722875152739
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASQ2,Calsequestrin-2,37562,-0.00342311086303433,0.00486498625002259,-0.0129584839130786,0.00611226218700994,0.481680765950238
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPRR1B,Cornifin-B,37714,0.00570243809778045,0.00826485728537838,-0.0104966821815612,0.0219015583771221,0.490230109196023
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRNN,Cornulin,39857,0.00440827677000185,0.00641430898296118,-0.00816376883660207,0.0169803223766058,0.491931331019993
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD82,CD82 antigen,37714,-0.00276638576366627,0.00406089818487223,-0.0107257462060158,0.0051929746786833,0.495740963979195
NMR metabolomics,X23501.Triglycerides in Large VLDL,FZD8,Frizzled-8,37541,-0.0029501103169627,0.00435498524434514,-0.0114858813958792,0.00558566076195377,0.498157862664727
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDNRB,Endothelin receptor type B,37598,0.00310888417817839,0.00459427257156555,-0.00589589006209008,0.0121136584184469,0.498616520068452
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,40042,-0.00218820191088494,0.00326009870684596,-0.00857799537630302,0.00420159155453315,0.50209845062878
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,-0.00261386233204633,0.00394220486302404,-0.0103405838635734,0.00511285919948078,0.507312827993855
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTN,Neuroplastin,39980,0.00533341271985832,0.00816363849957069,-0.0106673187393002,0.0213341441790169,0.513564063122238
NMR metabolomics,X23501.Triglycerides in Large VLDL,HRAS,GTPase Hras,37697,-0.00623547700654468,0.00954653612323221,-0.0249466878080798,0.0124757337949905,0.513660321188668
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.00366421120194359,0.00562619193314763,-0.0146915473909129,0.00736312498702577,0.514878901785937
NMR metabolomics,X23501.Triglycerides in Large VLDL,NELL2,Protein kinase C-binding protein NELL2,40422,0.00177104794437217,0.00272572756464356,-0.00357137808232921,0.00711347397107355,0.515861535335302
NMR metabolomics,X23501.Triglycerides in Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,-0.00161628773673962,0.0024890183320539,-0.00649476366756527,0.00326218819408603,0.516112209358438
NMR metabolomics,X23501.Triglycerides in Large VLDL,CAPN3,Calpain-3,37900,0.0023272957418672,0.00359578142075729,-0.00472043584281709,0.00937502732655148,0.51749448145939
NMR metabolomics,X23501.Triglycerides in Large VLDL,S100A3,Protein S100-A3,37900,0.00283919558808146,0.0044479779630525,-0.00587884121950144,0.0115572323956644,0.523281781853892
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIRREL1,Kin of IRRE-like protein 1,37541,-0.00380205018954069,0.00598892994236762,-0.0155403528765812,0.00793625249749984,0.525539740533378
NMR metabolomics,X23501.Triglycerides in Large VLDL,FBN2,Fibrillin-2,37572,0.00374408119047001,0.00590527251382349,-0.00783025293662402,0.015318415317564,0.526076578756039
NMR metabolomics,X23501.Triglycerides in Large VLDL,HDAC9,Histone deacetylase 9,37541,-0.00388268499478236,0.00615221335911036,-0.0159410231786387,0.00817565318907395,0.527983701505212
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3B,Sodium channel subunit beta-3,37541,0.00279972871653474,0.00445334860146502,-0.00592883454233671,0.0115282919754062,0.529569909568596
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00353166794744831,0.00561789770623695,-0.0074794115567761,0.0145427474516727,0.529591970865593
NMR metabolomics,X23501.Triglycerides in Large VLDL,PKLR,Pyruvate kinase PKLR,40374,0.00402660310183413,0.006419123780506,-0.00855487950795762,0.0166080857116259,0.530483160563403
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNNI3,"Troponin I, cardiac muscle",40042,0.00509852691126816,0.00818334171824294,-0.010940822856488,0.0211378766790243,0.533269141970289
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37572,-0.00234148550179904,0.00376018644375332,-0.00971145093155554,0.00502847992795746,0.533489463419457
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF6,Fibroblast growth factor 6,37598,-0.00259166259362433,0.0041704860092019,-0.0107658151716601,0.00558248998441139,0.534327912344728
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB7,Integrin beta-7,40489,0.00273046389277762,0.00439436090402494,-0.00588248347911126,0.0113434112646665,0.534374040787525
NMR metabolomics,X23501.Triglycerides in Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,0.00436652057602911,0.00704828466960043,-0.00944811737638774,0.0181811585284459,0.535587667718723
NMR metabolomics,X23501.Triglycerides in Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,37900,-0.0025155755133297,0.0041342650690621,-0.0106187350486914,0.00558758402203202,0.542886194742414
NMR metabolomics,X23501.Triglycerides in Large VLDL,CYTH3,Cytohesin-3,37482,0.00435197933644518,0.00715526517725439,-0.00967234041097343,0.0183762990838638,0.543051806796218
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00395404867400834,0.00650838403539434,-0.00880238403536456,0.0167104813833812,0.543508722652186
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGR,Progesterone receptor,37598,-0.00609770853211979,0.0100387107660448,-0.0257735816335677,0.0135781645693281,0.543583051704457
NMR metabolomics,X23501.Triglycerides in Large VLDL,HCG22,Protein PBMUCL2,37562,-0.00312831202801637,0.00518200358633742,-0.0132850390572377,0.00702841500120498,0.546061712218434
NMR metabolomics,X23501.Triglycerides in Large VLDL,RANGAP1,Ran GTPase-activating protein 1,39980,-0.0029049572766236,0.00481251336783062,-0.0123374834775716,0.0065275689243244,0.546101266897962
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSCA,Prostate stem cell antigen,37901,0.0151729665372437,0.0251726824653632,-0.0341654910948682,0.0645114241693556,0.546681683104667
NMR metabolomics,X23501.Triglycerides in Large VLDL,SELENOP,Selenoprotein P,38013,-0.00130068209128069,0.00218531072894757,-0.00558389112001793,0.00298252693745655,0.551724265014645
NMR metabolomics,X23501.Triglycerides in Large VLDL,SERPINB5,Serpin B5,40042,-0.00278550124277322,0.0047162217461307,-0.0120292958651894,0.00645829337964295,0.554782719591648
NMR metabolomics,X23501.Triglycerides in Large VLDL,DHODH,Dihydroorotate dehydrogenase,37562,0.0027662296807696,0.00468988872997467,-0.00642595222998076,0.01195841159152,0.555315849107385
NMR metabolomics,X23501.Triglycerides in Large VLDL,DAND5,DAN domain family member 5,37598,-0.0030958442906237,0.00527844280615935,-0.013441592190696,0.00724990360944862,0.557544848534584
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNGR1,Interferon gamma receptor 1,40422,0.00115505390573874,0.00197618478358776,-0.00271826827009326,0.00502837608157075,0.558901104983536
NMR metabolomics,X23501.Triglycerides in Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00487036705028461,0.0083484248184783,-0.0212332796945021,0.0114925455939329,0.559642538297733
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00281722588376266,0.00483308513112729,-0.00665562097324683,0.0122900727407721,0.559967798528607
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC2L,C-type lectin domain family 2 member L,37572,0.00278060466897048,0.00481019622400091,-0.0066473799300713,0.0122085892680123,0.563230355120268
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMCN2,Hemicentin-2,37648,0.00319103727763521,0.00553416263629155,-0.00765592148949622,0.0140379960447666,0.564214760176131
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC123,Cell division cycle protein 123 homolog,37482,0.00357278937133864,0.00621807363857143,-0.00861463496026137,0.0157602137029387,0.565584363176151
NMR metabolomics,X23501.Triglycerides in Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00123654785896009,0.00215558319607789,-0.00298839520535259,0.00546149092327276,0.566213563608873
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL31,Interleukin-31,37598,-0.00323666438547321,0.00564283900880785,-0.0142966288427366,0.00782330007179019,0.566256488901353
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00305422205038015,0.00541368495732967,-0.00755660046598601,0.0136650445667463,0.57265023838809
NMR metabolomics,X23501.Triglycerides in Large VLDL,CHP1,Calcineurin B homologous protein 1,37541,0.0039713192431549,0.00708214261829067,-0.00990968028869481,0.0178523187750046,0.574976826871137
NMR metabolomics,X23501.Triglycerides in Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00401303032125616,0.00716207286047597,-0.0100246324852767,0.0180506931277891,0.575271219361123
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRYBB2,Beta-crystallin B2,37942,-0.00372924158246198,0.00665962144442182,-0.0167820996135288,0.0093236164486048,0.57550373322808
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,-0.00293215901330692,0.00524613710658771,-0.0132145877422188,0.00735026971560499,0.576227418985558
NMR metabolomics,X23501.Triglycerides in Large VLDL,HMMR,Hyaluronan mediated motility receptor,37460,-0.00262581385066324,0.00472506737456578,-0.0118869459048122,0.00663531820348569,0.578411924975815
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC11A,C-type lectin domain family 11 member A,40296,-0.00255402854846914,0.00462614807864011,-0.0116212787826038,0.00651322168566549,0.580897670520688
NMR metabolomics,X23501.Triglycerides in Large VLDL,HK2,Hexokinase-2,40042,-0.00147596450653988,0.00267365533761068,-0.00671632896825681,0.00376439995517705,0.580928909138788
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00156877024149283,0.00285964715643508,-0.00403613818511993,0.00717367866810558,0.583295412388041
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF20,Fibroblast growth factor 20,37598,-0.00237701165104649,0.00433438358826397,-0.0108724034840439,0.00611838018195089,0.583420936217518
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,0.00191555063018197,0.00350257464717613,-0.00494949567828325,0.00878059693864719,0.584456580657318
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL1A,Interleukin-1 alpha,40044,0.00283952692559799,0.00521117590069274,-0.00737437783975978,0.0130534316909558,0.585835741590044
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPESP1,Sperm equatorial segment protein 1,37990,0.00145317849860788,0.00266967444502897,-0.00377938341364891,0.00668574041086467,0.586224760724393
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL22,Interleukin-22,37900,0.00343401711511198,0.00631671115403054,-0.00894673674678787,0.0158147709770118,0.586698211354354
NMR metabolomics,X23501.Triglycerides in Large VLDL,NEB,Nebulin,37562,0.00192050578873444,0.00353284492545914,-0.00500387026516547,0.00884488184263435,0.586716011183912
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPHA2,Glycoprotein hormone alpha-2,37901,0.00253966653368194,0.0047434739458739,-0.00675754240023089,0.0118368754675948,0.592380600493118
NMR metabolomics,X23501.Triglycerides in Large VLDL,PMCH,Pro-MCH,37562,-0.00433869054661939,0.00824325379644685,-0.0204954679876552,0.0118180868944164,0.598666263966717
NMR metabolomics,X23501.Triglycerides in Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.00642978329280696,0.0122274230871743,-0.0175359659580547,0.0303955325436686,0.599000346260944
NMR metabolomics,X23501.Triglycerides in Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00437494720236594,0.0083977259082247,-0.0120845955777545,0.0208344899824864,0.602397795076442
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,0.0017998474804038,0.00349971869435328,-0.00505960116052863,0.00865929612133623,0.607062385084274
NMR metabolomics,X23501.Triglycerides in Large VLDL,EVI2B,Protein EVI2B,37482,0.00210158813691875,0.00408700389492691,-0.005908939497138,0.0101121157709755,0.60711221034751
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF174,Zinc finger protein 174,37598,-0.00191170525893441,0.00376369893928062,-0.00928855517992443,0.00546514466205561,0.611509157519629
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY96,Lymphocyte antigen 96,40228,-0.00168758929987805,0.00334815666867,-0.00824997637047124,0.00487479777071514,0.614243578632389
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.00200273996599602,0.00397811153089693,-0.00979983856655401,0.00579435863456197,0.6146634788737
NMR metabolomics,X23501.Triglycerides in Large VLDL,NCLN,Nicalin,40044,-0.00259528709234125,0.00516712993425882,-0.0127228617634885,0.00753228757880603,0.615485690123141
NMR metabolomics,X23501.Triglycerides in Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.00236902525960127,0.00471832593343546,-0.00687889356993223,0.0116169440891348,0.615612498646924
NMR metabolomics,X23501.Triglycerides in Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00200907848885027,0.00400592806137782,-0.00584254051145025,0.0098606974891508,0.616007600641874
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00186018108080301,0.00371932122926622,-0.00915005069016479,0.00542968852855877,0.616984873298474
NMR metabolomics,X23501.Triglycerides in Large VLDL,AMY2A,Pancreatic alpha-amylase,39695,-0.00226493289610916,0.00455685899552526,-0.0111963765273387,0.00666651073512036,0.619169297061887
NMR metabolomics,X23501.Triglycerides in Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,0.00157968443694649,0.00318072013277801,-0.00465452702329841,0.0078138958971914,0.619448452890614
NMR metabolomics,X23501.Triglycerides in Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,-0.00204775948422357,0.00412780325294432,-0.0101382538599944,0.0060427348915473,0.619839401986026
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTSV,Cathepsin L2,40444,0.00202746188291263,0.00409708421394455,-0.00600282317641868,0.0100577469422439,0.620709400817566
NMR metabolomics,X23501.Triglycerides in Large VLDL,LMOD2,Leiomodin-2,37541,0.003113283136564,0.00630697225605281,-0.00924838248529951,0.0154749487584275,0.621578880884609
NMR metabolomics,X23501.Triglycerides in Large VLDL,ACHE,Acetylcholinesterase,37671,-0.00152562293020014,0.00309134847908828,-0.00758466594921317,0.0045334200888129,0.621657837108624
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB2,Integrin beta-2,40221,-0.00135961800355473,0.0027685383263396,-0.00678595312318035,0.00406671711607089,0.623365408997004
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.0019171984027821,0.00390819674662977,-0.00957726402617644,0.00574286722061225,0.62374701935361
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00115208114346434,0.00234951500270587,-0.00575713054876785,0.00345296826183916,0.623895270658946
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,0.00279458112200888,0.00581854288132756,-0.00860976292539313,0.0141989251694109,0.631030047718214
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL5,Interleukin-5,40044,-0.00676280629755523,0.0141118048982839,-0.0344219438981917,0.0208963313030812,0.63178143100106
NMR metabolomics,X23501.Triglycerides in Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00134681685077539,0.00282708398730108,-0.00419426776433473,0.00688790146588552,0.633797612096733
NMR metabolomics,X23501.Triglycerides in Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,37987,0.00160719835915415,0.00338011632576013,-0.00501782963933569,0.008232226357644,0.63444820534435
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.00253778156157746,0.00534969695385144,-0.00794762446797135,0.0130231875911263,0.635237677755315
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLEC4C,C-type lectin domain family 4 member C,40341,0.00206717734480984,0.00440553291403519,-0.00656766716669914,0.0107020218563188,0.638916689490202
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,37942,0.0012732067093633,0.00273767858484441,-0.00409264331693176,0.00663905673565835,0.641890266361419
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL21R,Interleukin-21 receptor,37598,0.002499158352837,0.00543006474098507,-0.00814376853949375,0.0131420852451677,0.64534822351752
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.00125275078198611,0.00273132543905429,-0.00660614864253252,0.00410064707856029,0.646485647426222
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA10,Annexin A10,39961,0.00363841442344291,0.00797584840210022,-0.0119942484446735,0.0192710772915593,0.648267664058396
NMR metabolomics,X23501.Triglycerides in Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00208419196005412,0.00457659748259007,-0.00688593910582241,0.0110543230259306,0.648826179781158
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00170294003409294,0.00375609349462414,-0.00906488328355626,0.00565900321537038,0.650280991459985
NMR metabolomics,X23501.Triglycerides in Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00425926937110953,0.00942879422826175,-0.0142211673162835,0.0227397060585026,0.651470964432661
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53BP1,TP53-binding protein 1,37598,0.00383920383917653,0.0086179142533589,-0.0130519080974069,0.02073031577576,0.655972247862844
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00259984725422711,0.00588045859762685,-0.0141255461055757,0.00892585159712151,0.658412306662832
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTNL10,Butyrophilin-like protein 10,37482,0.00178422592956345,0.00405968655891415,-0.00617275972590828,0.00974121158503519,0.660307697133628
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPSD1,Tryptase delta,37959,-0.00161237561983154,0.00370013682439167,-0.00886464379563922,0.00563989255597614,0.66301704800897
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00158180372406941,0.00363000123131144,-0.00553299868930102,0.00869660613743983,0.663018022560857
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,-0.00113398364216816,0.00263766395580857,-0.00630380499555295,0.00403583771121663,0.667259852553405
NMR metabolomics,X23501.Triglycerides in Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,0.00303562918050414,0.00710026391402969,-0.010880888090994,0.0169521464520023,0.668993627742775
NMR metabolomics,X23501.Triglycerides in Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00309098499694302,0.00724327668150867,-0.011105837298814,0.0172878072927,0.669576735092111
NMR metabolomics,X23501.Triglycerides in Large VLDL,PGM2,Phosphoglucomutase-2,37572,0.00247891595197647,0.00581425159923917,-0.00891701718253231,0.0138748490864852,0.669858598181237
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB1,Integrin beta-1,40333,-0.000897457071506549,0.00211126357781006,-0.00503553368401426,0.00324061954100116,0.670783719320068
NMR metabolomics,X23501.Triglycerides in Large VLDL,NPTXR,Neuronal pentraxin receptor,40359,-0.00138831798069208,0.00327417137812449,-0.00780569388181609,0.00502905792043193,0.671556107502681
NMR metabolomics,X23501.Triglycerides in Large VLDL,ERCC1,DNA excision repair protein ERCC-1,37482,0.00137755163802373,0.00325803156583817,-0.00500819023101909,0.00776329350706655,0.672435647626995
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,-0.00168984450132061,0.00400480234978846,-0.009539257106906,0.00615956810426478,0.673065118971752
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,0.00269799243304736,0.006400246381292,-0.00984649047428496,0.0152424753403797,0.673364004700156
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00201951619123345,0.00479816204647802,-0.00738488141986347,0.0114239138023304,0.673839614059557
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,37598,0.0017164996075899,0.00413708795653954,-0.00639219278722759,0.00982519200240739,0.678218020312065
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCND2,G1/S-specific cyclin-D2,37714,0.00146767030982499,0.00355731288464618,-0.00550466294408152,0.0084400035637315,0.679922229194899
NMR metabolomics,X23501.Triglycerides in Large VLDL,MB,Myoglobin,40536,-0.00195314294014929,0.00473906661550923,-0.0112417135065474,0.00733542762624879,0.680244774805682
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.00137868563423803,0.00335117993497325,-0.0079469983067856,0.00518962703830954,0.680782544990515
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPHA10,Ephrin type-A receptor 10,39961,-0.00255791603939051,0.00631604034288047,-0.0149373551114362,0.00982152303265522,0.685492441895446
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL3A1,Collagen alpha-1(III) chain,37998,-0.000905734904047162,0.00223685248075259,-0.00528996576632223,0.00347849595822791,0.685546457627465
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD177,CD177 antigen,40316,-0.00496822526802758,0.0123324761577439,-0.0291398785372056,0.0192034280011505,0.687058799690159
NMR metabolomics,X23501.Triglycerides in Large VLDL,UNC5D,Netrin receptor UNC5D,37598,-0.00102590190161706,0.00259145302604494,-0.00610514983266513,0.00405334602943102,0.6922006985793
NMR metabolomics,X23501.Triglycerides in Large VLDL,TEX101,Testis-expressed protein 101,37572,0.00149202767839849,0.00380745601218956,-0.00597058610549304,0.00895464146229003,0.695160656190787
NMR metabolomics,X23501.Triglycerides in Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,37598,0.00184362859498363,0.00474348150714948,-0.00745359515902935,0.0111408523489966,0.697529747695036
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDC25A,M-phase inducer phosphatase 1,37482,-0.00151308196968496,0.00397304359135364,-0.00930024740873809,0.00627408346936817,0.703330417121704
NMR metabolomics,X23501.Triglycerides in Large VLDL,DBH,Dopamine beta-hydroxylase,37967,-0.00381745681392879,0.0102065262957553,-0.0238222483536091,0.0161873347257515,0.708394440122413
NMR metabolomics,X23501.Triglycerides in Large VLDL,PALLD,Palladin,37598,-0.00149774653681944,0.00402500989023327,-0.00938676592167665,0.00639127284803777,0.709816929466183
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAGEA3,Melanoma-associated antigen 3,37714,0.0030332027932363,0.00819903106744881,-0.0130368980989634,0.019103303685436,0.711428265694016
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.00424688528007868,0.0114972961457352,-0.0267815857257197,0.0182878151655623,0.711848519006556
NMR metabolomics,X23501.Triglycerides in Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,-0.00122087147610137,0.00334016566255912,-0.00776759617471725,0.00532585322251451,0.714733894259693
NMR metabolomics,X23501.Triglycerides in Large VLDL,HLA_A,,37959,-0.0011540384596689,0.00316638682317591,-0.00736015663309369,0.00505207971375589,0.715516207321742
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.00145228405606891,0.00400334026884012,-0.00639426287085773,0.00929883098299555,0.716782940440874
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGLON5,IgLON family member 5,37482,-0.00330371821429709,0.00913695158849701,-0.0212121433277512,0.0146047068991571,0.717673471920706
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF3,Fibroblast growth factor 3,37598,0.00106756932851129,0.00295418103263881,-0.00472262549546077,0.00685776415248336,0.717824395707853
NMR metabolomics,X23501.Triglycerides in Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00235171677934303,0.00651888214700721,-0.0104252922287911,0.0151287257874772,0.718288710161148
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP1,Retinol-binding protein 1,37572,0.00238728988273639,0.00667791890145382,-0.0107014311641131,0.0154760109295859,0.720730687994894
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.00907691685650724,0.0254543505578149,-0.0589674439498244,0.04081361023681,0.721400062932405
NMR metabolomics,X23501.Triglycerides in Large VLDL,AREG,Amphiregulin,40305,-0.00169933046923884,0.00477316162654345,-0.011054727257264,0.00765606631878632,0.721831977369016
NMR metabolomics,X23501.Triglycerides in Large VLDL,HEBP1,Heme-binding protein 1,40042,0.0018382391490725,0.00526551614758369,-0.00848217250019152,0.0121586507983365,0.727012184710125
NMR metabolomics,X23501.Triglycerides in Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00188944087757756,0.00544566760553023,-0.0125629493844168,0.00878406762926168,0.728625311112756
NMR metabolomics,X23501.Triglycerides in Large VLDL,TLR1,Toll-like receptor 1,37598,-0.000878396253782227,0.00253703077295847,-0.00585097656878083,0.00409418406121637,0.729175385145613
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEP350,Centrosome-associated protein 350,37482,0.00124393168502659,0.00363528127750149,-0.00588121961887634,0.00836908298892951,0.732218648863781
NMR metabolomics,X23501.Triglycerides in Large VLDL,CGN,Cingulin,37572,0.00138749190249156,0.00406821227482152,-0.00658620415615863,0.00936118796114175,0.733066201576433
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.0013290104368342,0.00389798275893909,-0.00896905664435482,0.00631103577068642,0.733148005696203
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00210849523055689,0.00625309779323551,-0.0101475764441847,0.0143645669052985,0.735977421783065
NMR metabolomics,X23501.Triglycerides in Large VLDL,TNPO1,Transportin-1,37714,-0.00115888656037365,0.00344077840317075,-0.00790281223058831,0.00558503910984101,0.736265904848398
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPB41L5,Band 4.1-like protein 5,37572,-0.00207710425232554,0.00617351692379271,-0.0141771974229593,0.0100229889183082,0.736533940995636
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD55,Complement decay-accelerating factor,39802,0.000850680610471322,0.00253572461963066,-0.00411933964400477,0.00582070086494741,0.737268888369252
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL13,Interleukin-13,40044,0.00154007362797245,0.00464067854012028,-0.00755565631066331,0.0106358035666082,0.739996499527563
NMR metabolomics,X23501.Triglycerides in Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00185183728643845,0.00561821236981178,-0.00915985895839264,0.0128635335312695,0.741697477537449
NMR metabolomics,X23501.Triglycerides in Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00149907998900465,0.00457598422074961,-0.00746984908366458,0.0104680090616739,0.743221255196004
NMR metabolomics,X23501.Triglycerides in Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37883,0.00132048063897261,0.00407612005816636,-0.00666871467503345,0.00930967595297867,0.745976931179313
NMR metabolomics,X23501.Triglycerides in Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,-0.00194478074708874,0.00618743682397964,-0.0140721569220888,0.0101825954279114,0.753289630087554
NMR metabolomics,X23501.Triglycerides in Large VLDL,SDC1,Syndecan-1,40359,0.00120641189582803,0.00385845970351814,-0.00635616912306754,0.00876899291472359,0.754537989674831
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.0017746863407217,0.00567830357193641,-0.00935478866027365,0.0129041613417171,0.754636552325657
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00249357326094665,0.00799606657192777,-0.0181658637419251,0.0131787172200318,0.755159434743735
NMR metabolomics,X23501.Triglycerides in Large VLDL,WNT9A,Protein Wnt-9a,40044,-0.000864536661271697,0.00277312269885922,-0.00629985715103577,0.00457078382849238,0.755230402118195
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBP7,Retinoid-binding protein 7,37901,0.00176226958321676,0.00565375111386286,-0.00931908259995445,0.012843621766388,0.755273983207653
NMR metabolomics,X23501.Triglycerides in Large VLDL,DOC2B,Double C2-like domain-containing protein beta,37572,0.00108068758764847,0.00349114758354086,-0.00576196167609162,0.00792333685138856,0.756907478297871
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP73,Tumor protein p73,37572,0.00103612488871403,0.00338921751834024,-0.00560674144723285,0.0076789912246609,0.759828691060306
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGB5,Integrin beta-5,40411,-0.00108864884476957,0.00357536562060847,-0.00809636546116218,0.00591906777162304,0.760761612728716
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL9,Interleukin-9,37714,0.00162908316029847,0.00557544657609728,-0.0092987921288522,0.0125569584494491,0.770146829188903
NMR metabolomics,X23501.Triglycerides in Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.0011544703196045,0.00399403284619964,-0.00898277469815581,0.0066738340589468,0.772548567227253
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCP11,T-complex protein 11 homolog,37714,-0.00170082481332485,0.0058945212523359,-0.0132540864679032,0.00985243684125352,0.772935374228074
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.000981622841652222,0.00344444151664171,-0.00576948253096553,0.00773272821426998,0.775657504821626
NMR metabolomics,X23501.Triglycerides in Large VLDL,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0012285068381096,0.00432985625265193,-0.00971502509330737,0.00725801141708818,0.776621587609076
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL4,Myosin light chain 4,37628,-0.00144060300980197,0.00509678676293184,-0.0114303050651484,0.00854909904554443,0.777450154782388
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.000788642024359564,0.00279374075997356,-0.00468708986518861,0.00626437391390774,0.777725623314015
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00154068494472836,0.00547541368929988,-0.00919112588629941,0.0122724957757561,0.778421597963405
NMR metabolomics,X23501.Triglycerides in Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,40341,-0.000921954412650408,0.00328569280732712,-0.00736191231501157,0.00551800348971075,0.779023434817768
NMR metabolomics,X23501.Triglycerides in Large VLDL,INSL3,Insulin-like 3,37942,-0.00161106362327589,0.00578138731791952,-0.0129425827663982,0.00972045551984637,0.78050708210195
NMR metabolomics,X23501.Triglycerides in Large VLDL,RBM25,RNA-binding protein 25,37482,-0.00125070519575568,0.00449393381574605,-0.0100588154746179,0.00755740508310658,0.780779076857618
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRC1,Protein regulator of cytokinesis 1,37900,0.00125752568682651,0.00451876750179816,-0.00759925861669789,0.0101143099903509,0.780794390735735
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,37541,-0.00211967799662086,0.00762254270757745,-0.0170598617034727,0.0128205057102309,0.780955207528932
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMA1,Proteasome subunit alpha type-1,39980,-0.0012493366380992,0.00449886592350215,-0.0100671138481634,0.00756844057196501,0.781246089532178
NMR metabolomics,X23501.Triglycerides in Large VLDL,TFAP2A,Transcription factor AP-2-alpha,37541,-0.0016247915218185,0.00588368773139274,-0.0131568194753483,0.00990723643171127,0.782435762466403
NMR metabolomics,X23501.Triglycerides in Large VLDL,LY6D,Lymphocyte antigen 6D,40268,0.00098634783465982,0.00360718092018558,-0.00608372676890393,0.00805642243822356,0.784518518310267
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,0.00176365346438774,0.00646350084970293,-0.01090480820103,0.0144321151298055,0.784962449525893
NMR metabolomics,X23501.Triglycerides in Large VLDL,FOS,Proto-oncogene c-Fos,37457,0.000922760015634504,0.00340595011670558,-0.00575290221310843,0.00759842224437743,0.786452343341825
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS2,"Nitric oxide synthase, inducible",37562,-0.00102849414457603,0.00381129746686088,-0.00849863717962335,0.0064416488904713,0.787276768540193
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAP1A,Ras-related protein Rap-1A,37598,0.00182268133508007,0.00675833888441714,-0.0114236628783775,0.0150690255485377,0.787400150339039
NMR metabolomics,X23501.Triglycerides in Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00165721717088554,0.006175064464735,-0.0104459091799951,0.0137603435217661,0.788416874016047
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANK2,Ankyrin-2,37562,0.00192540449545083,0.00720322936148668,-0.0121929250530631,0.0160437340439647,0.789244391398525
NMR metabolomics,X23501.Triglycerides in Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00130232355151499,0.00489842927835145,-0.00829859783405384,0.0109032449370838,0.79034695171569
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL20,Interleukin-20,40044,0.00130883663936033,0.00493530667919501,-0.00836436445186189,0.0109820377305826,0.790859945235763
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00133045808855152,0.00509008304093935,-0.0113070208487927,0.00864610467168961,0.793801700029488
NMR metabolomics,X23501.Triglycerides in Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37714,-0.0016934793106083,0.00651792042973694,-0.0144686033528927,0.0110816447316761,0.795007457933334
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37692,0.00140406550154674,0.00540508190839921,-0.00918989503891572,0.0119980260420092,0.795047034254247
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37562,0.00103640759292225,0.00399456940841451,-0.00679294844757019,0.00886576363341469,0.795288931268938
NMR metabolomics,X23501.Triglycerides in Large VLDL,GAD2,Glutamate decarboxylase 2,37598,0.00117483563386421,0.00459301607717379,-0.00782747587739642,0.0101771471451248,0.798119006805018
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,-0.00103621504257087,0.00407863117212264,-0.00903033213993125,0.00695790205478951,0.799453555964464
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,37901,0.00315894200912232,0.0124668949021078,-0.0212761719990091,0.0275940560172537,0.799973484880698
NMR metabolomics,X23501.Triglycerides in Large VLDL,SCGN,Secretagogin,40044,-0.00106412009253986,0.0042438263859717,-0.00938201980904439,0.00725377962396467,0.802014234599192
NMR metabolomics,X23501.Triglycerides in Large VLDL,ENOPH1,Enolase-phosphatase E1,37900,0.00138926660550455,0.00555196758665183,-0.00949258986433303,0.0122711230753421,0.802413621323441
NMR metabolomics,X23501.Triglycerides in Large VLDL,RAB6B,Ras-related protein Rab-6B,39961,0.00116202525196338,0.00471418336708737,-0.00807777414752787,0.0104018246514546,0.805301906145529
NMR metabolomics,X23501.Triglycerides in Large VLDL,TCN2,Transcobalamin-2,40497,0.000709348560567147,0.00288065962812988,-0.00493674431056742,0.00635544143170171,0.805495590216677
NMR metabolomics,X23501.Triglycerides in Large VLDL,PFDN6,Prefoldin subunit 6,37572,-0.00157474186242301,0.00641002996964844,-0.014138400602934,0.0109889168780879,0.805942771729934
NMR metabolomics,X23501.Triglycerides in Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,37572,0.00181038577147457,0.00756757329010028,-0.013022057877122,0.0166428294200711,0.810931468531033
NMR metabolomics,X23501.Triglycerides in Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,-0.00126368431679367,0.00532354982514841,-0.0116978419740845,0.00917047334049721,0.812368608760301
NMR metabolomics,X23501.Triglycerides in Large VLDL,SKIV2L,Helicase SKI2W,37562,-0.000903352152506022,0.00393745876502064,-0.00862077133194648,0.00681406702693444,0.818542052822075
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC51B,Organic solute transporter subunit beta,37562,-0.00174562497345375,0.00772008405362244,-0.0168769897185537,0.0133857397716462,0.821115687944596
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.000528406006495204,0.00234002424748409,-0.0040580415185736,0.00511485353156401,0.821350385712145
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL3,Interleukin-3,37482,-0.00131508008192237,0.0058395256912085,-0.012760550436691,0.0101303902728463,0.82182470386071
NMR metabolomics,X23501.Triglycerides in Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,0.000799857320457057,0.00357463069891264,-0.00620641884941172,0.00780613349032584,0.822947885370186
NMR metabolomics,X23501.Triglycerides in Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.00107028557880187,0.00478393954216846,-0.0104468070814521,0.00830623592384832,0.822975009898683
NMR metabolomics,X23501.Triglycerides in Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00137075403816775,0.00617751146396324,-0.0107371684312002,0.0134786765075357,0.824399713848382
NMR metabolomics,X23501.Triglycerides in Large VLDL,STC2,Stanniocalcin-2,40309,0.000580532074854528,0.00262058598931365,-0.00455581646420022,0.00571688061390928,0.824684516083135
NMR metabolomics,X23501.Triglycerides in Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,-0.00108212863911408,0.00490332671812151,-0.0106926490066322,0.00852839172840409,0.82533507716647
NMR metabolomics,X23501.Triglycerides in Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00155804754327191,0.00716190193575987,-0.0155953753373613,0.0124792802508174,0.827785772006623
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,0.00105529659480904,0.00489096151198429,-0.00853098796868017,0.0106415811582982,0.829174582370039
NMR metabolomics,X23501.Triglycerides in Large VLDL,EFNB2,Ephrin-B2,37572,-0.00120142894303976,0.00561239017931406,-0.0122017136944953,0.0097988558084158,0.83049793952638
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAG,Myelin-associated glycoprotein,37572,-0.000954240593089699,0.00451803069370941,-0.00980958075276013,0.00790109956658074,0.832728876347997
NMR metabolomics,X23501.Triglycerides in Large VLDL,CLINT1,Clathrin interactor 1,37482,-0.000930393317857918,0.00445461953414716,-0.00966144760478635,0.00780066096907052,0.834560535935585
NMR metabolomics,X23501.Triglycerides in Large VLDL,NRN1,Neuritin,37959,-0.000716083113738653,0.00354778021230592,-0.00766973232985825,0.00623756610238095,0.840045035244647
NMR metabolomics,X23501.Triglycerides in Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,37572,0.000704547742506414,0.00357087417539554,-0.00629436564126884,0.00770346112628167,0.843592709189546
NMR metabolomics,X23501.Triglycerides in Large VLDL,PLB1,"Phospholipase B1, membrane-associated",37942,-0.00115261369405679,0.00587614144640916,-0.0126698509290187,0.0103646235409052,0.844494577810816
NMR metabolomics,X23501.Triglycerides in Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.000651958330667608,0.00334462345083349,-0.00590350363296603,0.00720742029430125,0.845452917369085
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRTN3,Myeloblastin,39897,-0.000879568592923094,0.00454256844638332,-0.00978300274783439,0.0080238655619882,0.846469692685233
NMR metabolomics,X23501.Triglycerides in Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,-0.000551961654357663,0.00290885488582171,-0.00625331723056822,0.00514939392185289,0.849506245671559
NMR metabolomics,X23501.Triglycerides in Large VLDL,MORN4,MORN repeat-containing protein 4,37482,0.00145062808956454,0.00765247663767548,-0.0135482261202794,0.0164494822994085,0.849654365753906
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC39A14,Zinc transporter ZIP14,39961,-0.000601156133722235,0.00322766716032417,-0.0069273837679576,0.00572507150051313,0.85225039223053
NMR metabolomics,X23501.Triglycerides in Large VLDL,REG1A,Lithostathine-1-alpha,40274,-0.000867845086091492,0.00470722074844596,-0.0100939977530456,0.0083583075808626,0.853729765730916
NMR metabolomics,X23501.Triglycerides in Large VLDL,RUVBL1,RuvB-like 1,39980,0.00190059076055363,0.0103806307475295,-0.0184454455046042,0.0222466270257115,0.854729710965851
NMR metabolomics,X23501.Triglycerides in Large VLDL,MTR,Methionine synthase,37562,0.00112420861505995,0.00634882260127685,-0.0113194836834427,0.0135679009135626,0.859453345813071
NMR metabolomics,X23501.Triglycerides in Large VLDL,TPT1,Translationally-controlled tumor protein,40044,0.00113708159239374,0.00643441943921102,-0.0114743805084599,0.0137485436932473,0.859731725717509
NMR metabolomics,X23501.Triglycerides in Large VLDL,IKZF2,Zinc finger protein Helios,39980,0.00159150711977715,0.00905218344580099,-0.0161507724339928,0.0193337866735471,0.860441795573
NMR metabolomics,X23501.Triglycerides in Large VLDL,COL9A1,Collagen alpha-1(IX) chain,40341,-0.000782532538873864,0.00455079769164,-0.00970209601448826,0.00813703093674053,0.863475075628304
NMR metabolomics,X23501.Triglycerides in Large VLDL,RSPO1,R-spondin-1,40228,-0.000573651892470943,0.00341669379635683,-0.00727037173333034,0.00612306794838845,0.866666634175698
NMR metabolomics,X23501.Triglycerides in Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.000528694600463069,0.00315139716350764,-0.00564804384001191,0.00670543304093804,0.866770632192387
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCTPP1,dCTP pyrophosphatase 1,40359,0.000484555726747807,0.00305868039983717,-0.00551045785693304,0.00647956931042865,0.874127974820281
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK1C,Divergent protein kinase domain 1C,37572,0.000646231416177752,0.00416011337431143,-0.00750759079747265,0.00880005362982816,0.876555785393602
NMR metabolomics,X23501.Triglycerides in Large VLDL,TSPAN7,Tetraspanin-7,37541,0.00137920381755089,0.00888733466825361,-0.0160399721322262,0.018798379767328,0.876675844952015
NMR metabolomics,X23501.Triglycerides in Large VLDL,MLLT1,Protein ENL,37482,0.00107788278053661,0.00694900353066689,-0.0125421641395705,0.0146979297006437,0.876734409881724
NMR metabolomics,X23501.Triglycerides in Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.000739778757076072,0.00481196834906863,-0.0101712367212506,0.00869167920709844,0.877818906454811
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.000850964324589865,0.00554361320299744,-0.0100145175532851,0.0117164462024648,0.878003554804631
NMR metabolomics,X23501.Triglycerides in Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.000374131739556374,0.00268519922452868,-0.00488885874051983,0.00563712221963258,0.889190278752651
NMR metabolomics,X23501.Triglycerides in Large VLDL,LRP2BP,LRP2-binding protein,37572,0.00116664013223761,0.00842011531973859,-0.01533678589445,0.0176700661589252,0.889804771048279
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHC1,SHC-transforming protein 1,37482,0.00155304619543292,0.0113280622287185,-0.0206499557728554,0.0237560481637212,0.890956043202317
NMR metabolomics,X23501.Triglycerides in Large VLDL,FH,"Fumarate hydratase, mitochondrial",37541,-0.00112614790949603,0.00830118174994184,-0.017396464139382,0.01514416832039,0.892091243217025
NMR metabolomics,X23501.Triglycerides in Large VLDL,NOS1,"Nitric oxide synthase, brain",39961,-0.000653308415099616,0.00481876393369453,-0.0100980857251409,0.00879146889494166,0.892158292140968
NMR metabolomics,X23501.Triglycerides in Large VLDL,OGN,Mimecan,40332,0.00052161259973972,0.00392985182056932,-0.00718089696857616,0.0082241221680556,0.894407920203923
NMR metabolomics,X23501.Triglycerides in Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,40465,0.000479170814177655,0.00391297505644055,-0.00719026029644581,0.00814860192480112,0.902538710727785
NMR metabolomics,X23501.Triglycerides in Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.000560396841955522,0.00470478597477219,-0.00866098366859797,0.00978177735250901,0.905188380686038
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRX,Cone-rod homeobox protein,40042,-0.001218816583244,0.0103858198117775,-0.0215750234143279,0.0191373902478399,0.906581116348504
NMR metabolomics,X23501.Triglycerides in Large VLDL,IFNL1,Interferon lambda-1,39961,0.00051036734615777,0.0043798491322141,-0.00807413695298187,0.00909487164529741,0.907237000916043
NMR metabolomics,X23501.Triglycerides in Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.000430450490892864,0.00370135173918707,-0.0068241989179138,0.00768509989969952,0.907420145817738
NMR metabolomics,X23501.Triglycerides in Large VLDL,KLK3,Prostate-specific antigen,37998,-0.000623272153234574,0.00553807280790781,-0.0114778948567339,0.0102313505502647,0.91039442670659
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,0.000912599051181862,0.00822225305051333,-0.0152030169278243,0.017028215030188,0.9116245997289
NMR metabolomics,X23501.Triglycerides in Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,37482,-0.00068264980599962,0.00615866659953085,-0.0127536363410801,0.0113883367290809,0.911741945245683
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL2,Interleukin-2,40044,0.000334709989665904,0.00303089857537186,-0.00560585121806294,0.00627527119739475,0.912067726803179
NMR metabolomics,X23501.Triglycerides in Large VLDL,EXOSC10,Exosome component 10,37562,0.000647113588330108,0.00609489081893503,-0.0112988724167825,0.0125930995934428,0.915446620141816
NMR metabolomics,X23501.Triglycerides in Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.000301988732506418,0.00285576832078991,-0.00589929464125464,0.0052953171762418,0.915784711089289
NMR metabolomics,X23501.Triglycerides in Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,37959,0.000797497064866439,0.00759601980019033,-0.0140907017435066,0.0156856958732395,0.916386248439881
NMR metabolomics,X23501.Triglycerides in Large VLDL,SHD,SH2 domain-containing adapter protein D,37531,0.000877538488325024,0.00851787115233875,-0.0158174889702589,0.017572565946909,0.917946123963258
NMR metabolomics,X23501.Triglycerides in Large VLDL,CDH4,Cadherin-4,37541,-0.000489083338979057,0.00480457490959247,-0.0099060501617803,0.00892788348382218,0.9189206834457
NMR metabolomics,X23501.Triglycerides in Large VLDL,ITGAV,Integrin alpha-V,40489,0.000157277534374986,0.00158023395702096,-0.0029399810213861,0.00325453609013607,0.92072029693192
NMR metabolomics,X23501.Triglycerides in Large VLDL,TXK,Tyrosine-protein kinase TXK,37714,0.000719045107339115,0.00735868966923828,-0.0137039866443679,0.0151420768590461,0.922161079504255
NMR metabolomics,X23501.Triglycerides in Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,0.000536027131358594,0.00552897509969453,-0.0103007640640427,0.0113728183267599,0.922768588452237
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL10,Interleukin-10,40044,-0.000786954213660118,0.00832020100302013,-0.0170945481795796,0.0155206397522593,0.924646825531218
NMR metabolomics,X23501.Triglycerides in Large VLDL,IGFL4,Insulin growth factor-like family member 4,37598,-0.000689069531025982,0.00763126487201482,-0.015646348680175,0.0142682096181231,0.928053703588362
NMR metabolomics,X23501.Triglycerides in Large VLDL,CASP4,Caspase-4,37714,-0.00149493074293282,0.016566357870989,-0.0339649921700712,0.0309751306842056,0.928098695532866
NMR metabolomics,X23501.Triglycerides in Large VLDL,MYL6B,Myosin light chain 6B,37572,0.000795619997571863,0.0089677056223064,-0.0167810830221487,0.0183723230172924,0.929305334814048
NMR metabolomics,X23501.Triglycerides in Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,-0.000660383261370783,0.00760107411934198,-0.0155584885352811,0.0142377220125395,0.93076801985191
NMR metabolomics,X23501.Triglycerides in Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00117409054548312,0.0137266320248931,-0.0257301082233074,0.0280782893142737,0.931838365784519
NMR metabolomics,X23501.Triglycerides in Large VLDL,ICAM2,Intercellular adhesion molecule 2,40536,-0.000256100939008302,0.0030061518584623,-0.0061481585815944,0.0056359567035778,0.932109586125284
NMR metabolomics,X23501.Triglycerides in Large VLDL,UPK3A,Uroplakin-3a,37541,0.000395025439782585,0.00485698320643471,-0.00912466164482945,0.00991471252439462,0.935179614572399
NMR metabolomics,X23501.Triglycerides in Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37714,0.000406736244514695,0.00527500506184111,-0.00993227367669388,0.0107457461657233,0.938540126055284
NMR metabolomics,X23501.Triglycerides in Large VLDL,EPGN,Epigen,37900,0.000346526597795168,0.00479215605498721,-0.00904609926997977,0.00973915246557011,0.942355319960079
NMR metabolomics,X23501.Triglycerides in Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,40278,0.000167456172441046,0.00246940780795786,-0.00467258313115635,0.00500749547603845,0.945935925306646
NMR metabolomics,X23501.Triglycerides in Large VLDL,FGF7,Fibroblast growth factor 7,37482,0.000531462384376289,0.00786024858606482,-0.0148746248443108,0.0159375496130633,0.946093994883509
NMR metabolomics,X23501.Triglycerides in Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00038465074135888,0.00634032065981535,-0.012811679234597,0.0120423777518792,0.951624880125249
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.00102023399236437,0.0168724054726678,-0.0340901487187932,0.0320496807340645,0.951783984887894
NMR metabolomics,X23501.Triglycerides in Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.000442293960152176,0.0073308461154786,-0.0139261644261859,0.0148107523464902,0.951891121109329
NMR metabolomics,X23501.Triglycerides in Large VLDL,GPA33,Cell surface A33 antigen,40305,0.000778354624247435,0.013135514465335,-0.0249672537278092,0.0265239629763041,0.9527491607287
NMR metabolomics,X23501.Triglycerides in Large VLDL,KCNIP4,Kv channel-interacting protein 4,39961,-0.000288936185699439,0.00496107646051478,-0.0100126460483084,0.00943477367690953,0.953557713173382
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL4,Interleukin-4,40044,-0.000503407979513542,0.00869147500222664,-0.0175386989838778,0.0165318830248507,0.953813300824235
NMR metabolomics,X23501.Triglycerides in Large VLDL,PXDNL,Peroxidasin-like protein,37900,0.00031102811224199,0.00567421413537039,-0.010810431593084,0.011432487817568,0.956287216932489
NMR metabolomics,X23501.Triglycerides in Large VLDL,ESR1,Estrogen receptor,37598,-0.000296704981414522,0.00564395433119667,-0.01135885547056,0.010765445507731,0.958074994192814
NMR metabolomics,X23501.Triglycerides in Large VLDL,PRRT3,Proline-rich transmembrane protein 3,37628,0.000186275784510661,0.00364266030586497,-0.00695333841498468,0.00732588998400601,0.959216895129915
NMR metabolomics,X23501.Triglycerides in Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.000404708746069361,0.00823274696022569,-0.0165408927881117,0.015731475295973,0.960793795877332
NMR metabolomics,X23501.Triglycerides in Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.000324098123898632,0.00673513093715784,-0.0128767585129307,0.013524954760728,0.961620902844202
NMR metabolomics,X23501.Triglycerides in Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,0.000242514461503493,0.00550472842338563,-0.0105467532483323,0.0110317821713393,0.964860586536004
NMR metabolomics,X23501.Triglycerides in Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.000135004371764333,0.0031800154909986,-0.00609782599059292,0.00636783473412159,0.966137326497387
NMR metabolomics,X23501.Triglycerides in Large VLDL,ZNF830,Zinc finger protein 830,37900,0.000314855001402968,0.00782419573153692,-0.0150205686324094,0.0156502786352153,0.967901431163818
NMR metabolomics,X23501.Triglycerides in Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.000298390175448788,0.00753381662495293,-0.0150646707603565,0.0144678904094589,0.968407214420082
NMR metabolomics,X23501.Triglycerides in Large VLDL,HBZ,Hemoglobin subunit zeta,37990,-0.000396347374666149,0.0101573656048397,-0.020304783960152,0.0195120892108197,0.968874471434332
NMR metabolomics,X23501.Triglycerides in Large VLDL,SLC1A4,Neutral amino acid transporter A,37572,0.000193295671030808,0.00509188074893813,-0.00978679059688793,0.0101733819389496,0.969718918421421
NMR metabolomics,X23501.Triglycerides in Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,40465,0.000230862394333749,0.00616507794818662,-0.011852690384112,0.0123144151727795,0.97012923062863
NMR metabolomics,X23501.Triglycerides in Large VLDL,ANXA5,Annexin A5,39896,9.52523885131496e-05,0.0029545564614538,-0.00569567827593629,0.00588618305296259,0.974281751931926
NMR metabolomics,X23501.Triglycerides in Large VLDL,KHDC3L,KH domain-containing protein 3,37482,0.000207119813473214,0.00661671829325945,-0.0127616480413153,0.0131758876682617,0.975028777416308
NMR metabolomics,X23501.Triglycerides in Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",39530,6.95868067926487e-05,0.00276093675312086,-0.00534184922932424,0.00548102284290953,0.979892534648402
NMR metabolomics,X23501.Triglycerides in Large VLDL,IL17F,Interleukin-17F,40044,0.000177612154973983,0.00769573760953512,-0.0149060335597149,0.0152612578696628,0.981587321332306
NMR metabolomics,X23501.Triglycerides in Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40536,4.93323022138292e-05,0.00217783149011771,-0.00421921741841689,0.00431788202284455,0.981928122261859
NMR metabolomics,X23501.Triglycerides in Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-8.41912550593151e-05,0.00490579774899074,-0.00969955484308117,0.00953117233296254,0.986307968714697
NMR metabolomics,X23501.Triglycerides in Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37598,-7.7228331098549e-05,0.00489423038773986,-0.00966991989106867,0.00951546322887157,0.98741057139112
NMR metabolomics,X23501.Triglycerides in Large VLDL,DIPK2B,Divergent protein kinase domain 2B,37671,-1.05809255756382e-05,0.00258539835267582,-0.00507796169682025,0.00505679984566897,0.996734671886458
NMR metabolomics,X23501.Triglycerides in Large VLDL,PCNA,Proliferating cell nuclear antigen,37482,-1.62402897155042e-05,0.00606467277572389,-0.0119029989301343,0.0118705183507033,0.997863427623405
NMR metabolomics,X23501.Triglycerides in Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,-8.51280738943678e-06,0.00486928245996732,-0.00955230642892539,0.00953528081414651,0.998605107313854
NMR metabolomics,X23501.Triglycerides in Large VLDL,TET2,Methylcytosine dioxygenase TET2,37697,1.17467376193343e-05,0.00976767956555254,-0.0191329052108636,0.0191563986861023,0.99904047206314
